Back to GetFilings.com
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-KSB
[X] Annual report under section 13 or 15(d) of the Securities Exchange Act
of 1934 [FEE REQUIRED] for the fiscal year ended June 30, 1999
[ ] Transition report under section 13 or 15(d) of the Securities Exchange
Act of 1934 [NO FEE REQUIRED] for the transition period from to
Commission file number: 0-23524
PHC, INC.
(Name of small business issuer in its charter)
MASSACHUSETTS 04-2601571
(State or other jurisdiction of (I.R.S. Employer Identification No.)
Incorporation or organization)
200 LAKE STREET, SUITE 102, PEABODY, MA 01960
(Address of principal executive offices) (Zip Code)
Issuer's telephone number: (978) 536-2777 (New area code)
Securities registered under Section 12(b) of the Act:
NONE.
Securities registered under Section 12(g) of the Act:
CLASS A COMMON STOCK, PAR VALUE $.01 PER SHARE
(Title of class)
Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Securities Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days. Yes X No
Check if there is no disclosure of delinquent filers in response to Item 405 of
Regulation S-B contained in this form, and no disclosure will be contained, to
the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-KSB or any
amendment to this Form 10-KSB. No Disclosure X
The issuer's revenues for the fiscal year ended June 30, 1999 were $ 19,139,496.
The aggregate market value of the voting stock held by non-affiliates computed
by reference to the price at which the stock was sold, or the average bid and
asked prices of such stock, as of September 15, 1999, was $6,353,776. (See
definition of affiliate in Rule 12b-2 of Exchange Act).
At September 15, 1999, 5,610,194 shares of the issuer's Class A Common Stock and
727,170 shares of the issuer's Class B Common Stock were outstanding.
TRANSITIONAL SMALL BUSINESS DISCLOSURE FORMAT:
Yes No X
PART I
ITEM 1. DESCRIPTION OF BUSINESS
INTRODUCTION
PHC, Inc. with its subsidiaries (the "Company") is a national health care
company specializing in the treatment of substance abuse, which includes alcohol
and drug dependency and related disorders, and in the provision of psychiatric
services. The Company currently operates two substance abuse treatment
facilities: Highland Ridge Hospital, located in Salt Lake City, Utah; and Mount
Regis Center, located in Salem, Virginia, near Roanoke and eight psychiatric
facilities: Harbor Oaks Hospital, a 64-bed psychiatric hospital located in New
Baltimore, Michigan; Harmony Healthcare, a provider of outpatient behavioral
health services at two locations in the Las Vegas, Nevada area; Total Concept
EAP, a provider of outpatient behavioral health services in Shawnee Mission,
Kansas; and North Point-Pioneer, Inc. ("NPP") which operates four outpatient
behavioral health centers under the name Pioneer Counseling Center in the
greater Detroit metropolitan area. The Company also operates BSC-NY, Inc.
("BSC"), which provides management and administrative services to psychotherapy
and psychological practices in the greater New York City metropolitan area.
Through its subsidiary, Behavioral Health Online, Inc., ("BHO"), the company
operates its web site, Behavioralhealthonline.com.
The Company's substance abuse facilities provide specialized treatment
services to patients who typically have poor recovery prognoses and who are
prone to relapse. These services are offered in small specialty care and
subacute facilities (i.e., facilities designed to provide care to individuals
who no longer require hospital care but who require some medical care), which
permits the Company to provide its clients with efficient and customized
treatment without the significant costs associated with the management and
operation of general acute care hospitals. The Company tailors these programs
and services to "safety-sensitive" industries and concentrates its marketing
efforts on the transportation, oil and gas exploration, heavy equipment,
manufacturing, law enforcement, gaming, and health services industries.
Harbor Oaks provides psychiatric care to children, adolescents and adults.
The Company draws patients from the local population and uses the facility as a
mental health resource to complement its substance abuse facilities. Harmony
Healthcare and Total Concept provide psychiatric treatment for adults,
adolescents and children. BSC is a manager of psychological service providers
with contracts at over 35 long-term care facilities. NPP provides outpatient
psychiatric treatment for adults, adolescents and children in the Metropolitan
Detroit area.
Behavioral Health Online, Inc. designs, develops and maintains the
Company's web site, Behavioralhealthonline.com. The web site, was designed to
provide products, information, and instruction to behavioral health
professionals and consumers for a fee.
In May 1998 the Company closed Good Hope Center, a substance abuse
treatment facility located in West Greenwich, Rhode Island and entered into an
agreement terminating the lease for the facility. All obligations under this
closure agreement were met by June 30, 1999. In June, 1998 the Company's sub
acute long-term care facility, Franvale Nursing and Rehabilitation Center, in
Braintree, Massachusetts was closed in a State Receivership action which was
precipitated when the Company caused the owner of the Franvale facility, Quality
Care Centers of Massachusetts, Inc., to institute a proceeding under Chapter 11
of the Federal Bankruptcy Code. The receivership was terminated September 16,
1998 and on October 5, 1998 Quality Care Centers of Massachusetts, Inc. filed a
Chapter 7 bankruptcy petition. A Trustee has been appointed; however, the
bankruptcy proceedings have not been finalized. For additional information see
"Business-Closed and Discontinued Operations-Franvale." In January 1999 the
Company closed its 80% owned outpatient operations in Virginia, Pioneer
Counseling of Virginia, Inc. The Company sold this business and retained
accounts receivable and most fixed assets, to the minority owners in exchange
for their shares of stock in Pioneer Counseling of Virginia, Inc., approximately
$25,000, release from the first mortgage on the property of approximately
$506,000 and release from Notes Payable to the minority owners of $20,000.
The Company intends to limit its business operations to behavioral health
through facilities providing services to particular markets through customized,
outcome-oriented programs, which the Company believes produce overall cost
savings to the patient or client organization and its web site which will
provide behavioral health professionals with the educational tools required to
keep them abreast of behavioral health breakthroughs and keep individuals
informed of current issues in behavioral health of interest to them.
The Company's substance abuse facilities provide treatment services
designed to prevent relapse. Such services, while potentially more costly on a
per patient stay basis, often result in long-term health care cost savings to
insurers, patients and patients' families. The goal of the Company's psychiatric
treatment programs is to provide care at the lowest level of intensity
appropriate for the patient in an integrated delivery system that includes
inpatient and outpatient treatment opportunities. The integrated nature of the
Company's psychiatric programs, which generally involves the same caregivers
supervising different treatment modalities, provides for efficient care delivery
and the avoidance of repeat procedures and diagnostic and therapeutic errors.
The Company was organized as a Delaware corporation in 1976 under the name
American International Health Services, Inc. In 1980, the Company merged into an
inactive publicly held Massachusetts Corporation and was the surviving
corporation in the merger. The Company changed its name to "PHC, Inc." as of
November 24, 1992. The Company is based in Massachusetts and is unaffiliated
with an inactive Minnesota corporation of the same name. The Company does
business under the trade name "Pioneer Healthcare" and "Pioneer Behavioral
Health." With the exception of the services provided directly by the Company
under the name Pioneer Development Support Services, the Company operates as a
holding company, providing administrative, legal and programmatic support to its
subsidiaries. The Company's executive offices are located at 200 Lake Street,
Suite 102, Peabody, Massachusetts, 01960 and its telephone number is (978)
536-2777.
PSYCHIATRIC SERVICES INDUSTRY
Substance Abuse Facilities
Industry Background
The demand for substance abuse treatment services increased rapidly in the
last decade. The Company believes that the increased demand is related to
clinical advances in the treatment of substance abuse, greater societal
willingness to acknowledge the underlying problems as treatable illnesses,
improved health insurance coverage for addictive disorders and chemical
dependencies and governmental regulation which requires certain employers to
provide information to employees about drug counseling and employee assistance
programs.
To contain costs associated with behavioral health issues in the 1980s,
many private payors instituted managed care programs for reimbursement, which
included pre-admission certification, case management or utilization review and
limits on financial coverage or length of stay. These cost containment measures
have encouraged outpatient care for behavioral problems, resulting in a
shortening of the length of stay and revenue per day in inpatient chemical abuse
facilities. The Company believes that it has addressed these cost containment
measures by specializing in treating relapse-prone patients with poor prognoses
who have failed in other treatment settings. These patients require longer
lengths of stay and come from a wide geographic area. The Company continues to
develop alternatives to inpatient care including partial day and evening
programs in addition to on site and off site outpatient programs.
The Company believes that because of the apparent unmet need for certain
clinical and medical services, its strategy has been successful despite national
trends towards outpatient treatment, shorter inpatient stays and rigorous
scrutiny by managed care organizations.
Company Operations
The Company has been able to secure insurance reimbursement for longer-term
inpatient treatment as a result of its success with poor prognosis patients. The
Company's two substance abuse facilities work together to refer patients to the
center that best meets the patient's clinical and medical needs. Each facility
caters to a slightly different patient population including high-risk,
relapse-prone chronic alcoholics, drug addicts, minority groups and dual
diagnosis patients (those suffering from both substance abuse and psychiatric
disorders). The Company concentrates on providing services to insurers, managed
care networks and health maintenance organizations for both adults and
adolescents. The Company's clinicians often work directly with managers of
employee assistance programs to select the best treatment facility possible for
their clients.
Each of the Company's facilities operates a case management program for
each patient including a clinical and financial evaluation of a patient's
circumstances to determine the most cost-effective modality of care from among
outpatient treatment, detoxification, inpatient, day care, specialized relapse
treatment and others. In addition to any care provided at one of the Company's
facilities, the case management program for each patient includes aftercare.
Aftercare may be provided through the outpatient services provided by a
facility. Alternatively, the Company may arrange for outpatient aftercare, as
well as family and mental health services, through its numerous affiliations
with clinicians located across the country once the patient is discharged.
In general, the Company does not accept patients who do not have either
insurance coverage or adequate financial resources to pay for treatment. Each of
the Company's substance abuse facilities does, however, provide treatment free
of charge to a small number of patients each year who are unable to pay for
treatment, but who meet certain clinical criteria and who are believed by the
Company to have the requisite degree of motivation for treatment to be
successful. In addition, the Company provides follow-up treatment free of charge
to relapse patients who satisfy certain criteria. The number of patient days
attributable to all patients who receive treatment free of charge in any given
fiscal year is less than 5%.
The Company believes that it has benefited from an increased awareness of
the need to make substance abuse treatment services accessible to the nation's
workforce. For example, subchapter D of the Anti-Drug Abuse Act of 1988
(commonly known as The Drug Free Workplace Act), requires employers who are
Federal contractors or Federal grant recipients to establish drug free awareness
programs to inform employees about available drug counseling, rehabilitation and
employee assistance programs and the consequences of drug abuse violations. In
response to the Drug Free Workplace Act, many companies, including many major
national corporations and transportation companies, have adopted policies that
provide for treatment options prior to termination of employment.
Although the Company does not provide federally approved mandated drug
testing, the Company treats employees who have been referred to the Company as a
result of compliance with the Drug Free Workplace Act, particularly from
companies that are part of the gaming industry as well as safety sensitive
industries such as railroads, airlines, trucking firms, oil and gas exploration
companies, heavy equipment companies, manufacturing companies and health
services.
HIGHLAND RIDGE
Highland Ridge is a 34-bed, freestanding alcohol and drug treatment
hospital, which the Company has been operating since 1984. It is the oldest
facility dedicated to substance abuse in Utah. Highland Ridge is accredited by
the Joint Commission on Accreditation of Healthcare Organizations ("JCAHO") and
is licensed by the Utah Department of Health. Highland Ridge is recognized
nationally for its excellence in treating substance abuse disorders.
Most patients are from Utah and surrounding states. Individuals typically
access Highland Ridge's services through professional referrals, family members,
employers, employee assistance programs or contracts between the Company and
health maintenance organizations located in Utah.
Highland Ridge was the first private for-profit hospital to address
specifically the special needs of chemically dependent women in Salt Lake
County. In addition, Highland Ridge has contracted with Salt Lake County to
provide medical detoxification services targeted to women. The hospital also
operates a specialized continuing care support group to address the unique needs
of women and minorities.
A pre-admission evaluation, which involves an evaluation of psychological,
cognitive and situational factors, is completed for each prospective patient. In
addition, each prospective patient is given a physical examination upon
admission. Diagnostic tools, including those developed by the American
Psychological Association, the American Society of Addiction Medicine and the
Substance Abuse Subtle Screening Inventory are used to develop an individualized
treatment plan for each client. The treatment regimen involves an
interdisciplinary team which integrates the twelve-step principles of self-help
organizations, medical detoxification, individual and group counseling, family
therapy, psychological assessment, psychiatric support, stress management,
dietary planning, vocational counseling and pastoral support. Highland Ridge
also offers extensive aftercare assistance at programs strategically located in
areas of client concentration throughout the United States. Highland Ridge
maintains a comprehensive array of professional affiliations to meet the needs
of discharged patients and other individuals not admitted to the hospital for
treatment.
Highland Ridge periodically conducts or participates in research projects.
Highland Ridge was the site of a recent research project conducted by the
University of Utah Medical School. The research explored the relationship
between individual motivation and treatment outcomes. The research was regulated
and reviewed by the Human Subjects Review Board of the University of Utah and
was subject to federal standards that delineated the nature and scope of
research involving human subjects. Highland Ridge benefited from this research
by expanding its professional relationships within the medical school community
and by applying the findings of the research to improve the quality of services
the Company delivers.
SPECIALIZED TREATMENT SERVICE
In the spring of 1994, the Company began to operate a crisis hotline
service under contract with a major transportation client. The hotline, Pioneer
Development Support Services, or PDS2 ("PDS2"), is a national, 24-hour telephone
service, which supplements the services provided by the client's Employee
Assistance Programs. The services provided include information, crisis
intervention, critical incidents coordination, employee counselor support,
client monitoring, case management and health promotion. The hotline is staffed
by counselors who refer callers to the appropriate professional resources for
assistance with personal problems. Four major transportation companies
subscribed to these services as of June 30, 1999. This operation is physically
located in Highland Ridge Hospital, but a staff dedicated to PDS2 provides the
services. PDS2 is currently operated by the parent entity, PHC, Inc.
MOUNT REGIS
Mount Regis is a 25-bed, freestanding alcohol and drug treatment center
located in Salem, Virginia, near Roanoke. The Company acquired the center in
1987. It is the oldest of its kind in the Roanoke Valley. Mount Regis is
accredited by the JCAHO, and licensed by the Department of Mental Health, Mental
Retardation and Substance Abuse Services of the Commonwealth of Virginia. In
addition, Mount Regis operates Changes, a freestanding outpatient clinic. The
Changes clinic provides structured intensive outpatient treatment for patients
who have been discharged from Mount Regis and for patients who do not need the
formal structure of a residential treatment program. The program is licensed by
the Commonwealth of Virginia and approved for reimbursement by major insurance
carriers
Mount Regis Center's programs are sensitive to needs of women and
minorities. The majority of Mount Regis clients are from Virginia and
surrounding states. In addition, because of its relatively close proximity and
accessibility to New York, Mount Regis has been able to attract an increasing
number of referrals from New York-based labor unions. Mount Regis has
established programs that allow the Company to better treat dual diagnosis
patients (those suffering from both substance abuse and psychiatric disorders),
cocaine addiction and relapse-prone patients. The multi-disciplinary case
management, aftercare and family programs are key to the prevention of relapse.
General Psychiatric Facilities
Introduction
The Company believes that its proven ability to provide high quality,
cost-effective care in the treatment of substance abuse has enabled it to grow
in the related behavioral health field of psychiatric treatment. The Company's
main advantage is its ability to provide an integrated delivery system of
inpatient and outpatient care. As a result of integration, the Company is better
able to manage and track patients.
The Company offers inpatient and partial hospitalization psychiatry
services through Harbor Oaks Hospital. The Company also currently operates seven
outpatient psychiatric facilities.
The Company's philosophy at these facilities is to provide the most
appropriate and efficacious care with the least restrictive modality of care. An
attending physician and a case manager with continuing oversight of the patient
as the patient receives care in different locations or programs handle case
management. The integrated delivery system allows for better patient tracking
and follow-up, and fewer repeat procedures and therapeutic or diagnostic errors.
Qualified, dedicated staff members take a full history on each new patient and
through test and evaluation procedures they provide a thorough diagnostic
write-up of the patient's condition. In addition a Physician does a complete
physical examination for each new patient. This information allows the
caregivers to determine which treatment alternative is best suited for the
patient and to design an individualized recovery program for the patient.
Managed health care organizations, state agencies, physicians and patients
themselves refer patients to our facilities. These facilities have a patient
population ranging from children as young as 5 years of age to senior citizens.
The psychiatric facilities treat a larger percentage of female patients than the
substance abuse facilities.
HARBOR OAKS
The Company acquired Harbor Oaks Hospital, a 64-bed psychiatric hospital
located in New Baltimore, Michigan, approximately 20 miles northeast of Detroit,
in September 1994. Harbor Oaks Hospital is licensed by the Michigan Department
of Commerce and it is accredited by JCAHO. Harbor Oaks provides inpatient
psychiatric care, partial hospitalization and outpatient treatment to children,
adolescents and adults. Harbor Oaks Hospital has serviced clients from Macomb,
Oakland and St. Clair Counties and has now expanded its coverage area to include
Wayne, Sanilac and Livingston Counties.
Until March 1998, Harbor Oaks Hospital worked in conjunction with New Life
Treatment Centers, Inc. ("New Life") to offer counseling programs with a
traditional Christian philosophy on an inpatient and partial hospitalization
basis. The Company and New Life terminated the contract by mutual agreement on
May 22, 1998.
The Company utilizes the Harbor Oaks facility as a mental health resource
to complement its nationally focused substance abuse treatment programs. Harbor
Oaks Hospital has a specialty program that treats substance abuse patients who
have a coexisting psychiatric disorder. This program provides an integrated
holistic approach to the treatment of individuals who have both substance abuse
and psychiatric problems. Both adults and adolescents can benefit from this
program.
On February 10, 1997, Harbor Oaks Hospital opened an 8-bed adjudicated
residential unit serving adolescents with a substance abuse problem and a
co-existing mental disorder who have been adjudicated to have committed criminal
acts and who have been referred or required to undergo psychiatric treatment by
a court or family service agency. The patients in the program range from 13 to
18 years of age. The program provides patients with educational and recreational
activities and adult life functioning skills as well as treatment. Typically, a
patient is admitted to the unit for an initial period of 30 days to six months.
A case review is done for any patient still in the program at six months, and
each subsequent six-month period thereafter, to determine if additional
treatment is required. State authorization allowed the Company to increase the
number of beds in the adjudicated residential unit to twelve on May 1, 1998 and
twenty on June 26, 1998.
In addition to direct patient care, Harbor Oaks works with major
manufacturers of psychiatric pharmaceuticals to assist in the study of the
effects of certain FDA approved products in the treatment of specific mental
illness.
Harmony Healthcare
Harmony Healthcare, which consists of two psychiatric clinics in Nevada,
provides outpatient psychiatric care to children, adolescents and adults in the
local area. Harmony also operates employee assistance programs for railroads,
health care companies and several large casino companies including Boyd Gaming
Corporation, the MGM Grand, the Mirage and Treasure Island resorts with a rapid
response program to provide immediate assistance 24 hours a day. Harmony also
provides outpatient psychiatric care and inpatient psychiatric case management
through a capitated rate behavioral health carve-out with Pacific Care
Insurance.
Total Concept EAP
Total Concept, an outpatient clinic located in Shawnee Mission, Kansas,
provides psychiatric and substance abuse treatment to children, adolescents and
adults and manages employee assistance programs for local businesses, gaming,
railroads and managed health care companies.
North Point-Pioneer, Inc.
NPP consists of four psychiatric clinics in Michigan. The clinics provide
outpatient psychiatric and substance abuse treatment to children, adolescents
and adults operating under the name Pioneer Counseling Center. The four clinics
are located in close proximity to the Harbor Oaks facility, which provides more
efficient integration of inpatient and outpatient services, a larger coverage
area and the ability to share personnel which results in cost savings.
BSC-NY, Inc.
BSC provides management and administrative services to psychotherapy and
psychological practices in the greater New York City metropolitan area.
Behavioral Health Online, Inc.
BHO designs, develops and maintains the Company's web site,
Behavioralhealthonline.com. The web site when fully operational will provide
behavioral health professionals with the educational tools required to keep them
abreast of behavioral health breakthroughs and keep individuals informed of
current issues in behavioral health of interest to them. The site was launched
in May 1999.
Operating Statistics
The following table reflects selected financial and statistical information
for all psychiatric services.
Year Ended June 30,
1999 1998 1997
Inpatient*
Net patient service revenues $ 10,491,517 $ 13,640,801 $ 13,557,703
Net revenues per patient day(1) $ 400 $ 476 $ 414
Average occupancy rate (2) 58.4% 51.7% 58.8%
Total number of licensed beds at
end of period 123 123 172
Source of Revenues:
Private (3) 81.5% 86.9% 91.6%
Government (4) 18.5% 13.1% 8.4%
Partial Hospitalization and Outpatient
Net Revenues:*
Individual $ 5,356,008 $4,705,454 $ 5,629,760
Contract $ 1,682,453 $ 1,423,098 $ 1,459,580
Sources of revenues:
Private 98.9% 94.0% 98.4%
Government 1.1% 6.0% 1.6%
Other Psychiatric Services
PDSS (5) $ 942,637 $ 763,086 $ 629,761
Practice Management (6) $ 576,881 $ 713,750 $ 650,852
* Includes revenue from Good Hope Center which was closed in May 1998:
Inpatient $ 0 $1,012,679 $ 1,300,745
Outpatient $ 0 $ 331,057 $ 457,018
* Includes revenue from Pioneer Counseling of Virginia which was closed in
January 1999:
Outpatient $ 537,688 $ 963,352 $ 227,601
(1) Net revenues per patient day equals net patient service revenues divided by
total patient days.
(2) Average occupancy rates were obtained by dividing the total number of
patient days in each period by the number of beds available in such period.
(3) Private pay percentage is the percentage of total patient revenue derived
from all payors other than Medicare and Medicaid.
(4) Government pay percentage is the percentage of total patient revenue
derived from the Medicare and Medicaid programs.
(5) PDSS, Pioneer Development and Support Services, provides clinical support,
referrals management and professional services for a number of the
Company's national contracts.
(6) Practice Management revenue is produced through BSC-NY.
Closed and Discontinued Operations
Franvale
The Company engaged Oasis Management Company ("Oasis") on November 1, 1996
to June 30, 1997 to provide management services to Franvale. On February 19,
1997, the Massachusetts Department of Public Health, as the result of a routine
survey, cited the Company's Franvale Nursing and Rehabilitation Center
("Franvale") for serious patient care and safety deficiencies. The State imposed
a civil penalty on the Company of $3,050 per day and reduced it to $2,250 per
day on March 12, 1997. The State reduced the fine to $90,545 in total after the
Company filed an appeal. The Department of Public Health and the federal agency,
HCFA, notified the Company at the time of the original citation, that Franvale
would be terminated from the Medicare and Medicaid programs unless Franvale was
in substantial compliance with regulatory requirements by March 14, 1997.
Franvale submitted a plan of correction to the Department of Public Health and
on March 12, 1997, as the result of a resurvey by the Department of Public
Health, a new statement of deficiencies was issued, which contained a
significant number of violations but recharacterized the level of seriousness of
the deficiencies to a lower degree of violation and which extended the
threatened date of termination to April 30, 1997.
As a result of the new statement of deficiencies, the Department of Public
Health had precluded the Company from admitting new patients to its Franvale
facility until at least April 30, 1997. However, on April 11, 1997, the Company
received authority to admit new patients on a case-by-case basis. The State
permitted previous patients to be readmitted to the Franvale facility only after
a case-by-case review by the Department of Public Health. The Company was
obligated to notify the attending physician of each resident of Franvale who was
found to have received substandard care of the deficiency notice and was
obligated also to notify the Massachusetts board which licenses the
administrator of Franvale.
On April 19, 1997 the Department of Public Health, Division of Health Care
Quality completed a follow-up survey of the Franvale Nursing Home. As a result
of this survey it was determined that all deficiencies cited from the April 17,
1997 visit had been corrected and the restrictions on Franvale's ability to
admit patients were lifted.
The Company replaced the management team at Franvale and expended
significant sums for staffing and programmatic improvements in order to bring
the facility into substantial compliance at the earliest possible date. The
Company conducted an intensive staff review, which resulted in a total
reorganization. The new staff was provided with in-service training.
On January 29, 1998 Franvale was again cited for patient care and safety
deficiencies by the Massachusetts Department of Public Health as a result of a
routine survey. A civil penalty of $224,250 was imposed for the period of time
that the facility was not in compliance. At the time of the citation the Company
was notified by the Department of Public Health and by the federal agency, HCFA,
that Franvale would be terminated from the Medicare and Medicaid programs if the
facility was not in substantial compliance with regulatory requirements by
February 21, 1998. As a result of this statement of deficiencies Franvale was
precluded from readmitting patients or admitting new patients. As of February
13, 1998 the ban from readmission was removed; however, Franvale was still
unable to admit new patients until after the resurvey was completed and the
facility was found to be in substantial compliance with Federal requirements.
On April 14, 1998 the State completed the resurvey of Franvale to determine
if the facility had corrected all patient care and safety deficiencies cited by
the Massachusetts Department of Public Health in its January 29, 1998 routine
survey. As a result of the resurvey the facility was found to be in substantial
compliance with regulatory requirements. In its letter of April 23, 1998 the
State Department of Public Health advised the facility that "all deficiencies
were found to have been corrected" and the facility "is now in substantial
compliance ...with the federal regulations applicable to long term care
facilities". The Department of Public Health also advised the facility in this
letter that it was withdrawing its recommendation to the Health Care Finance
Administration (HCFA) that the facility certification be terminated, and
recommending the denial of payment for new admissions and any civil monetary
penalties imposed on the facility cease as of the date the facility alleged that
it was in substantial compliance, which was March 29, 1998.
Despite the successful survey as documented in the Department's letter, the
notice continues by advising the facility that the "limitation on admissions
previously imposed ... shall remain in effect, irrespective of whether HCFA
accepts the state's recommendation to rescind its pending Medicaid termination
action, on the grounds that the Department has initiated and there is currently
pending a license revocation action against the facility.
On February 12, 1998, the Company entered into an Asset Purchase Agreement
with Lexington Healthcare Group, Inc. to sell substantially all the assets and
liabilities of Franvale Nursing and Rehabilitation Center. The inability of
Franvale to admit new patients and the State's pending license revocation made
completion of the sale an impossibility.
As a result of the decrease in census resulting from the inability of
Franvale to admit new patients and the limitations on its ability to re-admit
patients, the monetary penalties and the expenses that had been incurred by the
Company in correcting the cited deficiencies, continued facility cash flow
deficit of approximately $80,000 monthly, the stall of the sale of Franvale and
the probability that the State would not lift the admission freeze on the
facility, the Company concluded that it should file for protection under Chapter
11 of the United States Bankruptcy Code for the wholly owned subsidiary Quality
Care Centers of Massachusetts, Inc. which operates Franvale Nursing and
Rehabilitation Center.
On May 26, 1998 Franvale Nursing and Rehabilitation Center, filed for
reorganization under Chapter 11 of the United States bankruptcy Code in the
Eastern Division of the District of Massachusetts at Boston, Massachusetts. The
case was assigned to C J Kenner. On May 27, 1998 on motion of Franvale, the
court authorized the appointment of a Trustee and appointed Joseph Braunstein as
the Chapter 11 Trustee. On May 29, 1998, the Bankruptcy Court terminated the
Chapter 11 proceeding determining that there was no likelihood of reorganization
since the prospective acquirer of the facility was now imposing certain terms
unacceptable to all interested parties and that the transfer of patients and
liquidation of assets could be as readily effectuated in a state court
receivership under the aegis of the Massachusetts Health Care Statutes and
accordingly dismissed the Chapter 11 case. On June 1, 1998, on the Petition of
the Attorney General of the Commonwealth of Massachusetts on behalf of the
Department of Public Health with the acquiescence of Franvale, Robert Griffin
was appointed by J. Kottmyer as Receiver to transfer the patients and close the
facility expeditiously.
In October 1998 the Company's Bankruptcy Attorney received notification
that as of September 30, 1998 the patient care receivership for Quality Care
Centers of Massachusetts, Inc. was terminated. On October 5, 1998, in response
to the termination of the State Receivership, the Company filed for protection
under Chapter 7 of the United States bankruptcy Code in the Eastern Division of
the District of Massachusetts at Boston, Massachusetts. On October 7, 1998 the
court appointed Mark G. DeGiacomo as the Chapter 7 Trustee.
As a consequence of Franvale's bankruptcy and subsequent receivership, a
number of claims have been asserted against the Company or may be asserted
against the Company in the future. To date, such claims are as follows:
The Commonwealth of Massachusetts named Franvale, the Company and Bruce
Shear as party defendants in the Commonwealth receivership action, C.A. No.
98-2783 in the Superior Court, Suffolk County. On June 28, 1999, the Superior
Court entered a judgment of dismissal, dismissing the case without prejudice and
without costs, as of September 16, 1998. The Company understands that the
facility has been closed, all patients transferred and that the Commonwealth
receiver has resigned.
The Commonwealth of Massachusetts may institute a claim seeking to recover
any expenses incurred but not recovered by the Commonwealth as a consequence of
Franvale's receivership. The Commonwealth has a receivership statute that allows
the Commonwealth to seek indemnification for receivership expenses from
"licensee[s], persons responsible for the affairs of the licensee, or the
owner." Under Commonwealth law, the Commonwealth could seek to hold the Company
liable as a "licensee" or "a person responsible for the affairs of the licensee
[Franvale]." Management believes that there are defenses to any such claim. At
this time the potential claim does not appear to be a material issue, however,
since the Company understands that Franvale's collectible accounts receivable
are far in excess of the operating expenses and the receiver's fees that were
incurred during the receivership.
On or about September 14, 1998, the Company and its wholly owned
subsidiary, Franvale, were each served with document subpoenas in connection
with an on-going investigation of Franvale being conducted by the Massachusetts
Medicaid Fraud Control Unit. The focus of the investigation appears to be the
quality of patient care provided by Franvale during the period of early 1997
until the facility was placed into receivership in June 1998. The Company has
cooperated fully with the investigation including the production of documents.
While no specific dollar demand has yet been asserted by the state, the Attorney
General's office has indicated that a payment will be required to settle this
action. Preliminary negotiations between the Company and the State are under
way.
The Company has been named as a defendant in a proceeding captioned
Healthcare Services Group, Inc. v. Quality Care Centers of Massachusetts, Inc.
and PHC, Inc., C.A. No. 98-132 (Sup. Ct., Suffolk Co., MA). The plaintiff,
supplier of housekeeping and laundry services to Franvale, alleges two causes of
action against the Company in the Substitute First Amended Complaint. In Count
III (Accord and Satisfaction), plaintiff seeks $51,845 for the Company's alleged
breach of an agreement to pay plaintiff the money it was owed. In Count IV
(Guaranty), plaintiff alleges that the Company agreed to pay Franvale's debt but
did not do so; plaintiff seeks a judgment of $67,412. The Company filed an
answer contesting plaintiff's claims. Plaintiff propounded requests for
admissions to which the Company responded. Plaintiff recently noticed two
depositions and served the Company with a request for documents. Discovery was
set to close September 1, 1999, but was extended by the consent of the parties.
At this time it is not possible for the Company to evaluate the likelihood of an
unfavorable outcome or to predict the Company's potential loss. Based on the ad
damnum clause of the Substitute First Amended Complaint, the maximum potential
loss to the Company is alleged to be $67,412, plus costs and interest from the
date of demand.
On or about November 4, 1998, Mellon US Leasing, a division of Mellon
Leasing Corporation, a successor in interest to US Capital Corp. ("Mellon"),
brought a lawsuit against the Company in the Superior Court for Essex County,
Massachusetts, C.A. No. 98-2116. Mellon alleged that the Company had guaranteed
a lease agreement entered into by Quality Care Centers of Massachusetts, on
which Quality Care had defaulted. Mellon sought damages of $222,005, plus
interest costs and reasonable attorney's fees. Since the company did guarantee
of this debt of the subsidiary at the inception of the lease, on or about July
28, 1999, the Company and Mellon reached an agreement in principle, although no
documents have yet been signed memorializing the settlement. The terms of the
settlement are that the Company will pay Mellon the sum of $150,000 over a
period of 36 months at the interest rate of 9 percent per year in exchange for
dismissal of the lawsuit and the execution of releases.
The liquidation of the assets and liabilities of Franvale may result in a
non-cash financial statement gain of approximately $2,000,000. In the quarter
ended December 31, 1998 the company was relieved of the HUD mortgage of
approximately $6,741,000 and surrendered the underlying assets amounting to
approximately $4,329,000. The recognition of the gain has been deferred until
final resolution of all contingent liabilities.
Good Hope Center
Good Hope Center is a 49-bed substance abuse treatment facility located in
West Greenwich, Rhode Island which, until May, 1998 was operated by the
Company's subsidiary PHC of Rhode Island, Inc.
The Good Hope Center operated at a loss for the fiscal years ended June 30,
1998 and 1997 because of a decline in census, length of stay and lower
reimbursements from third party payors. Efforts to increase length of stay and
improve market share were unsuccessful requiring the closure of the facility.
In May 1998 the Company closed Good Hope Center and entered into an
agreement terminating the lease for the facility. As of June 30, 1999, the
company paid all of the expenses related to the facility and met all of the
terms of the agreement. During the fiscal year ended June 30, 1999, the Company
collected over $100,000 in accounts receivable previously written off resulting
in Net Income of approximately $108,000 for the facility for the year.
Pioneer Counseling of Virginia, Inc.
In June 1998 the Company decided to close the Blacksburg Clinic and
consolidate the Blacksburg resources and operations with the Salem Clinic
operations to enhance profitability of Pioneer Counseling of Virginia, Inc. The
write down of assets and anticipated costs related to the closing of the
Blacksburg clinic are reflected in the accompanying June 30, 1998 Financial
Statements. In December 1998 the Company decided to close the remaining Pioneer
Counseling of Virginia clinic located in Salem, Virginia. Since the Company was
required by contract to give 30-days notice to contract therapists before
closing the clinic, in January 1999 the Company closed its 80% owned outpatient
operations in Virginia, Pioneer Counseling of Virginia, Inc. The Company sold
this business, excluding accounts receivable and most fixed assets, to the
minority owners in exchange for their shares of stock in Pioneer Counseling of
Virginia, Inc. approximately $25,000, release from the first mortgage on the
property of approximately $506,000 and release from Notes Payable to the
minority owners of $20,000.
Operating Statistics
The following table reflects closed and discontinued operations:
For the Year Ended
June 30
1999 1998 1997
Discontinued Operations
Franvale:
Loss $ 0 $(2,220,296) $(1,958,756)
Closed Operations
Good Hope Center
Income (Loss) $ 108,372 $(1,540,772) $ (642,119)
Pioneer Counseling Centers of
Virginia, Inc.
Loss $ (811,957) $ (583,188) $ (120,914)
The Company experienced a recovery of accounts written off resulting in net
income from Good Hope Center in fiscal year 1999. No further significant
recoveries of this nature are expected in future periods.
Business Strategy
The Company's objective is to become a leading national provider of
treatment services, specializing in substance abuse and psychiatric care.
The Company focuses its marketing efforts on "safety-sensitive" industries.
This focus results in customized outcome oriented programs that the Company
believes produce overall cost savings to the patients and/or client
organizations. The Company intends to leverage experience gained from providing
services to customers in certain industries that it believes will enhance its
selling efforts within these certain industries.
Marketing And Customers
The Company markets its substance abuse, inpatient and outpatient
psychiatric health services both locally and nationally, primarily to safety
sensitive industries, including transportation, oil and gas exploration, heavy
machinery and equipment, manufacturing and healthcare services. Additionally,
the Company markets its services in the gaming industry both in Nevada and
nationally.
The Company employs six individuals dedicated to marketing among the
Company's facilities. Each facility performs marketing activities in its local
region. The National Marketing Director of the Company coordinates the majority
of the Company's national marketing efforts. In addition, employees at certain
facilities perform national marketing activities independent of the National
Marketing Director. The Company, with the support of its owned integrated
outpatient systems and management services, continues to pursue more at-risk
contracts and outpatient, managed health care fee-for-service contracts. In
addition to providing excellent services and treatment outcomes, the Company
will continue to negotiate pricing policies to attract patients for long-term
intensive treatment which meet length of stay and clinical requirements
established by insurers, managed health care organizations and the Company's
internal professional standards.
The Company's integrated system of comprehensive outpatient mental health
clinics and physician practices managed by the Company complement the Company's
inpatient facilities. These clinics and medical practices are strategically
located in Nevada, Virginia, Kansas City, Michigan, Utah and New York. They make
it possible for the Company to offer wholly integrated, comprehensive, mental
health services for corporations and managed care organizations on an at-risk or
exclusive fee-for-service basis. Additionally, the Company operates Pioneer
Development and Support Services (PDS2) located in the Highland Ridge facility
in Salt Lake City, Utah. PDS2 provides clinical support, referrals, management
and professional services for a number of the Company's national contracts. It
gives the Company the capacity to provide a complete range of fully integrated
mental health services.
The Company has been successful in securing a number of national accounts
with a variety of corporations including: Boyd Gaming, Canadian Rail, Conrail,
CSX, the IUE, MCC, MGM, Station Casinos, Union Pacific Railroad, Union Pacific
Railroad Hospital Association, VBH, and others.
In addition to its direct patient care services, the Company launched its
web site, Behavioralhealthonline.com, in May 1999. Although many of the articles
published on the web site are of interest to the general public, the Company's
primary target market is the behavioral health professional. When fully
operational the site will not only provide information to the behavioral health
professional, but will also provide a time and cost effective alternative for
acquiring the professional educational units required each year.
Competition
The Company's substance abuse programs compete nationally with other health
care providers, including general and chronic care hospitals, both non-profit
and for-profit, other substance abuse facilities and short-term detoxification
centers. Some competitors have substantially greater financial resources than
the Company. The Company believes, however, that it can compete successfully
with such institutions because of its success in treating poor-prognosis
patients. The Company will compete through its focus on such patients, its
willingness to negotiate appropriate rates and its capacity to build and service
corporate relationships.
The Company's psychiatric facilities and programs compete primarily within
the respective geographic area serviced by them. The Company competes with
private doctors, hospital-based clinics, hospital-based outpatient services and
other comparable facilities. The main reasons that the Company competes well are
its integrated delivery and dual diagnosis programming. Integrated delivery
provides for more efficient follow-up procedures and reductions in length of
stay. Dual diagnosis programming provides a niche service for clients with a
primary mental health and a secondary substance abuse diagnosis. The Company
developed its dual diagnosis service in response to demand from insurers,
employees and treatment facilities.
Revenue Sources And Contracts
The Company has entered into relationships with numerous employers, labor
unions and third-party payors to provide services to their employees and members
for the treatment of substance abuse and psychiatric disorders. In addition, the
Company admits patients who seek treatment directly without the intervention of
third parties and whose insurance does not cover these conditions in
circumstances where the patient either has adequate financial resources to pay
for treatment directly or is eligible to receive free care at one of the
Company's facilities. The Company's psychiatric patients either have insurance
or pay at least a portion of treatment costs. Free treatment provided each year
amounts to less than 5% of the Company's total patient days.
Each contract is negotiated separately, taking into account the insurance
coverage provided to employees and members, and, depending on such coverage, may
provide for differing amounts of compensation to the Company for different
subsets of employees and members. The charges may be capitated, or fixed with a
maximum charge per patient day, and, in the case of larger clients, frequently
result in a negotiated discount from the Company's published charges. The
Company believes that such discounts are appropriate as they are effective in
producing a larger volume of patient admissions. The Company treats non-contract
patients and bills them on the basis of the Company's standard per diem rates
and for any additional ancillary services provided to them by the Company.
Quality Assurance And Utilization Review
The Company has established comprehensive quality assurance programs at all
of its facilities. These programs are designed to ensure that each facility
maintains standards that meet or exceed requirements imposed upon the Company
with the objective of providing high-quality specialized treatment services to
its patients. To this end, the Joint Commission on Accreditation of Healthcare
Organizations ("JCAHO") survey and accredit the Company's inpatient facilities
and the Company's outpatient facilities comply with the standards of National
Commission Quality Assurance ("NCQA") although the facilities are not NCQA
certified. The Company's professional staff, including physicians, social
workers, psychologists, nurses, dietitians, therapists and counselors, must meet
the minimal requirements of licensure related to their specific discipline, in
addition to each facility's own internal quality assurance criteria. The Company
participates in the federally mandated National Practitioners Data Bank, which
monitors professional accreditation nationally.
In response to the increasing reliance of insurers and managed care
organizations upon utilization review methodologies, the Company has adopted a
comprehensive documentation policy to satisfy relevant reimbursement criteria.
Additionally, the Company has developed an internal case management system,
which provides assurance that services rendered to individual patients are
medically appropriate and reimbursable. Implementation of these internal
policies has been integral to the success of the Company's strategy of providing
services to relapse-prone, higher acuity patients.
Government Regulation
The Company's business and the development and operation of the Company's
facilities are subject to extensive federal, state and local government
regulation. In recent years, an increasing number of legislative proposals have
been introduced at both the national and state levels that would effect major
reforms of the health care system if adopted. Among the proposals under
consideration are reforms to increase the availability of group health
insurance, to increase reliance upon managed care, to bolster competition and to
require that all businesses offer health insurance coverage to their employees.
The Company cannot predict whether any such legislative proposals will be
adopted and, if adopted, what effect, if any, such proposals would have on the
Company's business.
In addition, both the Medicare and Medicaid programs are subject to
statutory and regulatory changes, administrative rulings, interpretations of
policy, intermediary determinations and governmental funding restrictions, all
of which may materially increase or decrease the rate of program payments to
health care facilities. Since 1983, Congress has consistently attempted to limit
the growth of federal spending under the Medicare and Medicaid programs and will
likely continue to do so. Additionally, congressional spending reductions for
the Medicaid program involving the issuance of block grants to states is likely
to hasten the reliance upon managed care as a potential savings mechanism of the
Medicaid program. As a result of this reform activity the Company can give no
assurance that payments under such programs will in the future remain at a level
comparable to the present level or be sufficient to cover the costs allocable to
such patients. In addition, many states, including the Commonwealth of
Massachusetts and the State of Michigan, are considering reductions in state
Medicaid budgets.
Health Planning Requirements
Some of the states in which the Company operates, and many of the states
where the Company may consider expansion opportunities, have health planning
statutes which require that prior to the addition or construction of new beds,
the addition of new services, the acquisition of certain medical equipment or
certain capital expenditures in excess of defined levels, a state health
planning agency must determine that a need exists for such new or additional
beds, new services, equipment or capital expenditures. These state determination
of need or certificate of need ("DoN") programs are designed to enable states to
participate in certain federal and state health related programs and to avoid
duplication of health services. DoN's typically are issued for a specified
maximum expenditure, must be implemented within a specified time frame and often
include elaborate compliance procedures for amendment or modification, if
needed. Several states, including the Commonwealth of Massachusetts, have
instituted moratoria on some types of DoN's or otherwise stated an intent not to
grant approvals for certain health services. Such moratoria may adversely affect
the Company's ability to expand in such states, but may also provide a barrier
to entry to potential competitors.
Licensure and Certification
State regulatory authorities must license all of the Company's facilities.
The Company's Harbor Oaks facility is certified for participation as a provider
in the Medicare and Medicaid programs.
The Company's initial and continued licensure of its facilities, and
certification to participate in the Medicare and Medicaid programs, depends upon
many factors, including accommodations, equipment, services, patient care,
safety, personnel, physical environment, the existence of adequate policies,
procedures and controls and the regulatory process regarding the facility's
initial licensure. Federal, state and local agencies survey facilities on a
regular basis to determine whether such facilities are in compliance with
governmental operating and health standards and conditions for participating in
government programs. Such surveys include review of patient utilization and
inspection of standards of patient care. The Company has procedures in place to
ensure that its facilities are operated in compliance with all such standards
and conditions. To the extent these standards are not met, however, the license
of a facility could be restricted, suspended or revoked, or a facility could be
decertified from the Medicare or Medicaid programs.
Medicare Reimbursement
Currently the only facility of the Company that receives Medicare
reimbursement is Harbor Oaks. For the fiscal year ended June 30, 1999 13.11% of
revenues for Harbor Oaks were derived from Medicare programs.
The Medicare program generally reimburses psychiatric facilities pursuant
to its prospective payment system ("PPS"), in which each facility receives an
interim payment of its allowable costs during the year which is later adjusted
to reflect actual allowable direct and indirect costs of services based upon the
submission of a cost report at the end of each year. However, current Medicare
payment policies allow certain psychiatric service providers an exemption from
PPS. In order for a facility to be eligible for exemption from PPS, the facility
must comply with numerous organizational and operational requirements.
PPS-exempt providers are cost reimbursed, receiving the lower of reasonable
costs or reasonable charges. The Medicare program fiscal intermediary pays a per
diem rate based upon prior year costs, which may be retroactively adjusted upon
the submission of annual cost reports.
The Harbor Oaks facility is currently PPS-exempt. The amount of its
cost-based reimbursement may be limited by the Tax Equity and Fiscal
Responsibility Act of 1982 ("TEFRA") and regulations promulgated under the Act.
Generally, TEFRA limits the amount of reimbursement a facility may receive to a
target amount per discharge, adjusted annually for inflation. The facility's
reasonable Medicare operating costs divided by Medicare discharges, plus a per
diem allowance for capital costs during its base year of operations determines
the target amount. It is not possible to predict the ability of Harbor Oaks to
remain PPS-exempt or to anticipate the impact of TEFRA upon the reimbursement
received by Harbor Oaks in future periods.
In order to receive Medicare reimbursement, each participating facility
must meet the applicable conditions of participation set forth by the federal
government relating to the type of facility, its equipment, its personnel and
its standards of medical care, as well as compliance with all state and local
laws and regulations. In addition, Medicare regulations generally require that
entry into such facilities be through physician referral. The Company must offer
services to Medicare recipients on a non-discriminatory basis and may not
preferentially accept private pay or commercially insured patients.
Medicaid Reimbursement Currently the only facility of the Company that
receives reimbursement under any state Medicaid program is Harbor Oaks. A
portion of Medicaid costs is paid by states under the Medicaid program and the
federal matching payments are not made unless the state's portion is made.
Accordingly, the timely receipt of Medicaid payments by a facility may be
affected by the financial condition of the relevant state.
Harbor Oaks is a participant in the Medicaid program administered by the
State of Michigan. The Company receives reimbursement on a per diem basis,
inclusive of ancillary costs. The state determines the rate and adjusts it
annually based on cost reports filed by the Company.
Fraud and Abuse Laws
Various federal and state laws regulate the business relationships and
payment arrangements between providers and suppliers of health care services,
including employment or service contracts, and investment relationships. These
laws include the fraud and abuse provisions of the Medicare and Medicaid
statutes as well as similar state statutes (collectively, the "Fraud and Abuse
Laws"), which prohibit the payment, receipt, solicitation or offering of any
direct or indirect remuneration intended to induce the referral of patients, the
ordering, arranging, or providing of covered services, items or equipment.
Violations of these provisions may result in civil and criminal penalties and/or
exclusion from participation in the Medicare, Medicaid and other
government-sponsored programs. The federal government has issued regulations
that set forth certain "safe harbors," representing business relationships and
payment arrangements that can safely be undertaken without violation of the
federal Fraud and Abuse Laws. Failure to fall within a safe harbor does not
constitute a per se violation of the federal fraud and abuse laws. The Company
believes that its business relationships and payment arrangements either fall
within the safe harbors or otherwise comply with the Fraud and Abuse Laws.
Employees
As of September 15, 1999, the Company had 299 employees of which 6 were
dedicated to marketing, 79 (12 part time) to finance and administration and 214
(91 part time) to patient care. All of the Company's 299 employees are leased
from Inovis, formerly International Personnel Resources, LTD. ("IPR"), a
national employee-leasing firm. The Company has elected to lease its employees
to provide more favorable employee health benefits at lower cost than would be
available to the Company as a single employer and to eliminate certain
administrative tasks which otherwise would be imposed on the management of the
Company. The agreement provides that Inovis will administer payroll, provide for
compliance with workers' compensation laws, including procurement of workers'
compensation insurance and administering claims, and procure and provide
designated employee benefits. The Company retains the right to reject the
services of any leased employee and Inovis has the right to increase its fees at
any time upon thirty days' written notice or immediately upon any increase in
payroll taxes, workers' compensation insurance premiums or the cost of employee
benefits provided to the leased employees.
The Company believes that it has been successful in attracting skilled and
experienced personnel. Competition for such employees is intense, however and
there can be no assurance that the Company will be able to attract and retain
necessary qualified employees in the future. None of the Company's employees are
covered by a collective bargaining agreement. The Company believes that its
relationships with its employees are good.
INSURANCE
Each of the Company's facilities maintains separate professional liability
insurance policies. Mount Regis, Harbor Oaks, Harmony Healthcare, Total Concept,
NPP and BSC have coverage of $1,000,000 per claim and $3,000,000 in the
aggregate. Highland Ridge has limits of $1,000,000 per claim and $6,000,000 in
the aggregate. In addition, these entities maintain general liability insurance
coverage in similar amounts.
The Company maintains $1,000,000 of directors and officers' liability
insurance coverage, general liability coverage of $1,000,000 per claim and
$2,000,000 in aggregate and an umbrella policy of $1,000,000. The Company
believes, based on its experience, that its insurance coverage is adequate for
its business and that it will continue to be able to obtain adequate coverage.
ITEM 2. DESCRIPTION OF PROPERTY
Executive Offices
The Company's executive offices are located in Peabody, Massachusetts. The
Company's new lease agreement in Peabody covers approximately 4,800 square feet
for a 60-month term, which expires September 17, 2004. The current annual
payment under the lease is $72,000 and increases to $87,516 in the final year.
This space will also house Behavioral Health Online, Inc. The Company believes
that this facility will be adequate to satisfy its needs for the foreseeable
future.
Highland Ridge Hospital
The Highland Ridge premises consist of approximately 24,000 square feet of
space occupying the majority of the first floor of a two-story hospital owned by
Valley Mental Health. The Company is currently operating on a month to month
basis until the lease is finalized. The lease currently in negotiations is for a
five-year agreement, which provides for monthly rental payments of approximately
$15,000, which includes housekeeping and maintenance for the first six months,
and includes changes in rental payments each year based on increases or
decreases in the CPI. After the initial six month term the faqcility will pay
yet undetermined additional amount each month for housekeeping and
maintenance.The leae in its current form would expire December 31, 2004, and
includes an option to renew for an additional five years. The Company believes
that these premises are adequate for its current and anticipated needs.
Mount Regis Center
The Company owns the Mount Regis facility, which consists of a three-story
wooden building located on an approximately two-acre site in a residential
neighborhood. The building consists of over 14,000 square feet and is subject to
a mortgage in the approximate amount of $460,000. The facility is used for both
inpatient and outpatient services. The Company believes that these premises are
adequate for its current and anticipated needs.
Psychiatric Facilities
The Company owns or leases premises for each of its psychiatric facilities.
Harmony, Total Concept, NPP and BSC each lease their premises. The Company
believes that each of these premises is leased at fair market value and coule be
replaced without significant time or expense if necessary. The Company believes
that all of these premises are adequate for its current and anticipated needs.
The Company owns the building in which Harbor Oaks operates, which is a
single story brick and wood frame structure comprising approximately 32,000
square feet situated on an approximately three acre site. The Company has a
$1,600,000 mortgage on this property. The Company believes that these premises
are adequate for its current and anticipated needs.
ITEM 3. LEGAL PROCEEDINGS.
As a consequence of Franvale's bankruptcy and subsequent receivership, a
number of claims have been asserted against the Company or may be asserted
against the Company in the future. To date, such claims are as follows:
The Commonwealth of Massachusetts named Franvale, the Company and Bruce
Shear as party defendants in the Commonwealth receivership action, C.A. No.
98-2783 in the Superior Court, Suffolk County. On June 28, 1999, the Superior
Court entered a judgment of dismissal, dismissing the case without prejudice and
without costs, as of September 16, 1998. The Company understands that the
facility has been closed, all patients transferred and that the Commonwealth
receiver has resigned.
The Commonwealth of Massachusetts may institute a claim seeking to recover
any expenses incurred but not recovered by the Commonwealth as a consequence of
Franvale's receivership. The Commonwealth has a receivership statute that allows
the Commonwealth to seek indemnification for receivership expenses from
"licensee[s], persons responsible for the affairs of the licensee, or the
owner." Under Commonwealth law, the Commonwealth could seek to hold the Company
liable as a "licensee" or "a person responsible for the affairs of the licensee
[Franvale]." Management believes that there are defenses to any such claim. At
this time the potential claim does not appear to be a material issue, however,
the Company understands that Franvale's collectible accounts receivable are far
in excess of the operating expenses and the receiver's fees that were incurred
during the receivership.
On or about September 14, 1998, the Company and its wholly owned
subsidiary, Franvale, were each served with document subpoenas in connection
with an on-going investigation of Franvale being conducted by the Massachusetts
Medicaid Fraud Control Unit. The focus of the investigation appears to be the
quality of patient care provided by Franvale during the period of early 1997
until the facility was placed into receivership in June 1998. The Company has
cooperated fully with the investigation including the production of documents.
While no specific dollar demand has yet been asserted by the state, the Attorney
General's office has indicated that a payment will be required to settle this
action. Preliminary negotiations between the Company and the State are under
way.
The Company has been named as a defendant in a proceeding captioned
Healthcare Services Group, Inc. v. Quality Care Centers of Massachusetts, Inc.
and PHC, Inc., C.A. No. 98-132 (Sup. Ct., Suffolk Co., MA). The plaintiff,
supplier of housekeeping and laundry services to Franvale, alleges two causes of
action against the Company in the Substitute First Amended Complaint. In Count
III (Accord and Satisfaction), plaintiff seeks $51,845 for the Company's alleged
breach of an agreement to pay plaintiff the money it was owed. In Count IV
(Guaranty), plaintiff alleges that the Company agreed to pay Franvale's debt but
did not do so; plaintiff seeks a judgment of $67,412. The Company filed an
answer contesting plaintiff's claims. Plaintiff propounded requests for
admissions to which the Company responded. Plaintiff recently noticed two
depositions and served the Company with a request for documents. Discovery was
set to close September 1, 1999, but has been extended by the consent of the
parties. At this time it is not possible for the Company to evaluate the
likelihood of an unfavorable outcome or to predict the Company's potential loss.
Based on the ad damnum clause of the Substitute First Amended Complaint, the
maximum potential loss to the Company is alleged to be $67,412, plus costs and
interest from the date of demand.
On or about November 4, 1998, Mellon US Leasing, a division of Mellon
Leasing Corporation, a successor in interest to US Capital Corp. ("Mellon"),
brought a lawsuit against the Company in the Superior Court for Essex County,
Massachusetts, C.A. No. 98-2116. Mellon alleged that the Company had guaranteed
a lease agreement entered into by Quality Care Centers of Massachusetts, on
which Quality Care had defaulted. Mellon sought damages of $222,005, plus
interest costs and reasonable attorney's fees. Since the company did guarantee
of this debt of the subsidiary at the inception of the lease on or about July
28, 1999, the Company and Mellon reached an agreement in principle, although no
documents have yet been signed memorializing the settlement. The terms of the
settlemen are that the Company will pay Mellon the sum of $150,000 over a period
of 36 months at the interest rate of 9 percent per year in exchange for
didmissal of the lawsuit and the execution of releases.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
No matters were submitted to a vote of the Company's security holders
during the fourth quarter of the fiscal year ended June 30, 1999.
PART II
ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
The Company's Units, Class A Common Stock and Class A Warrants have been
traded on the NASDAQ National Market under the symbols "PIHCU," "PIHC" and
"PIHCW," respectively, since the Company's initial public offering which was
declared effective on March 3, 1994. There is no public trading market for the
Company's Class B Common Stock. The following table sets forth, for the periods
indicated, the high and low sale price of the Company's Class A Common Stock, as
reported by NASDAQ.
1998
First Quarter $ 3 9/16 $ 2 1/4
Second Quarter $ 3 $ 1 7/8
Third Quarter $ 2 13/16 $ 1 7/8
Fourth Quarter $ 2 7/16 $ 1 5/8
1999 First Quarter $ 2 $ 5/8
Second Quarter $ 1 1/16 $ 9/16
Third Quarter $ 1 3/4 $ 13/16
Fourth Quarter $ 1 15/32 $ 13/16
2000
First Quarter(through
September 15, 1999) $1 5/16 $ 15/16
On September 15, 1999, the last reported sale price of the Class A Common
Stock was $1.09375. On September 15, 1999 there were 452 holders of record of
the Company's Class A Common Stock and 312 holders of record of the Company's
Class B Common Stock.
DIVIDEND POLICY
The Company has never paid any cash dividends on its Common Stock. While
there are currently no restrictions on the Company's ability to pay dividends,
the Company anticipates that in the future, earnings, if any, will be retained
for use in the business or for other corporate purposes, and it is not
anticipated that cash dividends in respect of Common Stock will be paid in the
foreseeable future. Any decision as to the future payment of dividends will
depend on the results of operations and financial position of the Company and
such other factors as the Company's Board of Directors, in its discretion, deems
relevant.
ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
The following is a discussion and analysis of the financial condition and
results of operations of the Company for the years ended June 30, 1999 and 1998.
It should be read in conjunction with the consolidated financial statements and
notes thereto appearing elsewhere herein. During the fiscal years several
businesses were acquired or closed which makes comparability of period results
difficult. See "Psychiatric Service Industry - Operating Statistics" in Part
One, Item One of this report for further detail.
Overview
The Company presently provides health care services through two substance
abuse treatment centers, a psychiatric hospital and seven outpatient psychiatric
centers (collectively called "treatment facilities"). The profitability of the
Company is largely dependent on the level of patient census at these treatment
facilities. The Company's administrative expenses do not vary greatly as a
percentage of total revenue but the percentage tends to decrease slightly as
revenue increases because of the fixed components of these expenses. The
Company's most recent addition, Behavioral Health Online, Inc., is a provider of
behavioral health information and education through its web site.
The healthcare industry is subject to extensive federal, state and local
regulation governing, among other things, licensure and certification, conduct
of operations, audit and retroactive adjustment of prior government billings and
reimbursement. In addition, there are ongoing debates and initiatives regarding
the restructuring of the health care system in its entirety. The extent of any
regulatory changes and their impact on the Company's business is unknown.
Managed care has had a profound impact on the Company's operations, in the form
of shorter lengths of stay, extensive certification of benefits requirements and
reduced payment for services.
Results of Operations
Years Ended June 30, 1999 and 1998
The Company experienced an increase in profitability from its continuing
operations. Earnings before taxes, interest, depreciation and amortization for
currently operating facilities increased by $1,351,169 for the year year ended
June 30, 1999 to $845,747 from a loss for the year ended June 30, 1998 of
$505,422. These amounts exclude income and loss for both years for the
California, Rhode Island, and Virginia operations. Although net revenue for the
operating facilities decreased by 2%, approximately $337,000, for the year ended
June 30, 1999, many changes toward more efficient operations resulted in
non-proportional decreases in many operating expenses. Total consultant fees
related to patient care decreased 16% to $2,273,601 for the year ended June 30,
1999 from $2,721,960 for the year ended June 30, 1998. While patient care
related payroll expense increased only 2% to $5,507,138 for the year ended June
30, 1999 from $5,417,628 for the year ended June 30, 1998. This is a combined 4%
reduction in the cost of salaries related to patient care as a result of the
more efficient use of salaried employees time and the reduction in the use of
non-employee therapists for patient care. More efficient ordering has resulted
in a decrease of 62% in the cost of hospital supplies excluding food, laboratory
fees and pharmacy, which also decreased. A change in laboratory service provider
and more efficient management of requests for lab tests resulted in a 37%,
approximately $76,000, decrease in laboratory fees expense for the fiscal year
ended June 30, 1999. A change in pharmacy and a shift in some pharmacy billing
from our facilities to the vendor resulted in a 7%, approximately $14,000,
decrease in pharmacy costs for the operating facilities. Savings were also
evident in administrative expenses for the operating facilities. More efficient
ordering also resulted in a decrease of 10.8%, approximately $25,000, in the
cost of general office supplies and expense. Consolidating marketing efforts
contributed toward a 24%, approximately $74,000, decrease in marketing,
promotion, and travel expenses. More efficient staffing in administrative
positions resulted in a decrease of 17%, approximately $458,000, in
administrative payroll, while the cost of administrative consultants also
decreased 26% or approximately $63,000. Bad debt expenses also decreased 27%,
approximately $775,000, due to the considerable charge to bad debt expense in
the previous year and the current decline in accounts receivable. Because most
of the changes outlined above were in place for all of the year ended June 30,
1999, the Company does not expect to experience the same decreases in expenses
in future years but intends to work at maintaining the current level of
expenses. The Company will, however, continue to evaluate operations looking for
less expensive alternatives to provide the same quality service.
The Company reduced its total loss by $5,090,703 for the fiscal year ended
June 30, 1999 compared to June 30, 1998. The Company also continued to divest
itself of facilities operating at a loss. The remaining Pioneer Counseling of
Virginia clinic was closed in January 1999 resulting in approximately $300,000
in expenses to write-down intangible assets. The total loss recorded for Pioneer
Counseling of Virginia, including this expense was approximately $810,000. The
final cost of the release from two of the Michigan outpatient clinic leases is
also reflected in the current fiscal year. The Company also experienced a loss
of approximately $160,000 through its start up operations for
Behavioralhealthonline.com. The web site produces minimal revenues during the
development stages when operating costs are high. The web site is expected to be
fully operational in the third quarter of the fiscal year 2000.
In the fiscal year ended June 30, 1998 the Company experienced a loss from
the discontinued operations of Franvale Nursing and Rehabilitation Center of
approximately $2,200,000.
The environment the Company operates in today makes collection of
receivables, particularly older receivables, more difficult than in previous
years. Accordingly, the Company has increased staff, standardized some
procedures for collecting receivables and instituted a more aggressive
collection policy, which has resulted in an overall decrease in its accounts
receivable. Although the Company's receivables have decreased, the Company
continues to reserve for bad debts based on managed care denials and past
difficulty in collections.
Total patient care revenue from all facilities, decreased 10% to
$19,139,496 for the year ended June 30, 1999 from $21,246,189 for the year ended
June 30, 1998. This decline in revenue is due primarily to the decline in census
and closure of Good Hope Center in Rhode Island. Net inpatient care revenue from
psychiatric services decreased 12% to $11,955,143 for the fiscal year ended June
30, 1999 compared to $13,640,801 for the year ended June 30, 1998 and net
outpatient care revenue decreased 7% to $5,574,835 for the year ended June 30,
1999 from $6,008,552 for the year ended June 30, 1998. Revenues from Practice
Management and Pioneer Development and Support Services ("PDSS") increased 3% to
$1,519,518 for the year ended June 30, 1999 from $1,476,836 for the year ended
June 30, 1998.
Total patient care expenses for all facilities decreased 12% to $9,384,070
for the year ended June 30, 1999 from $10,706,639 for the year ended June 30,
1998. This decrease in patient care expenses is largely a result of the closure
of Good Hope Center and the Virginia clinics. The Company expects these expenses
to decline in fiscal 2000 as compared to fiscal 1999. Total administrative
expenses for all facilities decreased 17% to $7,865,013 for the year ended June
30, 1999 from $9,488,631 for the year ended June 30, 1998. This decrease in
administrative expense is due largely to the one-time charges recorded in the
fiscal year ended June 30, 1998. Expenses for the closure of Good Hope Center
and the Blacksburg Clinic were among these one-time charges.
Year 2000 Compliance
The Company was unable to reach an agreement with its Information Systems
Vendor to upgrade its current accounts receivable software to accommodate a
four-digit year. The Company has identified alternative software solutions,
which are year 2000 compliant. The software installation is anticipated to be
operational by the deadline; however, as a precaution, the Company has contacted
each of its facilities' fiscal intermediaries and has been granted an extension
of time beyond the HCFA deadline for year 2000 compliance. In the event that
installation of the software is delayed, each facility is making plans to
complete the billing process by adding the four-digit year manually for those
bills that are not currently processed through a third party electronic biller.
Although this is a time consuming and costly alternative, it will allow the
Company to continue processing bills. The Company has already upgraded the
network software at the corporate offices and most of its facilities and is
currently upgrading hardware to accommodate all required software upgrades.
The Company is currently in the process of contacting each third party
payor of accounts receivable, financial institution, major supplier of essential
products and utility to request the status of their year 2000 compliance. The
company has received responses from approximately 60% of all vendors contacted.
All operation critical equipment, telephones, elevators, etc., has been tested
and found to be compliant. There are a few suppliers of goods and services
critical to operations that have not yet responded. The Company is in the
process of identifying alternate sources for these goods and services.
To date the Company has expended approximately $60,000 on items relating to
the year 2000 issues and anticipates approximately $165,000 in additional
expenses relating to the upgrade of Company's computer systems.
Liquidity and Capital Resources
For the two fiscal years ended June 30, 1999, the Company met its cash flow
needs through accounts receivable financing and by issuing debt and equity
securities as follows:
DATE TRANSACTION TYPE NUMBER PROCEEDS MATURITY TERMS STATUS
OF DATE
SHARES
9/97 Common Stock 172,414 $500,000 N/A Issued with Common
warrants at Stock Sold
a 3.3% discount
outstanding
9/97 Warrant issued as part 86,207 -- 09/30/2002 exercise price
of the units in the $2.90
Private Placement of
Common Stock
9/97 Warrant issued in 150,000 -- 05/31/2002 exercise price outstanding
exchange for cash $2.50
and financial advisory
services
12/97 Mortgage advance -- $500,000 10/31/2001 Prime Plus 5% outstanding
3/98 Warrant issued as a 3,000 -- 03/10/2003 exercise price outstanding
penalty for late $2.90
registration of
Private Placement
Common Stpck
3/98 Note Payable -- $350,000 05/10/99 Prime Plus 3.5% outstanding
as extended
3/98 Warrants issued as 52,500 -- 03/10/2003 exercise price outstanding
additional interest $2.38
on 3/98 debt
3/98 Common Stock issued to 227,347 $534,265 N/A N/A N/A
the former owners of
BSC-NY, Inc. for the
earn out agreement in
lieu of cash
3/98 Convertible Preferred 950 $950,000 03/18/2000 6% Interest per outstanding
Stock year convertible
at 80% of 5 day
average bid price
3/98 Warrants issued 49,990 -- 03/18/2001 exercise price outstanding
in connection $2.31
with the Private
Placement of
Convertible
Preferred Stock
on 3/98
5/98 Note Payable - -- $50,000 on demand 12% annual outstanding
Related Party interest rate
6/98 Note Payable - -- $50,000 on demand 12% annual outstanding
Related Party interest rate
7/98 Warrants issued as 52,500 -- 07/10/2003 exercise price outstanding
additional interest $1.81
on extension of 3/98
debt
7/98 Warrants issued as 20,000 -- 07/10/2003 exercise price outstanding
additional interest $1.81
on extension of 3/98
debt
8/98 Warrants issued for 50,000 -- 08/15/2001 exercise price outstanding
services $1.75
8/98 Note Payable - -- $100,000 on demand 12% annual outstanding
Related Party interest rate
12/98 Shares issued for 304,097 -- -- -- outstanding
price guarantee
12/98 Convertible Debentures -- $500,000 12/02/2004 12% annual outstanding
interest
convertible at
$2.00 in $1,000
increments
12/98 Warrants issued in 165,000 06/2004 issued from Dec outstanding
Private Placement thru June;
exercisable at
$1.00 to $2.00
01/99 Warrants for services 94,000 05/2004 issued from Jan outstanding
thru June;
exercisable at
$1.00 to $1.45
A significant factor in the liquidity and cash flow of the Company is the
timely collection of its accounts receivable. Accounts receivable from patient
care, net of allowance for doubtful accounts, decreased 14.6% to $6,938,227
during the year ended June 30, 1999 from $8,126,972 at June 30, 1998. This
decrease in accounts receivable is largely the result of the write-down of the
accounts receivable for closed facilities, increased staff, standardization of
some procedures for collecting receivables and a more aggressive collection
policy. The increased staff has allowed the company to concentrate on current
accounts receivable and resolve any problem issues before they become
uncollectable. At the same time, the Company continues to increase reserves for
bad debt based on potential insurance denials and past difficulty in
collections. In February 1998 the Company entered into an accounts receivable
funding revolving credit agreement with Healthcare Financial Partners-Funding
II, L.P. ("HCFP"), on behalf of five of its subsidiaries, which provides for
funding of up to $4,000,000 based on outstanding receivables. The outstanding
balance on this receivables financing on June 30, 1999 was approximately
$1,669,830.
The Company believes that it has sufficient financing available to sustain
existing operations for the foreseeable future. The Company also intends to
renew the expansion of its existing operations through new product lines and
expansion of contracts. The Company will also expand through its web site
operations offering the behavioral health professional goods and services unique
and specific to their needs for a fee.
The liquidation of the assets and liabilities of Franvale may result in a
non-cash financial statement gain of approximately $2,000,000. In the quarter
ended December 31, 1998 the company was relieved of the HUD mortgage of
approximately $6,741,000 and surrendered the underlying assets amounting to
approximately $4,329,000. The recognition of the gain has been deferred until
final resolution of all contingent liabilities.
ITEM 7. FINANCIAL STATEMENTS.
AT PAGE
Index F-1
Independent auditors' report F-2
Consolidated balance sheets F-3
Consolidated statements of operations F-4
Consolidated statements of changes in stockholders' equity F-5
Consolidated statements of cash flows F-6, F-7
Consolidated notes to financial statements F-8
PART III
ITEM 9. Directors, Executive Officers, Promoters and Control Persons
DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
The directors and officers of the Company as of June 30, 1999 are as
follows:
Name Age Position
Bruce A. Shear 44 Director, President and Chief Executive Officer
Robert H. Boswell 50 Senior Vice President
Paula C. Wurts 50 Controller, Assistant Clerk and Assistant
Treasurer
Gerald M. Perlow, M.D. 61 Director and Clerk
Donald E. Robar (1)(2) 62 Director and Treasurer
Howard W. Phillips 69 Director
William F. Grieco (1) 45 Director
(1) Member of Audit Committee.
(2) Member of Compensation Committee.
All of the directors hold office until the annual meeting of stockholders
next following their election, or until their successors are elected and
qualified. The Compensation Committee reviews and sets executive compensation.
Officers are elected annually by the Board of Directors and serve at the
discretion of the Board. There are no family relationships among any of the
directors or officers of the Company.
Information with respect to the business experience and affiliations of the
directors and officers of the Company is set forth below.
BRUCE A. SHEAR has been President, Chief Executive Officer and a Director
of the Company since 1980 and Treasurer of the Company from September 1993 until
February 1996. From 1976 to 1980 he served as Vice President, Financial Affairs,
of the Company. Mr. Shear has served on the Board of Governors of the Federation
of American Health Systems for over ten years. Mr. Shear received an M.B.A. from
Suffolk University in 1980 and a B.S. in Accounting and Finance from Marquette
University in 1976.
ROBERT H. BOSWELL has served as the Senior Vice President of the Company
since February 1999 and as Executive Vice Prisident of the Company from 1992
until 1999. From 1989 until the spring of 1994 Mr. Boswell served as the
Administrator of the Company's Highland Ridge Hospital facility where he is
based. Mr. Boswell is principally involved with the Company's substance abuse
facilities. From 1981 until 1989, he served as the Associate Administrator at
the Prevention Education Outpatient Treatment Program--the Cottage Program,
International. Mr. Boswell graduated from Fresno State University in 1975 and
from 1976 until 1978 attended Rice University's doctoral program in philosophy.
Mr. Boswell is a Board Member of the National Foundation for Responsible Gaming
and the Chair for the National Center for Responsible Gaming.
PAULA C. WURTS has served as the Controller of the Company since 1989 and
as Assistant Treasurer since 1993 and as Assistant Clerk since January 1996. Ms.
Wurts served as the Company's Accounting Manager from 1985 until 1989. Ms. Wurts
received an Associate's degree in Accounting from the University of South
Carolina in 1980, a B.S. in Accounting from Northeastern University in 1989 and
passed the examination for Certified Public Accountants. She received a Master's
Degree in Accounting from Western New England College in 1996.
GERALD M. PERLOW, M.D. has served as a Director of the Company since May
1993 and as Clerk since February 1996. Dr. Perlow is a cardiologist in private
practice in Lynn, Massachusetts, and has been Associate Clinical Professor of
Cardiology at the Tufts University School of Medicine since 1972. Dr. Perlow is
a Diplomat of the National Board of Medical Examiners and the American Board of
Internal Medicine (with a subspecialty in cardiovascular disease) and a Fellow
of the American Heart Association, the American College of Cardiology, the
American College of Physicians and the Massachusetts Medical Center. From 1987
to 1990, Dr. Perlow served as the Director, Division of Cardiology, at
AtlantiCare Medical Center in Lynn, Massachusetts. From October 30, 1996 to
March 1, 1997, Dr. Perlow served as President and Director of Shliselberg
Physician Services, P.C. formerly Perlow Physicians, P.C. which has a management
contract with BSC. Dr. Perlow currently holds no ownership interest in
Shliselberg Physician Services, P.C. Dr. Perlow received compensation of $8,333
for the period. Dr. Perlow received a B.A. from Harvard College in 1959 and an
M.D. from Tufts University School of Medicine in 1963.
DONALD E. ROBAR has served as a Director of the Company since 1985 and as
the Treasurer since February, 1996. He served as the Clerk of the Company from
1992 to 1996. Dr. Robar has been a professor of Psychology since 1961, most
recently at Colby-Sawyer College in New London, New Hampshire. Dr. Robar
received an Ed.D. from the University of Massachusetts in 1978, an M.A. from
Boston College in 1968 and a B.A. from the University of Massachusetts in 1960.
HOWARD W. PHILLIPS has served as a Director of the Company since August 27,
1996 and has been employed by the Company as a public relations specialist since
August 1, 1995. From 1982 until October 31, 1995, Mr. Phillips was the Director
of Corporate Finance for D.H. Blair Investment Corp. From 1969 until 1981, Mr.
Phillips was associated with Oppenheimer & Co. where he was a partner and
Director of Corporate Finance. Mr. Phillips currently is a member of the Board
of Directors of Food Court Entertainment Network, Inc., an operator of shopping
mall television networks, and Telechips Corp., a manufacturer of visual phones.
WILLIAM F. GRIECO has served as a Director of the Company since February
18, 1997. Since August 1999 Mr. Grieco has been a self-employed law consultant.
From November 1995 to July 1999 he served as Senior Vice President and General
Counsel for Fresenius Medical Care North America. From 1989 until November of
1995, Mr. Grieco was a partner at Choate, Hall & Stewart. Mr. Grieco received a
BS from Boston College in 1975, an MS in Health Policy and Management from
Harvard University in 1978 and a JD from Boston College Law School in 1981.
Compliance With Section 16(A) Of The Exchange Act
Based on a review of Forms 3 and 4 furnished to the company, all directors,
officers and beneficial owners of more than ten percent of any class of equity
securities of the Company registered pursuant to Section 12 of the Securities
Exchange Act filed on a timely basis reports required by Section 16(a) of the
Exchange Act during the most recent fiscal year.
ITEM 10. Executive compensation. Employment agreements
The Company has not entered into any employment agreements with its
executive officers. The Company owns and is the beneficiary on a $1,000,000 key
man life insurance policy on the life of Bruce A. Shear.
Executive Compensation
Two executive officers of the Company received compensation in the 1999
fiscal year, which exceeded $100,000. The following table sets forth the
compensation paid or accrued by the Company for services rendered to these
executives in fiscal year 1999,1998, and 1997:
Summary Compensation Table
Long Term
Compensation
Annual Compensation Awards
___________________ _____________
(a) (b) (c) (d) (e) (g) (i)
Name and Other Annual Securities All Other
Principal Year Salary Bonus Compensation Underlying Compensation
Position Options/SARs
$ $ $ # $
_______________________________________________________________________________
Bruce A. Shear 1999 $300,195(1) -- $ 6,490(2) 50,000 $21,622
President and 1998 $309,167(1) -- $ 8,363(3) 50,000 $51,256
Chief Executive 1997 $294,167(1) -- $12,633(4) -- --
Officer
Robert H. Boswell 1999 $111,083 $800 $ 7,955(5) 65,000 $29,753
Senior Vice 1998 $102,750 -- $ 7,836(6) 15,000 $14,149
President 1997 $ 92,750 -- $ 6,687(7) 5,000 $ 6,821
(1) Although the last Board of Director authorized base salary effective July
1, 1995, $310,000 base salary was drawn as listed above.
(2) This amount represents (i) $1,341 contributed by the Company to the
Company's Executive Employee Benefit Plan on behalf of Mr. Shear, (ii)
$2,792 in premiums paid by the Company with respect to life insurance for
the benefit of Mr. Shear and (iii) $2,357 personal use of a Company car
held by Mr. Shear
(3) This amount represents (i) $1,341 contributed by the Company to the
Company's Executive Employee Benefit Plan on behalf of Mr. Shear, (ii)
$4,768 in premiums paid by the Company with respect to life insurance for
the benefit of Mr. Shear and (iii) $2,254 personal use of a Company car
held by Mr. Shear.
(4) This amount represents (i) $2,687 contributed by the Company to the
Company's Executive Employee Benefit Plan on behalf of Mr. Shear, (ii)
$6,769 in premiums paid by the Company with respect to life insurance for
the benefit of Mr. Shear and (iii) $3,177 personal use of a Company car
held by Mr. Shear.
(5) This amount represents (i) $6,000 automobile allowance, (ii) $357
contributed by the Company to the Company's Executive Employee Benefit Plan
on behalf of Mr. Boswell (iii) $704 in other benefits paid by the Company
on behalf of Mr. Boswell and (vi) $894 in benefit derived from the purchase
of shares through the employees stock purchase plan.
(6) This amount represents (i) $6,000 automobile allowance, (ii) $408
contributed by the Company to the Company's Executive Employee Benefit Plan
on behalf of Mr. Boswell (iii) $408 in other benefits paid by the Company
on behalf of Mr. Boswell (iv) $115 in Class A Common Stock issued to
employees and (v) $905 in benefit derived from the purchase of shares
through the employees stock purchase plan.
(7) This amount represents (i) an automobile allowance and (ii) $897 in benefit
derived from the purchase of shares through the employees stock purchase
plan.
COMPENSATION OF DIRECTORS
Directors who are employees of the Company receive no compensation for
services as members of the Board. Directors who are not employees of the Company
receive $2,500 stipend per year and $1,000 for each Board meeting they attend.
In addition, directors of the Company are entitled to receive certain stock
option grants under the Company's Non-Employee Director Stock Option Plan (the
"Director Plan").
COMPENSATION COMMITTEE
The Compensation Committee consists of Mr. Donald Robar and Dr. Gerald
Perlow. The compensation Committee met once during fiscal 1999. Mr. Shear does
not participate in discussions concerning, or vote to approve, his salary.
OPTION PLANS
Stock Plan
The Board of Directors adopted the Company's Stock Plan on August 26, 1993
and the stockholders of the Company approved the plan on November 30, 1993. The
Stock Plan provides for the issuance of a maximum of 300,000 shares of the Class
A Common Stock of the Company pursuant to the grant of incentive stock options
to employees and the grant of nonqualified stock options or restricted stock to
employees, directors, consultants and others whose efforts are important to the
success of the Company.
The Board of Directors administers the Stock Plan. Subject to the
provisions of the Stock Plan, the Board of Directors has the authority to select
the optionees or restricted stock recipients and determine the terms of the
options or restricted stock granted, including: (i) the number of shares, (ii)
option exercise terms, (iii) the exercise or purchase price (which in the case
of an incentive stock option cannot be less than the market price of the Class A
Common Stock as of the date of grant), (iv) type and duration of transfer or
other restrictions and (v) the time and form of payment for restricted stock and
upon exercise of options. Generally, an option is not transferable by the option
holder except by will or by the laws of descent and distribution. Also,
generally, no option may be exercised more than 60 days following termination of
employment. However, in the event that termination is due to death or
disability, the option is exercisable for a period of one year following such
termination.
During the fiscal year ended June 30, 1999, the Company issued additional
options to purchase 212,500 shares of Class A Common Stock under the 1993 Stock
Plan at a price per share ranging from $1.03 to $1.25. Generally, options are
exercisable upon grant for 25% of the shares covered with an additional 25%
becoming exercisable on each of the first three anniversaries of the date of
grant.
During the fiscal years ended June 30, 1998 and June 30, 1999 no options
were exercised.
On November 17, 1997 the Board of Directors voted to amend the 1993 Stock
Plan to increase the number of shares of Class A Common Stock available for
issuance under the plan from 300,000 shares to 400,000 shares. The Stockholders
approved this amendment at the annual meeting on December 26, 1997. On September
15, 1998 the Board of Directors voted to amend the 1993 Stock Plan to increase
the number of shares of Class A Common Stock available for issuance under the
plan from 400,000 shares to 1,000,000 shares. The Stockholders approved this
amendment at the annual meeting on December 23, 1998.
Employee Stock Purchase Plan
On October 18, 1995, the Board of Directors voted to provide employees who
work in excess of 20 hours per week and more than five months per year rights to
elect to participate in an Employee Stock Purchase Plan (the "Plan") which
became effective February 1, 1996. The price per share shall be the lesser of
85% of the average of the bid and ask price on the first day of the plan period
or the last day of the plan period. An offering period under the plan began on
February 1, 1997 and ended on January 31, 1998. Twenty-four employees purchased
an aggregate of 14,743 shares of Class A Common Stock. A new offering commenced
on February 1, 1998 and ended on January 31, 1999. Eleven employees purchased an
aggregate of 15,475 shares of Class A Common Stock. Eleven employees are
participating in the current offering period under the plan, which began on
February 1, 1999 and will end on January 31, 2000.
On November 17, 1997 the Board of Directors voted to amend The Plan to
increase the number of shares of Class A Common Stock available for issuance
under the plan from 100,000 shares to 150,000 shares. The Stockholders approved
this amendment to the plan at the annual meeting on December 26, 1997.
Non-Employee Director Stock Plan
The Board of Directors adopted the Company's Non-Employee Director Stock
Plan (the "Director Plan") on October 18, 1995. The Stockholders of the Company
approved the plan on December 15, 1995. Non-qualified options to purchase a
total of 30,000 shares of Class A Common Stock are available for issuance under
the Director Plan.
The Board of Directors or a committee of the Board administers the Director
Plan. Under the Director Plan, each director of the Company who was a director
at the time of adoption of the Director Plan and who was not a current or former
employee of the Company received an option to purchase that number of shares of
Class A Common Stock as equals 500 multiplied by the years of service of such
director as of the date of the grant. At the first meeting of the Board of
Directors subsequent to each annual meeting of stockholders, each non-employee
director is granted under the Director Plan an option to purchase 2,000 shares
of the Class A Common Stock of the Company. The option exercise price is the
fair market value of the shares of the Company's Class A Common Stock on the
date of grant. The options are non-transferable and become exercisable as
follows: 25% immediately and 25% on each of the first, second and third
anniversaries of the grant date. If an optionee ceases to be a member of the
Board of Directors other than for death or permanent disability, the unexercised
portion of the options, to the extent unvested, immediately terminate, and the
unexercised portion of the options which have vested lapse 180 days after the
date the optionee ceases to serve on the Board. In the event of death or
permanent disability, all unexercised options vest and the optionee or his or
her legal representative has the right to exercise the option for a period of
180 days or until the expiration of the option, if sooner.
On February 18, 1997, the Company issued options to purchase 6,000 shares
of Class A Common Stock under the Director Plan at an exercise price of $3.50
per share. On January 22, 1998, the Company issued options to purchase 6,000
shares of Class A Common Stock under the Director Plan at an exercise price of
$2.06. On February 23, 1999, the Company issued options to purchase 6,000 shares
of Class A Common Stock under the Director Plan at an exercise price of $1.03.
As of June 30, 1999, none of the options issued had been exercised.
On November 17, 1997 the Board of Directors voted to amend the Director
Plan to increase the number of shares of Class A Common Stock available for
issuance under the plan from 30,000 shares to 50,000 shares. The Stockholders
approved the amendment to the plan at the annual meeting on December 26, 1997.
The following table provides information about options granted to the named
executive officers during fiscal 1999 under the Company's Stock Plan, Employee
Stock Purchase Plan and Non-Employee Director Stock Plan.
Individual Grants
____________________
(a) (b) (c) (d) (e)
Number of % of Total
Securities Options/SARs
Underlying Granted to Exercise or
Options/SARs Employees Base Price Expiration
Granted in Fiscal Year ($/Share) Date
Name #
_________________ _____________ ______________ ___________ ___________
Bruce A. Shear 50,000 23.5% $1.17 3/15/2004
Robert H. Boswell 50,000 23.5% $1.25 9/15/2003
15,000 7.0% $1.20 2/23/2004
All Directors and 183,000 83.8% $1.03-$1.25 9/15/2003-2/23/0224
Officers as a
group (7 persons)
The following table provides information about options exercised by the
named executive officers during fiscal 1999 and the number and value of options
held at the end of fiscal 1999.
(a) (b) (c) (d) (e)
Number of
Securities Value of
Underlying Unexercised
Unexercised In-the-Money
Options/SARs at Options/SARs
Shares FY-End (#) FY-End ($)
Acquired on Value Exercisable/ Exercisable/
Name Exercise (#) Realized ($) Unexercisable Unexercisable
____ ____________ ____________ ______________ _____________
Bruce A. Shear -- -- 37,500/62,500 $0/$0
Robert H. Boswell -- -- 69,000/45,000 $0/$0
All Directors and
Officers as a group
(7 persons) -- -- 198,000/163,250 $0/$0
In February 1997, all 95,375 shares underlying the then outstanding
employee stock options were repriced to the current market price, using the
existing exercise durations. In September 1998, all 21,875 options due to
expire, were extended for an additional five years. Also in September 1998, all
183,875 shares underlying the then outstanding employee stock options were
repriced to the current market price, using the existing exercise durations.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT
The following table sets forth certain information regarding the ownership
of shares of the Company's Class A Common Stock and Class B Common Stock (the
only classes of capital stock of the Company currently outstanding) as of August
15, 1999 by (i) each person known by the Company to beneficially own more than
5% of any class of the Company's voting securities, (ii) each director of the
Company, (iii) each of the named executive officers as defined in 17 CFR
228.402(a)(2) and (iv) all directors and officers of the Company as a group.
Unless otherwise indicated below, to the knowledge of the Company, all persons
listed below have sole voting and investment power with respect to their shares
of Common Stock, except to the extent authority is shared by spouses under
applicable law. In preparing the following table, the Company has relied on the
information furnished by the persons listed below:
Name and Address Amount and Nature Percent of
Tital of Class of Beneficial Owner of Beneficial Owner Class (12%)
Class A Common Stock Gerald M. Perlow 27,750(1) *
c/o PHC, Inc.
200 Lake Street
Peabody, MA 01960
Donald E. Robar 22,750(2) *
c/o PHC, Inc.
200 Lake Street
Peabody, MA 01960
Bruce A. Shear 58,000(3) 1.0%
c/o PHC, Inc.
200 Lake Street
Peabody, MA 01960
Robert H. Boswell 83,844(4) 1.5%
c/o PHC, Inc.
200 Lake Street
Peabody, MA 01960
Howard W. Phillips 11,750(5) *
P. O. Box 2047
East Hampton, NY 11937
William F. Grieco 71,030(6)(7) 1.3%
115 Marlborough Street
Boston, MA 02116
J. Owen Todd 59,280(7) 1.1%
c/o Todd and Weld
1 Boston Place
Boston, MA 02108
ProFutures Special Equities 751,082(9) 12.1%
Fund, LP
11612 Bee Cave Rd - STE 100
Austin TX 78734
All Directors and Officers 311,285(8) 5.3%
as a Group (7 persons)
Class B Common Stock (10)Bruce A. Shear 671,259(11) 92.8%
c/o PHC, Inc.
200 Lake Street
Peabody, MA 01960
All Directors and Officers 671,259 92.8%
as a Group (7 persons)
* Less than 1%.
(1) Includes 17,750 shares issuable pursuant to currently exercisable stock
options or stock options which will become exercisable within sixty days,
having an exercise price range of $1.03 to $6.63 per share.
(2) Includes 21,250 shares issuable pursuant to currently exercisable stock
options or stock options which will become exercisable within sixty days,
having an exercise price range of $1.03 to $6.63 per share.
(3) Includes 50,000 shares of Class A Common Stock issuable pursuant to
currently exercisable stock options, having an exercise price range of
$1.17 to 2.63 per share. Excludes an aggregate of 59,280 shares of Class A
Common Stock owned by the Shear Family Trust and the NMI Trust, of which
Bruce A. Shear is a remainder beneficiary.
(4) Includes an aggregate of 71,500 shares of Class A Common Stock issuable
pursuant to currently exercisable stock options at an exercise price range
of $1.20 to $1.25 per share.
(5) Includes 11,750 shares issuable pursuant to currently exercisable stock
options having an exercise price range of $1.03 to $3.50 per share.
(6) Includes 11,750 shares of Class A Common Stock issuable pursuant to
currently exercisable stock options, having an exercise price range of
$1.03 to $3.50 per share.
(7) Messrs. Todd and Grieco are the two trustees of the Trusts which
collectively hold 59,280 shares of the Company's outstanding Common Stock.
Gertrude Shear, Bruce A. Shear's mother, is the lifetime beneficiary of the
Trusts. In addition to the shares held by the Trusts, to the best of the
Company's knowledge, Gertrude Shear currently owns less than 1% of the
Company's outstanding Class B Common Stock.
(8) Includes an aggregate of 215,500 shares issuable pursuant to currently
exercisable stock options. Of those options, 5,500 have an exercise price
of $6.63 per share, 10,000 have an exercise price of $5.00 per share,
19,500 have an exercise price of $3.50 per share, 37,500 have an exercise
price of $2.63 per share, 3,000 have an exercise price of $2.06 per share,
119,250 have an exercise price of $1.25 per share, 6,250 have an exercise
price of $1.20 per share, 12,500 have an exercise price of $1.17 per share
and 2,000 have an exercise price of $1.03 per share.
(9) Includes 458,750 shares estimated as issuable upon the conversion of 367
shares of series B preferred stock and 165,522 shares issuable upon the
exercise of warrants issued in connection with various financing and
private placement transactions.
(10) Each share of Class B Common Stock is convertible into one share of Class A
Common Stock automatically upon any sale or transfer or at any time at the
option of the holder.
(11) Includes 56,369 shares of Class B Common Stock pledged to Steven J. Shear
of 2 Addison Avenue, Lynn, Massachusetts 01902, Bruce A. Shear's brother,
to secure the purchase price obligation of Bruce A. Shear in connection
with his purchase of his brother's stock in the Company in December 1988.
In the absence of any default under this obligation, Bruce A. Shear retains
full voting power with respect to these shares.
(12) Represents percentage of equity of class, based on numbers of shares listed
under the column headed "Amount and Nature of Beneficial Ownership". Each
share of Class A Common Stock is entitled to one vote per share and each
share of Class B Common Stock is entitled to five votes per share on all
matters on which stockholders may vote (except that the holders of the
Class A Common Stock are entitled to elect two members of the Company's
Board of Directors and holders of the Class B Common Stock are entitled to
elect all the remaining members of the Company's Board of Directors).
By virtue of the fact that class B shareholders have the right to elect
three of the five members of the Board of Directors and Mr. Shear owns 92% of
the class B shares, Mr. Shear has the right to elect the nominees and therefore,
control the Board of Directors.
Based on the number of shares listed under the column headed "Amount and
Nature of Beneficial Ownership," the following persons or groups held the
following percentages of voting rights for all shares of common stock combined
as of August 15, 1999:
Bruce A. Shear ........................................36.72%
J. Owen Todd............................................0.64%
William F. Grieco.......................................0.77%
ProFutures Special Equities Fund, LP....................7.61%
All Directors and Officers as a Group
(7 persons)............................................38.75%
ITEM 12. CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS.
Related Party Indebtedness
For approximately the last ten years, Bruce A. Shear, a director and the
President and Chief Executive Officer of the Company, and persons affiliated and
associated with him have made a series of unsecured loans to the Company and its
subsidiaries to enable them to meet ongoing financial commitments. The
borrowings generally were entered into when the Company did not have financing
available from outside sources and, in the opinion of the Company, were entered
into at market rates given the financial condition of the Company and the risks
of repayment at the time the loans were made. As of June 30, 1999, the Company
owed an aggregate of $200,000 to related parties.
During the period ended June 30, 1999, the Company paid Mr. Shear and
affiliates approximately $157,600 in principal and accrued interest under
various notes. As of June 30, 1999, the Company owed Bruce A. Shear $100,000 on
a promissory note, which is dated August 13, 1998, bears interest at the rate of
12% per year and is payable on demand and Tot Care, Inc., an affiliate of Bruce
A. Shear, $100,000 on promissory notes dated May 28, 1998 and June 9, 1998 which
bear interest at the rate of 12% per year and are payable on demand.
ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K.
Exhibit No. Description
3.1 Restated Articles of Organization of the Registrant, as amended. (Filed as
exhibit 3.1 to the Company's Registration Statement on March 2, 1994)
3.1.1Articles of Amendment filed with the Commonwealth of Massachusetts. (Filed
with the 10-QSB dated May, 1997.)
3.2 By-laws of the Registrant, as amended. (Filed as exhibit 3.2 to the
Company's Post-Effective Amendment No. 2 on Form S-3 to Registration
Statement on Form SB-2 under the Securities Act of 1933 dated November 13,
1995. Commission file number 333-71418).
3.3 Certificate of Vote of Directors establishing a Series of a Class of stock.
(Filed with the SB-2/A dated June 3, 1997.
4.1 Form of Warrant Agreement. (Filed as exhibit 4.1 to the Company's
Registration Statement on March 2, 1994)
4.2 Form of Unit Purchase Option. (Filed as exhibit 4.4 to the Company's
Registration Statement on March 2, 1994)
4.3 Form of warrant issued to Robert A. Naify, Marshall Naify, Sarah M.
Hassanein and Whitney Gettinger. (Filed as exhibit 4.6 to the Company's
Registration Statement on Form 3 dated March 12, 1996. Commission file
number 333-71418).
4.4 Form of Warrant Agreement by and among the Company, American Stock Transfer
& Trust Company and AmeriCorp Securities, Inc. executed in connection with
the Private Placement. (Filed as exhibit 4.8 to the Company's Registration
Statement on Form 3 dated March 12, 1996. Commission file number
333-71418).
4.5 Form of Warrant Agreement issued to Alpine Capital Partners, Inc. to
purchase 25,000 Class A Common shares dated October 7, 1996. (Filed as
exhibit 4.15 to the Company's Current Report on Form 8-K, filed with the
Securities and Exchange Commission November 5, 1996. Commission file number
0-23524).
4.6 Form of Warrant Agreement issued to Barrow Street Research, Inc. to
purchase 3,000 Class A Common shares dated February 18, 1997. (Filed as
exhibit 4.17 to the Company's Registration Statement on Form SB-2 dated
April 15, 1997. Commission file number 333-25231).
4.7 Form of Consultant Warrant Agreement by and between PHC, Inc., and C.C.R.I.
Corporation dated March 3, 1997 to purchase 160,000 shares Class A Common
Stock. (Filed as an exhibit to the Company's Registration Statement on Form
SB-2 dated April 15, 1997. Commission file number 333-25231).
4.8 Warrant Agreement by and between PHC, Inc. and ProFutures Special Equities
Fund, L.P. for 50,000 shares of Class A Common Stock dated 6/4/97. (Filed
as exhibit 4.22 to the Company's Registration Statement on Form SB-2 dated
April 15, 1997. Commission file number 333-25231).
4.9 Warrant Agreement by and between PHC, Inc. and ProFutures Special Equities
Fund, L.P. for up to 86,207 shares of ClassA Common Stock dated 09/19/97.
(Filed as exhibit 4.25 to the Company's report on Form 10-KSB, filed with
the Securities and Exchange Commission on October 14, 1997. Commission file
number 0-23524).
4.10 Transfer from Seacrest Capital Securities of PHC, Inc. and securities to
Summit Capital Limited dated 12/19/97. (Filed as exhibit 4.26 to the
Company's report on Form 10-KSB, filed with the Securities and Exchange
Commission on October 14, 1997. Commission file number 0-23524).
4.11 Warrant Agreement by and between PHC, Inc. and ProFutures Special Equities
Fund, LP for 3,000 shares of Class A Common Stock. (Filed as exhibit 4.27
to the Company's Current Report on Form 8-K, filed with the Securities and
Exchange Commission on April 29, 1998. Commission file number 0-23524).
4.12 Subscription Agreements and Warrants for Series B Convertible Preferred
Shares and Warrants by and between PHC, Inc., ProFutures Special Equities
Fund, L.P., Gary D. Halbert, John F. Mauldin and Augustine Fund, L.P. dated
March 16, 1998. (Filed as exhibit 4.28 to the Company's Current Report on
Form 8-K, filed with the Securities and Exchange Commission on April 29,
1998. Commission file number 0-23524).
4.13 Warrant to purchase up to 52,500 shares of Class A Common Stock by and
between PHC, Inc., and HealthCare Financial Partners, Inc. dated March 10,
1998. (Filed as exhibit 4.16 to the Company's Registration Statement on
Form SB-2 dated July 24, 1998. Commission file number 333-59927.)
4.14 Warrant to purchase up to 52,500 shares of Class A Common Stock by and
between PHC, Inc., and HealthCare Financial Partners, Inc. dated July 10,
1998. (Filed as exhibit 4.15 to the Company's Registration Statement on
Form SB-2 dated July 24, 1998. Commission file number 333-59927.)
4.15 Warrant Agreement by and between Joan Finsilver and PHC, Inc. dated
07/31/98 for 60,000 shares common stock. (Filed as exhibit 4.16 to the
Company's report on 10-KSB filed with the Securities and Exchange
Commission on October 13, 1998. Commission file number 0-23524. Replaces
exhibit 4.23 to the Company's report on Form 10-KSB. Filed with the
Securities and Exchange Commission on October 14, 1997. Commission file
number 0-23524).
4.16 Warrant Agreement by and between Brean Murray and Company and PHC, Inc.
dated 07/31/98 for 90,000 shares common stock. (Filed as exhibit 4.17 to
the Company's report on 10-KSB filed with the Securities and Exchange
Commission on October 13, 1998. Replaces exhibit 4.23 to the Company's
report on Form 10-KSB, filed with the Securities and Exchange Commission on
October 14, 1997. Commission file number 0-23524).
4.17 Warrant Agreement by and between HealthCare Financial Partners, Inc. and
its subsidiaries (collectively "HCFP" and PHC, Inc. dated July 10, 1998 -
Warrant No. 3 for 20,000 shares of Class A Common Stock. (Filed as exhibit
4.18 to the Company's report on Form 10-KSB, filed with the Securities and
Exchange Commission on October 14, 1997. Commission file number 0-23524).
4.18 Warrant Guaranty Agreement for Common Stock Purchase Warrants issuable by
PHC, Inc. dated August 14, 1998 for Warrants No 2 and No. 3. (Filed as
exhibit 4.19 to the Company's report on Form 10-KSB, filed with the
Securities and Exchange Commission on October 14, 1997. Commission file
number 0-23524.)
4.19 12% Convertible Debenture by and between PHC, Inc., and Dean & Co., dated
December 3, 1998 in the amount of $500,000. (Filed as exhibit 4.20 to the
Company's report on Form 10-QSB dated February 12, 1999. Commission file
number 0-23524).
4.20 Securities Purchase Agreement for 12% Convertible Debenture by and between
PHC, Inc. and Dean & Co., a Wisconsin nominee partnership for Common Stock.
(Filed as exhibit 4.21 to the Company's report on Form 10-QSB dated
February 12, 1999. Commission file number 0-23524).
4.21 Warrant Agreement to purchase up to 25,000 shares of Class A Common Stock
by and between PHC, Inc., and Dean & Co., dated December 3, 1998. (Filed as
exhibit 4.22 to the Company's report on Form 10-QSB dated February 12,
1999. Commission file number 0-23524).
4.22 Warrant Agreement by and between PHC, Inc., and National Securities
Corporation dated January 5, 1999 to purchase 37,500 shares of Class A
Common Stock. (Filed as exhibit 4.23 to the Company's report on Form 10-QSB
dated February 12, 1999. Commission file number 0-23524).
4.23 Warrant Agreements by and between PHC, Inc., and George H. Gordon for
10,000 shares, 15,000 shares, 5,000 shares, 5,000 shares, 50,000 shares and
10,000 shares of Class A Common Stock dated December 31, 1998; 5,000 shares
of Class A Common Stock dated December 1, 1998; 10,000 shares of Class A
Common Stock dated January 1, 1999; and 10,000 shares of Class A Common
Stock dated February 1, 1999. (Filed as exhibit 4.24 to the Company's
report on Form 10-QSB dated February 12, 1999. Commission file number
0-23524).
4.24 Warrant Agreement by and between PHC, Inc., and Barrow Street Research for
3,000 shares of Class A Common Stock dated February 23, 1999. (Filed as
exhibit 4.24 to the Company's Registration Statement on Form S-3 dated
April 13, 1999. Commission file number 333-76137).
4.25 Warrant Agreement by and between PHC, Inc., and George H. Gordon for 10,000
shares of Class A Common Stock dated March 1, 1999. (Filed as exhibit 4.25
to the Company's Registration Statement on Form S-3 dated April 13, 1999.
Commission file number 333-76137).
4.26 Warrant Agreement by and between PHC, Inc., and George H. Gordon for 10,000
shares of Class A Common Stock dated April 1, 1999. (Filed as exhibit 4.26
to the Company's Registration Statement on Form S-3 dated April 13, 1999.
Commission file number 333-76137).
4.27 Warrant Agreements by and between PHC, Inc., and George H. Gordon for
10,000 shares of Class A Common Stock dated May 1, 1999. (Filed as exhibit
4.27 to the Company's report on Form 10-QSB dated May 14, 1999. Commission
file number 0-23524).
*4.28 Warrant Agreements by and between PHC, Inc., and George H. Gordon for
10,000 shares of Class A Common Stock dated April 1, 1999. (Filed as
exhibit to the Company's report on Form 10-KSB dated October 13, 1999.
Commission file number 0-23524).
*4.29 Warrant Agreements by and between PHC, Inc., and George H. Gordon for
10,000 shares of Class A Common Stock dated July 1, 1999. (Filed as exhibit
to the Company's report on Form 10-KSB dated October 13, 1999, Commission
file number 0-23524).
*4.30 Warrant Agreements by and between PHC, Inc., and George H. Gordon for
10,000 shares of Class A Common Stock dated June 1, 1999. (Filed as exhibit
to the Company's report on Form 10-KSB dated October 13, 1999. Commission
file number 0-23524).
*4.31 Warrant to purchase up to 37,500 shares of Class A Common Stock by and
between PHC, Inc., and National Securities Corporation dated April 5, 1998.
(Filed as exhibit to the Company's report on Form 10-KSB dated October 13,
1999. Commission file number 0-23524.)
*4.32 Warrant to purchase up to 37,500 shares of Class A Common Stock by and
between PHC, Inc., and National Securities Corporation dated July 5, 1998.
(Filed as exhibit to the Company's report on Form 10-KSB dated October 13,
1999. Commission file number 0-23524.)
*4.33 Subscription Agreement and Warrants Series B Convertible Preferred Shares
and Warrants by and between PHC, Inc., ProFutures Special Equities Fund,
L.P., Gary D. Halbert John F. Mauldin and Augustine Fund L.P. dated March
16, 1998.
10.1 1993 Stock Purchase and Option Plan of PHC, Inc., as amended December 26,
1997. (Filed as exhibit 10.1 to the Company's Post-Effective Amendment No.
2 on Form S-3 to Registration Statement on Form SB-2 under the Securities
Act of 1933 dated November 13, 1995. Commission file number 333-71418).
10.2 Form of Warrant Agreement for Bridge financing with List of bridge
investors holding warrant agreements and corresponding numbers of bridge
units for which warrant is exercisable. (Filed as exhibit 10.6 to the
Company's Registration Statement on Form SB-2 dated March 2, 1994.
Commission file number 333-71418).
10.3 Lease Agreement between Palmer-Wells Enterprises and AIHS, Inc. and Edwin
G. Brown, dated September 23, 1983, with Addendum dated March 23, 1989, and
Renewal of Addendum dated April 7, 1992. (Filed as exhibit 10.14 to the
Company's Registration Statement on Form SB-2 dated March 2, 1994.
Commission file number 333-71418).
10.4 Note of PHC of Virginia, Inc. in favor of Himanshu S. Patel and Anna H.
Patel, dated April 1, 1995, in the amount of $10,000. (Filed as exhibit
10.29 to the Company's annual report on Form 10-KSB. Filed with the
Securities and Exchange on October 2, 1995. Commission file number
0-23524).
10.5 Note of PHC of Virginia, Inc. in favor of Mukesh P. Patel and Falguni M.
Patel, dated April 1, 1993, in the amount of $10,000. (Filed as exhibit
10.30 to the Company's Registration Statement on Form SB-2 dated March 2,
1994. Commission file number 333-71418).
10.6 Deed of Trust Note of Mount Regis Center Limited Partnership in favor of
Douglas M. Roberts, dated July 28, 1987, in the amount of $560,000,
guaranteed by PHC, Inc., with Deed of Trust executed by Mount Regis Center,
Limited Partnership of even date. (Filed as exhibit 10.33 to Form SB-2
dated March 2, 1994). Assignment and Assumption of Limited Partnership
Interest, by and between PHC of Virginia Inc. and each assignor dated as of
June 30, 1994. (Filed as exhibit 10.57 to Form 10-KSB on September 28,
1994.)
10.7 Security Agreement Note of PHC of Virginia, Inc. in favor of Mount Regis
Center, Inc., dated July 28, 1987, in the amount of $90,000, guaranteed by
PHC, Inc., with Security Agreement, dated July 1987. (Filed as exhibit
10.34 to the Company's Registration Statement on Form SB-2 dated March 2,
1994. Commission file number 333-71418).
10.8 Copy of Note of Bruce A. Shear in favor of Steven J. Shear, dated December
1988, in the amount of $195,695; Pledge Agreement by and between Bruce A.
Shear and Steven J. Shear, dated December 15, 1988; Stock Purchase
Agreement by and between Steven J. Shear and Bruce A. Shear, dated December
1, 1988. (Filed as exhibit 10.52 to the Company's Registration Statement on
Form SB-2 dated March 2, 1994. Commission file number 333-71418).
10.9 Lease Agreement by and between Conestoga Corp. and PHC, Inc., dated July
11, 1994. (Filed as exhibit 10.69 to the Company's annual report on Form
10-KSB, filed with the Securities and Exchange Commission on September 28,
1994. Commission file number 0-23524).
10.10 Renewal of Lease Addendum between Palmer Wells Enterprises and PHC of
Utah, Inc., executed February 20, 1995. (Filed as exhibit 10.73 to the
Company's annual report on Form 10-KSB, filed with the Securities and
Exchange on October 2, 1995. Commission file number 0-23524)
10.11 1995 Employee Stock Purchase Plan.(Filed as exhibit 10.74 to the Company's
Post-Effective Amendment No. 2 on Form S-3 to Registration Statement on
Form SB-2 under the Securities Act of 1933 dated November 13, 1995.
Commission file number 333-71418. As amended on Form S-8 dated March 12,
1999. Commission File number 333-74373).
10.12 1995 Employee Stock Purchase Plan. (Filed as exhibit 10.74 to the
Company's Post-Effective Amendment No. 2 on Form S-3 to Registration
Statement on Form SB-2 under the Securities Act of 1933 dated November 13,
1995. Commission file number 333-71418. As amended on Form S-8 dated March
12, 1999. Commission File number 333-74373).
10.13 1995 Non-Employee Director Stock Option Plan. (Filed as exhibit 10.75 to
the Company's Post-Effective Amendment No. 2 on Form S-3 to Registration
Statement on Form SB-2 under the Securities Act of 1933 dated November 13,
1995. Commission file number 333-71418. As amended on Form S-8 dated March
12, 1999. Commission File number 333-74373).
10.14 Note of PHC of Nevada, Inc., in favor of LINC Anthem Corporation, dated
November 7, 1995; Security Agreement of PHC, Inc., PHC of Rhode Island,
Inc., and PHC of Virginia, Inc., in favor of LINC Anthem Corporation, dated
November 7, 1995; Loan and Security Agreement of PHC of Nevada, Inc., in
favor of LINC Anthem Corporation, dated November 7, 1995; Guaranty of PHC,
Inc., in favor of LINC Anthem Corporation, dated November 7, 1995; Stock
Pledge and Security Agreement of PHC, Inc., in favor of LINC Anthem
Corporation, dated November 7, 1995. (Filed as exhibit 10.76 to the
Company's Post-Effective Amendment No. 2 on Form S-3 to Registration
Statement on Form SB-2 under the Securities Act of 1933 dated November 13,
1995. Commission file number 333-71418).
10.15 Secured Promissory Note in the amount of $750,000 by and between PHC of
Nevada, Inc. and LINC Anthem Corp. (Filed as exhibit 10.77 to the Company's
Post-Effective Amendment No. 2 on Form S-3 to Registration Statement on
Form SB-2 under the Securities Act of 1933 dated November 13, 1995.
Commission file number 333-71418).
10.16 Stock Pledge by and between PHC, Inc. and Linc Anthem Corporation. (Filed
as exhibit 10.81 to the Company's report on Form 10-KSB, filed with the
Securities and Exchange Commission on September 28, 1994.)
10.17 Custodial Agreement by and between LINC Anthem Corporation and PHC, Inc.
and Choate, Hall and Stewart dated July 25, 1996. (Filed as exhibit 10.85
to the Company's quarterly report on Form 10-QSB, filed with the Securities
and Exchange Commission on February 25, 1997. Commission file number
0-23524)
10.18 Loan and Security Agreement by and between Northpoint-Pioneer Inc. and
LINC Anthem Corporation dated July 25, 1996. (Filed as exhibit 10.86 to the
Company's quarterly report on Form 10-QSB, filed with the Securities and
Exchange Commission on December 5, 1996. Commission file number 0-23524).
10.19 Coporate Guaranty by PHC, Inc., PHC of Rhode Island, Inc., PHC of
Virginia, Inc., PHC of Nevada, Inc. and LINC Anthem Corporation dated July
25, 1996 for North Point-Pioneer, Inc. (Filed as exhibit 10.87 to the
Company's quarterly report on Form 10-QSB, filed with the Securities and
Exchange Commission on December 5, 1996. Commission file number 0-23524).
10.20 Stock Pledge and Security Agreement by and between PHC, Inc. and LINC
Anthem Corporation. (Filed as exhibit 10.88 to the Company's quarterly
report on Form 10-QSB, filed with the Securities and Exchange Commission on
December 5, 1996. Commission file number 0-23524).
10.21Secured Promissory Note of North Point-Pioneer, Inc. in favor of LINC
Anthem Corporation dated July 25, 1996 in the amount of $500,000. (Filed as
exhibit 10.89 to the Company's quarterly report on Form 10-QSB, filed with
the Securities and Exchange Commission on December 5, 1996. Commission file
number 0-23524).
10.22 Lease Agreement by and between PHC, Inc. and 94-19 Associates dated
October 31, 1996 for BSC-NY, Inc. (Filed as exhibit 10.90 to the Company's
quarterly report on Form 10-QSB, filed with the Securities and Exchange
Commission on December 5, 1996. Commission file number 0-23524).
10.23 Note by and between PHC Inc. and Yakov Burstein in the amount of $180,000.
(Filed as exhibit 10.91 to the Company's quarterly report on Form 10-QSB,
filed with the Securities and Exchange Commission on December 5, 1996.
Commission file number 0-23524).
10.24 Note by and between PHC, Inc. and Irwin Mansdorf in the amount of
$570,000. (Filed as exhibit 10.92 to the Company's quarterly report on Form
10-QSB, filed with the Securities and Exchange Commission on December 5,
1996. Commission file number 0-23524).
10.25 Employment Agreement by and between BSC-NY, Inc. and Yakov Burstein dated
November 1, 1996. (Filed as exhibit 10.93 to the Company's quarterly report
on Form 10-QSB, filed with the Securities and Exchange Commission on
December 5, 1996. Commission file number 0-23524).
10.26 Consulting Agreement by and between BSC-NY, Inc. and Irwin Mansdorf dated
November 1, 1996. (Filed as exhibit 10.94 to the Company's quarterly report
on Form 10-QSB, filed with the Securities and Exchange Commission on
December 5, 1996. Commission file number 0-23524).
10.27 Agreement and Plan of Merger by and among PHC, Inc., BSC-NY, Inc.,
Behavioral Stress Centers, Inc., Irwin Mansdorf, and Yakov Burstein dated
October 31, 1996. (Filed as exhibit 10.95 to the Company's quarterly report
on Form 10-QSB, filed with the Securities and Exchange Commission on
December 5, 1996. Commission file number 0-23524).
10.28 Employment Agreement by and between Perlow Physicians, P.C. and Yakov
Burstein dated November 1, 1996. (Filed as exhibit 10.98 to the Company's
quarterly report on Form 10-QSB, filed with the Securities and Exchange
Commission on December 5, 1996. Commission file number 0-23524).
10.29 Agreement for Purchase and Sale of Assets by and between Clinical
Associates and Clinical Diagnostics and PHC, Inc., BSC-NY, Inc., Perlow
Physicians, P.C., Irwin Mansdorf, and Yakov Burstein dated October 31,
1996. (Filed as exhibit 10.99 to the Company's quarterly report on Form
10-QSB, filed with the Securities and Exchange Commission on December 5,
1996. Commission file number 0-23524).
10.30 Consulting Agreement by and between Perlow Physicians, P.C. and Irwin
Mansdorf dated November 1, 1996. (Filed as exhibit 10.100 to the Company's
quarterly report on Form 10-QSB, filed with the Securities and Exchange
Commission on December 5, 1996. Commission file number 0-23524).
10.31 Mortgage by and between PHC of Michigan, Inc. and HCFP Funding Inc. dated
January 13, 1997 in the amount of $2,000,000. (Filed as exhibit 10.106 to
the Company's quarterly report on Form 10-QSB, filed with the Securities
and Exchange Commission on February 25, 1997 Commission file number
0-23524).
10.32 Employment Agreement for Dr. Himanshu Patel; Employment Agreement for Dr.
Mukesh Patel; and Fringe Benefit Exhibit for both of the Patels' Employment
Agreements. (Filed as exhibit 10.107 to the Company's quarterly report on
Form 10-QSB, filed with the Securities and Exchange Commission on February
25, 1997. Commission file number 0-23524).
10.33 Unconditional Guaranty of Payment and performance by and between PHC, Inc.
in favor of HCFP. (Filed as exhibit 10.112 to the Company's quarterly
report on Form 10-QSB, filed with the Securities and Exchange Commission on
February 25, 1997. Commission file number 0-23524).
10.34 Amendment number 1 to Loan and Security Agreement dated May 21, 1996 by
and between PHC, of Utah, Inc. and HCFP Funding providing collateral for
the PHC of Michigan, Inc. Loan and Security Agreement. (Filed as exhibit
10.113 to the Company's quarterly report on Form 10-QSB, filed with the
Securities and Exchange Commission on February 25, 1997 Commission
file number 0-23524).
10.35 Employment Agreement by and between Perlow Physicians P.C. and Nissan
Shliselberg, M.D dated March 1997. (Filed as exhibit 10.114 to the
Company's Registration Statement on Form SB-2 dated April 15, 1997.
Commission file number 333-25231).
10.36 Option and Indemnity Agreement by and between PHC, Inc. and Nissan
Shliselberg, M.D dated February 1997. (Filed as exhibit 10.115 to the
Company's Registration Statement on Form SB-2 dated April 15, 1997.
Commission file number 333-25231).
10.37 Secured Term Note by and between PHC of Michigan, Inc. and Healthcare
Financial Partners - Funding II, L.P. in the amount of $1,100,000 dated
March 1997. (Filed as exhibit 10.116 to the Company's Registration
Statement on Form SB-2 dated April 15, 1997. Commission file number
333-25231).
10.38 Mortgage between PHC of Michigan, Inc. and Healthcare Financial Partners -
Funding II, L.P. in the amount of $1,100,000 dated March 1997 for Secured
Term Note. (Filed as exhibit 10.117 to the Company's Registration Statement
on Form SB-2 dated April 15, 1997. Commission file number 333-25231).
10.39 Submission of Lease between PHC, Inc. and Conestoga Corporation dated
11/09/95 for space at 200 Lake Street, Suite 101b, Peabody, MA 01960.
(Filed as exhibit 10.119 to the Company's Registration Statement on Form
SB-2 dated April 15, 1997. Commission file number 333-25231).
10.40 Master Equipment Lease Agreement by and between PHC, Inc. and LINC Capital
Partners dated March 18, 1997 in the amount of $200,000. (Filed as exhibit
10.121 to the Company's Registration Statement on Form SB-2 dated April 15,
1997. Commission file number 333-25231).
10.41 Agreement between Family Independence Agency and Harbor Oaks Hospital
effective January 1, 1997. (Filed as exhibit 10.122 to the Company's report
on Form 10-KSB, with the Securities and Exchange Commission on October 14,
1997. Commission file number 0-23524).
10.42 Master Contract by and between Family Independence Agency and Harbor Oaks
Hospital effective January 1, 1997. (Filed as exhibit 10.122 to the
Company's report on Form 10-KSB, filed with the Securities and Exchange
Commission on October 14, 1997. Commission file number 0-23524).
10.43 Deed, Deed of Trust and Deed Trust Note in the amount of $540,000 by and
between Dillon and Dillon Associates and Pioneer Counseling of Virginia,
Inc. (Filed as exhibit 10.124 to the Company's report on Form 10-KSB, filed
with the Securities and Exchange Commission on October 14, 1997. Commission
file number 0-23524).
10.44 Financial Advisory Agreement, Indemnification Agreement and Form of
Warrant by and between Brean Murray & Compay and PHC, Inc. dated 06/01/97.
(Filed as exhibit 10.125 to the Company's report on Form 10-KSB, filed with
the Securities and Exchange Commission on October 14, 1997. Commission file
number 0-23524).
10.45 Secured Term Note; Mortgage; Environmental Indemnity; Agreement Guaranty
by PHC, Inc.; and Amendment No. 2 Loan and Security Agreement by and
between Healthcare Financial; and PHC, Inc. of Michigan dated December
1997. (Filed as exhibit 10.129 to the Company's Registration Statement on
Form SB-2 dated January 8, 1997. Commission file number 333-25231).
10.46First Amendment to Sale and Purchase Agreement by and between LINC
Financial Services, Inc., LINC Finance Corporation VII and PHC of Rhode
Island dated January 20, 1995 and Sale and Purchase Agreement dated March
6, 1995. (Filed as exhibit 10.132 to the Company's 10-QSB dated February
17, 1998).
10.47 Agreement by and between PHC, Inc., and Irwin Mansdorf and Yakov Burstein
dated March 2, 1998. (Filed as exhibit 10.135 to the Company's Current
Report on Form 8-K, filed with the Securities and Exchange Commission.
Commission file number 0-23524 on April 29, 1998).
10.48 Secured Bridge Loan to be made to PHC, Inc. by HCFP Funding II, Inc. in
the amount of $350,000 dated March 10, 1998. (Filed as exhibit 10.136 to
the Company's Current Report on Form 8-K, filed with the Securities and
Exchange Commission. Commission file number 0-23524 on April 29, 1998).
10.49 First Amendment to Mortgage between PHC of Michigan, Inc. and HCFP
Funding, Inc. (Filed as Exhibit 10.137 to the Company's 10-QSB filed on May
15, 1998. Commission file number 0-23524).
10.50 Secured Unconditional Guaranty of Payment and performance by and between
BSC-NY, Inc. and HCFP Funding II, Inc. in the amount of $350,000. (Filed as
exhibit 10.58 to the Company's Registration Statement on Form SB-2 dated
July 24, 1998. Commission file number 333-59927).
10.51 Loan and Security Agreement by and among HCFP Funding, Inc., and PHC of
Michigan, Inc., PHC of Utah, Inc., PHC of Virginia, Inc., PHC of Rhode
Island, Inc., and Pioneer Counseling of Virginia, Inc. dated as of February
18, 1998. (Filed as exhibit 10.59 to the Company's Registration Statement
on Form SB-2 dated July 24, 1998. Commission file number 333-59927).
10.52 Credit Line Deed of Trust by and between PHC of Virginia, Inc., and HCFP
Funding II, Inc. dated July 1998. (Filed as exhibit 10.60 to the Company's
Registration Statement on Form SB-2 dated July 24, 1998. Commission file
number 333-59927).
10.53 Amendment No. 1 to Secured Bridge Note dated July 10, 1998 by and between
PHC, Inc. and HCFP Funding II, Inc. (Filed as exhibit 10.61 to the
Company's Registration Statement on Form SB-2 dated July 24, 1998.
Commission file number 333-59927).
10.54 Promissory Note for $50,000 dated May 18, 1998 by and between PHC, Inc.
and Tot Care, Inc. (Filed as exhibit 10.62 to the Company's Registration
Statement on Form SB-2 dated July 24, 1998. Commission file number
333-59927).
10.55 Promissory Note for $50,000 dated June 9, 1998 by and between PHC, Inc.
and Tot Care, Inc. (Filed as exhibit 10.63 to the Company's Registration
Statement on Form SB-2 dated July 24, 1998. Commission file number
333-59927).
10.56 Letter Agreement dated May 31, 1998 by and between NMI Realty, Inc. and
PHC of Rhode Island, Inc. to terminate the Lease and Option Agreement
entered into March 16, 1994. (Filed as exhibit 10.64 to the Company's
Registration Statement on Form SB-2 dated July 24, 1998. Commission file
number 333-59927).
10.57 Amendment No. 1 to Loan and Security Agreement in the amount of
$4,000,000.00 by and among HCFP Funding, Inc., and PHC of Michigan, Inc.,
PHC of Utah, Inc., PHC of Virginia, Inc., PHC of Rhode Island, Inc., and
Pioneer Counseling of Virginia, Inc. dated as of February 18, 1998. (Filed
as exhibit 10.65 to the Company's report on Form 10-KSB dated October 13,
1998. Commission file number 0-23524).
10.58 Promissory Note by and between PHC, Inc. and Bruce A. Shear dated August
13, 1998, in the amount of $100,000. (Filed as exhibit 10.66 to the
Company's report on Form 10-QSB dated November 3, 1998. Commission file
number 0-23524).
10.59 Amendment to Overline Letter Agreement pursuant to the Loan and Security
Agreement by and among HCFP Funding, Inc., and PHC of Michigan, Inc., PHC
of Utah, Inc., PHC of Virginia, Inc., PHC of Rhode Island, Inc., and
Pioneer Counseling of Virginia, Inc. dated June 8, 1998 extending the
maturity date from November 10, 1998 to May 10, 1999. (Filed as exhibit
10.67 to the Company's report on Form 10-QSB filed with the Securities and
Exchange Commission on February 12, 1999. Commission file number 0-23524).
10.60 The Overline Letter agreement pursuant to the Loan and Security Agreement
by and among HCFP Funding, Inc., and PHC of Michigan, Inc., PHC of Utah,
Inc., PHC of Virginia, Inc., PHC of Rhode Island, Inc., and Pioneer
Counseling of Virginia, Inc. dated as of February 18, 1998 extending the
maturity date from November 10, 1998 to May 10, 1999. (Filed as exhibit
10.68 to the Company's Registration Statement on Form 10-QSB dated February
12, 1999. Commission file number 0-23524).
10.61 Financial Advisory and Consultant Agreement by and between National
Securities Corporation and PHC, Inc. dated 01/05/99 (Filed as exhibit 10.69
to the Company's report on Form 10-Q-SB dated February 12, 1999. Commission
file number 0-23524).
10.62 Agreementfor Purchase and Sale of Pioneer Counseling of Virginia, Inc. to
Dr. Mukesh Patel and Dr. Himanshu Patel dated February 15, 1999. (Filed as
exhibit 10.62 to the Company's Report on Form 10-QSB filed with the
Securities and Exchange Commission on May 14, 1999. Commission file number
0-23524).
10.63 Letter Agreement by and between PHC, Inc. and Dr. Mukesh Patel and Dr.
Himanshu Patel dated March 3, 1999 regarding the transfer of minority
ownership in Pioneer Counseling of Virginia, Inc. to PHC, Inc. (Filed as
exhibit 10.63 to the Company's Report on Form 10-QSB filed with the
Securities and Exchange Commission on May 14, 1999. Commission file number
0-23524).
10.64 Seller's Settlement Statement related to the sale of the real estate owned
by Pioneer Counseling of Virginia, Inc. dated March 15, 1999. (Filed as
exhibit 10.64 to the Company's Report on Form 10-QSB filed with the
Securities and Exchange Commission on May 14, 1999. Commission file number
0-23524).
*10.65 This amendment no. 2 to secured bridge note (the "Amendment") is hereby
entered into as of the 10th day of May 1999 by and among PHC, INC., a
Massachusetts corporation ("Borrower"), and HCFP FUNDING II, INC., a
Delaware corporation ("Lender"). (Filed as an exhibit to the Company's
report on Form 10-KSB dated October 13, 1999. Commission file number
0-23524).
*10.66 Loan and Security Agreement by and between Heller Healthcare Finance,
Inc. f/k/a HCFP Funding, Inc. and PHC of Michigan, Inc. PHC of Utah, Inc.
PHC of Virginia, Inc. PHC of Rhode Island, Inc. and Pioneer Counseling of
Virginia, Inc. dated August 11, 1999. (Filed as an exhibit to the Company's
report on Form 10-KSB dated October 13, 1999. Commission file number
0-23524).
*10.67 Amendment number 3 to Secured Bridge Note dated May 10, 1999 by and
between PHC, Inc. and HCFP (Filed as exhibit to the Company's report on
Form 10-KSB, filed with the Securities and Exchange Commission on October
13, 1999. Commission file number 0-23524).
16.1 Letter on Change in Independent Public Accountants. (Filed as an exhibit to
the Company's report on Form 10-KSB, filed with the Securities and Exchange
Commission on September 28, 1994 and as exhibit 16.1 in the Company's
Current Report on Form 8-K, filed with the Securities and Exchange
Commission. Commission file number 0-23524 on April 29, 1998).
*21.1 List of Subsidiaries. (Filed as an exhibit to the Company's report on Form
10-KSB dated October 13, 1999. Commission file number 0-23524).
23.1 Consent of Independent Auditors.
27 Financial Data Schedule
99.1 Cautionary Statement for Purposes of the "Safe Harbor" Provisions of the
Private Securities Litigation Reform Act of 1995.
* Filed herewith
(b) REPORTS ON FROM 8-K
The Company filed no reports on Form 8-K during the Quarater ended June
30, 1999.
SIGNATURES
In accordance with Section 13 or 15(d) of the Securities Exchange Act of
1934, the registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
PHC, INC.
Date: October 13, 1999 By: /s/ Bruce A. Shear, President and
Chief Executive Officer
In accordance with the Securities Exchange Act of 1934, the following
persons on behalf of the registrant and in the capacities and on the dates
indicated have signed this report below.
/s/ Bruce A. Shear President, Chief Executive October 13 , 1999
Officer and Director
(principal executive officer)
/s/ Paula C. Wurts Controller and Assistant October 13 , 1999
Treasurer (principal financial
and accounting officer)
/s/ Gerald M. Perlow Director October 13 , 1999
/s/ Donald E. Robar Director October 13 , 1999
__________________ Director
Howard Phillips
/s/ William F. Grieco Director October 13 , 1999
PHC, INC. AND SUBSIDIARIES
Contents
Consolidated Financial Statements
Independent auditors' report F-2
Consolidated balance sheets F-3
Consolidated statements of operations F-4
Consolidated statements of changes in stockholders' equity F-5
Consolidated statements of cash flows F-6, F-7
Consolidated notes to financial statements F-8
F-1
INDEPENDENT AUDITORS' REPORT
Board of Directors and Stockholders
PHC, Inc.
Peabody, Massachusetts
We have audited the accompanying Consolidated balance sheets of PHC, Inc. and
subsidiaries as of June 30, 1999 and 1998 and the related consolidated
statements of operations, changes in stockholders' equity, and cash flows for
the years then ended. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the consolidated financial position of PHC,
Inc. and subsidiaries at June 30, 1999 and 1998 and the results of their
operations and their cash flows for the years then ended in conformity with
generally accepted accounting principles.
The consolidated financial statements referred to above as of June 30, 1998 and
for the year then ended have been restated (See Note P).
BDO Seidman, LLP
Boston, Massachusetts
September 10, 1999
F2
PHC, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
June 30,
1999 1998
(as restated)
____ ___________
ASSETS (Notes C and D)
Current assets:
Cash and cash equivalents (Note A) $ 381,170 $ 227,077
Accounts receivable, net of allowance for
doubtful accounts of $3,647,848 at June 30,
1999 and $3,488,029 at June 30, 1998
(Notes A, L and M) 6,343,227 7,441,972
Prepaid expenses 101,865 156,695
Other receivables and advances 334,155 127,064
Deferred income tax asset (Note F) 459,280 515,300
Other receivables, related party 53,517 64,065
___________ ___________
Total current assets 7,673,214 8,532,173
Accounts receivable, noncurrent 595,000 685,000
Other receivables, noncurrent, related party,
net of allowance for doubtful accounts of
$782,000 in 1999 and $382,000 in 1998(Note K) 2,908,113 2,941,402
Other receivables 109,165 426,195
Property and equipment, net (Notes A, B and D) 1,483,319 2,128,273
Deferred income tax asset (Note F) 154,700 154,700
Deferred financing costs, net of amortization
of $64,041 and $18,065 at June 30, 1999 and
1998, respectively 45,067 53,608
Goodwill, net of accumulated amortization of
$116,900 and $307,707 at June 30, 1999 and 1998,
respectively (Note A) 1,761,075 2,011,613
Other assets (Note A) 297,781 19,386
___________ ___________
Total assets $15,027,434 $16,952,350
___________ ___________
LIABILITIES
Current liabilities:
Accounts payable $ 1,832,750 $ 2,346,213
Notes payable - related parties (Note E) 200,000 159,496
Current maturities of long-term debt (Note C) 1,286,318 1,107,167
Revolving credit note (Note C) 1,669,830 1,683,458
Current portion of obligations under capital
leases (Note D) 60,815 67,492
Accrued payroll, payroll taxes and benefits 333,955 729,194
Accrued expenses and other liabilities 1,459,290 1,004,763
Deferred Gain (Note A and I) 2,641,537 2,641,537
___________ ___________
Total current liabilities 9,484,495 9,739,320
Long-term debt, less current maturities (Note C) 1,730,230 2,850,089
Obligations under capital leases (Note D) 51,657 93,747
Convertible debentures (Note C) 500,000 --
___________ ___________
Total noncurrent liabilities 2,281,887 2,943,836
___________ ___________
Total liabilities 11,766,382 12,683,156
___________ ___________
Commitments and contingent liabilities
(Notes A, D, G, H, J, and K)
STOCKHOLDERS' EQUITY (Notes H, J and K)
Convertible Preferred stock, $.01 par value;
1,000,000 shares authorized, 813 and 950
shares issued and outstanding June 30, 1999
and 1998 respectively 8 10
Class A common stock, $.01 par value; 20,000,000
shares authorized, 5,612,930 and 4,935,267
shares issued June 30,1999 and 1998, respectively 56,129 49,353
Class B common stock, $.01 par value; 2,000,000
shares authorized, 727,210 and 727,328
issued and outstanding June 30, 1999 and 1998,
respectively, convertible into one share of
Class A common stock 7,272 7,273
Additional paid-in capital 15,967,176 15,485,895
Treasury stock, 2,776 common shares at cost June
30, 1999 and 1998 (12,122) (12,122)
Accumulated deficit (12,757,411) (11,261,215)
___________ ____________
Total stockholders' equity 3,261,052 4,269,194
___________ ___________
Total liabilities and stockholders' equity $15,027,434 $16,952,350
___________ ___________
See notes to financial statements
F-3
PHC, INC. AND SUBSIDIARIES
Consolidated Statements of Operations
For the Year Ended June 30,
1999 1998
(as restated)
Revenues:
Patient care, net (Note A) $ 17,529,978 $ 19,649,353
Management fees (Note K) 666,881 833,750
Other 942,637 763,086
Total revenues 19,139,496 21,246,189
Operating expenses:
Patient care expenses 9,384,070 10,706,639
Cost of management contracts 259,012 467,065
Provision for doubtful accounts 2,183,139 3,684,452
Administrative expenses 7,865,013 9,488,631
Total operating expenses 19,691,234 24,346,787
___________ _____________
Loss from operations (551,738) (3,100,598)
Other income (expense):
Interest income 451,271 391,353
Interest expense (1,258,314) (1,289,642)
Other income, net 64,129 58,583
___________ _____________
Total other expense, net (742,914) (839,706)
Loss before income taxes (1,294,652) (3,940,304)
Income taxes (Note F) 59,434 219,239
Loss from continuing operations (1,354,086) (4,159,543)
Loss from discontinued operations
(Notes A and I) -- (2,220,296)
Net loss (1,354,086) (6,379,839)
Dividends (Note J) (142,110) (207,060)
Loss applicable to common shareholders $ (1,496,196) $ (6,586,899)
Basic and diluted loss per common share
(Note A):
Continuing operations $ (.25) $ (.84)
Discontinued operations -- (.42)
Total $ (.25) $ (1.26)
Basic and diluted weighted average
number of shares outstanding 6,008,263 5,237,168
See notes to financial statements.
F-4
PHC, INC. AND SUBSIDIARIES
Consolidated Statements of Changes In Stockholders' Equity (See Notes A, C, H, J, K and N)
Class A Class B Class C
Common Stock Common Stock Common Stock Preferred Stock
Shares Amount Shares Amount Shares Amount Shares Amount
Balance - June 30, 1997 2,877,836 $28,778 730,360 $ 7,304 199,816 $ 1,998 500 $ 5
Conversion of debt 1,331,696 13,317
Conversion of preferred stock
series A 246,305 2,463 (500) (5)
Issuance of shares with
acquisition 41,024 410
Issuance private placement
shares 172,414 1,724
Conversion of shares 3,032 31 (3,032) (31)
Cancel class C common stock (199,816) (1,998)
Issue warrants for services
Issuance of shares with
consulting agreement 20,870 209
Issuance of shares with
earn out agreement 227,347 2,274
Issuance of employee stock purchase
plan shares 14,743 147
Issuance of preferred stock Series B 950 10
Adjustment related to beneficial
conversion feature of convertible
preferred stock
Warrant issued with debt
Treasury stock issued to employees
Dividends on preferred stock
Costs related to private placements
Net Loss - year ended June 30, 1998 -- -- -- -- -- -- -- --
_______ _______ _______ _______ ______ ________ ______ ______
Balance -June 30, 1998
(as restated) 4,935,267 $49,353 727,328 $7,273 0 $0 950 $10
Costs related to private placement
Conversion of preferred stock 248,129 2,481 (190) (3)
Price guarantee shares 304,097 3,041
Issue warrants for services
Issuance of shares with consulting
agreement 56,470 564
Issuance of shares with earn out
agreement 53,374 534
Issuance of employee stock
purchase plan shares 15,475 155
Issue warrants for financing
Conversion from class B to class A 118 1 (118) (1)
Dividends on preferred stock 53 l
Net Loss - year ended June 30, 1999 -- -- -- -- -- -- -- --
_______ _______ _______ _______ ______ ________ ______ ______
Balance - June 30, 1999 5,612,930 $56,129 727,210 $7,272 0 $ 0 813 $ 8
See notes to financial statements.
PHC, INC. AND SUBSIDIARIES (con't)
Consolidated Statements of Changes In Stockholders' Equity (See Notes A, C, H,
J, K and N)
Additional
Paid-in
Capital,
Common Treasury Shares Accumulated
Stock Shares Amount Deficit Total
_____________ ________ ______ ____________ _____
Balance - June 30,
1997 $10,398,630 8,656 $(37,818) $(4,674,316) $5,724,581
Conversion of debt 2,696,789 2,710,106
Conversion of preferred
stock series A (2,458) 0
Issuance of shares with
acquisition 79,605 80,015
Issuance private placement
shares 498,276 500,000
Conversion of shares -0-
Cancel class C common
stock 1,998 -0-
Issue warrants for
services 184,523 184,523
Issuance of shares with
consulting agreement 36,249 36,458
Issuance of shares with
earn out agreement 531,991 534,265
Issuance of employee
stock purchase plan
shares 35,750 35,897
Issuance of preferred
stock series B 949,990 950,000
Adjustment related to
beneficial conversion
feature of convertible
preferred stock 190,000 (190,000) -0-
Warrant issued with debt 48,809 48,809
Treasury stock issued to
employees (5,880) 25,696 25,696
Dividends on preferred stock (17,060) (17,060)
Costs related to private
placements (164,257) (164,257)
Net loss-year ended June
30, 1998 -- -- -- (6,379,839) (6,379,839)
_____________ ________ ______ ____________ _________
Balance - June 30,
1998 as restated) $15,485,895 2,776 $(12,122) $(11,261,215) $ 4,269,194
Costs related to private
placement (56,565) (56,565)
Conversion of preferred
stock 91,959 (92,569) 1,868
Price guarantee shares 117,076 120,117
Issue warrants for
services 108,354 108,354
Issuance of shares with
consulting agreement 38,436 39,000
Issuance of shares with
earn out agreement 59,513 60,047
Issuance of employee
stock purchase plan
shares 18,261 18,415
Issue warrants for
financing 51,248 51,248
Conversion from class B
to class A
Dividends on preferred
stock 52,999 (49,541) 3,460
Net Loss-year ended June
30, 1999 -- -- -- (1,354,086) (1,354,086)
_____________ ________ ________ ____________ __________
Balance-June 30, 1999 15,967,176 2,776 ($2,122) $(12,757,411) $3,261,052
See notes to financial statements
F-5
PHC, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
For the Year Ended June 30,
1999 1998
____ ____
(as restated)
Cash flows from operating activities:
Net loss $(1,354,086) $(6,379,839)
Adjustments to reconcile net loss to
net cash provided by (used in)
operating activities:
Depreciation and amortization 325,764 674,162
Compensatory stock options and
stock and warrants issued
for obligations 279,719 269,790
Changes in:
Accounts receivable 1,188,745 1,544,791
Prepaid expenses and other
current assets (141,713) 257,173
Other assets 693,275 (257,941)
Accounts payable (513,463) (182,913)
Accrued expenses and other liabilities 59,288 758,072
Net liabilities of discontinued operations -- 1,161,903
____________ _____________
Net cash provided by (used in)
operating activities 537,529 (2,154,802)
____________ _____________
Cash flows from investing activities:
Acquisition of property and equipment
and intangibles (115,254) (212,492)
Loan receivable -- 152,749
____________ _____________
Net cash (used in) investing
activities (115,254) (59,743)
____________ _____________
Cash flows from financing activities:
Revolving debt, net 13,628 (106,513)
Proceeds from borrowings 485,829 950,000
Payments on debt (1,274,969) (557,883)
Deferred financing costs -- 6,967
Preferred stock dividends (7,681) (17,060)
Issuance of capital stock 15,011 1,321,640
Convertible debt 500,000 --
____________ _____________
Net cash provided by (used in)
financing activities (268,182) 1,597,151
____________ _____________
Net increase (decrease) in cash and
cash equivalents 154,093 (617,394)
Beginning balance of cash and cash equivalents 227,077 844,471
____________ _____________
Ending balance of cash and cash equivalents $ 381,170 $ 227,077
____________ _____________
Supplemental cash flow information:
Cash paid during the period for:
Interest $1,227,628 $1,567,763
Income taxes $ 189,027 $ 130,290
See notes to financial statements
F-6
Supplemental disclosures of noncash investing and financing
activities:
Stock issued for acquisitions and earn-out agreement $ 60,047 $614,280
Capital leases 25,010 83,082
Conversion of preferred stock 190,000 500,000
Beneficial conversion feature of preferred stock -- 190,000
Warrant Valuations 159,602 233,332
Conversion of Debt to Common Stock -- 2,710,106
Issuance of Preferred Stock in lieu of cash for
Dividends due 53,000 --
Issuance of Common Stock in lieu of Preferred Stock
Dividends 81,429 --
See notes to financial statements F-7
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE A - THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation and consolidation:
PHC, Inc. ("PHC" or the "Company") operates substance abuse treatment centers in
several locations in the United States, a psychiatric hospital in Michigan and
psychiatric outpatient facilities in Nevada, Kansas and Michigan. PHC also
manages a psychiatric practice in New York, operates an outpatient facility
through a physicians practice, and operates behavioral health centers and
maintains a behavioral health web site. PHC of Utah, Inc. ("PHU") and PHC of
Virginia, Inc. ("PHV") provide treatment of addictive disorders and chemical
dependency. PHC of Michigan, Inc. ("PHM") provides inpatient and outpatient
psychiatric care. PHC of Nevada, Inc. ("PHN") and PHC of Kansas, Inc. ("PHK")
provide psychiatric treatment on an outpatient basis. North Point-Pioneer, Inc.
("NPP") operates four outpatient behavioral health centers under the name of
Pioneer Counseling Centers. Behavioral Stress Centers, Inc. ("BSC") provides
management and administrative services to psychotherapy and psychological
practices (see Note K). Behavioral Health Online, Inc. ("BHO") provides
behavioral health information and education through its web site. Quality Care
Centers of Massachusetts, Inc. ("Quality Care") operated a long-term care
facility known as the Franvale Nursing and Rehabilitation Center (see Note I).
The consolidated financial statements include PHC and its subsidiaries. All
significant intercompany transactions and balances have been eliminated in
consolidation.
Until January 1999, the Company operated Pioneer Counseling of Virginia, Inc.
("PCV"), an 80% owned subsidiary which provided outpatient services through a
physicians practice. Until May 31, 1998, the Company operated Good Hope Center,
a substance abuse treatment facility in West Greenwich, Rhode Island ("Good
Hope"). Until June 1, 1998 the Company also operated a subacute long-term care
facility, Franvale Nursing and Rehabilitation Center ("Franvale"), in Braintree
Massachusetts. On June 1, 1998 Franvale was placed into state receivership. On
October 5, 1998 Franvale filed for protection under the Chapter 7 Bankruptcy
code. All financial information for Franvale is reported in the accompanying
financial statements as discontinued operations. The liquidation of the assets
and liabilities of Franvale may result in a non-cash financial statement gain of
approximately $2,000,000. In the quarter ended December 31, 1998 the company was
relieved of the HUD mortgage of approximately $6,741,000 and surrendered the
underlying assets amounting to approximately $4,329,000. The recognition of the
gain has been deferred until final resolution of all contingent liabilities.
During the year ended June 30, 1999, the Company recorded an increase in its
accounts receivable reserve in line with its more aggressive reserve policy
established last year and reserved for the remaining accounts receivable balance
for the closed Rhode Island facility and the closed Pioneer Counseling of
Virginia facilities.
Revenues and accounts receivable: Patient care revenues are recorded at
established billing rates or at the amount realizable under agreements with
third-party payors, including Medicaid and Medicare. Revenues under third-party
payor agreements are subject to examination and adjustment, and amounts
realizable may change due to periodic changes in the regulatory environment.
Provisions for estimated third party payor settlements are provided in the
period the related services are rendered. Differences between the amounts
accrued and subsequent settlements are recorded in operations in the year of
settlement.
F-8
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE A - THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Revenues and accounts receivable (continued)
Medicaid reimbursements are currently based on established rates depending on
the level of care provided and are adjusted prospectively. Medicare
reimbursements are currently based on provisional rates that are adjusted
retroactively based on annual cost reports filed by the Company with Medicare.
The Company's cost reports to Medicare are routinely audited on an annual basis.
The Company periodically reviews its provisional billing rates and provides for
estimated Medicare adjustments. The Company believes that adequate provision has
been made in the financial statements for any adjustments that might result from
the outcome of Medicare audits.
The Company has $585,714 of receivables from Medicaid and Medicare at June 30,
1999, which constitute a concentration of credit risk should Medicaid and
Medicare defer or be unable to make reimbursement payments as due.
Charity care amounted to approximately $242,000 and $504,000 for the years ended
June 30, 1999 and 1998, respectively, and is classified as patient care revenue
and an equal amount of cost is charged to patient care expenses in the
statements of operations.
Property and equipment:
Property and equipment are stated at cost. Depreciation is provided over the
estimated useful lives of the assets using accelerated and straight-line
methods. The estimated useful lives are as follows:
Assets Estimated Useful Life
Buildings 39 years
Furniture and equipment 3 through 10 years
Motor vehicles 5 years
Leasehold improvements Term of Lease
Other assets:
Other assets are primarily deposits and deferred expenses.
Goodwill, net of accumulated amortization:
The excess of the purchase price over the fair market value of net assets
acquired is being amortized on a straightline basis over twenty years.
F-9
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE A-THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Basic and diluted loss per share:
The loss per share is computed by dividing the loss applicable to common
shareholders, net of dividends charged directly to retained earnings, by the
weighted average number of shares of common stock outstanding for each fiscal
year. No common stock equivalents have been included in the calculation of
diluted loss per share because their effect would be anti-dilutive.
In 1997, the Financial Accounting Standards Board (FASB) issued Statement No.
128, Earnings per share. Statement 128 replaced the calculation of primary and
fully diluted earnings per share with basic and diluted earnings per share.
Unlike primary earnings per share, basic earnings per share excludes any
dilutive affects of options, warrants and convertible securities. Dilutive
earnings per share is similar to the previously reported fully diluted earnings
per share.
Estimates and assumptions:
The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amount of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements and
the reported amounts of revenue and expenses during the reporting period. Actual
results could differ from those estimates.
Cash equivalents:
Cash equivalents are short-term highly liquid investments with maturities of
less than three months, when purchased.
Fair value of financial instruments:
The carrying amounts of cash, trade receivables, other current assets, accounts
payable, notes payable and accrued expenses approximate fair value.
Impairment of long-lived assets:
During the year ended June 30, 1999 the Company wrote off the carrying value of
goodwill for Pioneer Counseling of Virginia, Inc., approximately $305,000, and
wrote down the remaining balance of accounts receivable for the facility of
approximately $43,000. During the year ended June 30, 1998 the Company wrote off
the carrying value of goodwill for PHC of Rhode Island, Inc., approximately
$23,000, and wrote off equipment and the land and building assets related to the
capital lease from that facility aggregating approximately $1,240,000 in total
assets and the related liability of approximately $1,300,000. Also in 1998 the
Company wrote down the remaining balance of accounts receivable from a closed
California facility, approximately $92,000, and the equipment, goodwill and
additional closing costs recorded for the Blacksburg facility, approximately
$136,000, which was closed in fiscal year 1999 to consolidate operations in the
Salem, Virginia.
In accordance with FASB statement no. 121, long-lived assets are reviewed for
impairment whenever events or changes in circumstances indicate that the
carrying amount of an asset may not be recoverable. For purposes of evaluating
the recoverability of long-lived assets, the recoverability test is performed
using undiscounted net cash flows related to the long-lived assets.
F-10
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE A-THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Stock-based compensation:
The Company accounts for its employee stock-based compensation under Accounting
Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees". In
October 1995, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards No. 123, "Accounting for Stock-Based
Compensation" ("SFAS No. 123"). SFAS No. 123 establishes a fair-value-based
method of accounting for stock-based compensation plans. The Company adopted the
disclosure only alternative, which requires disclosure of the pro forma effects
on loss and loss per share as if SFAS No. 123 had been adopted, as well as
certain other information.
Recent Accounting Pronouncements:
In June 1998 and July 1999, the Financial Accounting Standards Board issued
Statements of Financial Accounting Standards No. 133 and 137. ("SFAS No. 133),
"Accounting for Derivative Instruments and Hedging Activities," and ("SFAS No.
137"), "Accounting for Derivative Instruments and Hedging Activities - Deferral
of the Effective Date of FASB Statement No. 133." SFAS No. 133 and SFAS No. 137
require companies to recognize all derivative contracts at their fair value as
either assets or liabilities on the balance sheet. If certain conditions are
met, a derivative may be specifically designated as a hedge, the objective of
which is to match the timing of gain or loss recognition on the hedging
derivative with the recognition of (1) the changes in the fair value of the
hedged asset or liability that are attributable to the hedged risk or (2) the
earnings effect of the hedged forecasted transaction. For a derivative not
designated as a hedging instrument, the gain or loss is recognized in income in
the period of change. These statements are effective for all quarters beginning
after July 15, 1999.
Historically, the Company has not entered into derivative contracts either to
hedge existing risks or for speculative purposes. Accordingly, the Company does
not expect the adoption of the new standard to affect its financial statements.
NOTE B - PROPERTY AND EQUIPMENT
Property and equipment is comprised of the following:
June 30,
1999 1998
____ ____
Land $ 69,259 $ 119,859
Buildings 1,136,963 1,676,963
Furniture and equipment 868,722 839,972
Motor vehicles 41,444 41,444
Leasehold improvements 358,207 354,687
___________ ___________
2,474,595 3,032,925
Less accumulated depreciation and
amortization 991,276 904,652
___________ ___________
$1,483,319 $2,128,273
___________ ___________
F-11
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE C - NOTES PAYABLE AND LONG-TERM DEBT
Long-term debt is summarized as follows:
June 30,
1999 1998
____ ____
Note payable with interest at 9% requiring monthly
payments of $1,150 through May 2001. $ 23,509 $34,636
9% mortgage note due in monthly installments
of $4,850, including interest through July 1,
2012, when the remaining principal balance is
payable. 462,814 478,582
Note payable due in monthly installments of $21,506
including interest at 10.5% through November 1,
1999 when the remaining principal balance is
payable, collateralized by all assets of PHN and
certain receivables. Interest only payments were
made from May 1998 through October 1998 per
subsequent agreement. 261,802 374,190
Note payable due in monthly installments of $26,131
including interest at 11.5% through June 2000 when
the remaining principal balance is payable,
collateralized by all assets of NPP. Interest
only payments were made from May 1998 through
October 1998 per subsequent agreement. 471,297 598,848
Note payable due in monthly installments of $5,558
including interest at 9.25% through May 2012 when
the remaining principal balance is payable,
collateralized by real estate. 0 521,000
Term mortgage note payable with interest only payments
through March 1998 principal due in monthly
installments of $9,167 beginning April 1998
through February 2001. A balloon payment of
approximately $1,300,000 plus interest is due March
2001, interest at prime plus 5% (12.75% at June 30,
1999) collateralized by all assets of PHM. 1,433,333 1,600,000
Note payable bearing interest at prime plus 3 1/2%
(11.25% at June 30, 1999) with the principal due
on November 10, 1998 as extended and collateralized
by MRC's real property and BSC's accounts receivable
and cross-collateralized with the revolving credit
note referred to below. 324,730 350,000
Note payable due in monthly installments of $2,378
including interest at 12% through October 1999. 9,278 0
Note payable due in monthly installments of $7,633
including interest at 12% through October 1999. 29,785 0
__________ _________
3,016,548 3,957,256
Less current maturities 1,286,318 1,107,167
__________ _________
Noncurrent maturities $ 1,730,230 $ 2,850,089
__________ _________
F-12
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE C - LONG-TERM DEBT (CONTINUED)
Maturities of long-term debt are as follows as of June 30, 1999:
Year Ending
June 30, Amount
____________ ______________
2000 $1,286,318
2001 1,303,527
2002 20,634
2003 22,570
2004 24,687
Thereafter $ 358,812
______________
$3,016,548
______________
The Company has a revolving credit note under which a maximum of $4,000,000 may
be outstanding at any time. At June 30, 1999 the outstanding balance was
$1,669,830. Advances are made based on a percentage of accounts receivable and
principal is payable upon receipt of proceeds of the accounts receivable.
Interest is payable monthly at prime plus 2.25% (10% at June 30, 1999). The
agreement is automatically renewable for one-year periods unless terminated by
either party. Upon expiration, all remaining principal and interest is due. The
notes are collateralized by substantially all of the assets of the Company's
subsidiaries excluding Franvale and guaranteed by PHC.
On December 7, 1998 the Company issued $500,000 in 12% convertible debentures to
private investors. These debentures are convertible in $1,000 increments for 500
shares of PHC, Inc. Class A Common Stock and expire December 2, 2004.
NOTE D - CAPITAL LEASE OBLIGATION
At June 30, 1999, the Company was obligated under various capital leases for
equipment providing for monthly payments of approximately $5,000 for fiscal 2000
and terms expiring from July 1999 through July 2003.
The carrying value of assets under capital leases included in property and
equipment is as follows:
June 30,
1999 1998
____ ____
Equipment and improvements $ 528,820 $ 511,517
Less accumulated amortization (259,564) (225,703)
$ 269,256 $ 285,814
F-13
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE D - CAPITAL LEASE OBLIGATION (CONTINUED)
Future minimum lease payments under the terms of the capital lease agreements
are as follows at June 30, 1999:
Year Ending
June 30,
____________
2000 $ 65,327
2001 47,302
2002 11,201
2003 2,821
Thereafter 235
_________
Total future minimum lease payments 126,886
Less amount representing interest 14,414
_________
Present value of future minimum
lease payments 112,472
Less current portion 60,815
Long-term obligations under capital lease $51,657
_________
NOTE E - NOTES PAYABLE - RELATED PARTIES
Related party debt is summarized as follows: June 30,
1999 1998
____ ____
Note payable, President and principal stockholder,
interest at 8%, due in installments through
December 1998 $ -0- $ 39,496
Notes payable, Tot Care, Inc., Company owned by the
President and principal stockholder, interest at
12% payable on demand 100,000 100,000
Note payable, President and principal stockholder,
interest at 12% payable on demand 100,000 -0-
Notes payable, other related parties, interest at
12% and payable on demand -0- 20,000
_________ _________
Total $ 200,000 $ 159,496
_________ _________
F-14
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE F - INCOME TAXES
The Company has the following deferred tax assets included in the accompanying
balance sheets:
Year Ended
June 30,
1999 1998
____ ____
Temporary differences attributable to:
Allowance for doubtful accounts $1,546,000 $1,315,000
Facility Closing Costs 198,000 85,000
Depreciation 237,000 225,000
Other 86,000 2,000
Operating loss carryforward 1,542,000 1,650,000
___________ ___________
Total deferred tax asset 3,609,000 3,277,000
Less:
Valuation allowance (2,995,000) (2,607,000)
___________ ___________
Subtotal 614,000 670,000
Current portion (459,300) (515,300)
___________ ___________
Long-term portion $ 154,700 $ 154,700
___________ ___________
The Company had no deferred tax liabilities at June 30, 1999 and 1998.
Income tax expense is as follows: Year Ended
June 30,
1999 1998
____ ____
Current state income taxes $ 59,434 $ 219,239
Reconciliations of the statutory U.S. Federal income taxes based on a rate of
34% to actual income taxes is as follows:
Year Ended
June 30,
1999 1998
____ ____
Income tax benefit at statutory rate $ (440,200) $(2,044,400)
State income taxes, net of federal
benefit 39,000 144,700
Increase in valuation allowance 388,000 1,780,000
Increase due to nondeductible items,
primarily penalties and travel and
entertainment expenses 37,000 161,231
Other 35,634 177,708
__________ ________
$ 59,434 $ 219,239
At June 30,1999 the Company had a net operating loss carryforward amounting to
approximately $4,500,000 which expires at various dates through 2019.
If the Company has significant sales of stock in future years, the utilization
of the net operating loss carryforward in any given year may be limited under
provisions of the Internal Revenue Code.
F-15
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE G - COMMITMENTS AND CONTINGENT LIABILITIES
Operating leases:
The Company leases office and treatment facilities and furniture and equipment
under operating leases expiring on various dates through January 31, 2004. Rent
expense for the years ended June 30, 1999 and 1998 was approximately $784,000
and $882,000, respectively. Rent expense includes certain short term rentals
and, in 1998, additional rent expense associated with the closing of Good Hope
Center. Minimum future rental payments under noncancelable operating leases,
having remaining terms in excess of one year as of June 30, 1999 are as follows:
Year Ending
June 30, Amount
____________ ____________
2000 $ 606,854
2001 562,243
2002 552,339
2003 504,989
2004 562,320
Thereafter 14,584
___________
$ 2,803,329
Litigation and contingency:
In connection with the liquidation of Franvale, some vendors allege that there
are amounts due for services which are the obligation of PHC, Inc. At June 30,
1999 total claims pending amounted to approximately $67,000.
In September 1998, the Company and Franvale were each served with subpoenas in
connection with an on-going investigation of Franvale being conducted by the
Attorney General of the Commonwealth of Massachusetts. The focus is the quality
of patient care provided by Franvale during the period of early 1997 until the
facility was placed into receivership in June 1998. The Company is cooperating
fully with the investigation and currently is engaged in producing documents
requested in the subpoenas. The Company does not believe that it has violated
any laws and does not believe that any monetary payments required in connection
with this matter will be material to the financial position or results of
operations of the Company.
In addition, the Commonwealth of Massachusetts may institute a claim against
PHC, Inc. to recover expenses incurred as a consequence of Franvale's
receivership. The Company believes that it has valid defenses to any such claim
and, in any event, it believes that there will be adequate assets remaining in
Franvale to satisfy any receivership expenses.
NOTE H - STOCK PLANS
[1] Stock plans:
The Company has three stock plans: a stock option plan, an employee
stock purchase plan and a nonemployee directors' stock option plan.
F-16
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE H - STOCK PLANS (CONTINUED)
[1] Stock plans: (continued)
The stock option plan provides for the issuance of a maximum of
1,000,000 shares of Class A common stock of the Company pursuant to
the grant of incentive stock options to employees or nonqualified
stock options to employees, directors, consultants and others whose
efforts are important to the success of the Company. Subject to the
provisions of this plan, the compensation committee of the Board of
Directors has the authority to select the optionees and determine the
terms of the options including: (i) the number of shares, (ii) option
exercise terms, (iii) the exercise or purchase price (which in the
case of an incentive stock option will not be less than the market
price of the Class A common stock as of the date of grant), (iv) type
and duration of transfer or other restrictions and (v) the time and
form of payment for restricted stock upon exercise of options.
The employee stock purchase plan provides for the purchase of Class A
common stock at 85 percent of the fair market value at specific dates,
to encourage stock ownership by all eligible employees. A maximum of
150,000 shares may be issued under this plan.
The non-employee directors' stock option plan provides for the grant
of nonstatutory stock options automatically at the time of each annual
meeting of the Board. Through June 30, 1999, options for 23,500 shares
were granted under this plan. A maximum of 50,000 shares may be issued
under this plan. Each outside director is granted an option to
purchase 2,000 shares of Class A common stock at fair market value on
the date of grant, vesting 25% immediately and 25% on each of the
first three anniversaries of the grant.
In February 1997, all 95,375 shares underlying the then outstanding
employee stock options were repriced to the current market price,
using the existing exercise durations. In September 1998, all 21,875
options due to expire, were extended for an additional five years.
Also in September 1998, all 183,875 shares underlying the then
outstanding employee stock options were repriced to the current market
price, using the existing exercise durations.
Under the above plans, at June 30, 1999, 601,580 shares were available
for future grant or purchase.
F-17
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE H - STOCK PLANS (CONTINUED)
The Company had the following activity in its stock option plans for fiscal
1999 and 1998:
Weighted-
Number Average
of Exercise Price
Shares Per Share
_________ _____________
Option plans:
Balance - June 30, 1997 205,375 $4.27
Granted 210,000 $2.37
Cancelled (40,000) $3.21
_________
Balance - June 30, 1998 375,375 $3.32
Granted 218,500 $1.21
Cancelled (71,000) $1.95
Repriced Options
Original (183,875) $2.96
Repriced 183,875 $1.25
_________
Balance - June 30 ,1999 522,875 $2.02
_________
[2] Stock-based compensation:
Options for 252,000 shares are exercisable as of June 30, 1999 at
exercise prices ranging from $1.03 to $6.63 and a weighted-average
exercise price of approximately $3.08 per share, with a
weighted-average remaining contractual life of approximately three
years.
The exercise prices of options outstanding at June 30, 1999 range from
$1.03 to $6.63 per share and have a weighted-average exercise price of
approximately $2.02 per share, with a weighted-average remaining
contractual life of approximately four years.
The Company has adopted the disclosure-only provisions of SFAS No.
123, but applies Accounting Principles Board Opinion No. 25 and
related interpretations in accounting for its plans. There was no
compensation expense recognized in 1999 or 1998. If the Company had
elected to recognize compensation cost for the plans based on the fair
value at the grant date for awards granted, consistent with the method
prescribed by SFAS No. 123, loss per share would have been changed to
the pro forma amounts indicated below:
F-18
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE H - STOCK PLANS (CONTINUED)
Year Ended
June 30,
1999 1998
____ ____
Loss applicable As reported
to common Continuing Operations $(1,496,196) $(4,366,603)
shareholders Discontinued Operations -- (2,220,296)
Pro forma
Continuing Operations (1,595,475) (4,494,930)
Discontinued Operations -- (2,220,296)
Loss per share As reported
Continuing Operations (.25) (.84)
Discontinued Operations -- (.42)
Pro forma
Continuing Operations (.27) (.86)
Discontinued Operations -- (.42)
The fair value of the Company's stock options used to compute pro forma loss and
loss per share disclosures is the estimated present value at grant date using
the Black-Scholes option-pricing model with the following weighted-average
assumptions for 1999 and 1998: dividend yield of 0%; expected volatility of 30%;
a risk-free interest rate of 6.5%; and an expected holding period of five years.
The per share weighed-average grant-date fair value of options granted during
the years ended June 30, 1999 and 1998 was $.48 and $.87, respectively.
F-19
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE I - OPERATIONS HELD FOR SALE AND DISCONTINUED OPERATIONS
On May 26, 1998, PHC, Inc.'s wholly owned subsidiary, Quality Care, which
operates Franvale filed for reorganization under Chapter 11. On May 29, 1998,
the Bankruptcy Court terminated the Chapter 11 proceeding determining that there
was no likelihood of reorganization since the prospective acquirer of the
facility was now imposing certain terms unacceptable to all interested parties
and that the transfer of patients and liquidation of assets could be as readily
effectuated in a state court receivership under the aegis of the Massachusetts
Health Care Statutes and accordingly dismissed the Chapter 11 case. On June 1,
1998, a receiver was appointed to transfer the patients and close the facility
expeditiously. The Company has recorded the losses of Franvale through May 31,
1998 in the accompanying financial statements.
The Company's Bankruptcy Attorney was notified that effective September 30, 1998
the patient care receivership for Quality Care had been terminated. On October
5, 1998, in response to the termination of the State Receivership, the Company
filed for protection under Chapter 7.
Although the full extent of the financial impact on PHC, Inc. cannot be
determined at this time, the management of PHC, Inc. does not believe that the
liquidation of the assets and liabilities of Quality Care will have a
substantial negative impact on PHC's financial position or the results of
operations. The Company is subject to a guarantee signed by PHC, Inc. for
furniture and equipment purchased by Quality Care during the fiscal year ended
June 30, 1996. The amount of this debt recorded by Quality Care in the
accompanying financial statements is approximately $150,000. The liquidation of
the assets and liabilities of Franvale may result in a non-cash financial
statement gain of approximately $2,000,000. In the quarter ended December 31,
1998 the company was relieved of the HUD mortgage of approximately $6,741,000
and surrendered the underlying assets amounting to approximately $4,329,000. The
recognition of the gain has been deferred until final resolution of all
contingent liabilities.
F-20
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE J - CERTAIN CAPITAL TRANSACTIONS
In addition to the outstanding options under the Company's stock plans (Note H),
the Company has the following options and warrants outstanding at June 30, 1999:
Number of Exercise Expiration
Description Shares Price Date
______________
IPO warrants 1,792,862 shares $5.90 per share March 2000
Private placement warrants 746,662 shares $3.71 per share January 2001
Bridge warrants 37,002 shares $6.94 per share February 2001
Warrant for services 25,000 shares $2.00 per share October 2001
Warrant for services 3,559 shares $2.95 per share February 2002
Consultant warrant 80,000 shares $2.62 per share March 2002
Convertible debenture warrants 150,000 shares $2.00 per share March 2002
Preferred stock warrant 50,000 shares $2.75 per share June 2000
Warrant for services 150,000 shares $2.50 per share May 2002
Private Placement 86,207 shares $2.90 per share Sept 2002
Private Placement 3,000 shares $2.90 per share March 2003
Debt Service 52,500 shares $2.38 per share March 2003
Private Placement 49,990 shares $2.31 per share March 2001
Debt Service 52,500 shares $1.82 per share July 2003
Debt Service 20,000 shares $1.50 per share July 2003
Private Placement 25,000 shares $1.00 per share Dec 2004
Private Placement 60,000 shares $1.00 per share Dec 2003
Private Placement 10,000 shares $2.00 per share Dec 2003
Private Placement 15,000 shares $1.50 per share Dec 2003
Private Placement 10,000 shares $1.00 per share Dec 2003
Private Placement 10,000 shares $1.00 per share Jan 2004
Private Placement 10,000 shares $1.00 per share Jan 2004
Private Placement 10,000 shares $1.00 per share Feb 2004
Private Placement 10,000 shares $1.00 per share March 2004
Private Placement 10,000 shares $1.00 per share April 2004
Private Placement 10,000 shares $1.00 per share May 2004
Private Placement 10,000 shares $1.00 per share June 2004
Warrant for Services 37,500 shares $1.45 per share Jan 2004
Warrant for Services 37,500 shares $1.45 per share Apr 2004
Warrant for Services 3,000 shares $1.20 per share Feb 2004
Warrant for Services 5,000 shares $1.00 per share April 2004
Warrant for Services 5,000 shares $1.00 per share April 2004
Warrant for Services 5,000 shares $1.00 per share April 2004
Warrant for Services 1,000 shares $1.00 per share May 2004
Warrants issued for services or in connection with debt are valued at fair value
at grant date using the Black-Scholes pricing model and charged to operations
consistent with the underlying reason the warrants were issued. Charges to
operations in connection with these warrants amounted to approximately $160,000
and $233,000 in fiscal 1999 and 1998 respectively.
In February 1998, the Company received $950,000 in exchange for the issuance of
Series B convertible preferred stock and warrants to purchase 49,990 shares of
Class A common stock. The warrants are exercisable at $2.31 per share and expire
in 2001. The number of shares of Class A common stock into which the preferred
stock may be converted is equal to 80% of the closing bid price of the Class A
common stock as reported by NASDAQ for the five trading days immediately
preceding the conversion which resulted in a deemed dividend of $190,000 in
fiscal 1998. Cumulative preferred dividends are at the rate of $60 per share per
year, payable quarterly. Dividends are payable in cash or in shares of preferred
stock at $1,000 per share. For the year ended June 30, 1999 and 1998 dividends
amounted to $ 142,110 and $17,060 respectively. During the fiscal year ended
June 30, 1999 the Company issued 53 shares of series B preferred stock in
payment of dividends in lieu of cash.
F-21
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE J - CERTAIN CAPITAL TRANSACTIONS (CONTINUED)
Under existing dilution agreements with other stockholders the issuance of
common stock under agreements other than the employee stock purchase and option
plans will increase the number of shares issuable and decrease the exercise
price of certain of the above warrant agreements based on the difference between
the then current market price and the price at which the new common stock is
being issued. The dilutive effect of transactions through June 30, 1999 are
reflected in the table above.
During fiscal 1998, the Class C common stock was canceled and retired because of
restrictions on the release of the stock, due to earnings targets which were not
achieved.
NOTE K - ACQUISITIONS
In September 1996, the Company purchased the assets of seven outpatient
behavioral health centers located in Michigan ("NPP"). The centers were
purchased for $532,559 and 15,000 shares of Class A common stock of PHC, Inc.
valued at $5.04 per share. The Company borrowed $900,000 (see Note C) to finance
the purchase and to provide working capital for the centers.
Concurrent with the asset purchase agreement, NPP entered into an employment
agreement with a former owner which requires an annual salary of $150,000 and an
annual bonus. The agreement is effective for four years and is automatically
extended for successive one year terms unless terminated. The salary and bonus
are subject to adjustment based on collected billings. NPP also entered into a
management agreement whereby $1,500 per month would be paid for five years to
the former owners. During fiscal 1998 in connection with the asset purchase
agreement, the Company issued 15,000 unregistered shares of Class A common stock
which was accounted for as additional purchase price
On November 1, 1996, BSC-NY, Inc. ("BSC"), merged with Behavioral Stress
Centers, Inc., a provider of management and administrative services to
psychotherapy and psychological practices in the greater New York City
Metropolitan Area. In connection with the merger, the Company issued 150,000
shares of PHC, Inc. Class A common stock to the former owners of Behavioral
Stress Centers, Inc. Also, in connection with the merger, another entity was
formed, Shliselberg Physician Services, P.C. formerly Perlow Physicians, P.C.
("Shliselberg"), to acquire the assets of the medical practices theretofore
serviced by BSC. The Company advanced Shliselberg the funds to acquire those
assets and at June 30, 1999 Shliselberg owed the Company $3,690,113 which
includes in addition to acquisition costs, management fees of approximately
$1,657,500 and interest on the advances of approximately $576,300. During fiscal
1998 the Company established a reserve against this receivable in the amount of
$382,000. The Company increased the reserve to $782,000 in the fiscal year ended
June 30, 1999. It is expected that collections will be received over the next
several years and accordingly, these amounts have been classified as noncurrent.
The Company has no ownership interest in Shliselberg.
F-22
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE K - ACQUISITIONS (CONTINUED)
The merger agreement requires additional purchase price to be paid by BSC to the
former owners of Behavioral Stress Centers, Inc. for the three years following
the merger date. The additional purchase price is based on the income of BSC
before taxes and is to be paid in PHC stock, at market value up to $200,000 and
the balance, if any, in cash. On March 26, 1998 the Company issued 227,347
shares of the Company's Class A Common Stock to the former owners of Behavioral
Stress Centers, Inc. now BSC-NY, Inc. in full payment for the earn-out due to be
paid to them for the year ended October 31, 1997 resulting in additional
goodwill. Of the 227,347 shares issued 127,924 were issued in lieu of cash and
were subject to a price guarantee of $2.35, payable in shares. Under the price
guarantee the Company issued an additional 304,097 shares of Common Stock in the
fiscal year ended June 30, 1999.
BSC also entered into a management agreement with Shliselberg whereby management
fees are required of Shliselberg on a monthly basis over a five-year period with
an automatic renewal for an additional five-year period. The management fee was
calculated at 25% of the total monthly expenses of Shliselberg and effective
January 1, 1998 the management agreement was amended to provide for a management
fee of 20% of the total monthly expenses of Shliselberg. In November 1998 the
management fee was further reduced to 18% of the total monthly expenses of
Shliselberg.
On November 1, 1996, BSC entered into a lease agreement for its facilities. The
lease payments are due in equal monthly installments over a three-year period
with an option to extend annually for three additional years. The lease is to be
paid by Shliselberg in accordance with the management agreement.
Summary, unaudited financial information for Shliselberg as of and for the year
ended June 30, 1999 is as follows:
Total assets $ 3,580,000
Stockholder's deficit $ (782,000)
Net revenue $ 2,930,000
. Net loss $ (400,349)
Effective January 1, 1997, the Company entered into a Stock Exchange Agreement
with a Virginia corporation owned by two individuals to whom the Company has an
outstanding note payable. The corporation consists of private practices of
psychiatry. The Stock Exchange Agreement provided that in exchange for $50,000
in cash and 64,500 shares of restricted Class A common stock, the Company
received an 80% ownership interest in the Virginia corporation. The Company also
paid $80,444 in legal fees in connection with the Agreement. Concurrent with the
Stock Exchange Agreement the two owners of the Virginia corporation each
executed Employment Agreements with the Virginia corporation to provide
professional services and each was granted an option to purchase 15,000 shares
of Class A common stock at an exercise price of $4.87 per share. The options
expire on April 1, 2002. Each agreement requires an annual salary of $200,000
and expires in five years. Further, a Plan and Agreement of Merger was executed
whereby the Virginia corporation was merged into PCV.
F-23
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE K - ACQUISITIONS (CONTINUED)
On January 17, 1997 PCV entered into a purchase and sale agreement with an
unrelated general partnership, to purchase real estate with buildings and
improvements utilized by the Virginia Corporation for approximately $600,000 of
which $540,000 was paid through the issuance of a note (Note C).
In accordance with the agreement the two owners will be paid a finders fee for
all subsequently acquired medical practices within a 200 mile radius of PCV and
those medical practices identified by the owners wherever the location. The
finders fee is payable in Class A common stock and in cash.
On October 1, 1997 PCV purchased the assets of a clinic located in Blacksburg,
Virginia in exchange for $50,000 in cash and 26,024 shares of Class A Common
Stock. The company entered into a lease with the former owners for the clinic
property and an employment agreement with one of the owners.
In accordance with the above agreements the purchase price was allocated as
follows:
Fixed Assets 10,000
Covenant not to compete 50,000
Goodwill 38,632
________
$ 98,632
________
During fiscal 1998 the Company consolidated the operations of the Blacksburg
clinic with the Salem, Virginia clinic to enhance profitability. The closure of
the Blacksburg clinic, including the write down of related assets and buy out of
the lease, is reflected in the June 30, 1998 financial statements.
During fiscal 1999 the Company decided to close the remaining Pioneer Counseling
of Virginia clinic located in Salem, Virginia. Since the Company was required by
contract to give 30-days notice to contract therapists before closing the
clinic, in January 1999 the Company closed its 80% owned outpatient operations
in Virginia, Pioneer Counseling of Virginia, Inc. The Company sold this
business, excluding accounts receivable and most fixed assets, to the minority
owners in exchange for their shares of stock in Pioneer Counseling of Virginia,
Inc. approximately $25,000, release from the first mortgage on the property of
approximately $506,000 and release from notes payable to the minority owners of
$20,000. The closure of this clinic resulted in a loss of approximately $300,000
which was charged to administrative expenses in the accompanying statement of
operations.
Information is not available to present pro forma financial information relating
to the October 1997 acquisition. The Company so advised the Securities and
Exchange Commission and received a no action letter with respect to this matter.
Had the Blacksburg acquisition made during the fiscal year ended June 30, 1998
(October 1, 1997), been made as of July 1, 1997, the pro forma effect on the
Company's results of operations would have been immaterial and therefore are not
shown.
F-24
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE L - SALE OF RECEIVABLES
The Company had a sale and purchase agreement whereby third-party receivables
were sold at a discount with recourse. In February 1998 the Company entered into
a finance agreement with Healthcare Financial Partners, Inc. to provide for
receivables funding and liquidate the debt due to the above referenced sale and
purchase agreement and provide receivables funding for PHC of Virginia, Inc.,
PHC of Rhode Island, Inc. and Pioneer Counseling of Virginia, Inc.
NOTE M - FOURTH QUARTER ADJUSTMENTS
The Company recorded significant adjustments in the fourth quarter of fiscal
1998 related to the closure of Good Hope Center, the write down of receivables
of the closed California facility, the write down of the amount due BSC from
Shliselberg, the closure of the Blacksburg facility and an increase in accounts
receivable reserves of the other facilities.
In the quarter ended December 31, 1998 the Company recognized a gain of
approximately $1,100,000 in its form 10-QSB related to the liquidation of the
assets and liabilities of Franvale (See Note I). The Company subsequently
determined that it was more appropriate to defer recognition of any gain until
final resolution of all potential liabilities. Accordingly, the Company will
amend its December 31, 1998 10-QSB to reversed recognition of this gain in
fiscal 1999.
NOTE N - EVENTS SUBSEQUENT TO JUNE 30, 1999
On July 1, 1999 the Company issued warrants to purchase 10,000 shares of PHC,
Inc. Class A Common Stock, exercisable at $1.00 per share, to George H. Gordon
as part of the December 1998 private placement agreement.
On July 5, 1999 the Company issued warrants to purchase 37,500 shares of PHC,
Inc. Class A Common Stock, Class A Common Stock, exercisable at $1.45 per share,
to National Securities Corporation as part of a service agreement.
On August 1, 1999 the Company issued warrants to purchase 10,000 shares of PHC,
Inc. Class A Common Stock, exercisable at $1.00 per share, to George H. Gordon
as part of the December 1998 private placement agreement.
On August 11, 1999 the Company borrowed approximately $310,000 from Heller
Healthcare Finance, Inc. f/k/a HCFP Funding, Inc. through an extension of the
February 18, 1989 Loan and Security Agreement.
NOTE O - BUSINESS SEGMENT INFORMATION
The Company's operations are conducted in one business segment, the operation of
behavioral health treatment centers. All of the Company's operations are in the
United States.
F-25
PHC, INC. AND SUBSIDIARIES
Notes to Financial Statements
June 30, 1999 and 1998
NOTE P - RESTATEMENT OF FINANCIAL STATEMENTS
The Company has restated its financial statements as of June 30, 1998 and for
the year then ended. The restatement related to the Company's accounting for a
beneficial conversion feature of a preferred stock issuance and the amortization
of the value of warrants issued to a financial advisor. The Company has
determined that the beneficial conversion feature, amounting to $190,000, should
have been recorded in the 1998 financial statements as a dividend. The Company
also determined that the value of the warrants issued to the financial advisor
should have been fully amortized in 1998, resulting in an additional expense in
1998 of $147,618. The table below reflects the impact of the restatement.
AS REPORTED AS RESTATED
Loss from continuing operations $(4,011,925) $ (4,159,543)
Loss from discontinued operations (2,220,296) (2,220,296)
____________ ______________
Loss (6,232,221) (6,379,839)
Dividends (17,060) (207,060)
____________ ______________
Loss applicable to common
shareholders $(6,249,281) $ (6,586,899)
____________ ______________
Basic and diluted loss per
common share:
Continuing operations $ (0.77) $ (0.84)
Discontinued operations (0.42) (0.42)
____________ ______________
Total $ (1.19) $ (1.26)
____________ ______________
F-26
EXHIBIT INDEX
*4.28 Warrant Agreements by and between PHC, Inc., and George H. Gordon for
10,000 shares of Class A Common Stock dated April 1, 1999. (Filed as
exhibit to the Company's report on Form 10-KSB dated October 13, 1999.
Commission file number 0-23524).
*4.29 Warrant Agreements by and between PHC, Inc., and George H. Gordon for
10,000 shares of Class A Common Stock dated July 1, 1999. (Filed as exhibit
to the Company's report on Form 10-KSB dated October 13, 1999, Commission
file number 0-23524).
*4.30 Warrant Agreements by and between PHC, Inc., and George H. Gordon for
10,000 shares of Class A Common Stock dated June 1, 1999. (Filed as exhibit
to the Company's report on Form 10-KSB dated October 13, 1999. Commission
file number 0-23524).
*4.31 Warrant to purchase up to 37,500 shares of Class A Common Stock by and
between PHC, Inc., and National Securities Corporation dated April 5, 1998.
(Filed as exhibit to the Company's report on Form 10-KSB dated October 13,
1999. Commission file number 0-23524.)
*4.32 Warrant to purchase up to 37,500 shares of Class A Common Stock by and
between PHC, Inc., and National Securities Corporation dated July 5, 1998.
(Filed as exhibit to the Company's report on Form 10-KSB dated October 13,
1999. Commission file number 0-23524.)
*4.33 Subscription Agreement and Warrants Series B Convertible Preferred Shares
and Warrants by and between PHC, Inc., ProFutures Special Equities Fund,
L.P., Gary D. Halbert John F. Mauldin and Augustine Fund L.P. dated March
16, 1998.
*10.65 This amendment no. 2 to secured bridge note (the "Amendment") is hereby
entered into as of the 10th day of May 1999 by and among PHC, INC., a
Massachusetts corporation ("Borrower"), and HCFP FUNDING II, INC., a
Delaware corporation ("Lender"). (Filed as an exhibit to the Company's
report on Form 10-KSB dated October 13, 1999. Commission file number
0-23524).
*10.66 Loan and Security Agreement by and between Heller Healthcare Finance,
Inc. f/k/a HCFP Funding, Inc. and PHC of Michigan, Inc. PHC of Utah, Inc.
PHC of Virginia, Inc. PHC of Rhode Island, Inc. and Pioneer Counseling of
Virginia, Inc. dated August 11, 1999. (Filed as an exhibit to the Company's
report on Form 10-KSB dated October 13, 1999. Commission file number
0-23524).
*10.67 Amendment number 3 to Secured Bridge Note dated May 10, 1999 by and
between PHC, Inc. and HCFP (Filed as exhibit to the Company's report on
Form 10-KSB, filed with the Securities and Exchange Commission on October
13, 1999. Commission file number 0-23524).
*21.1 List of Subsidiaries. (Filed as an exhibit to the Company's report on Form
10-KSB dated October 13, 1999. Commission file number 0-23524).
EXHIBIT 21.1
STATE
NAME OF DOING BUSINESS AS (NAME) OF
SUBSIDIARY INCORPORATION
PHC, Inc. Pioneer Behavioral Health Massachusetts
Pioneer Healthcare
PDS2
PHC of Utah, Inc. Highland Ridge Hospital Massachusetts
PHC of Virginia, Inc. Mount Regis Massachusetts
Center
Changes
PHC of Rhode Island, Inc. Good Hope Center Massachusetts
PHC of Michigan, Inc. Harbor Oaks Hospital Massachusetts
PHC of Nevada, Inc. Harmony Healthcare Massachusetts
Harmony Behavioral Nevada
Healthcare
Northpoint-Pioneer, Inc. Pioneer Counseling Center Massachusetts
PHC of Kansas, Inc. Total Concept EAP Massachusetts
Quality Care Centers of Franvale Nursing and Massachusetts
Massachusetts, Inc. Rehabilitation Center
Pioneer Counseling of Counseling Associates of Massachusetts
Virginia, Inc. Virginia, Inc.
Counseling Associates of MassachusettS
Virginia
BSC-NY, Inc. Behavioral Stress Center New York
Professional Health New York
Associates, Inc.
Shliselberg Physicians New York
Services, PC
Exhibit 23.1
CONSENT OF INDEPENDENT AUDITORS
We hereby consent to the incorporation by reference in the Registration
Statement on Form S-8 of PHC, Inc. (the "Company")of our report dated September
10, 1999, relating to the consolidated financial statements of the Company
appearing in the Company's Annual Report on Form 10-KSB for the year ended June
30, 1999.
BDO Seidman, LLP
Boston, Massachusetts
October 13, 1999
Exhibit 4.28
THE SECURITIES REPRESENTED BY THIS WARRANT (AND THE SECURITIES ISSUABLE UPON
EXERCISE OF THIS WARRANT) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, OR ANY STATE SECURITIES STATUTE. THE SECURITIES HAVE BEEN ACQUIRED
FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE
SOLD, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED WITHOUT AN
EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT
OF 1933 AND ANY APPLICABLE STATE SECURITIES STATUTE, OR UNLESS AN EXEMPTION
FROM REGISTRATION IS AVAILABLE THEREUNDER.
Shares Issuable Upon Exercise: Up to 10,000 shares of the Class A Common
Stock, $.01 par value, of PHC, Inc.
WARRANT TO PURCHASE
SHARES OF CLASS A COMMON STOCK
Expires June 1, 2004
THIS CERTIFIES THAT, for value received, George H. Gordon is
entitled to subscribe for and purchase that number of shares (the "Shares")
of the fully paid and nonassessable Class A Common Stock, $.01 par value,
(the "Class A Common Stock") of PHC, Inc., a Massachusetts corporation (the
"Company"), for a price of $1.00 per Share (the "Warrant Price"), subject to
the provisions and upon the terms and conditions hereinafter set forth. As
used herein, the term "Shares" shall mean the Company's Class A Common Stock,
or any stock into or for which such Class A Common Stock shall have been or
may hereafter be converted or exchanged pursuant to the Articles of
Incorporation of the Company as from time to time amended as provided by law
and in such Articles (hereinafter the "Charter"), and the term "Grant Date"
shall mean June 1, 1999.
1. Term. Subject to the provisions of this Warrant, the purchase
right represented by this Warrant is exercisable, in whole or in part, at any
time and from time to time from and after the Grant Date and prior to June 1,
2004.
Notwithstanding anything to the contrary contained herein, neither
this Warrant nor any rights hereunder may be transferred or assigned except
to an Assignee who is an "accredited investor" within the meaning of
Regulation D of the General Rules and Regulations of the Securities Act of
1933.
2. Method of Exercise. The purchase right represented by this Warrant
may be exercised by the holder hereof, in whole or in part and from time to
time, by either, at the election of this holder, (a) the surrender of the
Warrant (with the notice of exercise form attached hereto as Exhibit A-1 duly
executed) at the principal office of the Company and by the payment to the
Company by certified or bank check or by wire transfer, of an amount equal to
the then applicable Warrant Price multiplied by the number of shares then
being purchased or (b) if in connection with a registered public offering of
the Company's securities (provided that such offering includes the shares),
the surrender of this Warrant (with the notice of exercise form attached
hereto as Exhibit A-2 duly executed) at the principal office of the Company
together with notice of arrangements reasonably satisfactory to the Company
and any underwriter, in the case of an underwritten registered public
offering, for payment to the Company either by certified or bank check or by
wire transfer of from the proceeds of the sale of Shares to be sold by the
holder in such public offering of an amount equal to the then applicable
Warrant Price per Share multiplied by the number of Shares then being
purchased. The person or persons in whose name(s) any certificate(s)
representing Shares which shall be issuable upon exercise of this Warrant
shall be deemed to have become the holder(s) of record of, and shall be
treated for all purposes as the record holder(s) of, the shares represented
thereby (and such shares shall be deemed to have been issued) immediately
prior to the close of business on the date or dates upon which this Warrant
is exercised and the then applicable Warrant Price paid. In the event of any
exercise of the rights represented by this Warrant, certificates for the
shares of stock so purchased shall be delivered to the holder hereof as soon
as possible and in any event within ten (10) days of receipt of such notice
and payment of the then applicable Warrant Price and, unless this Warrant has
been fully exercised or expired, a new Warrant representing the portion of
the Shares, if any, with respect to which this Warrant shall not then have
been exercised shall also be issued to the holder hereof as soon as possible
and in any event within such ten-day period.
3. Stock Fully Paid; Reservation of Shares. All shares that may be
issued upon the exercise of the rights represented by this Warrant will upon
issuance, be fully paid and nonassessable, and free from all taxes, liens and
charges with respect to the issue thereof. During the period within which
the rights represented by the Warrant may be exercised, the Company will at
all times have authorized and reserved for the purpose of issuance upon
exercise of the purchase rights evidenced by this Warrant, a sufficient
number of shares of Class A Common Stock to provide for the exercise of the
rights represented by this Warrant.
4. Adjustment of Warrant Price and Number of Shares. The number and
kind of securities purchasable upon the exercise of the Warrant Agreement and
the Warrant Price shall be subject to adjustment from time to time upon the
occurrence of certain events, as follows:
4.1 Reclassification. In case of any reclassification, change or
conversion of the Company's Class A Common Stock (other than a change in par
value, or from par value to no par value, or from no par value to par value,
or as a result of a subdivision or combination), the Company, shall execute a
new Warrant Agreement (in form and substance reasonably satisfactory to the
Holder) providing that the Holder of this Warrant Agreement shall have the
right to exercise such new Warrant Agreement and upon such exercise and
payment of the then applicable Warrant Price to receive, in lieu of each
Share theretofore issuable upon exercise of this Warrant Agreement, the kind
and amount of shares of stock, other securities, money and property
receivable upon such reclassification or change by a holder of one share of
Class A Common Stock. Such new Warrant Agreement shall provide for
adjustments that shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Section 4.1. The provisions of this Section
4.1 shall similarly apply to successive reclassifications and changes.
4.2 Subdivision or Combination of Shares. If the Company at any
time while this Warrant remains outstanding and unexpired shall subdivide or
combine its Class A Common Stock, the Warrant Price and the number of Shares
issuable upon exercise hereof shall be equitably adjusted.
4.3 Stock Dividends. If the Company at any time while this
Warrant is outstanding and unexpired shall pay a dividend payable in shares
of Class A Common Stock (except any distribution specifically provided for in
the foregoing Sections 4.1 and 4.2), then the Warrant Price shall be
adjusted, from and after the date of determination of shareholders entitled
to receive such dividend or distribution, to that price determined by
multiplying the Warrant Price in effect immediately prior to such date of
determination by a fraction (a) the numerator of which shall be the total
number of shares of Class A Common Stock outstanding immediately prior to
such dividend or distribution, and (b) the denominator of which shall be the
total number of shares of Class A Common Stock outstanding immediately after
such dividend or distribution and the number of Shares subject to this
Warrant shall be appropriately adjusted.
4.4 No Impairment. The Company will not, by amendment of its
Charter or through any reorganization, recapitalization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any
of the terms to be observed or performed hereunder by the Company, but will
at all times in good faith assist in the carrying out of all the provisions
of this Article 4 and in the taking of all such action as may be necessary or
appropriate in order to protect the rights of the Holder of this Warrant
Agreement against impairment.
4.5 Notices of Record Date. In the event of any taking by the
Company of a record of its shareholders for the purpose of determining
shareholders who are entitled to receive payment of any dividend or other
distribution, or for the purpose of determining shareholders who are entitled
to vote in connection with any proposed merger or consolidation of the
Company with or into any other corporation, or any proposed sale, lease or
conveyance of all or substantially all of the assets of the Company, or any
proposed liquidation, dissolution or winding up of the Company, the Company
shall mail to the holder of this Warrant, at least fifteen (15) days prior to
the date specified therein, a notice specifying the date on which any such
record is to be taken for the purpose of such dividend, distribution or vote,
and the amount and character of such dividend, distribution or vote.
4.6 Adjustment to Number of Shares and Warrant Price Based on
Dilutive Issuance If and whenever the Company should issue shares of its
Class A Common Stock at a price per share less than the average of the
closing of the bid and asked prices for such Class A Common Stock for the
last trading day immediately prior to the issuance of such shares (other than
shares issued pursuant to an employee benefit plan including Class A Common
Stock issued or issuable to the officers or employees or directors of or
consultants to the Company and approved by a disinterested majority of the
directors of the Company), then the Warrant Price shall be adjusted by
dividing (1) the sum of (A) the total number of shares of Class A Common
Stock outstanding immediately prior to such issuance multiplied by the then
effective Warrant Price and (B) the value of the consideration received by
the Company upon such issuances as determined by the Board of Directors by
(2) the total number of shares of Class A Common Stock outstanding
immediately after such issuance. The holder of the Warrant shall thereafter
be entitled to purchase, at the Warrant Price resulting from such adjustment,
the number of Shares (calculated to the nearest whole share) obtained by
multiplying the Warrant Price in effect immediately prior to such adjustment
by the number of shares issuable upon the exercise hereof immediately prior
to such adjustment and dividing the product thereof by the Warrant Price
resulting from such adjustment. For the purpose of this paragraph (d) the
issuance of securities convertible into or exercisable for the Class A Common
Stock shall be deemed the issuance of the number of shares of Class A Common
Stock into which such securities are convertible or for which such securities
are exercisable, and the consideration received for such securities shall be
deemed to include the minimum aggregate amount payable upon conversion or
exercise of such securities expire unexercised, the Warrant Price of Shares
issuable upon the exercise hereof shall be readjusted accordingly.
5. Notice of Adjustments. Whenever the Warrant Price or number of
Shares shall be adjusted pursuant to the provisions hereof, the Company shall
within thirty (30) days of such adjustments deliver a certificate signed by
its chief financial officer to the registered holder(s) hereof setting forth
in reasonable detail, the event requiring the adjustment, the amount of the
adjustment, the method by which such adjustment was calculated, and the
Warrant Price after giving effect to such adjustment.
6. Fractional Shares. No fractional Shares will be issued in
connection with any exercise hereunder, but in lieu of such fractional shares
the Company shall make a cash payment therefor upon the basis of the Warrant
Price then in effect.
7. Compliance with Securities Act, Disposition of Shares.
7.1 Compliance with Securities Act. The holder of this Warrant,
by acceptance hereof, reconfirms the representations made by the Purchaser in
a letter agreement with the Company as of the date hereof (the "Letter
Agreement") and agrees to the placement of a restrictive transfer legend on
this Warrant and the certificates representing the shares.
7.2 Disposition of Warrants and Shares. With respect to any
offer, sale or other disposition of this Warrant or any Shares acquired
pursuant to the exercise of this Warrant prior to registration of this
Warrant or such Shares, the holder hereof and each subsequent holder of this
Warrant agrees to give written notice to the Company prior thereto,
describing briefly the manner thereof, together with a written opinion of
such holder's counsel, if reasonably requested by the Company (and, in such
case, such counsel and opinion must be reasonably acceptable to the Company),
to the effect that such offer, sale or other disposition my be effected
without registration or qualification (under the Securities Act of 1933 (the
"Act") as then in effect or any federal or state law then in effect) and
indicating whether or not under the Act certificates for this Warrant or such
Shares to be sold or otherwise disposed of require any restrictive legend as
to applicable restrictions on transferability in order to insure compliance
with the Act. Each certificate representing this Warrant or the Shares thus
transferred (except a transfer pursuant to Rule 144) shall bear a legend as
to the applicable restrictions on transferability in order to ensure
compliance with the Act, unless in the aforesaid opinion of counsel for the
holder, such legend is not required in order to ensure compliance with the
Act. The Company may issue stop transfer instructions to its transfer agent
in connection with the foregoing restrictions.
8. Rights as Shareholders. No holder of the Warrant, as such, shall
be entitled to vote or receive dividends or be deemed the holder of Shares or
any other securities of the Company which may at any time be issuable on the
exercise thereof for any purpose, nor shall anything contained herein, be
construed to confer upon the holder of this Warrant, as such any of the
rights of a shareholder of the Company or any right to vote for the election
of directors or upon any matter submitted to shareholders at any meeting
thereof, or to receive notice of meetings (except as otherwise provided in
Section 4.5 of this warrant), or to receive dividends or subscription rights
or otherwise until this Warrant shall have been exercised and the Shares
purchasable upon the exercise hereof shall have become deliverable, as
provided herein.
9. Representations and Warranties. This Warrant is issued and
delivered on the basis of the following:
9.1 Authorization and Delivery. This Warrant has been duly
authorized and executed by the Company and when delivered will be valid and
binding obligation of the Company enforceable in accordance with its terms;
and
9.2 Shares. The Shares have been duly authorized and
reserved for issuance by the Company and when issued and paid for in
accordance with the terms hereof, will be validly issued, fully paid and
nonassessable.
10. Modification and Waiver. This Warrant and any provision hereof may
be changed, waived, discharged or terminated only by an instrument in writing
signed by the party against which enforcement of the same is sought.
11. Notices. Any notice, request or other document required or
permitted to be given or delivered to the holder hereof or the Company shall
be delivered in the manner set forth in the Letter Agreement.
12. Binding Effect of Successors. This Warrant shall be binding upon
any corporation succeeding the Company by merger of consolidation, and all of
the obligations of the Company relating to the Shares issuable upon the
exercise of this Warrant shall be as set forth in the Letter Agreement, the
Company's Charter and the Company's by-laws (each as amended from time to
time) and shall survive the exercise and termination of this Warrant and all
of the covenants and agreements herein and in such other documents and
instruments of the Company shall inure to the benefit of the successors and
assigns of the holder hereof. The Company will, at the time of the exercise
of this Warrant, in whole or in part, upon request of the holder hereof but
at the Company's expense, acknowledge in writing its continuing obligation to
the holder hereof in respect of any rights (including without limitation, any
right to registration of the Shares) to which the holder hereof shall
continue to be entitled after such exercise in accordance with this Warrant;
provided that the failure of the holder hereof to make any such request shall
not affect the continuing obligation of the Company to the holder hereof in
respect of such rights.
13. Lost Warrants or Stock Certificates. The Company covenants to the
holder hereof that upon receipt of evidence reasonable satisfactory to the
Company of the loss, theft, destruction, or mutilation of this Warrant or any
stock certificates and, in the case of any such loss, theft or destruction,
upon receipt of an indemnity reasonable satisfactory to the Company, or in
the case of any such mutilation upon surrender and cancellation of such
Warrant or stock certificate, the Company will make and deliver a new Warrant
or stock certificate, or like tenor, in lieu of the lost, stolen, destroyed
or mutilated Warrant or stock certificate.
14. Descriptive Headings. The descriptive headings of the several
paragraphs of this Warrant are inserted for convenience only and do not
constitute a part of this Warrant.
15. Governing Law. This Warrant shall be construed and enforced in
accordance with, and the rights of the parties shall be governed by, the laws
of the Commonwealth of Massachusetts.
PHC, INC.
By: /s/ Bruce A. Shear, President
Date: June 1, 1999
Exhibit A-1
Notice of Exercise
To:
1. The undersigned hereby elects to purchase _______ Shares of PHC,
Inc. pursuant to the terms of the attached Warrant, and tenders herewith
payment of the purchase price of such Shares in full.
2. Please issue a certificate or certificates representing the Shares
deliverable upon the exercise set forth in paragraph 1 in the name of the
undersigned or, subject to compliance with the restrictions on transfer set
forth in Section 7 of the Warrant, in such other name or names as are
specified below:
____________________________________
(Name)
_____________________________________
_____________________________________
_____________________________________
(Address)
3. The undersigned represents that the aforesaid shares are being
acquired for the account of the undersigned for investment and not with a
view to, or for resale in connection with, the distribution thereof and that
the undersigned has not present intention of distributing or reselling such
shares.
_______________________________
Signature
_______________________________
Date
Exhibit A-2
Notice of Exercise
To:
1. Contingent upon and effective immediately prior to the closing (the
"Closing") of the Company's public offering contemplated by the Registration
Statement of Form S _____________, filed ______________, ______ the
undersigned hereby elects to purchase Shares of the Company (or such lesser
number of Shares as may be sold on behalf of the undersigned at the Closing)
pursuant to the terms of the attached Warrant.
2. Please deliver to the custodian for the selling shareholders a
certificate representing the Shares being so purchased.
3. The undersigned has instructed the custodian for the selling
shareholders to deliver to the Company $ _________________ of, if less, the
net proceeds due the undersigned from the sales of Shares in the aforesaid
public offering. If such net proceeds are less than the purchase price for
such Shares, the undersigned agrees to deliver the difference to the Company
prior to the Closing.
_______________________________
Signature
_______________________________
Date
warrants.dot
Exhibit 4.29
THE SECURITIES REPRESENTED BY THIS WARRANT (AND THE SECURITIES ISSUABLE UPON
EXERCISE OF THIS WARRANT) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, OR ANY STATE SECURITIES STATUTE. THE SECURITIES HAVE BEEN ACQUIRED
FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE
SOLD, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED WITHOUT AN
EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT
OF 1933 AND ANY APPLICABLE STATE SECURITIES STATUTE, OR UNLESS AN EXEMPTION
FROM REGISTRATION IS AVAILABLE THEREUNDER.
Shares Issuable Upon Exercise: Up to 10,000 shares of the Class A Common
Stock, $.01 par value, of PHC, Inc.
WARRANT TO PURCHASE
SHARES OF CLASS A COMMON STOCK
Expires July 1, 2004
THIS CERTIFIES THAT, for value received, George H. Gordon is
entitled to subscribe for and purchase that number of shares (the "Shares")
of the fully paid and nonassessable Class A Common Stock, $.01 par value,
(the "Class A Common Stock") of PHC, Inc., a Massachusetts corporation (the
"Company"), for a price of $1.00 per Share (the "Warrant Price"), subject to
the provisions and upon the terms and conditions hereinafter set forth. As
used herein, the term "Shares" shall mean the Company's Class A Common Stock,
or any stock into or for which such Class A Common Stock shall have been or
may hereafter be converted or exchanged pursuant to the Articles of
Incorporation of the Company as from time to time amended as provided by law
and in such Articles (hereinafter the "Charter"), and the term "Grant Date"
shall mean July 1, 1999.
1. Term. Subject to the provisions of this Warrant, the purchase
right represented by this Warrant is exercisable, in whole or in part, at any
time and from time to time from and after the Grant Date and prior to July 1,
2004.
Notwithstanding anything to the contrary contained herein, neither
this Warrant nor any rights hereunder may be transferred or assigned except
to an Assignee who is an "accredited investor" within the meaning of
Regulation D of the General Rules and Regulations of the Securities Act of
1933.
2. Method of Exercise. The purchase right represented by this Warrant
may be exercised by the holder hereof, in whole or in part and from time to
time, by either, at the election of this holder, (a) the surrender of the
Warrant (with the notice of exercise form attached hereto as Exhibit A-1 duly
executed) at the principal office of the Company and by the payment to the
Company by certified or bank check or by wire transfer, of an amount equal to
the then applicable Warrant Price multiplied by the number of shares then
being purchased or (b) if in connection with a registered public offering of
the Company's securities (provided that such offering includes the shares),
the surrender of this Warrant (with the notice of exercise form attached
hereto as Exhibit A-2 duly executed) at the principal office of the Company
together with notice of arrangements reasonably satisfactory to the Company
and any underwriter, in the case of an underwritten registered public
offering, for payment to the Company either by certified or bank check or by
wire transfer of from the proceeds of the sale of Shares to be sold by the
holder in such public offering of an amount equal to the then applicable
Warrant Price per Share multiplied by the number of Shares then being
purchased. The person or persons in whose name(s) any certificate(s)
representing Shares which shall be issuable upon exercise of this Warrant
shall be deemed to have become the holder(s) of record of, and shall be
treated for all purposes as the record holder(s) of, the shares represented
thereby (and such shares shall be deemed to have been issued) immediately
prior to the close of business on the date or dates upon which this Warrant
is exercised and the then applicable Warrant Price paid. In the event of any
exercise of the rights represented by this Warrant, certificates for the
shares of stock so purchased shall be delivered to the holder hereof as soon
as possible and in any event within ten (10) days of receipt of such notice
and payment of the then applicable Warrant Price and, unless this Warrant has
been fully exercised or expired, a new Warrant representing the portion of
the Shares, if any, with respect to which this Warrant shall not then have
been exercised shall also be issued to the holder hereof as soon as possible
and in any event within such ten-day period.
3. Stock Fully Paid; Reservation of Shares. All shares that may be
issued upon the exercise of the rights represented by this Warrant will upon
issuance, be fully paid and nonassessable, and free from all taxes, liens and
charges with respect to the issue thereof. During the period within which
the rights represented by the Warrant may be exercised, the Company will at
all times have authorized and reserved for the purpose of issuance upon
exercise of the purchase rights evidenced by this Warrant, a sufficient
number of shares of Class A Common Stock to provide for the exercise of the
rights represented by this Warrant.
4. Adjustment of Warrant Price and Number of Shares. The number and
kind of securities purchasable upon the exercise of the Warrant Agreement and
the Warrant Price shall be subject to adjustment from time to time upon the
occurrence of certain events, as follows:
4.1 Reclassification. In case of any reclassification, change or
conversion of the Company's Class A Common Stock (other than a change in par
value, or from par value to no par value, or from no par value to par value,
or as a result of a subdivision or combination), the Company, shall execute a
new Warrant Agreement (in form and substance reasonably satisfactory to the
Holder) providing that the Holder of this Warrant Agreement shall have the
right to exercise such new Warrant Agreement and upon such exercise and
payment of the then applicable Warrant Price to receive, in lieu of each
Share theretofore issuable upon exercise of this Warrant Agreement, the kind
and amount of shares of stock, other securities, money and property
receivable upon such reclassification or change by a holder of one share of
Class A Common Stock. Such new Warrant Agreement shall provide for
adjustments that shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Section 4.1. The provisions of this Section
4.1 shall similarly apply to successive reclassifications and changes.
4.2 Subdivision or Combination of Shares. If the Company at any
time while this Warrant remains outstanding and unexpired shall subdivide or
combine its Class A Common Stock, the Warrant Price and the number of Shares
issuable upon exercise hereof shall be equitably adjusted.
4.3 Stock Dividends. If the Company at any time while this
Warrant is outstanding and unexpired shall pay a dividend payable in shares
of Class A Common Stock (except any distribution specifically provided for in
the foregoing Sections 4.1 and 4.2), then the Warrant Price shall be
adjusted, from and after the date of determination of shareholders entitled
to receive such dividend or distribution, to that price determined by
multiplying the Warrant Price in effect immediately prior to such date of
determination by a fraction (a) the numerator of which shall be the total
number of shares of Class A Common Stock outstanding immediately prior to
such dividend or distribution, and (b) the denominator of which shall be the
total number of shares of Class A Common Stock outstanding immediately after
such dividend or distribution and the number of Shares subject to this
Warrant shall be appropriately adjusted.
4.4 No Impairment. The Company will not, by amendment of its
Charter or through any reorganization, recapitalization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any
of the terms to be observed or performed hereunder by the Company, but will
at all times in good faith assist in the carrying out of all the provisions
of this Article 4 and in the taking of all such action as may be necessary or
appropriate in order to protect the rights of the Holder of this Warrant
Agreement against impairment.
4.5 Notices of Record Date. In the event of any taking by the
Company of a record of its shareholders for the purpose of determining
shareholders who are entitled to receive payment of any dividend or other
distribution, or for the purpose of determining shareholders who are entitled
to vote in connection with any proposed merger or consolidation of the
Company with or into any other corporation, or any proposed sale, lease or
conveyance of all or substantially all of the assets of the Company, or any
proposed liquidation, dissolution or winding up of the Company, the Company
shall mail to the holder of this Warrant, at least fifteen (15) days prior to
the date specified therein, a notice specifying the date on which any such
record is to be taken for the purpose of such dividend, distribution or vote,
and the amount and character of such dividend, distribution or vote.
4.6 Adjustment to Number of Shares and Warrant Price Based on
Dilutive Issuance If and whenever the Company should issue shares of its
Class A Common Stock at a price per share less than the average of the
closing of the bid and asked prices for such Class A Common Stock for the
last trading day immediately prior to the issuance of such shares (other than
shares issued pursuant to an employee benefit plan including Class A Common
Stock issued or issuable to the officers or employees or directors of or
consultants to the Company and approved by a disinterested majority of the
directors of the Company), then the Warrant Price shall be adjusted by
dividing (1) the sum of (A) the total number of shares of Class A Common
Stock outstanding immediately prior to such issuance multiplied by the then
effective Warrant Price and (B) the value of the consideration received by
the Company upon such issuances as determined by the Board of Directors by
(2) the total number of shares of Class A Common Stock outstanding
immediately after such issuance. The holder of the Warrant shall thereafter
be entitled to purchase, at the Warrant Price resulting from such adjustment,
the number of Shares (calculated to the nearest whole share) obtained by
multiplying the Warrant Price in effect immediately prior to such adjustment
by the number of shares issuable upon the exercise hereof immediately prior
to such adjustment and dividing the product thereof by the Warrant Price
resulting from such adjustment. For the purpose of this paragraph (d) the
issuance of securities convertible into or exercisable for the Class A Common
Stock shall be deemed the issuance of the number of shares of Class A Common
Stock into which such securities are convertible or for which such securities
are exercisable, and the consideration received for such securities shall be
deemed to include the minimum aggregate amount payable upon conversion or
exercise of such securities expire unexercised, the Warrant Price of Shares
issuable upon the exercise hereof shall be readjusted accordingly.
5. Notice of Adjustments. Whenever the Warrant Price or number of
Shares shall be adjusted pursuant to the provisions hereof, the Company shall
within thirty (30) days of such adjustments deliver a certificate signed by
its chief financial officer to the registered holder(s) hereof setting forth
in reasonable detail, the event requiring the adjustment, the amount of the
adjustment, the method by which such adjustment was calculated, and the
Warrant Price after giving effect to such adjustment.
6. Fractional Shares. No fractional Shares will be issued in
connection with any exercise hereunder, but in lieu of such fractional shares
the Company shall make a cash payment therefor upon the basis of the Warrant
Price then in effect.
7. Compliance with Securities Act, Disposition of Shares.
7.1 Compliance with Securities Act. The holder of this Warrant,
by acceptance hereof, reconfirms the representations made by the Purchaser in
a letter agreement with the Company as of the date hereof (the "Letter
Agreement") and agrees to the placement of a restrictive transfer legend on
this Warrant and the certificates representing the shares.
7.2 Disposition of Warrants and Shares. With respect to any
offer, sale or other disposition of this Warrant or any Shares acquired
pursuant to the exercise of this Warrant prior to registration of this
Warrant or such Shares, the holder hereof and each subsequent holder of this
Warrant agrees to give written notice to the Company prior thereto,
describing briefly the manner thereof, together with a written opinion of
such holder's counsel, if reasonably requested by the Company (and, in such
case, such counsel and opinion must be reasonably acceptable to the Company),
to the effect that such offer, sale or other disposition my be effected
without registration or qualification (under the Securities Act of 1933 (the
"Act") as then in effect or any federal or state law then in effect) and
indicating whether or not under the Act certificates for this Warrant or such
Shares to be sold or otherwise disposed of require any restrictive legend as
to applicable restrictions on transferability in order to insure compliance
with the Act. Each certificate representing this Warrant or the Shares thus
transferred (except a transfer pursuant to Rule 144) shall bear a legend as
to the applicable restrictions on transferability in order to ensure
compliance with the Act, unless in the aforesaid opinion of counsel for the
holder, such legend is not required in order to ensure compliance with the
Act. The Company may issue stop transfer instructions to its transfer agent
in connection with the foregoing restrictions.
8. Rights as Shareholders. No holder of the Warrant, as such, shall
be entitled to vote or receive dividends or be deemed the holder of Shares or
any other securities of the Company which may at any time be issuable on the
exercise thereof for any purpose, nor shall anything contained herein, be
construed to confer upon the holder of this Warrant, as such any of the
rights of a shareholder of the Company or any right to vote for the election
of directors or upon any matter submitted to shareholders at any meeting
thereof, or to receive notice of meetings (except as otherwise provided in
Section 4.5 of this warrant), or to receive dividends or subscription rights
or otherwise until this Warrant shall have been exercised and the Shares
purchasable upon the exercise hereof shall have become deliverable, as
provided herein.
9. Representations and Warranties. This Warrant is issued and
delivered on the basis of the following:
9.1 Authorization and Delivery. This Warrant has been duly
authorized and executed by the Company and when delivered will be valid and
binding obligation of the Company enforceable in accordance with its terms;
and
9.2 Shares. The Shares have been duly authorized and
reserved for issuance by the Company and when issued and paid for in
accordance with the terms hereof, will be validly issued, fully paid and
nonassessable.
10. Modification and Waiver. This Warrant and any provision hereof may
be changed, waived, discharged or terminated only by an instrument in writing
signed by the party against which enforcement of the same is sought.
11. Notices. Any notice, request or other document required or
permitted to be given or delivered to the holder hereof or the Company shall
be delivered in the manner set forth in the Letter Agreement.
12. Binding Effect of Successors. This Warrant shall be binding upon
any corporation succeeding the Company by merger of consolidation, and all of
the obligations of the Company relating to the Shares issuable upon the
exercise of this Warrant shall be as set forth in the Letter Agreement, the
Company's Charter and the Company's by-laws (each as amended from time to
time) and shall survive the exercise and termination of this Warrant and all
of the covenants and agreements herein and in such other documents and
instruments of the Company shall inure to the benefit of the successors and
assigns of the holder hereof. The Company will, at the time of the exercise
of this Warrant, in whole or in part, upon request of the holder hereof but
at the Company's expense, acknowledge in writing its continuing obligation to
the holder hereof in respect of any rights (including without limitation, any
right to registration of the Shares) to which the holder hereof shall
continue to be entitled after such exercise in accordance with this Warrant;
provided that the failure of the holder hereof to make any such request shall
not affect the continuing obligation of the Company to the holder hereof in
respect of such rights.
13. Lost Warrants or Stock Certificates. The Company covenants to the
holder hereof that upon receipt of evidence reasonable satisfactory to the
Company of the loss, theft, destruction, or mutilation of this Warrant or any
stock certificates and, in the case of any such loss, theft or destruction,
upon receipt of an indemnity reasonable satisfactory to the Company, or in
the case of any such mutilation upon surrender and cancellation of such
Warrant or stock certificate, the Company will make and deliver a new Warrant
or stock certificate, or like tenor, in lieu of the lost, stolen, destroyed
or mutilated Warrant or stock certificate.
14. Descriptive Headings. The descriptive headings of the several
paragraphs of this Warrant are inserted for convenience only and do not
constitute a part of this Warrant.
15. Governing Law. This Warrant shall be construed and enforced in
accordance with, and the rights of the parties shall be governed by, the laws
of the Commonwealth of Massachusetts.
PHC, INC.
By: /s/ Bruce A. Shear, President
Date: July 1, 1999
Exhibit A-1
Notice of Exercise
To:
1. The undersigned hereby elects to purchase _______ Shares of PHC,
Inc. pursuant to the terms of the attached Warrant, and tenders herewith
payment of the purchase price of such Shares in full.
2. Please issue a certificate or certificates representing the Shares
deliverable upon the exercise set forth in paragraph 1 in the name of the
undersigned or, subject to compliance with the restrictions on transfer set
forth in Section 7 of the Warrant, in such other name or names as are
specified below:
____________________________________
(Name)
_____________________________________
_____________________________________
_____________________________________
(Address)
3. The undersigned represents that the aforesaid shares are being
acquired for the account of the undersigned for investment and not with a
view to, or for resale in connection with, the distribution thereof and that
the undersigned has not present intention of distributing or reselling such
shares.
_______________________________
Signature
_______________________________
Date
Exhibit A-2
Notice of Exercise
To:
1. Contingent upon and effective immediately prior to the closing (the
"Closing") of the Company's public offering contemplated by the Registration
Statement of Form S _____________, filed ______________, ______ the
undersigned hereby elects to purchase Shares of the Company (or such lesser
number of Shares as may be sold on behalf of the undersigned at the Closing)
pursuant to the terms of the attached Warrant.
2. Please deliver to the custodian for the selling shareholders a
certificate representing the Shares being so purchased.
3. The undersigned has instructed the custodian for the selling
shareholders to deliver to the Company $ _________________ of, if less, the
net proceeds due the undersigned from the sales of Shares in the aforesaid
public offering. If such net proceeds are less than the purchase price for
such Shares, the undersigned agrees to deliver the difference to the Company
prior to the Closing.
_______________________________
Signature
_______________________________
Date
warrants.dot
Exhibit 4.30
THE SECURITIES REPRESENTED BY THIS WARRANT (AND THE SECURITIES ISSUABLE UPON
EXERCISE OF THIS WARRANT) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, OR ANY STATE SECURITIES STATUTE. THE SECURITIES HAVE BEEN ACQUIRED
FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE
SOLD, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED WITHOUT AN
EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT
OF 1933 AND ANY APPLICABLE STATE SECURITIES STATUTE, OR UNLESS AN EXEMPTION
FROM REGISTRATION IS AVAILABLE THEREUNDER.
Shares Issuable Upon Exercise: Up to 10,000 shares of the Class A Common
Stock, $.01 par value, of PHC, Inc.
WARRANT TO PURCHASE
SHARES OF CLASS A COMMON STOCK
Expires August 1, 2004
THIS CERTIFIES THAT, for value received, George H. Gordon is
entitled to subscribe for and purchase that number of shares (the "Shares")
of the fully paid and nonassessable Class A Common Stock, $.01 par value,
(the "Class A Common Stock") of PHC, Inc., a Massachusetts corporation (the
"Company"), for a price of $1.00 per Share (the "Warrant Price"), subject to
the provisions and upon the terms and conditions hereinafter set forth. As
used herein, the term "Shares" shall mean the Company's Class A Common Stock,
or any stock into or for which such Class A Common Stock shall have been or
may hereafter be converted or exchanged pursuant to the Articles of
Incorporation of the Company as from time to time amended as provided by law
and in such Articles (hereinafter the "Charter"), and the term "Grant Date"
shall mean August 1, 1999.
1. Term. Subject to the provisions of this Warrant, the purchase right
represented by this Warrant is exercisable, in whole or in part, at any time and
from time to time from and after the Grant Date and prior to August 1, 2004.
Notwithstanding anything to the contrary contained herein, neither
this Warrant nor any rights hereunder may be transferred or assigned except
to an Assignee who is an "accredited investor" within the meaning of
Regulation D of the General Rules and Regulations of the Securities Act of
1933.
2. Method of Exercise. The purchase right represented by this Warrant
may be exercised by the holder hereof, in whole or in part and from time to
time, by either, at the election of this holder, (a) the surrender of the
Warrant (with the notice of exercise form attached hereto as Exhibit A-1 duly
executed) at the principal office of the Company and by the payment to the
Company by certified or bank check or by wire transfer, of an amount equal to
the then applicable Warrant Price multiplied by the number of shares then
being purchased or (b) if in connection with a registered public offering of
the Company's securities (provided that such offering includes the shares),
the surrender of this Warrant (with the notice of exercise form attached
hereto as Exhibit A-2 duly executed) at the principal office of the Company
together with notice of arrangements reasonably satisfactory to the Company
and any underwriter, in the case of an underwritten registered public
offering, for payment to the Company either by certified or bank check or by
wire transfer of from the proceeds of the sale of Shares to be sold by the
holder in such public offering of an amount equal to the then applicable
Warrant Price per Share multiplied by the number of Shares then being
purchased. The person or persons in whose name(s) any certificate(s)
representing Shares which shall be issuable upon exercise of this Warrant
shall be deemed to have become the holder(s) of record of, and shall be
treated for all purposes as the record holder(s) of, the shares represented
thereby (and such shares shall be deemed to have been issued) immediately
prior to the close of business on the date or dates upon which this Warrant
is exercised and the then applicable Warrant Price paid. In the event of any
exercise of the rights represented by this Warrant, certificates for the
shares of stock so purchased shall be delivered to the holder hereof as soon
as possible and in any event within ten (10) days of receipt of such notice
and payment of the then applicable Warrant Price and, unless this Warrant has
been fully exercised or expired, a new Warrant representing the portion of
the Shares, if any, with respect to which this Warrant shall not then have
been exercised shall also be issued to the holder hereof as soon as possible
and in any event within such ten-day period.
3. Stock Fully Paid; Reservation of Shares. All shares that may be
issued upon the exercise of the rights represented by this Warrant will upon
issuance, be fully paid and nonassessable, and free from all taxes, liens and
charges with respect to the issue thereof. During the period within which
the rights represented by the Warrant may be exercised, the Company will at
all times have authorized and reserved for the purpose of issuance upon
exercise of the purchase rights evidenced by this Warrant, a sufficient
number of shares of Class A Common Stock to provide for the exercise of the
rights represented by this Warrant.
4. Adjustment of Warrant Price and Number of Shares. The number and
kind of securities purchasable upon the exercise of the Warrant Agreement and
the Warrant Price shall be subject to adjustment from time to time upon the
occurrence of certain events, as follows:
4.1 Reclassification. In case of any reclassification, change or
conversion of the Company's Class A Common Stock (other than a change in par
value, or from par value to no par value, or from no par value to par value,
or as a result of a subdivision or combination), the Company, shall execute a
new Warrant Agreement (in form and substance reasonably satisfactory to the
Holder) providing that the Holder of this Warrant Agreement shall have the
right to exercise such new Warrant Agreement and upon such exercise and
payment of the then applicable Warrant Price to receive, in lieu of each
Share theretofore issuable upon exercise of this Warrant Agreement, the kind
and amount of shares of stock, other securities, money and property
receivable upon such reclassification or change by a holder of one share of
Class A Common Stock. Such new Warrant Agreement shall provide for
adjustments that shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Section 4.1. The provisions of this Section
4.1 shall similarly apply to successive reclassifications and changes.
4.2 Subdivision or Combination of Shares. If the Company at any
time while this Warrant remains outstanding and unexpired shall subdivide or
combine its Class A Common Stock, the Warrant Price and the number of Shares
issuable upon exercise hereof shall be equitably adjusted.
4.3 Stock Dividends. If the Company at any time while this
Warrant is outstanding and unexpired shall pay a dividend payable in shares
of Class A Common Stock (except any distribution specifically provided for in
the foregoing Sections 4.1 and 4.2), then the Warrant Price shall be
adjusted, from and after the date of determination of shareholders entitled
to receive such dividend or distribution, to that price determined by
multiplying the Warrant Price in effect immediately prior to such date of
determination by a fraction (a) the numerator of which shall be the total
number of shares of Class A Common Stock outstanding immediately prior to
such dividend or distribution, and (b) the denominator of which shall be the
total number of shares of Class A Common Stock outstanding immediately after
such dividend or distribution and the number of Shares subject to this
Warrant shall be appropriately adjusted.
4.4 No Impairment. The Company will not, by amendment of its
Charter or through any reorganization, recapitalization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any
of the terms to be observed or performed hereunder by the Company, but will
at all times in good faith assist in the carrying out of all the provisions
of this Article 4 and in the taking of all such action as may be necessary or
appropriate in order to protect the rights of the Holder of this Warrant
Agreement against impairment.
4.5 Notices of Record Date. In the event of any taking by the
Company of a record of its shareholders for the purpose of determining
shareholders who are entitled to receive payment of any dividend or other
distribution, or for the purpose of determining shareholders who are entitled
to vote in connection with any proposed merger or consolidation of the
Company with or into any other corporation, or any proposed sale, lease or
conveyance of all or substantially all of the assets of the Company, or any
proposed liquidation, dissolution or winding up of the Company, the Company
shall mail to the holder of this Warrant, at least fifteen (15) days prior to
the date specified therein, a notice specifying the date on which any such
record is to be taken for the purpose of such dividend, distribution or vote,
and the amount and character of such dividend, distribution or vote.
4.6 Adjustment to Number of Shares and Warrant Price Based on
Dilutive Issuance If and whenever the Company should issue shares of its
Class A Common Stock at a price per share less than the average of the
closing of the bid and asked prices for such Class A Common Stock for the
last trading day immediately prior to the issuance of such shares (other than
shares issued pursuant to an employee benefit plan including Class A Common
Stock issued or issuable to the officers or employees or directors of or
consultants to the Company and approved by a disinterested majority of the
directors of the Company), then the Warrant Price shall be adjusted by
dividing (1) the sum of (A) the total number of shares of Class A Common
Stock outstanding immediately prior to such issuance multiplied by the then
effective Warrant Price and (B) the value of the consideration received by
the Company upon such issuances as determined by the Board of Directors by
(2) the total number of shares of Class A Common Stock outstanding
immediately after such issuance. The holder of the Warrant shall thereafter
be entitled to purchase, at the Warrant Price resulting from such adjustment,
the number of Shares (calculated to the nearest whole share) obtained by
multiplying the Warrant Price in effect immediately prior to such adjustment
by the number of shares issuable upon the exercise hereof immediately prior
to such adjustment and dividing the product thereof by the Warrant Price
resulting from such adjustment. For the purpose of this paragraph (d) the
issuance of securities convertible into or exercisable for the Class A Common
Stock shall be deemed the issuance of the number of shares of Class A Common
Stock into which such securities are convertible or for which such securities
are exercisable, and the consideration received for such securities shall be
deemed to include the minimum aggregate amount payable upon conversion or
exercise of such securities expire unexercised, the Warrant Price of Shares
issuable upon the exercise hereof shall be readjusted accordingly.
5. Notice of Adjustments. Whenever the Warrant Price or number of
Shares shall be adjusted pursuant to the provisions hereof, the Company shall
within thirty (30) days of such adjustments deliver a certificate signed by
its chief financial officer to the registered holder(s) hereof setting forth
in reasonable detail, the event requiring the adjustment, the amount of the
adjustment, the method by which such adjustment was calculated, and the
Warrant Price after giving effect to such adjustment.
6. Fractional Shares. No fractional Shares will be issued in
connection with any exercise hereunder, but in lieu of such fractional shares
the Company shall make a cash payment therefor upon the basis of the Warrant
Price then in effect.
7. Compliance with Securities Act, Disposition of Shares.
7.1 Compliance with Securities Act. The holder of this Warrant,
by acceptance hereof, reconfirms the representations made by the Purchaser in
a letter agreement with the Company as of the date hereof (the "Letter
Agreement") and agrees to the placement of a restrictive transfer legend on
this Warrant and the certificates representing the shares.
7.2 Disposition of Warrants and Shares. With respect to any
offer, sale or other disposition of this Warrant or any Shares acquired
pursuant to the exercise of this Warrant prior to registration of this
Warrant or such Shares, the holder hereof and each subsequent holder of this
Warrant agrees to give written notice to the Company prior thereto,
describing briefly the manner thereof, together with a written opinion of
such holder's counsel, if reasonably requested by the Company (and, in such
case, such counsel and opinion must be reasonably acceptable to the Company),
to the effect that such offer, sale or other disposition my be effected
without registration or qualification (under the Securities Act of 1933 (the
"Act") as then in effect or any federal or state law then in effect) and
indicating whether or not under the Act certificates for this Warrant or such
Shares to be sold or otherwise disposed of require any restrictive legend as
to applicable restrictions on transferability in order to insure compliance
with the Act. Each certificate representing this Warrant or the Shares thus
transferred (except a transfer pursuant to Rule 144) shall bear a legend as
to the applicable restrictions on transferability in order to ensure
compliance with the Act, unless in the aforesaid opinion of counsel for the
holder, such legend is not required in order to ensure compliance with the
Act. The Company may issue stop transfer instructions to its transfer agent
in connection with the foregoing restrictions.
8. Rights as Shareholders. No holder of the Warrant, as such, shall
be entitled to vote or receive dividends or be deemed the holder of Shares or
any other securities of the Company which may at any time be issuable on the
exercise thereof for any purpose, nor shall anything contained herein, be
construed to confer upon the holder of this Warrant, as such any of the
rights of a shareholder of the Company or any right to vote for the election
of directors or upon any matter submitted to shareholders at any meeting
thereof, or to receive notice of meetings (except as otherwise provided in
Section 4.5 of this warrant), or to receive dividends or subscription rights
or otherwise until this Warrant shall have been exercised and the Shares
purchasable upon the exercise hereof shall have become deliverable, as
provided herein.
9. Representations and Warranties. This Warrant is issued and
delivered on the basis of the following:
9.1 Authorization and Delivery. This Warrant has been duly
authorized and executed by the Company and when delivered will be valid and
binding obligation of the Company enforceable in accordance with its terms;
and
9.2 Shares. The Shares have been duly authorized and
reserved for issuance by the Company and when issued and paid for in
accordance with the terms hereof, will be validly issued, fully paid and
nonassessable.
10. Modification and Waiver. This Warrant and any provision hereof may
be changed, waived, discharged or terminated only by an instrument in writing
signed by the party against which enforcement of the same is sought.
11. Notices. Any notice, request or other document required or
permitted to be given or delivered to the holder hereof or the Company shall
be delivered in the manner set forth in the Letter Agreement.
12. Binding Effect of Successors. This Warrant shall be binding upon
any corporation succeeding the Company by merger of consolidation, and all of
the obligations of the Company relating to the Shares issuable upon the
exercise of this Warrant shall be as set forth in the Letter Agreement, the
Company's Charter and the Company's by-laws (each as amended from time to
time) and shall survive the exercise and termination of this Warrant and all
of the covenants and agreements herein and in such other documents and
instruments of the Company shall inure to the benefit of the successors and
assigns of the holder hereof. The Company will, at the time of the exercise
of this Warrant, in whole or in part, upon request of the holder hereof but
at the Company's expense, acknowledge in writing its continuing obligation to
the holder hereof in respect of any rights (including without limitation, any
right to registration of the Shares) to which the holder hereof shall
continue to be entitled after such exercise in accordance with this Warrant;
provided that the failure of the holder hereof to make any such request shall
not affect the continuing obligation of the Company to the holder hereof in
respect of such rights.
13. Lost Warrants or Stock Certificates. The Company covenants to the
holder hereof that upon receipt of evidence reasonable satisfactory to the
Company of the loss, theft, destruction, or mutilation of this Warrant or any
stock certificates and, in the case of any such loss, theft or destruction,
upon receipt of an indemnity reasonable satisfactory to the Company, or in
the case of any such mutilation upon surrender and cancellation of such
Warrant or stock certificate, the Company will make and deliver a new Warrant
or stock certificate, or like tenor, in lieu of the lost, stolen, destroyed
or mutilated Warrant or stock certificate.
14. Descriptive Headings. The descriptive headings of the several
paragraphs of this Warrant are inserted for convenience only and do not
constitute a part of this Warrant.
15. Governing Law. This Warrant shall be construed and enforced in
accordance with, and the rights of the parties shall be governed by, the laws
of the Commonwealth of Massachusetts.
PHC, INC.
By: /s/ Bruce A. Shear, President
Date: August 1, 1999
Exhibit A-1
Notice of Exercise
To:
1. The undersigned hereby elects to purchase _______ Shares of PHC,
Inc. pursuant to the terms of the attached Warrant, and tenders herewith
payment of the purchase price of such Shares in full.
2. Please issue a certificate or certificates representing the Shares
deliverable upon the exercise set forth in paragraph 1 in the name of the
undersigned or, subject to compliance with the restrictions on transfer set
forth in Section 7 of the Warrant, in such other name or names as are
specified below:
____________________________________
(Name)
_____________________________________
_____________________________________
_____________________________________
(Address)
3. The undersigned represents that the aforesaid shares are being
acquired for the account of the undersigned for investment and not with a
view to, or for resale in connection with, the distribution thereof and that
the undersigned has not present intention of distributing or reselling such
shares.
_______________________________
Signature
_______________________________
Date
Exhibit A-2
Notice of Exercise
To:
1. Contingent upon and effective immediately prior to the closing (the
"Closing") of the Company's public offering contemplated by the Registration
Statement of Form S _____________, filed ______________, ______ the
undersigned hereby elects to purchase Shares of the Company (or such lesser
number of Shares as may be sold on behalf of the undersigned at the Closing)
pursuant to the terms of the attached Warrant.
2. Please deliver to the custodian for the selling shareholders a
certificate representing the Shares being so purchased.
3. The undersigned has instructed the custodian for the selling
shareholders to deliver to the Company $ _________________ of, if less, the
net proceeds due the undersigned from the sales of Shares in the aforesaid
public offering. If such net proceeds are less than the purchase price for
such Shares, the undersigned agrees to deliver the difference to the Company
prior to the Closing.
_______________________________
Signature
_______________________________
Date
warrants.dot
Exhibit 4.31
THE SECURITIES REPRESENTED BY THIS WARRANT (AND THE SECURITIES ISSUABLE UPON
EXERCISE OF THIS WARRANT) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, OR ANY STATE SECURITIES STATUTE. THE SECURITIES HAVE BEEN ACQUIRED
FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE
SOLD, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED WITHOUT AN
EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT
OF 1933 AND ANY APPLICABLE STATE SECURITIES STATUTE, OR UNLESS AN EXEMPTION
FROM REGISTRATION IS AVAILABLE THEREUNDER.
Shares Issuable Upon Exercise: Up to 37,500 shares of the Class A Common
Stock, $.01 par value, of PHC, Inc.
WARRANT TO PURCHASE
SHARES OF CLASS A COMMON STOCK
Expires April 5, 2004
THIS CERTIFIES THAT, for value received, National Securities
Corporation is entitled to subscribe for and purchase that number of shares
(the "Shares") of the fully paid and nonassessable Class A Common Stock, $.01
par value, (the "Class A Common Stock") of PHC, Inc., a Massachusetts
corporation (the "Company"), for a price of $1.45 per Share (the "Warrant
Price"), subject to the provisions and upon the terms and conditions
hereinafter set forth. As used herein, the term "Shares" shall mean the
Company's Class A Common Stock, or any stock into or for which such Class A
Common Stock shall have been or may hereafter be converted or exchanged
pursuant to the Articles of Incorporation of the Company as from time to time
amended as provided by law and in such Articles (hereinafter the "Charter"),
and the term "Grant Date" shall mean April 5, 1999.
1. Term. Subject to the provisions of this Warrant, the purchase
right represented by this Warrant is exercisable, in whole or in part, at any
time and from time to time from and after the Grant Date and prior to April
5, 2004.
Notwithstanding anything to the contrary contained herein, neither
this Warrant nor any rights hereunder may be transferred or assigned except
to an Assignee who is an 'accredited investor" within the meaning of
Regulation D of the General Rules and Regulations of the Securities Act of
1933.
2. Method of Exercise. The purchase right represented by this Warrant
may be exercised by the holder hereof, in whole or in part and from time to
time, by either, at the election of this holder, (a) the surrender of the
Warrant (with the notice of exercise form attached hereto as Exhibit A-1 duly
executed) at the principal office of the Company and by the payment to the
Company by certified or bank check or by wire transfer, of an amount equal to
the then applicable Warrant Price multiplied by the number of shares then
being purchased or (b) if in connection with a registered public offering of
the Company's securities (provided that such offering includes the shares),
the surrender of this Warrant (with the notice of exercise form attached
hereto as Exhibit A-2 duly executed) at the principal office of the Company
together with notice of arrangements reasonably satisfactory to the Company
and any underwriter, in the case of an underwritten registered public
offering, for payment to the Company either by certified or bank check or by
wire transfer of from the proceeds of the sale of Shares to be sold by the
holder in such public offering of an amount equal to the then applicable
Warrant Price per Share multiplied by the number of Shares then being
purchased. The person or persons in whose name(s) any certificate(s)
representing Shares which shall be issuable upon exercise of this Warrant
shall be deemed to have become the holder(s) of record of, and shall be
treated for all purposes as the record holder(s) of, the shares represented
thereby (and such shares shall be deemed to have been issued) immediately
prior to the close of business on the date or dates upon which this Warrant
is exercised and the then applicable Warrant Price paid. In the event of any
exercise of the rights represented by this Warrant, certificates for the
shares of stock so purchased shall be delivered to the holder hereof as soon
as possible and in any event within ten (10) days of receipt of such notice
and payment of the then applicable Warrant Price and, unless this Warrant has
been fully exercised or expired, a new Warrant representing the portion of
the Shares, if any, with respect to which this Warrant shall not then have
been exercised shall also be issued to the holder hereof as soon as possible
and in any event within such ten-day period.
3. Stock Fully Paid; Reservation of Shares. All shares that may be
issued upon the exercise of the rights represented by this Warrant will upon
issuance, be fully paid and nonassessable, and free from all taxes, liens and
charges with respect to the issue thereof. During the period within which
the rights represented by the Warrant may be exercised, the Company will at
all times have authorized and reserved for the purpose of issuance upon
exercise of the purchase rights evidenced by this Warrant, a sufficient
number of shares of Class A Common Stock to provide for the exercise of the
rights represented by this Warrant.
4. Adjustment of Warrant Price and Number of Shares. The number and
kind of securities purchasable upon the exercise of the Warrant Agreement and
the Warrant Price shall be subject to adjustment from time to time upon the
occurrence of certain events, as follows:
4.1 Reclassification. In case of any reclassification, change or
conversion of the Company's Class A Common Stock (other than a change in par
value, or from par value to no par value, or from no par value to par value,
or as a result of a subdivision or combination), the Company, shall execute a
new Warrant Agreement (in form and substance reasonably satisfactory to the
Holder) providing that the Holder of this Warrant Agreement shall have the
right to exercise such new Warrant Agreement and upon such exercise and
payment of the then applicable Warrant Price to receive, in lieu of each
Share theretofore issuable upon exercise of this Warrant Agreement, the kind
and amount of shares of stock, other securities, money and property
receivable upon such reclassification or change by a holder of one share of
Class A Common Stock. Such new Warrant Agreement shall provide for
adjustments that shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Section 4.1. The provisions of this Section
4.1 shall similarly apply to successive reclassifications and changes.
4.2 Subdivision or Combination of Shares. If the Company at any
time while this Warrant remains outstanding and unexpired shall subdivide or
combine its Class A Common Stock, the Warrant Price and the number of Shares
issuable upon exercise hereof shall be equitably adjusted.
4.3 Stock Dividends. If the Company at any time while this
Warrant is outstanding and unexpired shall pay a dividend payable in shares
of Class A Common Stock (except any distribution specifically provided for in
the foregoing Sections 4.1 and 4.2), then the Warrant Price shall be
adjusted, from and after the date of determination of shareholders entitled
to receive such dividend or distribution, to that price determined by
multiplying the Warrant Price in effect immediately prior to such date of
determination by a fraction (a) the numerator of which shall be the total
number of shares of Class A Common Stock outstanding immediately prior to
such dividend or distribution, and (b) the denominator of which shall be the
total number of shares of Class A Common Stock outstanding immediately after
such dividend or distribution and the number of Shares subject to this
Warrant shall be appropriately adjusted.
4.4 No Impairment. The Company will not, by amendment of its
Charter or through any reorganization, recapitalization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any
of the terms to be observed or performed hereunder by the Company, but will
at all times in good faith assist in the carrying out of all the provisions
of this Article 4 and in the taking of all such action as may be necessary or
appropriate in order to protect the rights of the Holder of this Warrant
Agreement against impairment.
4.5 Notices of Record Date. In the event of any taking by the
Company of a record of its shareholders for the purpose of determining
shareholders who are entitled to receive payment of any dividend or other
distribution, or for the purpose of determining shareholders who are entitled
to vote in connection with any proposed merger or consolidation of the
Company with or into any other corporation, or any proposed sale, lease or
conveyance of all or substantially all of the assets of the Company, or any
proposed liquidation, dissolution or winding up of the Company, the Company
shall mail to the holder of this Warrant, at least fifteen (15) days prior to
the date specified therein, a notice specifying the date on which any such
record is to be taken for the purpose of such dividend, distribution or vote,
and the amount and character of such dividend, distribution or vote.
4.6 Adjustment to Number of Shares and Warrant Price Based on
Dilutive Issuance If and whenever the Company should issue shares of its
Class A Common Stock at a price per share less than the average of the
closing of the bid and asked prices for such Class A Common Stock for the
last trading day immediately prior to the issuance of such shares (other than
shares issued pursuant to an employee benefit plan including Class A Common
Stock issued or issuable to the officers or employees or directors of or
consultants to the Company and approved by a disinterested majority of the
directors of the Company), then the Warrant Price shall be adjusted by
dividing (1) the sum of (A) the total number of shares of Class A Common
Stock outstanding immediately prior to such issuance multiplied by the then
effective Warrant Price and (B) the value of the consideration received by
the Company upon such issuances as determined by the Board of Directors by
(2) the total number of shares of Class A Common Stock outstanding
immediately after such issuance. The holder of the Warrant shall thereafter
be entitled to purchase, at the Warrant Price resulting from such adjustment,
the number of Shares (calculated to the nearest whole share) obtained by
multiplying the Warrant Price in effect immediately prior to such adjustment
by the number of shares issuable upon the exercise hereof immediately prior
to such adjustment and dividing the product thereof by the Warrant Price
resulting from such adjustment. For the purpose of this paragraph (d) the
issuance of securities convertible into or exercisable for the Class A Common
Stock shall be deemed the issuance of the number of shares of Class A Common
Stock into which such securities are convertible or for which such securities
are exercisable, and the consideration received for such securities shall be
deemed to include the minimum aggregate amount payable upon conversion or
exercise of such securities expire unexercised, the Warrant Price of Shares
issuable upon the exercise hereof shall be readjusted accordingly.
5. Notice of Adjustments. Whenever the Warrant Price or number of
Shares shall be adjusted pursuant to the provisions hereof, the Company shall
within thirty (30) days of such adjustments deliver a certificate signed by
its chief financial officer to the registered holder(s) hereof setting forth
in reasonable detail, the event requiring the adjustment, the amount of the
adjustment, the method by which such adjustment was calculated, and the
Warrant Price after giving effect to such adjustment.
6. Fractional Shares. No fractional Shares will be issued in
connection with any exercise hereunder, but in lieu of such fractional shares
the Company shall make a cash payment therefor upon the basis of the Warrant
Price then in effect.
7. Compliance with Securities Act, Disposition of Shares.
7.1 Compliance with Securities Act. The holder of this Warrant,
by acceptance hereof, reconfirms the representations made by the Purchaser in
a letter agreement with the Company as of the date hereof (the "Letter
Agreement") and agrees to the placement of a restrictive transfer legend on
this Warrant and the certificates representing the shares.
7.2 Disposition of Warrants and Shares. With respect to any
offer, sale or other disposition of this Warrant or any Shares acquired
pursuant to the exercise of this Warrant prior to registration of this
Warrant or such Shares, the holder hereof and each subsequent holder of this
Warrant agrees to give written notice to the Company prior thereto,
describing briefly the manner thereof, together with a written opinion of
such holder's counsel, if reasonably requested by the Company (and, in such
case, such counsel and opinion must be reasonably acceptable to the Company),
to the effect that such offer, sale or other disposition my be effected
without registration or qualification (under the Securities Act of 1933 (the
"Act") as then in effect or any federal or state law then in effect) and
indicating whether or not under the Act certificates for this Warrant or such
Shares to be sold or otherwise disposed of require any restrictive legend as
to applicable restrictions on transferability in order to insure compliance
with the Act. Each certificate representing this Warrant or the Shares thus
transferred (except a transfer pursuant to Rule 144) shall bear a legend as
to the applicable restrictions on transferability in order to ensure
compliance with the Act, unless in the aforesaid opinion of counsel for the
holder, such legend is not required in order to ensure compliance with the
Act. The Company may issue stop transfer instructions to its transfer agent
in connection with the foregoing restrictions.
8. Rights as Shareholders. No holder of the Warrant, as such, shall
be entitled to vote or receive dividends or be deemed the holder of Shares or
any other securities of the Company which may at any time be issuable on the
exercise thereof for any purpose, nor shall anything contained herein, be
construed to confer upon the holder of this Warrant, as such any of the
rights of a shareholder of the Company or any right to vote for the election
of directors or upon any matter submitted to shareholders at any meeting
thereof, or to receive notice of meetings (except as otherwise provided in
Section 4.5 of this warrant), or to receive dividends or subscription rights
or otherwise until this Warrant shall have been exercised and the Shares
purchasable upon the exercise hereof shall have become deliverable, as
provided herein.
9. Representations and Warranties. This Warrant is issued and
delivered on the basis of the following:
9.1 Authorization and Delivery. This Warrant has been duly
authorized and executed by the Company and when delivered will be valid and
binding obligation of the Company enforceable in accordance with its terms;
and
9.2 Shares. The Shares have been duly authorized and
reserved for issuance by the Company and when issued and paid for in
accordance with the terms hereof, will be validly issued, fully paid and
nonassessable.
10. Modification and Waiver. This Warrant and any provision hereof may
be changed, waived, discharged or terminated only by an instrument in writing
signed by the party against which enforcement of the same is sought.
11 Notices. Any notice, request or other document required or
permitted to be given or delivered to the holder hereof or the Company shall
be delivered in the manner set forth in the Letter Agreement.
12. Binding Effect of Successors. This Warrant shall be binding upon
any corporation succeeding the Company by merger of consolidation, and all of
the obligations of the Company relating to the Shares issuable upon the
exercise of this Warrant shall be as set forth in the Letter Agreement, the
Company's Charter and the Company's by-laws (each as amended from time to
time) and shall survive the exercise and termination of this Warrant and all
of the covenants and agreements herein and in such other documents and
instruments of the Company shall inure to the benefit of the successors and
assigns of the holder hereof. The Company will, at the time of the exercise
of this Warrant, in whole or in part, upon request of the holder hereof but
at the Company's expense, acknowledge in writing its continuing obligation to
the holder hereof in respect of any rights (including without limitation, any
right to registration of the Shares) to which the holder hereof shall
continue to be entitled after such exercise in accordance with this Warrant;
provided that the failure of the holder hereof to make any such request shall
not affect the continuing obligation of the Company to the holder hereof in
respect of such rights.
13. Lost Warrants or Stock Certificates. The Company covenants to the
holder hereof that upon receipt of evidence reasonable satisfactory to the
Company of the loss, theft, destruction, or mutilation of this Warrant or any
stock certificates and, in the case of any such loss, theft or destruction,
upon receipt of an indemnity reasonable satisfactory to the Company, or in
the case of any such mutilation upon surrender and cancellation of such
Warrant or stock certificate, the Company will make and deliver a new Warrant
or stock certificate, or like tenor, in lieu of the lost, stolen, destroyed
or mutilated Warrant or stock certificate.
14. Descriptive Headings. The descriptive headings of the several
paragraphs of this Warrant are inserted for convenience only and do not
constitute a part of this Warrant.
15. Governing Law. This Warrant shall be construed and enforced in
accordance with, and the rights of the parties shall be governed by, the laws
of the Commonwealth of Massachusetts.
PHC, INC.
By: ____________________________
Bruce A. Shear, President
Date: April 5, 1999
Exhibit A-1
Notice of Exercise
To:
1. The undersigned hereby elects to purchase _______ Shares of PHC,
Inc. pursuant to the terms of the attached Warrant, and tenders herewith
payment of the purchase price of such Shares in full.
2. Please issue a certificate or certificates representing the Shares
deliverable upon the exercise set forth in paragraph 1 in the name of the
undersigned or, subject to compliance with the restrictions on transfer set
forth in Section 7 of the Warrant, in such other name or names as are
specified below:
____________________________________
(Name)
_____________________________________
_____________________________________
_____________________________________
(Address)
3. The undersigned represents that the aforesaid shares are being
acquired for the account of the undersigned for investment and not with a
view to, or for resale in connection with, the distribution thereof and that
the undersigned has not present intention of distributing or reselling such
shares.
_______________________________
Signature
_______________________________
Date
Exhibit A-2
Notice of Exercise
To:
1. Contingent upon and effective immediately prior to the closing (the
"Closing") of the Company's public offering contemplated by the Registration
Statement of Form S _____________, filed ______________, ______ the
undersigned hereby elects to purchase Shares of the Company (or such lesser
number of Shares as may be sold on behalf of the undersigned at the Closing)
pursuant to the terms of the attached Warrant.
2. Please deliver to the custodian for the selling shareholders a
certificate representing the Shares being so purchased.
3. The undersigned has instructed the custodian for the selling
shareholders to deliver to the Company $ _________________ of, if less, the
net proceeds due the undersigned from the sales of Shares in the aforesaid
public offering. If such net proceeds are less than the purchase price for
such Shares, the undersigned agrees to deliver the difference to the Company
prior to the Closing.
_______________________________
Signature
_______________________________
Date
warrants.dot
Exhibit 4.32
THE SECURITIES REPRESENTED BY THIS WARRANT (AND THE SECURITIES ISSUABLE UPON
EXERCISE OF THIS WARRANT) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, OR ANY STATE SECURITIES STATUTE. THE SECURITIES HAVE BEEN ACQUIRED
FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE
SOLD, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED WITHOUT AN
EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT
OF 1933 AND ANY APPLICABLE STATE SECURITIES STATUTE, OR UNLESS AN EXEMPTION
FROM REGISTRATION IS AVAILABLE THEREUNDER.
Shares Issuable Upon Exercise: Up to 37,500 shares of the Class A Common
Stock, $.01 par value, of PHC, Inc.
WARRANT TO PURCHASE
SHARES OF CLASS A COMMON STOCK
Expires July 5, 2004
THIS CERTIFIES THAT, for value received, National Securities
Corporation is entitled to subscribe for and purchase that number of shares
(the "Shares") of the fully paid and nonassessable Class A Common Stock, $.01
par value, (the "Class A Common Stock") of PHC, Inc., a Massachusetts
corporation (the "Company"), for a price of $1.45 per Share (the "Warrant
Price"), subject to the provisions and upon the terms and conditions
hereinafter set forth. As used herein, the term "Shares" shall mean the
Company's Class A Common Stock, or any stock into or for which such Class A
Common Stock shall have been or may hereafter be converted or exchanged
pursuant to the Articles of Incorporation of the Company as from time to time
amended as provided by law and in such Articles (hereinafter the "Charter"),
and the term "Grant Date" shall mean July 5, 1999.
1. Term. Subject to the provisions of this Warrant, the purchase
right represented by this Warrant is exercisable, in whole or in part, at any
time and from time to time from and after the Grant Date and prior to July 5,
2004.
Notwithstanding anything to the contrary contained herein, neither
this Warrant nor any rights hereunder may be transferred or assigned except
to an Assignee who is an "accredited investor" within the meaning of
Regulation D of the General Rules and Regulations of the Securities Act of
1933.
2. Method of Exercise. The purchase right represented by this Warrant
may be exercised by the holder hereof, in whole or in part and from time to
time, by either, at the election of this holder, (a) the surrender of the
Warrant (with the notice of exercise form attached hereto as Exhibit A-1 duly
executed) at the principal office of the Company and by the payment to the
Company by certified or bank check or by wire transfer, of an amount equal to
the then applicable Warrant Price multiplied by the number of shares then
being purchased or (b) if in connection with a registered public offering of
the Company's securities (provided that such offering includes the shares),
the surrender of this Warrant (with the notice of exercise form attached
hereto as Exhibit A-2 duly executed) at the principal office of the Company
together with notice of arrangements reasonably satisfactory to the Company
and any underwriter, in the case of an underwritten registered public
offering, for payment to the Company either by certified or bank check or by
wire transfer of from the proceeds of the sale of Shares to be sold by the
holder in such public offering of an amount equal to the then applicable
Warrant Price per Share multiplied by the number of Shares then being
purchased. The person or persons in whose name(s) any certificate(s)
representing Shares which shall be issuable upon exercise of this Warrant
shall be deemed to have become the holder(s) of record of, and shall be
treated for all purposes as the record holder(s) of, the shares represented
thereby (and such shares shall be deemed to have been issued) immediately
prior to the close of business on the date or dates upon which this Warrant
is exercised and the then applicable Warrant Price paid. In the event of any
exercise of the rights represented by this Warrant, certificates for the
shares of stock so purchased shall be delivered to the holder hereof as soon
as possible and in any event within ten (10) days of receipt of such notice
and payment of the then applicable Warrant Price and, unless this Warrant has
been fully exercised or expired, a new Warrant representing the portion of
the Shares, if any, with respect to which this Warrant shall not then have
been exercised shall also be issued to the holder hereof as soon as possible
and in any event within such ten-day period.
3. Stock Fully Paid; Reservation of Shares. All shares that may be
issued upon the exercise of the rights represented by this Warrant will upon
issuance, be fully paid and nonassessable, and free from all taxes, liens and
charges with respect to the issue thereof. During the period within which
the rights represented by the Warrant may be exercised, the Company will at
all times have authorized and reserved for the purpose of issuance upon
exercise of the purchase rights evidenced by this Warrant, a sufficient
number of shares of Class A Common Stock to provide for the exercise of the
rights represented by this Warrant.
4. Adjustment of Warrant Price and Number of Shares. The number and
kind of securities purchasable upon the exercise of the Warrant Agreement and
the Warrant Price shall be subject to adjustment from time to time upon the
occurrence of certain events, as follows:
4.1 Reclassification. In case of any reclassification, change or
conversion of the Company's Class A Common Stock (other than a change in par
value, or from par value to no par value, or from no par value to par value,
or as a result of a subdivision or combination), the Company, shall execute a
new Warrant Agreement (in form and substance reasonably satisfactory to the
Holder) providing that the Holder of this Warrant Agreement shall have the
right to exercise such new Warrant Agreement and upon such exercise and
payment of the then applicable Warrant Price to receive, in lieu of each
Share theretofore issuable upon exercise of this Warrant Agreement, the kind
and amount of shares of stock, other securities, money and property
receivable upon such reclassification or change by a holder of one share of
Class A Common Stock. Such new Warrant Agreement shall provide for
adjustments that shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Section 4.1. The provisions of this Section
4.1 shall similarly apply to successive reclassifications and changes.
4.2 Subdivision or Combination of Shares. If the Company at any
time while this Warrant remains outstanding and unexpired shall subdivide or
combine its Class A Common Stock, the Warrant Price and the number of Shares
issuable upon exercise hereof shall be equitably adjusted.
4.3 Stock Dividends. If the Company at any time while this
Warrant is outstanding and unexpired shall pay a dividend payable in shares
of Class A Common Stock (except any distribution specifically provided for in
the foregoing Sections 4.1 and 4.2), then the Warrant Price shall be
adjusted, from and after the date of determination of shareholders entitled
to receive such dividend or distribution, to that price determined by
multiplying the Warrant Price in effect immediately prior to such date of
determination by a fraction (a) the numerator of which shall be the total
number of shares of Class A Common Stock outstanding immediately prior to
such dividend or distribution, and (b) the denominator of which shall be the
total number of shares of Class A Common Stock outstanding immediately after
such dividend or distribution and the number of Shares subject to this
Warrant shall be appropriately adjusted.
4.4 No Impairment. The Company will not, by amendment of its
Charter or through any reorganization, recapitalization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any
of the terms to be observed or performed hereunder by the Company, but will
at all times in good faith assist in the carrying out of all the provisions
of this Article 4 and in the taking of all such action as may be necessary or
appropriate in order to protect the rights of the Holder of this Warrant
Agreement against impairment.
4.5 Notices of Record Date. In the event of any taking by the
Company of a record of its shareholders for the purpose of determining
shareholders who are entitled to receive payment of any dividend or other
distribution, or for the purpose of determining shareholders who are entitled
to vote in connection with any proposed merger or consolidation of the
Company with or into any other corporation, or any proposed sale, lease or
conveyance of all or substantially all of the assets of the Company, or any
proposed liquidation, dissolution or winding up of the Company, the Company
shall mail to the holder of this Warrant, at least fifteen (15) days prior to
the date specified therein, a notice specifying the date on which any such
record is to be taken for the purpose of such dividend, distribution or vote,
and the amount and character of such dividend, distribution or vote.
4.6 Adjustment to Number of Shares and Warrant Price Based on
Dilutive Issuance If and whenever the Company should issue shares of its
Class A Common Stock at a price per share less than the average of the
closing of the bid and asked prices for such Class A Common Stock for the
last trading day immediately prior to the issuance of such shares (other than
shares issued pursuant to an employee benefit plan including Class A Common
Stock issued or issuable to the officers or employees or directors of or
consultants to the Company and approved by a disinterested majority of the
directors of the Company), then the Warrant Price shall be adjusted by
dividing (1) the sum of (A) the total number of shares of Class A Common
Stock outstanding immediately prior to such issuance multiplied by the then
effective Warrant Price and (B) the value of the consideration received by
the Company upon such issuances as determined by the Board of Directors by
(2) the total number of shares of Class A Common Stock outstanding
immediately after such issuance. The holder of the Warrant shall thereafter
be entitled to purchase, at the Warrant Price resulting from such adjustment,
the number of Shares (calculated to the nearest whole share) obtained by
multiplying the Warrant Price in effect immediately prior to such adjustment
by the number of shares issuable upon the exercise hereof immediately prior
to such adjustment and dividing the product thereof by the Warrant Price
resulting from such adjustment. For the purpose of this paragraph (d) the
issuance of securities convertible into or exercisable for the Class A Common
Stock shall be deemed the issuance of the number of shares of Class A Common
Stock into which such securities are convertible or for which such securities
are exercisable, and the consideration received for such securities shall be
deemed to include the minimum aggregate amount payable upon conversion or
exercise of such securities expire unexercised, the Warrant Price of Shares
issuable upon the exercise hereof shall be readjusted accordingly.
5. Notice of Adjustments. Whenever the Warrant Price or number of
Shares shall be adjusted pursuant to the provisions hereof, the Company shall
within thirty (30) days of such adjustments deliver a certificate signed by
its chief financial officer to the registered holder(s) hereof setting forth
in reasonable detail, the event requiring the adjustment, the amount of the
adjustment, the method by which such adjustment was calculated, and the
Warrant Price after giving effect to such adjustment.
6. Fractional Shares. No fractional Shares will be issued in
connection with any exercise hereunder, but in lieu of such fractional shares
the Company shall make a cash payment therefor upon the basis of the Warrant
Price then in effect.
7. Compliance with Securities Act, Disposition of Shares.
7.1 Compliance with Securities Act. The holder of this Warrant,
by acceptance hereof, reconfirms the representations made by the Purchaser in
a letter agreement with the Company as of the date hereof (the "Letter
Agreement") and agrees to the placement of a restrictive transfer legend on
this Warrant and the certificates representing the shares.
7.2 Disposition of Warrants and Shares. With respect to any
offer, sale or other disposition of this Warrant or any Shares acquired
pursuant to the exercise of this Warrant prior to registration of this
Warrant or such Shares, the holder hereof and each subsequent holder of this
Warrant agrees to give written notice to the Company prior thereto,
describing briefly the manner thereof, together with a written opinion of
such holder's counsel, if reasonably requested by the Company (and, in such
case, such counsel and opinion must be reasonably acceptable to the Company),
to the effect that such offer, sale or other disposition my be effected
without registration or qualification (under the Securities Act of 1933 (the
"Act") as then in effect or any federal or state law then in effect) and
indicating whether or not under the Act certificates for this Warrant or such
Shares to be sold or otherwise disposed of require any restrictive legend as
to applicable restrictions on transferability in order to insure compliance
with the Act. Each certificate representing this Warrant or the Shares thus
transferred (except a transfer pursuant to Rule 144) shall bear a legend as
to the applicable restrictions on transferability in order to ensure
compliance with the Act, unless in the aforesaid opinion of counsel for the
holder, such legend is not required in order to ensure compliance with the
Act. The Company may issue stop transfer instructions to its transfer agent
in connection with the foregoing restrictions.
8. Rights as Shareholders. No holder of the Warrant, as such, shall
be entitled to vote or receive dividends or be deemed the holder of Shares or
any other securities of the Company which may at any time be issuable on the
exercise thereof for any purpose, nor shall anything contained herein, be
construed to confer upon the holder of this Warrant, as such any of the
rights of a shareholder of the Company or any right to vote for the election
of directors or upon any matter submitted to shareholders at any meeting
thereof, or to receive notice of meetings (except as otherwise provided in
Section 4.5 of this warrant), or to receive dividends or subscription rights
or otherwise until this Warrant shall have been exercised and the Shares
purchasable upon the exercise hereof shall have become deliverable, as
provided herein.
9. Representations and Warranties. This Warrant is issued and
delivered on the basis of the following:
9.1 Authorization and Delivery. This Warrant has been duly
authorized and executed by the Company and when delivered will be valid and
binding obligation of the Company enforceable in accordance with its terms;
and
9.2 Shares. The Shares have been duly authorized and
reserved for issuance by the Company and when issued and paid for in
accordance with the terms hereof, will be validly issued, fully paid and
nonassessable.
10. Modification and Waiver. This Warrant and any provision hereof may
be changed, waived, discharged or terminated only by an instrument in writing
signed by the party against which enforcement of the same is sought.
11 Notices. Any notice, request or other document required or
permitted to be given or delivered to the holder hereof or the Company shall
be delivered in the manner set forth in the Letter Agreement.
12. Binding Effect of Successors. This Warrant shall be binding upon
any corporation succeeding the Company by merger of consolidation, and all of
the obligations of the Company relating to the Shares issuable upon the
exercise of this Warrant shall be as set forth in the Letter Agreement, the
Company's Charter and the Company's by-laws (each as amended from time to
time) and shall survive the exercise and termination of this Warrant and all
of the covenants and agreements herein and in such other documents and
instruments of the Company shall inure to the benefit of the successors and
assigns of the holder hereof. The Company will, at the time of the exercise
of this Warrant, in whole or in part, upon request of the holder hereof but
at the Company's expense, acknowledge in writing its continuing obligation to
the holder hereof in respect of any rights (including without limitation, any
right to registration of the Shares) to which the holder hereof shall
continue to be entitled after such exercise in accordance with this Warrant;
provided that the failure of the holder hereof to make any such request shall
not affect the continuing obligation of the Company to the holder hereof in
respect of such rights.
13. Lost Warrants or Stock Certificates. The Company covenants to the
holder hereof that upon receipt of evidence reasonable satisfactory to the
Company of the loss, theft, destruction, or mutilation of this Warrant or any
stock certificates and, in the case of any such loss, theft or destruction,
upon receipt of an indemnity reasonable satisfactory to the Company, or in
the case of any such mutilation upon surrender and cancellation of such
Warrant or stock certificate, the Company will make and deliver a new Warrant
or stock certificate, or like tenor, in lieu of the lost, stolen, destroyed
or mutilated Warrant or stock certificate.
14. Descriptive Headings. The descriptive headings of the several
paragraphs of this Warrant are inserted for convenience only and do not
constitute a part of this Warrant.
15. Governing Law. This Warrant shall be construed and enforced in
accordance with, and the rights of the parties shall be governed by, the laws
of the Commonwealth of Massachusetts.
PHC, INC.
By: ____________________________
Bruce A. Shear, President
Date: July 5, 1999
Exhibit A-1
Notice of Exercise
To:
1. The undersigned hereby elects to purchase _______ Shares of PHC,
Inc. pursuant to the terms of the attached Warrant, and tenders herewith
payment of the purchase price of such Shares in full.
2. Please issue a certificate or certificates representing the Shares
deliverable upon the exercise set forth in paragraph 1 in the name of the
undersigned or, subject to compliance with the restrictions on transfer set
forth in Section 7 of the Warrant, in such other name or names as are
specified below:
____________________________________
(Name)
_____________________________________
_____________________________________
_____________________________________
(Address)
3. The undersigned represents that the aforesaid shares are being
acquired for the account of the undersigned for investment and not with a
view to, or for resale in connection with, the distribution thereof and that
the undersigned has not present intention of distributing or reselling such
shares.
_______________________________
Signature
_______________________________
Date
Exhibit A-2
Notice of Exercise
To:
1. Contingent upon and effective immediately prior to the closing (the
"Closing") of the Company's public offering contemplated by the Registration
Statement of Form S _____________, filed ______________, ______ the
undersigned hereby elects to purchase Shares of the Company (or such lesser
number of Shares as may be sold on behalf of the undersigned at the Closing)
pursuant to the terms of the attached Warrant.
2. Please deliver to the custodian for the selling shareholders a
certificate representing the Shares being so purchased.
3. The undersigned has instructed the custodian for the selling
shareholders to deliver to the Company $ _________________ of, if less, the
net proceeds due the undersigned from the sales of Shares in the aforesaid
public offering. If such net proceeds are less than the purchase price for
such Shares, the undersigned agrees to deliver the difference to the Company
prior to the Closing.
_______________________________
Signature
_______________________________
Date
warrants.dot
Exhibit 10.65
AMENDMENT NO. 2 TO SECURED BRIDGE NOTE
THIS AMENDMENT NO. 2 TO SECURED BRIDGE NOTE (the "Amendment") is hereby
entered into as of the 10th day of November, 1998 by and among PHC, INC., a
Massachusetts corporation ("Borrower"), and HCFP FUNDING II, INC., a Delaware
corporation ("Lender").
A. Borrower and Lender entered into that certain Secured Bridge Note (the
"Note") dated March 10, 1998 in the principal sum of Three Hundred Fifty and
00/100 Dollars ($350,000.00), which had an original Maturity Date of July 10,
1998.
B. Pursuant to Amendment No. 1 to Secured Bridge Note dated as of July 10,
1998, Lender agreed to extend the Maturity Date of the Note until November 10,
1998.
C. Borrower has requested that the Maturity Date of the Note be extended
for an additional six (6) months, which extension of the Maturity Date is
essential to Borrower in continuing to finance its operations.
D. Borrower has requested that the Maturity Date of the Note be extended
for an additional two (2) months, which extension of the Maturity Date is
essential to Borrower in continuing to finance its operations.
E. Lender has agreed to extend the Maturity Date upon the terms and
conditions of this Amendment.
NOW, THEREFORE, the parties agree as follows:
1. Capitalized terms used and not otherwise defined in this Amendment shall
have the meanings given them in the Note.
2. Borrower and Lender hereby affirm and agree that the Maturity Date of
the Note is hereby extended to May 10, 1999.
3. Borrower acknowledges and agrees to pay concurrently with the extension
of this Amendment an extension fee equal to Seventeen Thousand Five Hundred and
00/100 Dollars ($17,500.00).
4. Borrower and Lender are parties to that certain Letter Agreement dated
as of September 2, 1998 (the "September Letter") relating to Common Stock
Purchase Warrants of Borrower that are held by Lende4r and to the exercise by
Lender of certain rights related to those Warrants. Borrower and Lender agree
that for purposes of the September Letter, the extension of the Maturity Date by
this Amendment shall be construed as a repayment of the Note, permitting Lender
to exercise its rights under the September Letter on and after May 10, 1999.
H:\WP\LEGAL\CLIENTS\PHCINC\secnote2amend.wpd
5
This amendment may be executed in several counterparts, and each copy so
executed shall be deemed an
original.
6. Except as expressly stated in this Amendment, the terms, conditions, and
provisions of the Note, as amended by this Amendment, shall remain in full force
and effect and shall not be modified or othe5rwise affected by the execution of
the agreement.
IN WITNESS WHEREOF, the parties have executed or caused this Amendment to
be executed by their respective officers thereunto duly authorized as of the day
and year first above written.
LENDER:
HCFP FUNDING II, INC.
a Delaware corporation
By: /s/ Michael Gardullo
Title: Vice President
BORROWER:
PHC, INC
a Massachusetts corporation
By: /s/ Bruce A. Shear
Title: President
H:\WP\LEGAL\CLIENTS\PHCINC\secnote2amend.wpd
2
Exhibit 4.33
SUBSCRIPTION AGREEMENT
PHC, INC.
THE SECURITIES WHICH ARE THE SUBJECT OF THIS SUBSCRIPTION AGREEMENT (AS IT MAY
BE AMENDED FROM TIME TO TIME, THE "AGREEMENT") HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR UNDER THE
APPLICABLE SECURITIES LAWS OF ANY STATE AND WILL BE OFFERED AND SOLD IN RELIANCE
ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THESE LAWS BY VIRTUE OF PHC,
INC.'S INTENDED COMPLIANCE WITH SECTIONS 3(b), 4(2) AND 4(6) OF THE SECURITIES
ACT, THE PROVISIONS OF REGULATION D UNDER SUCH ACT AND SIMILAR EXEMPTIONS UNDER
STATE LAW. THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE U.S.
SECURITIES AND EXCHANGE COMMISSION ("SEC"), ANY STATE SECURITIES COMMISSION OR
ANY OTHER REGULATORY AUTHORITY. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.
The undersigned purchaser (hereafter, the "Purchaser") hereby offers to
purchase certain Series B Convertible Preferred Stock (referred to herein as a
"Share" or collectively as "Shares") of PHC, Inc. (the "Company"), a publicly
held corporation formed under the laws of the Commonwealth of Massachusetts.
This offer to purchase may, for any reason whatsoever, be revoked by the
Purchaser or rejected by the Company prior to acceptance of this offer by the
Company.
Section 1.1 Purchase and Sale of Shares. Upon the following terms and
conditions, the Company shall issue and sell to the Purchaser, and the Purchaser
shall purchase from the Company, the number of Shares indicated herein, which
Shares shall have the rights, designations and preferences set forth in Schedule
I hereto.
Section 1.2 Purchase Price. The purchase price for the Shares (the
"Purchase Price") shall be $1,000 per Share.
Section 1.3 The Closing.
(a) The closing of the purchase and sale of the Shares (the "Closing"),
shall take place at the law offices of Arent, Fox, Kintner, Plotkin & Kahn, 1050
Connecticut Avenue, N.W., Washington, D.C. 20036, at 10:00 a.m., local
Washington, D.C. time, on the later of the following: (i) the date on which the
last to be fulfilled or waived of the conditions set forth in Section 4.1 and
4.2 hereof and applicable to the Closing shall be fulfilled or waived in
accordance herewith, or (ii) such other time and place and/or on such other date
as the Purchaser and the Company may agree. The date on which the Closing occurs
is referred to herein as the "Closing Date."
(b) On the Closing Date, the Company shall deliver to the Purchaser (i) a
certificate representing the Shares registered in the name of the Purchaser or
deposit such Shares into accounts designated by the Purchaser and (ii) the
Warrant for the number of shares of the Company's Common Stock indicated herein,
in the form attached hereto as Exhibit A, incorporated herein by reference. The
Purchaser shall on the Closing Date deliver to the Company the Purchase Price
for all the Shares by cashier's check or wire transfer in immediately available
funds to such account as shall be designated in writing by the Company. In
addition, each party shall deliver all documents, instruments and writings
required to be delivered by such party pursuant to this Agreement at or prior to
the Closing.
Section 1.4 Covenant to Register.
(a) For purposes of this Section, the following definitions shall apply:
The terms "register," "registered," and "registration" refer to a
registration under the Securities Act of 1933, as amended (the "Act"), effected
by preparing and filing a registration statement or similar document in
compliance with the Act, and the declaration or ordering of effectiveness of
such registration statement, document or amendment thereto.
(ii) The term "Registrable Securities" means the shares of the Company's
Class A Common Stock, par value $.01 per share (the "Common Stock"), issuable
upon conversion of shares of the Shares and upon exercise of the Warrant, or
upon conversion of any other stock issued in payment of dividends on the Shares
or otherwise issuable pursuant to this Agreement or the provisions of Schedule I
hereto, and any securities of the Company or securities of any successor
corporation issued as, or issuable upon the conversion or exercise of any
warrant right or other security that is issued as a dividend or other
distribution with respect to, or in exchange for, or in replacement of, the
Shares.
(iii) The term "holder of Registrable Securities" means the Purchaser and
any permitted assignee of registration rights pursuant to Section 1.4(h).
(b) (i) The Company shall as soon as possible file a registration statement
on Form SB-2 or Form S-3 covering at least 200% of the number of Registrable
Securities which would then be issuable upon conversion of the Shares at the
conversion price then in effect, and shall use its best efforts to cause such
registration statement to become effective on or before ninety (90) days after
the Closing Date (the "Initial Registration"). In the event such registration is
not so declared effective or does not include all Registrable Securities, a
holder of Registrable Securities shall have the right to require by notice in
writing that the Company register all or any part of the Registrable Securities
held by such holder (a "Demand Registration") and the Company shall thereupon
effect such registration in accordance herewith (which may include adding such
shares to an existing shelf registration). The parties agree that if the holder
of Registrable Securities demands registration of less than all of the
Registrable Securities, the Company, at its option, may nevertheless file a
registration statement covering all of the Registrable Securities. If such
registration statement is declared effective with respect to all Registrable
Securities and the Company is in compliance with its obligations under
Subsection (d) of this Section 1.4, the demand registration rights granted
pursuant to this Subsection (b)(i) shall cease. If such registration statement
is not declared effective with respect to all Registrable Securities or if the
Company is not in compliance with such obligations, the demand registration
rights described herein shall remain in effect.
(ii) The Company shall not be obligated to effect a Demand Registration
under Subsection (b)(i) above: (A) if all of the Registrable Securities held by
the holder of Registrable Securities which are demanded to be covered by the
Demand Registration are, at the time of such demand, included in an effective
registration statement and the Company is in compliance with its obligations
under Subsection (d) of this Section 1.4; (B) if all of the Registrable
Securities may be sold under Rule 144(k) of the Act and the Company's transfer
agent has accepted an instruction from the Company to such effect; or (C) at any
time after two (2) years from the Closing Date.
(iii) Subject to Subsection (iv)(B) hereof, the Company may suspend the
effectiveness of any such registration effected pursuant to this Subsection (b)
in the event and for such period of time as, such a suspension is required by
the rules and regulations of the Securities and Exchange Commission ("SEC"). The
Company will use its best efforts to cause such suspension to terminate at the
earliest possible date.
(iv) (A) If the Company is advised by the SEC that a registration statement
filed hereunder is subject to a "no-review" and such registration statement is
not declared effective within five (5) business days thereafter (an
"Acceleration Date") or, irrespective of the SEC review, a registration
statement is not declared effective by the ninety first (91st) day after the
Closing Date (the "Target Date"), the Company shall pay Purchaser as liquidated
damages an amount equal to two percent (2%) of the total Purchase Price of the
Shares for each thirty (30) day period following the earlier of the Acceleration
Date or Target Date, as applicable, until such time as the registration
statement is declared effective; provided, however, that such damages shall not
be payable if the failure to meet the Acceleration Date or Target Date, as
applicable, is due to action or inaction by Purchaser with respect to providing
information for the registration statement. The payment set forth above shall be
pro-rated daily as to any period of less than thirty (30) days. Such payment
shall be made to the Purchaser either (I) by cashier's check or wire transfer in
immediately available funds to such account as shall be designated in writing by
the Purchaser or (II) in Shares, the number of which shall be equal to the
amount due under this Subsection divided by $1,000 per Share. The foregoing
amount shall be paid irrespective of the amount of Registrable Securities then
held by Purchaser.
(B) If, following effectiveness of a registration, either the effectiveness
of the registration statement is suspended or a current prospectus meeting the
requirements of Section 10 of the Act is not available for delivery by the
Purchaser (either referred to herein as a "suspension"), the Company shall
thereupon pay to Purchaser as liquidated damages an amount equal to two percent
(2%) of the Purchase Price of the Shares for each thirty (30) day period of the
suspension. The payment set forth above shall be pro-rated daily as to periods
of less than thirty (30) days. Such payment shall be made to the Purchaser by
cashiers check or wire transfer in immediately available funds to such account
as shall be designated in writing by the Purchaser, and shall be paid
irrespective of the amount of Registrable Securities held by Purchaser on or
after the date following the suspension.
(C) Any amount payable pursuant to the foregoing provisions of this
Subsection (iv) shall be delivered on or before the fifth (5th) day following
the end of the calendar month in which such payment obligation arose. The
"Purchase Price" of Registrable Securities shall be (1) if derived from
conversion or substitution of Shares, the Purchase Price of the Shares, and (2)
if received in satisfaction of a Company obligation, the dollar amount of such
obligation.
(D) This Subsection is in addition to the provisions of Section 7.2(a)
hereof.
(c) If the Company proposes to register (including for this purpose a
registration effected by the Company for shareholders other than the Purchaser)
any of its stock or other securities under the Act in connection with a public
offering of such securities (other than a registration on Form S-4, Form S-8 or
other limited purpose form) and all Registrable Securities have not theretofore
been included in a registration statement under Subsection (b) of this Section
1.4 which remains effective, the Company shall, at such time, promptly give all
holders of Registrable Securities written notice of such registration. Upon the
written request of any holder of Registrable Securities given within twenty (20)
days after receipt of such notice by the holder of Registrable Securities, the
Company shall use its best efforts to cause to be registered under the Act all
Registrable Securities that such holder of Registrable Securities requests to be
registered. However, the Company shall have no obligation under this Subsection
(c) if (i) the Registrable Securities may be sold without registration under
Rule 144(k) and the Company's transfer agent has accepted an instruction from
the Company to such effect, (ii) the Registration Statement is filed more than
two (2) years after the Closing Date, or (iii) to the extent that, with respect
to any underwritten offering initiated by the Company later than one calendar
year following the Closing, the managing underwriter of such offering reasonably
notifies such holder(s) in writing of its determination that the Registrable
Securities or a portion thereof shall be excluded therefrom.
(d) Whenever required under this Section 1.4 to effect the registration of
any Registrable Securities including, without limitation, the Initial
Registration, the Company shall, as expeditiously as reasonably possible:
(i) Prepare and file with the SEC a registration statement with respect to
such Registrable Securities and use its best efforts to cause such registration
to become effective as provided in Section 1.4(b)(i), and keep such registration
statement effective for so long as any holder of Registrable Securities desires
to dispose of the securities covered by such registration statement; provided,
however, that in no event shall the Company be required to keep the Registration
Statement effective for a period greater than two (2) years from the Closing
Date;
(ii) Respond to comments made by the SEC with respect to a registration
statement filed pursuant to this Agreement within ten (10) business days after
the date of the comment letter, and prepare and file with the SEC such
amendments and supplements to such registration statement and the prospectus
used in connection with such registration statement as may be necessary to
comply with the provisions of the Act with respect to the disposition of all
securities covered by such registration statement and notify the holders of the
filing and effectiveness of such Registration Statement and any amendments or
supplements;
(iii) Furnish to each holder of Registrable Securities such numbers of
copies of a current prospectus, including a preliminary prospectus, conforming
with the requirements of the Act, copies of the registration statement any
amendment or supplement to any thereof and any documents incorporated by
reference therein and such other documents, all free of charge, as such holder
of Registrable Securities may reasonably require in order to facilitate the
disposition of Registrable Securities owned by such holder of Registrable
Securities;
(iv) Use its best efforts to register and qualify the securities covered by
such registration statement under such other securities or "Blue Sky" laws of
such jurisdictions as shall be reasonably requested by the holder of Registrable
Securities;
(v) Notify each holder of Registrable Securities immediately of the
happening of any event as a result of which the prospectus included in such
registration statement, as then in effect, includes an untrue statement of
material fact or omits to state a material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the
circumstances then existing, and use its best efforts to promptly update and/or
correct such prospectus;
(vi) Furnish, at the request of any holder of Registrable Securities in
connection with any underwritten public offering, (A) an opinion of counsel of
the Company, dated the effective date of the registration statement, in form and
substance reasonably satisfactory to the holder and its counsel and covering,
without limitation, such matters as the due authorization and issuance of the
securities being registered and certain matters pertaining to disclosure under
and compliance with securities laws by the Company in connection with the
registration thereof and/or (B) a "comfort" letter or letters of the Company's
independent public accountants provided at the Company's expense in form and
substance reasonably satisfactory to the holder and its counsel;
(vii) Use its best efforts to list the Registrable Securities covered by
such registration statement with any national market or securities exchange on
which such securities are then listed;
(viii) Make available for inspection by the holder of Registrable
Securities, upon request, all SEC Documents (as defined below) filed subsequent
to the Closing and require the Company's officers, directors and employees to
supply all information reasonably requested by any holder of Registrable
Securities in connection with such registration statement: and
(ix) Furnish to each holder of Registrable Securities prompt notice of the
commencement of any stop-order proceedings under the Act, together with copies
of all documents in connection therewith, and use its best efforts to obtain
withdrawal of any such stop order as soon as possible.
(e) Upon request of the Company, each holder of Registrable Securities will
furnish to the Company in connection with any registration under this Section
such information regarding itself, the Registrable Securities and other
securities of the Company held by it, and the intended method of disposition of
such securities as shall be reasonably required to effect the registration of
the Registrable Securities held by such holder of Registrable Securities. The
intended method of disposition (Plan of Distribution) of such securities as so
provided by Purchaser shall be included without alteration in the Registration
Statement covering the Registrable Securities and shall not be changed without
the prior written consent of the Purchaser.
(f) (i) The Company shall indemnify, defend and hold harmless each holder
of Registrable Securities which are included in a registration statement
pursuant to the provisions of Subsections (b) or (c) hereof and each of its
officers, directors, employees, agents, partners or controlling persons (within
the meaning of the Act) (each, an "indemnified party") from and against, and
shall reimburse such indemnified party with respect to, any and all claims,
suits, demands, causes of action, losses, damages, liabilities, costs or
expenses ("Liabilities") to which such indemnified party may become subject
under the Act or otherwise, arising from or relating to (A) any untrue statement
or alleged untrue statement of any material fact contained in such registration
statement, any prospectus contained therein or any amendment or supplement
thereto, or (B) the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances in which they were made, not misleading; provided,
however, that the Company shall not be liable in any such case to the extent
that any such Liability arises out of or is based upon an untrue statement or
omission so made in strict conformity with information furnished by such
indemnified party in writing specifically for use in a registration statement.
(ii) In the event of any registration under the Act of Registrable
Securities pursuant to Subsections (b) or (c), each holder of such Registrable
Securities hereby severally agrees to indemnity, defend and hold harmless the
Company, and its officers, directors, employees, agents, partners, or
controlling persons (within the meaning of the Act) (each, an "indemnified
party") from and against, and shall reimburse such indemnified party with
respect to, any and all Liabilities to which such indemnified party may become
subject under the Act or otherwise, arising from or relating to (A) any untrue
statement or alleged untrue statement of any material fact contained in such
registration statement, any prospectus contained therein or any amendment or
supplement thereto, or (B) the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances in which they were made, not misleading;
provided, that such holders will be liable in any such case to the extent and
only to the extent, that any such Liability arises out of or is based upon an
untrue statement or alleged untrue statement or omission or alleged omission
made in such registration statement, prospectus or amendment or supplement
thereto in reliance upon and in conformity with written information furnished by
such holder specifically for use in the preparation thereof.
(iii) Promptly after receipt by any indemnified party of notice of the
commencement of any action, such indemnified party shall, if a claim in respect
thereof is to be made against another party (the "indemnifying party")
hereunder, notify such party in writing thereof, but the omission so to notify
such party shall not relieve such party from any Liability which it may have to
the indemnified party other than under this Section and shall only relieve it
from any Liability which it may have to the indemnified party under this section
if and to the extent an indemnifying party is materially prejudiced by such
omission. In case any such action shall be brought against any indemnified party
and such indemnified party shall notify an indemnifying party of the
commencement thereof, the indemnifying party shall be entitled to participate in
and, to the extent it shall wish, to assume and undertake the defense thereof
with counsel reasonably satisfactory to such indemnified party, and, after
notice from the indemnifying party to the indemnified party of its election so
to assume and undertake the defense thereof, the indemnifying party shall not be
liable to the indemnified party under this section for any legal expenses
subsequently incurred by the indemnified party in connection with the defense
thereof other than reasonable costs of investigation and of liaison with counsel
so selected; provided however, that if the defendants in any such action include
both parties and the indemnified party shall have reasonably concluded that
there may be reasonable defenses available to them which are different from or
additional to those available to the indemnifying party or if the interests of
the indemnified party reasonably may be deemed to conflict with the interests of
the indemnifying party, the indemnified party shall have the right to select a
separate counsel and to assume such legal defenses and otherwise to participate
in the defense of such action, with the reasonable expenses and fees of one such
separate counsel and other reasonable expenses related to such participation to
be reimbursed by the indemnifying party as incurred.
(g) (i) With respect to the inclusion of Registrable Securities in a
registration statement pursuant to Subsections (b) or (c), all fees, costs and
expenses of and incidental to such registration, inclusion and public offering
shall be borne by the Company, provided, however, that any securityholders
participating in such registration shall bear their pro-rata share of the
underwriting discounts and commissions, if any, incurred by them in connection
with such registration.
(ii) The fees, costs and expenses of registration to be borne by the
Company as provided in this Subsection shall include, without limitation, all
registration, filing and NASD fees, printing expenses, fees and disbursements of
counsel and accountants for the Company, and all legal fees and disbursements
and other expenses of complying with state securities or Blue Sky laws of any
jurisdiction or jurisdictions in which securities to be offered are to be
registered and qualified. Subject to appropriate agreements as to
confidentiality, the Company shall make available to the holders of Registrable
Securities and their counsel its documents and personnel for due diligence
purposes. Except as otherwise provided herein, fees and disbursements of counsel
and accountants for the selling security holders shall be borne by the
respective selling security holders.
(h) The rights to cause the Company to register all or any portion of
Registrable Securities pursuant to this Section 1.4 may be assigned by Purchaser
to a transferee or assignee. Within a reasonable time after such transfer, the
Purchaser shall notify the Company of the name and address of such transferee or
assignee, and the securities with respect to which such registration rights are
being assigned. Such assignment shall be effective only if, immediately
following such transfer, the further disposition of such securities by the
transferee or assignee is restricted under the Act. Any transferee asserting
registration rights hereunder shall be bound by the applicable provisions of
this Agreement.
(i) The Company shall not agree to allow the holders of any securities of
the Company to include any of their securities in any registration statement
filed by the Company pursuant to Subsection (b) unless such inclusion will not
reduce the amount of the Registrable Securities included therein.
Section 1.5 Company Standoff, Except in a corporate reorganization,
business combination, stock or asset purchase, merger or consolidation, under
existing employee stock incentive or purchase plans or pursuant to this
Agreement, the Company shall not for its own account effect any public sale or
distribution of any securities similar to the Registrable Securities or any
securities exercisable for or convertible or changeable into the Registrable
Securities during the thirty (30) days prior to, and during the sixty (60) days
immediately following, the effective date of any registration statement filed or
amended pursuant to Section 1.4(b); provided, however, that the Company may
effect such public sale or distribution during the sixty (60) days immediately
following the effective date of such registration statement if such sale or
distribution of securities is at a price equal to or greater than 125% of the
last trade price of the Company's Common Stock on the day of Closing.
Section 2.1 Representations and Warranties of the Purchaser. The Purchaser
makes the following representations and warranties to the Company.
(a) Accredited Investor. The Purchaser is an "accredited investor", as such
term is defined in Rule 50 1 (a) of Regulation D, promulgated under the Act.
(b) Speculative Investment. The Purchaser is aware that an investment in
the Shares is highly speculative and subject to substantial risks. The Purchaser
is capable of bearing the high degree of economic risk and the burden of this
venture, including, but not limited to, the possibility of complete loss of the
Purchaser's investment in the Shares and underlying Common Stock which make
liquidation of this investment impossible for the indefinite future.
(c) Disposition. The Purchaser understands that (i) except as provided for
in Section 1.4, the Shares and underlying Common Stock of the Company (the
"Securities"), have not been and are not being registered under the Securities
Act or any applicable state securities laws, and may not be transferred unless
(A) subsequently registered thereunder, or (B) the Securities may be sold or
transferred pursuant to an exemption from securities registration under the
Securities Act and any applicable state securities laws or (C) sold pursuant to
Rule 144, promulgated under the Securities Act (or any successor Rule), or (ii)
any sale of such Securities made in reliance on Rule 144 may be made only in
accordance with the terms of such Rule and further, if such Rule is not
applicable, any resale of such Securities under circumstances in which the
seller (or the person through whom the sale is made) may be deemed to be an
underwriter (as that term is defined in the Securities Act) may require
compliance with another exemption under the Securities Act or the rules of the
SEC thereunder. Notwithstanding any provision to the contrary contained herein,
a holder may pledge such Securities as collateral for a revolving credit note
pursuant to a loan and security agreement with a lending institution.
(d) Privately Offered. The offer to acquire the Shares was directly
communicated to the Purchaser in such manner that the Purchaser was able to ask
questions of and receive answers concerning the terms and conditions of this
transaction. At no time was the Purchaser presented with or solicited by or
through any leaflet, public promotional meeting, television advertisement, or
any other form of general advertising.
(e) Purchase for Investment, The Securities are being acquired solely for
the Purchaser's own account, for investment, and are not being purchased with
view to the resale, distribution, subdivision or fractionalization thereof
without proper registration with applicable securities administrators.
Section 2.2 Representations and Warranties of the Company. The Company
hereby makes the following representations and warranties to the Purchaser:
(a) Organizations and Qualifications. The Company is a corporation duly
incorporated and existing in good standing under the laws of the Commonwealth of
Massachusetts and has the requisite corporate power to own its properties and to
carry on its business as now being conducted. The Company does not have any
subsidiaries except as listed in Exhibit B, attached hereto and incorporated
herein by reference. The Company and each such subsidiary, if any, is duly
qualified as a foreign corporation to do business and is in good standing in
every jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary other than those in which the
failure so to qualify would not have a Material Adverse Effect. "Material
Adverse Effect", for purposes of this Agreement, means any adverse effect on the
business operations, properties, prospects, or financial condition of the entity
with respect to which such term is used and which is material to such entity and
other entities controlled by such entity taken as a whole.
(b) Authorizations Enforcement. (i) The Company has the requisite corporate
power and authority to enter into and perform this Agreement and to issue the
Shares and Registrable Securities in accordance with the terms hereof, (ii) the
execution and delivery of this Agreement by the Company and the consummation by
it of the transactions contemplated hereby have been duly authorized by all
necessary corporate action, and no further consent or authorization of the
Company or its Board of Directors or stockholders is required, (iii) this
Agreement has been duly executed and delivered by the Company, (iv) this
Agreement constitutes a valid and binding obligation of the Company enforceable
against the Company in accordance with its terms (except as such enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally the enforcement
of, creditor' rights and remedies or by other equitable principles of general
application) and (v) prior to the Closing Date, any necessary Certificate of
Amendment to the Company's Charter authorizing Company to issue all of the
Shares and Registerable Securities, in accordance with Schedule 1, will have
been filed with the Massachusetts Secretary of State and will be in full force
and effect enforceable against the Company in accordance with the terms of such
amended Charter.
(c) Authorized Capital Rights or Commitments to Stock. The authorized
capital stock of the Company consists of 22,200,000 shares of Common Stock and
1,000,000 shares of Series B Preferred Stock; there are 4,704,956 shares of
Common Stock issued and 730,292 shares of Class B Common Stock outstanding;
there are no shares of such Preferred Stock issued and outstanding; and, upon
issuance of the Shares in accordance with the terms hereof, there will be
4,704,956 shares of Class B Common Stock and 950 shares of such Preferred Stock
issued and outstanding.
All of the outstanding shares of the Company's Common Stock have been
validly issued and are fully paid and nonassessable. Except as set forth in
Exhibit B hereto or as described in the SEC Documents, no shares of Common
Stock are entitled to preemptive rights or registration rights and there are
no outstanding options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company, or contracts,
commitments, understandings, or arrangements by which the Company is or may
become bound to issue additional shares of capital stock of the Company or
options, warrants, scrip, rights to subscribe to, or commitments to purchase
or acquire, any shares. or securities or rights convertible into shares, of
capital stock of the Company. The Company has furnished or made available to
the Purchaser true and correct copies of the Company's Articles of
Organization as in effect on the date hereof (the "Charter"), and the
Company's By-Laws, as in effect on the date hereof (the "By-Laws").
(d) Issuance of Shares. The issuance of the Shares has been duly authorized
and, when paid for and issued in accordance with the terms hereof, the shall be
validly issued, fully paid and non-assessable and entitled to the rights and
preferences set forth in Schedule I hereto. The Common Stock issuable upon
conversion of the Shares will be duly authorized and reserved for issuance and,
upon conversion, will be validly issued, fully paid and non-assessable and the
holders shall be entitled to all rights and preferences accorded to a holder of
Common Stock.
(e) No Conflicts. The execution, delivery and performance of this Agreement
by the Company and the consummation by the Company of the transactions
contemplated hereby do not and will not (i) result in a violation of the
Company's Charter or By-Laws or (ii) conflict with, or constitute a default (or
an event which with notice or lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Company or
any of its subsidiaries is a party, or result in a violation of any federal,
state, local or foreign law, rule, regulation, order, judgment or decree
(including Federal and state securities laws and regulations) applicable to the
Company or any of its subsidiaries or by which any property or assets of the
Company or any of its subsidiaries is bound or affected (except for such
conflicts, defaults, terminations, amendments, accelerations, cancellations and
violations as would not, individually or in the aggregate, have a Material
Adverse Effect); provided that, for purposes of such representation as to
Federal, state, local or foreign law, rule or regulation, no representation is
made herein with respect to any of the same applicable solely to the Purchaser
and not to the Company. The business of the Company is not being conducted in
violation of any law, ordinance or regulations of any governmental entity,
except for violations which either singly or in the aggregate do not and will
not have a Material Adverse Effect. The Company is not required under Federal,
state or local law, rule or regulation in the United States to obtain any
consent, authorization or order of, or make any filing (other than any filing of
a vote establishing a class or series of stock with the Massachusetts Secretary
of State) or registration with, any court or governmental agency in order for it
to execute, deliver or perform any of its obligations under this Agreement or
issue and sell the Shares in accordance with the terms hereof (other than any
SEC, NASD or state securities filings which may be required to be made by the
Company subsequent to the Closing, and any registration statement which may be
filed pursuant hereto); provided that, for purposes of the representation made
in this sentence, the Company is assuming and relying upon the accuracy of the
relevant representations and agreements of the Purchaser herein.
(f) SEC Documents, Financial Statements. The Common Stock of the Company is
registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as
amended (the "Exchange Act") and, except as set forth in Exhibit B, the Company
has filed on a timely basis all reports, schedules, forms, statements and other
documents required to be filed by it with the SEC pursuant to the reporting
requirements of the Exchange Act, including material filed pursuant to Section
13(a) or 15(d), in addition to one or more registration statements and
amendments thereto heretofore filed by the Company with the SEC under the Act
(all of the foregoing including filings incorporated by reference therein being
referred to herein as the "SEC Documents"). The Company directly or through its
agent has delivered to the Purchaser true and complete copies of the SEC
Documents except for the exhibits and incorporated documents. The Company has
not provided to the Purchaser any information which, according to applicable
law, rule or regulation, should have been disclosed publicly by the Company but
which has not been so disclosed, other than with respect to the transactions
contemplated by this Agreement.
Except as set forth in Exhibit B, as of their respective dates the SEC
Documents complied in all material respects with the requirements of the Act or
the Exchange Act as the case may be and the rules and regulations of the SEC
promulgated thereunder and other federal, state and local laws, rules and
regulations applicable to such SEC Documents, and none of the SEC Documents
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading. Except as set forth in Exhibit B, the financial statements of the
Company included in the SEC Documents comply as to form in all material respects
with applicable accounting requirements and the published rules and regulations
of the SEC or other applicable rules and regulations with respect thereto. Such
financial statements have been prepared in accordance with generally accepted
accounting principles applied on a consistent basis during the periods involved
(except (i) as may be otherwise indicated in such financial statements or the
notes thereto or (ii) in the case of unaudited interim statements, to the extent
they may not include footnotes or may be condensed or summary statements) and
fairly present in all material respects the financial position of the Company as
of the dates thereof and the results of operations and cash flows for the
periods then ended (subject, in the case of unaudited statements, to normal
year-end audit adjustments).
(g) No Material Adverse Change. Since the date through which the most
recent quarterly report of the Company on Form 10-Q has been prepared and filed
with the SEC, a copy of which is included in the SEC Documents, no Material
Adverse Effect has occurred or exists with respect to the Company or any of its
subsidiaries.
(h) No Undisclosed Liabilities. The Company and its subsidiaries have no
material liabilities or obligations not disclosed in the SEC Documents, other
than those incurred in the ordinary course of the Company's or any of its
subsidiaries' respective businesses since the date of the most recently filed
SEC Documents which, individually or in the aggregate, do not or would not have
a Material Adverse Effect on the Company or any of its subsidiaries.
(i) No Undisclosed Events or Circumstances. No event or circumstance has
occurred or exists with respect to the Company or any of its subsidiaries or
their respective businesses, properties, prospects, operations or financial
condition which, under applicable law, rule or regulation, requires public
disclosure or announcement by the Company but which has not been so publicly
announced or disclosed.
(j) No General Solicitation. Neither the Company, nor any of its
affiliates, or, to the best of its knowledge, any person acting on its or their
behalf, has engaged in any form of general solicitation or general advertising
(within the meaning of Regulation D under the Act) in connection with the offer
or sale of the Shares.
(k) No Integrated Offering. Neither the Company, nor any of its affiliates,
nor any person acting on its or their behalf has, directly or indirectly, made
any offers or sales of any security or solicited any offers to buy any security,
under circumstances that would require registration of the Shares under the Act.
Section 3.1 Securities Compliance. The Company shall notify the SEC and
NASD, in accordance with their requirements, of the transactions contemplated by
this Agreement, and shall take all other necessary action and proceedings as may
be required and permitted by applicable law, rule and regulation, for the legal
and valid issuance of the Shares, and the Common Stock issuable upon conversion
thereof, to the Purchaser.
Section 3.2 Registration and Listing. Until. at least two (2) years after
all Shares have been converted into Registrable Securities, the Company will
cause its Common Stock to continue to be registered under Sections 12(b) or
12(g) of the Exchange Act, will comply in all respects with its reporting and
filing obligations under such Exchange Act, will comply with all requirements
related to any registration statement filed pursuant to this Agreement and will
not take any action or file any document (whether or not permitted by the Act or
the Exchange Act or the rules thereunder) to terminate or suspend such
registration or to terminate or suspend its reporting and filing obligations
under said Acts, except as permitted herein. Until at least two (2) years after
all Shares have been converted into Common Stock the Company will take all
action within its power to continue the listing or trading of its Common Stock
on the NASDAQ Small Cap Market and will comply in all respects with the
Company's reporting, filing and other obligations under the bylaws or rules of
the NASD and NASDAQ. The covenants set forth in this Section 3.2 shall not be
deemed to prohibit a merger, sale of all assets or other corporate
reorganization if the entity surviving or succeeding to the Company is bound by
this Agreement with respect to its securities issued in exchange for or in
replacement of the Shares or Common Stock or the consideration received for or
in replacement of the Shares or Common Stock is cash.
Section 3.3 Right of First Refusal and Most-Favored-Nation Clause. If at
any time during the period beginning on the fifth (5th) day prior to (but not
including) the Closing Date and ending sixty (60) days immediately following the
effective date of the Initial Registration, the Company proposes to issue Common
Stock or securities convertible into or exercisable for Common Stock or other
convertible securities, pursuant to an offering exempt from registration under
the Act, the Company shall provide to Purchaser reasonable advance notice of all
the terms of such proposed issuance. The Purchaser shall have the right to
purchase or refuse to purchase all or any part of such securities proposed to be
issued in such offering, and shall have at least seventy two (72) hours after
receipt of such notice to review the terms of the proposed issuance.
If the Company issues Common Stock or securities convertible into or
exercisable for Common Stock or other convertible securities, at a time when any
of the Shares remain outstanding, at an effective price per share of Common
Stock which is lower than the conversion price of the Shares at that time, then
the Company shall, within five (5) business days, deliver to each holder upon
conversion an additional number of shares of Common Stock necessary to reduce
the effective conversion price to such lower issue price. This Section shall not
be applicable to issuances of Common Stock pursuant to (a) any business
combination, acquisition transaction, stock or asset purchase undertaken by the
Company or (b) any shareholder-approved option plan covering not more than 10%
of the Company's outstanding stock.
Section 4.1 Conditions Precedent to the Obligation of the Company to Sell
the Shares. The obligation hereunder of the Company to issue and/or sell the
Shares to the Purchaser is subject to the satisfaction, at or before the
Closing, of each of the conditions set forth below. These conditions may be
waived by the Company at any time in its sole discretion.
(a) Accuracy of the Purchaser's Representations and Warranting. The
representations and warranties of the Purchaser shall be true and correct in all
material respects as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
particular date).
(b) Performance by the Purchaser. The Purchaser shall have performed all
agreements and satisfied all conditions required to be performed or satisfied by
the Purchaser at or prior to the Closing.
(c) No Injunction. No statute, rule, regulation. executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits
the consummation of any of the transactions contemplated by this Agreement.
(d) Legal action. No legal action, suit or proceeding shall be pending or
threatened which seeks to restrain or prohibit the transactions contemplated by
this Agreement.
(e) Execution. The Purchaser shall have executed this Agreement, and
delivered such Agreement to the Company.
(f) Purchase Price. The Purchaser shall have delivered the Purchase Price
in accordance with Section 1.3(b) above.
Section 4.2 Conditions Precedent to the Obligation of the Purchaser to
Purchase the Shares. The obligation hereunder of the Purchaser to acquire and
pay for the Shares is subject to the satisfaction, at or before the Closing, of
each of the conditions set forth below. These conditions may be waived by the
Purchaser at any time in its sole discretion.
(a) Accuracy of the Company's Representations and Warranties. The
representations and warranties of the Company shall be true and correct in all
material respects as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
particular date).
(b) Performance by the Company. The Company shall have performed all
agreements and satisfied all conditions required to be performed or satisfied by
the Company at or prior to the Closing.
(c) NASDAO. From the date hereof to the Closing Date, trading in the
Company's Common Stock shall not have been suspended by the SEC or the NASDAQ
Small Cap Market (except for any suspension of trading of limited duration
agreed to between the Company and the NASDAQ Small Cap Market solely to permit
dissemination of material information regarding the Company), and trading in
securities generally as reported by NASDAQ shall not have been suspended or
limited or minimum prices shall not have been established on
securities whose trades are reported by NASDAQ.
(d) No Injunction. No statute, rule, regulation, executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits
the consummation of any of the transactions contemplated by this Agreement.
(e) Opinion of Counsel Etc. The Purchaser shall have received before or at
the Closing an opinion of counsel to the Company (covering, without limitation,
such of the matters set forth in Section 2.2(a) through (e)), as are in form and
substance reasonably satisfactory to the Purchaser and its counsel, and such
other certificates and documents as the Purchaser or its counsel shall
reasonably require incident to the Closing.
(f) Execution. The Company shall have executed this Agreement, and
delivered such Agreement to the Purchaser.
Section 5.1 Legend on Stock. Each certificate representing the Shares and,
if necessary, Common Stock issued upon conversion thereof, shall be stamped or
otherwise imprinted with a legend substantially in the following form:
THESE SECURITIES [AND THE SHARES OF COMMON STOCK ISSUABLE UPON THE CONVERSION
HEREOF] HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD OR OFFERED FOR SALE UNLESS
THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND ANY APPLICABLE
STATE SECURITIES LAW OR, IN THE OPINION OF COUNSEL, REGISTRATION UNDER SUCH ACT
OR APPLICABLE STATE SECURITIES LAW IS NOT REQUIRED IN CONNECTION WITH SUCH SALE
OR OFFER, AND SUCH OPINION IS REASONABLY SATISFACTORY TO THE COMPANY.
The Company agrees to reissue certificates representing the Shares or, if
applicable, the Common Stock issued upon conversion thereof, without the legend
set forth above at such time as (a) the holder thereof is permitted to dispose
of such Shares (or securities issued upon conversion thereof) pursuant to Rule
144(k) under the Act, (b) the securities are sold to a purchaser or purchasers
who (in the opinion of counsel to such holders, in form and substance reasonably
satisfactory to the Company and its counsel) are able to dispose of such
securities publicly without registration under the Act, or (iii) such securities
are registered under the Act
Section 6.1 Termination by Mutual Consent. This Agreement may be terminated
at any time prior to the Closing by the mutual written consent of the Company,
and the Purchaser.
Section 6.2 Other Termination. This Agreement may be terminated by action
of the Board of Directors or other governing body of the Purchaser or the
Company at any time if the Closing shall not have been consummated by the fifth
(5th) business day following the date of this Agreement, provided that the party
seeking to terminate the Agreement is not in breach of the Agreement.
Section 6.3 Automatic Termination. This Agreement shall automatically
terminate without any further action of either party hereto if the Closing shall
not have occurred by the seventh (7th) business day following the date of this
Agreement, provided, however, that any such termination shall not terminate the
liability of any party which is then in breach of the Agreement.
Section 7.1 Fees and Expenses. Except as otherwise set forth in Section 1.4
hereof with respect to the registration of Registrable Securities, the Company
shall pay the fees, commissions and expenses of its advisers, brokers, finders,
counsel, accountants and other experts, if any, and all other expenses
associated therewith, and shall on the Closing Date reimburse ProFutures Special
Equities Fund, L.P. up to $5,000 for fees and expenses of its counsel in
connection with the preparation, negotiation and coordination of this Agreement.
The Company shall pay all stamp and other taxes and duties levied in connection
with the issuance of the Shares and Common Stock pursuant hereto.
Section 7.2 Specific Enforcement, Consent to Jurisdiction.
(a) The Company and the Purchaser acknowledge and agree that irreparable
damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that the parties shall be entitled to an
injunction or injunctions to prevent or cure breaches of the provisions of this
Agreement and to enforce specifically the terms and provisions hereof, this
being in addition to any other remedy to which either of them may be entitled by
law or equity.
(b) The Company and the Purchaser each (i) hereby irrevocably submits to
the jurisdiction of the United States District Court and other courts of the
United States sitting in the State of Texas for the purposes of any suit, action
or proceeding arising out of or relating to this Agreement and (ii) hereby
waives, and agrees not to assert in any such suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of such court, that
the suit, action or proceeding is brought in an inconvenient forum or that the
venue of the suit, action or proceeding is improper. The Company and the
Purchaser each consents to process being served in any such suit, action or
proceeding by mailing a copy thereof to such party at the address in effect for
notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing in this
paragraph shall affect or limit any right to serve process in any other manner
permitted by law.
Section 7.3 Entire Agreement: Amendment. This Agreement contains the entire
understanding of the parties with respect to the matters covered hereby and,
except as specifically set forth herein, neither the Company nor the Purchaser
makes any representation, warranty, covenant or undertaking with respect to such
matters. No provision of this Agreement may be waived or amended other than by a
written instrument signed by the party against whom enforcement of any such
amendment or waiver is sought.
Section 7.4 Notices. Any notice or other communication required or
permitted to be given hereunder shall be in writing and shall be effective (a)
upon hand delivery or delivery by telex (with correct answer back received),
telecopy or facsimile at the address or number designated below (if delivered on
a business day during normal business hours where such notice is to be
received), or the first business day following such delivery (if delivered other
than on a business day during normal business hours where such notice is to be
received) or (b) on the second (2nd) business day following the date of mailing
by express courier service, fully prepaid, addressed to such address, or upon
actual receipt of such mailing, whichever shall first occur.
The addresses for such communications shall be:
to the Company: Bruce A. Shear, President and Chief Executive Officer
PHC, Inc.
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
to the Purchaser: At the address set forth at the foot of this Agreement or
as specified in writing by Purchaser.
Any party hereto may from time to time change its address for notices by giving
at least ten (10) days' written notice of such changed address to the other
party hereto.
Section 7.5 Waivers. No waiver by either party of any default with respect
to any provision, condition or requirement of this Agreement shall be deemed to
be a continuing waiver in the future or a waiver of any other provision,
condition or requirement hereof, nor shall any delay or omission of either party
to exercise any right hereunder in any manner impair the exercise of any such
right accruing to it thereafter.
Section 7.6 Headings. The headings herein are for convenience only, do not
constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.
Section 7.7 Governing Law. This Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the present state
of incorporation of the Company without regard to such state's principles of
conflict of laws.
Section 7.8 Survival. The representations and warranties of the Company and
the Purchaser contained in herein and the agreements and covenants set forth in
Sections 1.1 through 1.5, 3.1 through 3.3 and 7.1 through 7.16 shall survive the
Closing for a period of two (2) years.
Section 7.9 Publicity. The Company agrees that it will not disclose, and
will not include in any public announcement, the name of the Purchaser without
its consent, unless and until such disclosure is required by law or applicable
regulation, and then only to the extent of such requirement.
Section 7.10 NASDAO. The term "NASDAQ" or "NASDAQ Small Cap Market" herein
refers to the principal market on which the Common Stock of the Company is
traded. If the Common Stock is listed on a securities exchange. or if another
market becomes the principal market on which the Common Stock is traded or
through which price quotations for the Common Stock are reported, the term
"NASDAQ" or "NASDAQ Small Cap Market" shall be deemed to refer to such exchange
or other principal market.
Section 7.11 Acceptance. Execution and delivery of this Agreement shall
constitute an offer to purchase the Shares, which offer, unless previously
revoked by the Purchaser, may be accepted or rejected by the Company, in its
sole discretion for any cause or for no cause and without liability to the
Purchaser. The Company shall indicate acceptance of this Agreement by signing as
indicated on the signature page hereof.
Section 7.12 Binding Agreement. Upon acceptance of this Agreement by the
Company, the Purchaser agrees that he may not cancel, terminate or revoke any
agreement of the Purchaser made hereunder, and that this Agreement shall survive
the death or disability of the Purchaser and shall be binding upon heirs,
successors, assigns, executors, administrators, guardians, conservators or
personal representatives of the Purchaser.
Section 7.13 Incorporation by Reference. All information set forth on the
signature page is incorporated as integral terms of this Agreement.
Section 7.14 Counterparts. This Agreement may be signed in multiple
counterparts, which counterparts shall constitute one and the same original
instrument.
Section 7.15 Severability. If any portion of this Agreement shall be held
illegal, unenforceable, void or voidable by any court each of the remaining
terms hereof shall nevertheless remain in full force and effect as a separate
contract.
Section 7.16 Successors and Assigns. This Agreement shall be binding upon
and inure to the benefit of the parties hereto and their respective successors
and permitted assigns.
[This space has been left blank intentionally. The signature page follows.]
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$500,000 (500 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
26,315 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
ProFutures Special Equities Fund, L.P.
Address of Purchaser: % ProFutures Fund Management, Inc.
1030 Highway 620 South - Suite 200
Austin, TX 78734
Social Security or IRS Employer Identification Number(s):
74-2786952
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
______________________________________________
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: ProFutures Special Equities Fund, L.P.
By ProFutures Fund Management, Inc., a General Partner
By: ______________________________________
(Signature)
Name: /s/ Gary D. Halbert
Title: President
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$150,000 (150 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
7,890 shares
The exact name(s)(Including correct,legible spelling) and the information under
which title to the Shares will be taken is as follows (Please print or type):
Gary D. Halbert
Address of Purchaser: 1030 Highway 620 South - Suite 200
Austin, TX 78734
Social Security or IRS Employer Identification Number(s):
451-96-0684
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
/s/ Gary D. Halbert
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: _______________________________________
By: ______________________________________
(Signature)
Name: ____________________________________________
Title: ____________________________________________
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$100,000 (100 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
5,260 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
John F. Mauldin
Address of Purchaser: 1000 Ballpark in Arlington - Suite 216
Arlington, TX 76011
Social Security or IRS Employer Identification Number(s):
459-84-6606
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
/s/ John F. Mauldin
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: ________________________________
By: ______________________________________
(Signature)
Name: _________________________________
Title: _________________________________
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$200,000 (200 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
10,525 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
Augustine Fund, L.P.
Address of Purchaser: 141 West Jackson Boulevard - Suite 2182
Chicago, IL 60604
Social Security or IRS Employer Identification Number(s):
36-418-6782
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
______________________________________________
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: Augustine Fund, L.P.
By Augustine Capital Management, Inc., the General Partner
By: ______________________________________
(Signature)
Name: /s/ Thomas Duszynski
Title: Chief Operating Officer
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
SCHEDULE I
PHC, INC.
RESOLUTIONS ESTABLISHING RIGHTS AND PREFERENCES
FOR SERIES B CONVERTIBLE PREFERRED STOCK
RESOLVED, that there shall be a series of shares of the Corporation
designated "Series B Convertible Preferred Stock"; that the number of shares of
such series shall be 1,000, that the Corporation issue such shares, and that the
rights and preferences of such series (the "6% Preferred") and the limitations
or restrictions thereon, shall be as set forth herein.
The following terms and conditions shall be adopted and incorporated by
reference into the foregoing resolutions as if fully set forth therein:
1. Dividends.
(a) The holders of the 6% Preferred shall be entitled to receive out of any
assets legally available therefor cumulative dividends at the rate of $60 per
share per annum, accrued daily and payable quarterly in arrears on March 31,
June 30, September 30 and December 31 of each year, in preference and priority
to any payment of any dividend on the Common Stock or any other class or series
of stock of the Corporation. Such dividends shall accrue on any given share from
the day of original issuance of such share and shall accrue from day to day
whether or not earned or declared. If at any time dividends on the outstanding
6% Preferred at the rate set forth above shall not have been paid or declared
and set apart for payment with respect to all preceding periods, the amount of
the deficiency shall be fully paid or declared and set apart for payment, but
without interest, before any distribution, whether by way of dividend or
otherwise, shall be declared or paid upon or set apart for the shares of any
other class or series of stock of the Corporation.
(b) Any dividend payable on a dividend payment date may be paid, at the
option of the Corporation, either (i) in cash or (ii) in shares of 6% Preferred
valued at $1,000 per share, if the Common Stock issuable upon conversion of such
shares has been registered for resale under the Securities Act of 1933, as
amended (the "Act"), and the registration statement including a current
prospectus with respect thereto remains in effect at the date of delivery of
such shares, and if the Corporation shall have given written notice of its
intention to pay such dividend in stock to all holders of the 6% Preferred at
least ten (10) days before the record date for such dividend.
2. Liquidation Preference, Redemption.
(a) In the event of any liquidation, dissolution or winding up of the
Corporation, either voluntary or involuntary, the holders of the 6% Preferred
shall be entitled to receive, prior and in preference to any distribution of any
assets of the Corporation to the holders of any other class or series of shares,
the amount of $1,000 per share plus any accrued but unpaid dividends (the
"Liquidation Preference").
(b) A consolidation or merger of the Corporation with or into any other
corporation or corporations, or a sale of all or substantially all of the assets
of the Corporation (other than a sale or transfer to a wholly-owned subsidiary
of the Corporation), shall, at the option of the holders of the 6% Preferred, be
deemed a liquidation, dissolution or winding up within the meaning of this
Section 2 if the shares of stock of the Corporation outstanding immediately
prior to such transaction represent immediately after such transaction less than
a majority of the voting power of the surviving corporation (or of the acquirer
of the Corporation's assets in the case of a sale of assets). Such option may be
exercised by the vote or written consent of holders of a majority of the 6%
Preferred at any time within thirty (30) days after written notice (which shall
be given promptly) of the essential terms of such transaction shall have been
given to the holders of the 6% Preferred in the manner provided by law for the
giving of notice of meetings of shareholders.
- 1 -
(c) The Corporation may, at its option, cause all outstanding shares of the
6% Preferred to be redeemed after the date on which a registration statement
under the Act ("Registration Statement") has been declared effective (the
"effective date"); provided the Corporation has given notice of its intention to
redeem to the holders of the 6% Preferred at least five (5) days prior to the
redemption date. In addition, if any conversion of 6% Preferred, when aggregated
with all prior conversions, will cause the Company to issue a number of shares
of Common Stock which exceeds twenty percent (20%) of the shares of Common Stock
then issued and outstanding, the Company shall redeem such number of shares of
6% Preferred as is necessary to limit such issuance of Common Stock to twenty
percent (20%) of the shares of Common Stock then issued and outstanding, unless
the Company has previously obtained stockholder approval to issue in excess of
twenty percent (20%) of the shares of Common Stock then issued and outstanding.
If a redemption will occur under either of the preceding sentences, on the
redemption date, the Corporation shall pay such holders by cashiers check or
wire transfer in immediately available funds the amount of $1,300 per share of
6% Preferred plus all accrued but unpaid dividends. Promptly thereafter, the
holders shall surrender the certificate or certificates representing the 6%
Preferred, duly endorsed, at the office of the Corporation or of any transfer
agent for such shares, or at such other place designated by the Corporation.
3. 6% Preferred - Forced Conversion.
(a) The Corporation may, at its option, cause all outstanding shares of the
6% Preferred to be converted into Common Stock at any time beginning one (1)
year after the date of issuance, on at least twenty (20) days' advance notice,
at a conversion price determined as set forth in Section 4 hereof (the
"Conversion Price") as of the date specified in such notice (the "Conversion
Date") and otherwise on the terms set forth in Section 4 hereof, provided, that
the Corporation may not exercise such right of conversion unless (i) the Closing
Price (last trade price) of the Common Stock as reported by NASDAQ for the
twenty (20) consecutive trading days prior to the date the Conversion Notice is
mailed has not on any day been less than one hundred forty percent (140%) of the
last trade price of the Company's Common Stock on the day of Closing (subject to
adjustment for stock dividends, stock splits and reverse stock splits), and (ii)
the shares issuable upon conversion of the 6% Preferred are registered for
resale by an effective Registration Statement which became effective not more
than one hundred twenty (120) days after the date of issuance of the 6%
Preferred, and a current prospectus meeting the requirements of Section 10 of
the Act is available for delivery at the Conversion Date.
(b) At least twenty (20) days prior to the Conversion Date, written notice
(the "Conversion Notice") shall be mailed, first class postage prepaid, by the
Corporation to each holder of record of the 6% Preferred, at the address last
shown on the records of the Corporation for such holder, notifying such holder
of the conversion which is to be effected, specifying the Conversion Date and
calling upon each such holder to surrender to the Corporation, in the manner and
at the place designated, a certificate or certificates representing the number
of shares of 6% Preferred held by such holder. Subject to the provisions of the
following subsection (c), on or after the Conversion Date, each holder of 6%
Preferred shall surrender to the Corporation the certificate or certificates
representing the shares of 6% Preferred owned by such holder as of the
Conversion Date, in the manner and at the place designated in the Conversion
Notice, and thereupon the shares issuable upon such conversion shall be
delivered as provided in Section 4(b) hereof.
(c) If, on the Conversion Date, the registration condition specified in
clause (ii) of subsection (a) shall not be satisfied, then no shares shall be
converted and the Conversion Notice shall be deemed to be withdrawn. In such
event, any certificates for 6% Preferred which have been surrendered for
conversion shall be returned to the persons surrendering the same; provided,
however, that if a holder has received shares of Common Stock upon conversion of
6% Preferred after the Conversion Notice was given but before the Conversion
Date, such holder may elect either to retain such Common Stock or rescind such
conversion by tendering such shares of Common Stock to the Corporation.
(d) On the second anniversary of the issuance of the 6% Preferred, all then
outstanding shares of 6% Preferred shall be automatically converted into Common
Stock at the Conversion Price and otherwise pursuant to the applicable
provisions set forth in Section 4 hereof.
- 2 -
4. 6% Preferred - Optional Conversion. The holders of the 6% Preferred
shall have optional conversion rights as follows:
(a) Right to Convert. At any time after the earlier of (i) the date on
which a Registration Statement has been declared effective, or (ii) the close of
business on the ninety first (91st) day following the date of issuance of the 6%
Preferred, shares of 6% Preferred shall become convertible, at the option of the
holder thereof, into such number of fully paid and nonassessable shares of
Common Stock as is determined by dividing (A) the Liquidation Preference of the
6% Preferred determined pursuant to Section 2 hereof on the date the notice of
conversion is given, by (B) the Conversion Price determined as hereinafter
provided in effect on the applicable conversion date.
(b) Mechanics of Conversion. To convert shares of 6% Preferred into shares
of Common Stock, the holder shall give written notice to the Corporation (which
notice may be given by facsimile transmission) that such holder elects to
convert the shares and shall state therein date of the conversion, the number of
shares to be converted and the name or names in which such holder wishes the
certificate or certificates for shares of Common Stock to be issued. Promptly
thereafter, the holder shall surrender the certificate or certificates
representing the shares to be converted, duly endorsed, at the office of the
Corporation or of any transfer agent for such shares, or at such other place
designated by the Corporation; provided that the holder shall not be required to
deliver the certificates representing such shares if the holder is waiting to
receive all or part of such certificates from the Corporation. The Corporation
shall, immediately upon receipt of such notice, issue and deliver to or upon the
order of such holder, against delivery of the certificates representing the
shares which have been converted, a certificate or certificates for the number
of shares of Common Stock to which such holder shall be entitled and such
certificate or certificates shall not bear any restrictive legend; provided (A)
the Common Stock evidenced thereby are sold pursuant to an effective
registration statement under the Act, (B) the holder provides the Corporation
with an opinion of counsel reasonably acceptable to the Corporation to the
effect that a public sale of such shares may be made without registration under
the Act, or (C) such holder provides the Corporation with reasonable assurance
that such shares can be sold free of any limitations imposed by Rule 144,
promulgated under the Act. The Corporation shall cause such issuance and
delivery to be effected within three (3) business days and shall transmit the
certificates by messenger or overnight delivery service to reach the address
designated by such holder within three (3) business days after the receipt of
such notice. The notice of conversion may be given by a holder at any time
during the day up to 5:00 p.m. Boston, Massachusetts time and such conversion
shall be deemed to have been made immediately prior to the close of business on
the date such notice of conversion is given (a "conversion date"). The person or
persons entitled to receive the shares of Common Stock issuable upon such
conversion shall be treated for all purposes as the record holder or holders of
such shares of Common Stock at the close of business on such date.
(c) Conversion, Redemption and Note Delivery Required. The Corporation
acknowledges and understands that a delay in the issuance of the Common Stock
upon conversion or pursuant to a redemption according to the provisions hereof,
or a delay in delivering the Promissory Note set forth in Subsection (d) hereof,
could result in economic loss to the holders of the 6% Preferred. As
compensation to any holder when the Corporation has failed with respect to such
holder to comply with the Corporation's obligations hereunder, and not as a
penalty, the Corporation shall pay to such holder liquidated damages of $500 per
day plus an amount equal to: (i) two percent (2%) of the total Purchase Price of
Shares for the first thirty (30) day period after the date on which the Common
Stock should have been issued by the Corporation (i.e., the end of the three (3)
business day period described in Subsection (b)), shares of 6% Preferred
redeemed by the Corporation or Promissory Note delivered to holder (i.e., the
end of the three (3) business day period described in Subsection (d)), as
applicable; plus (ii) an amount equal to three percent (3%) of the total
Purchase Price of Shares for each subsequent thirty (30) day period thereafter.
Amounts payable shall be pro-rated daily as to a periods of less than thirty
(30) days. Such amounts shall be paid to the holder at the end of each month in
which such amounts have accrued. Payment shall be made immediately by cashier's
check or wire transfer in immediately available funds to such account as shall
be designated in writing by the holder. Each holder shall be entitled to an
injunction or injunctions to prevent or cure breaches of the provisions of
hereof and. to enforce specifically the terms and provisions hereof, this being,
in addition to any other remedy to which a holder may be entitled by law or
equity.
- 3 -
(d) Determination of Conversion Price:
(i )The "Conversion Price" for purposes of hereof shall be equal to eighty
percent (80%) of the average of the closing bid prices of the Common Stock as
reported by NASDAQ during the five (5) consecutive trading days preceding the
conversion date (but not including such date); provided, however, that in no
event may the Conversion Price be more than three dollars and twenty cents
($3.20) (the "Maximum Conversion Price") or less than an amount equal to the
closing bid price per share of the Common Stock on the date of issuance minus
fifty cents ($0.50) (the "Minimum Conversion Price"). If, but for this Section
4(d)(i), the Conversion Price would have been below Minimum Conversion Price,
the Company shall pay the holder by delivering to holder a Promissory Note, the
form which has been delivered to the Corporation and is incorporated herein by
reference, bearing the principal amount equal to the difference between (A) the
number of shares of Common Stock that would have been issued at the amount the
Conversion Price would have been but for this Section 4(d)(i) multiplied by 100%
of the closing bid price of the Common Stock on the conversion date as
determined in accordance with the Subsection (d) (the latter amount being
referred to herein as the "Conversion Date Price"), minus (B) the number of
shares of Common Stock actually issued pursuant to the conversion multiplied by
the Conversion Date Price. Such Promissory Note shall be delivered to holder by
the third (3rd) day following the applicable conversion date.
(ii) The "closing bid price" of the Common Stock on a trading day shall be
the closing bid price of the Common Stock on the NASDAQ Small Cap Market or any
other principal securities price quotation system or market on which prices of
the Common Stock are reported. The term "trading day" means a day on which
trading is reported on the principal quotation system or market on which prices
of the Common Stock are reported.
(iii) If, during the period of consecutive trading days provided for above,
the Corporation shall declare or pay any dividend on the Common Stock payable in
Common Stock or in rights to acquire Common Stock, or shall effect a stock split
or reverse stock split, or a combination, consolidation or reclassification of
the Common Stock, the Conversion Price, Maximum Conversion Price and Minimum
Conversion Price shall be proportionately decreased or increased, as
appropriate, to give effect to such event.
(e) Distributions. If the Corporation shall at any time or from time to
time make or issue, or fix a record date for the determination of holders of
Common Stock entitled to receive, a dividend or other distribution payable in
securities of the Corporation or any of its subsidiaries other than additional
shares of Common Stock, then in each such event provision shall be made so that
the holders of 6% Preferred shall receive, upon the conversion thereof, the
securities of the Corporation which they would have received had they been the
owners on the date of such event of the number of shares of Common Stock
issuable to them upon conversion.
(f) Certificates as to Adjustments. Upon the occurrence of any adjustment
or readjustment of the Conversion Price, the Maximum Conversion Price and
Minimum Conversion Price pursuant to this Section 4, the Corporation at its
expense shall promptly compute such adjustment or readjustment in accordance
with the terms hereof and cause the independent public accountants regularly
employed to audit the financial statements of the Corporation to verify such
computation and prepare and furnish to each holder of 6% Preferred a certificate
setting forth such adjustment or readjustment and showing in detail the facts
upon which such adjustment or readjustment is based. The Corporation shall, upon
the written request at any time of any holder of 6%. Preferred, furnish or cause
to be furnished to such holder a like certificate prepared by the Corporation
setting forth (i) such adjustments and readjustments, and (ii) the number of
other securities and the amount, if any, of other property which at the time
would be received upon the conversion of 6% Preferred with respect to each share
of Common Stock received upon such conversion.
(g) Notice of Record Date. In the event of any taking by the Corporation of
a record of the holders of any class of securities for the purpose of
determining the holders thereof who are entitled to receive any dividend (other
than a cash dividend) or other distribution, any security or right convertible
into or entitling the holder thereof to receive additional shares of Common
Stock, or any right to subscribe for, purchase or otherwise acquire any shares
of stock of any class or any other securities or property, or to receive any
other right, the Corporation shall mail to each holder of 6% Preferred at least
ten (10) days prior to the date specified therein, a notice specifying the date
on which any such record is to be taken for the purpose of such dividend,
distribution, security or right and the amount and character of such dividend,
distribution, security or right.
- 4 -
(h) Issue Taxes. The Corporation shall pay any and all issue and other
taxes, excluding any income, franchise or similar taxes, that may be payable in
respect of any issue or delivery of shares of Common Stock on conversion of
shares of 6% Preferred pursuant hereto; provided, however, that the Corporation
shall not be obligated to pay any transfer taxes resulting from any transfer
requested by any holder in connection with any such conversion.
(i) Reservation of Stock Issuable Upon Conversion. The Corporation shall at
all times reserve and keep available out of its authorized but unissued shares
of Common Stock, solely for the purpose of effecting the conversion of the
shares of the 6% Preferred, such number of its shares of Common Stock as shall
from time to time be sufficient to effect the conversion of all outstanding
shares of the 6% Preferred, and if at any time the number of authorized but
unissued shares of Common Stock shall not be sufficient to effect the conversion
of all then outstanding shares of the 6% Preferred, the Corporation will take
such corporate action as may be necessary to increase its authorized but
unissued shares of Common Stock to such number of shares as shall be sufficient
for such purpose, including, without limitation, engaging in best efforts to
obtain any requisite shareholder approval.
(j) Fractional Shares. No fractional shares shall be issued upon the
conversion of any share or shares of 6% Preferred. All shares of Common Stock
(including fractions thereof) issuable upon conversion of more than one share of
6% Preferred by a holder thereof shall be aggregated for purposes of determining
whether the conversion would result in the issuance of any fractional share. If,
after the aforementioned aggregation, the conversion would result in the
issuance of a fraction of a share of Common Stock, the Corporation shall, in
lieu of issuing any fractional share, pay the holder otherwise entitled to such
fraction a sum in cash equal to the fair market value of such fraction on the
date of conversion (as determined in good faith by the Board of Directors of the
Corporation or an authorized Committee thereof).
(k) Notices. Any notice required by the provisions of this Section to be
given to the holders of shares of 6% Preferred shall be deemed given if
deposited in the United States mail, postage prepaid, and addressed to each
holder of record at its address appearing on the books of the Corporation.
(1) Reorganization or Merger. In case of any reorganization or any
reclassification of the capital stock of the Corporation or any consolidation or
merger of the Corporation with or into any other corporation or corporations or
a sale of all or substantially all of the assets of the Corporation to any other
person (other than a sale or transfer to a wholly owned subsidiary of the
Corporation), and the holders of 6% Preferred do not elect to treat such
transaction as a liquidation, dissolution or winding up as provided in Section 2
hereof, then, as part of such reorganization, consolidation, merger or sale,
provision shall be made so that each share of 6% Preferred shall thereafter be
convertible into the number of shares of stock or other securities or property
(including cash) to which a holder of the number of shares of Common Stock
deliverable upon conversion of such share of 6% Preferred would have been
entitled upon the record date of (or date of, if no record date is fixed) such
event and, in any case, appropriate adjustment (as determined by the Board of
Directors) shall be made in the application of the provisions herein set forth
with respect to the rights and interests thereafter of the holders of the 6%
Preferred, to the end that the provisions set forth herein shall thereafter be
applicable, as nearly as equivalent as is practicable, in relation to any shares
of stock or the securities or property (including cash) thereafter deliverable
upon the conversion of the shares of 6% Preferred.
5. Re-issuance of Certificates. In the event of a conversion (or, if
applicable, redemption) of 6% Preferred in which less than all of the shares of
6% Preferred of a particular certificate are converted or redeemed, as the case
may be, the Corporation shall promptly without delay cause to be issued and
delivered to the holder of such certificate, a certificate representing the
remaining shares of 6% Preferred which have not been so
converted or redeemed.
- 5 -
6. Other Provisions. For all purposes of this Resolution, the term "date of
issuance" and the terms "Closing" or "Closing Date" shall mean the day on which
shares of the 6% Preferred are first issued by the Corporation. Any provision
herein which conflicts with or violates any applicable usury law shall be deemed
modified to the extent necessary to avoid such conflict or violation. The term
"NASDAQ" herein refers to the principal market on which the Common Stock of the
Corporation is traded. If the Common Stock is listed on a securities exchange,
or if another market becomes the principal market on which the Common Stock is
traded or through which price quotations for the Common Stock are reported, the
term "NASDAQ" shall be deemed to refer to such exchange or other principal
market.
7. Restrictions and Limitations. The Corporation shall not undertake the
following actions without the consent of the holders of a majority of the 6%
Preferred: (i) modify its Articles of Organization or Bylaws so as to amend or
change any of the rights, preferences, or privileges of the 6% Preferred, (ii)
authorize or issue any other preferred equity security senior to or on a parity
with the 6% Preferred as to dividends, liquidation preferences, conversion
rights, redemption rights or other rights, preferences or privileges for a
period of thirty (30) days after Closing, as applicable or (iii), purchase or
otherwise acquire for value any Common Stock or other equity security of the
Corporation either junior or senior to or on a parity with the 6% Preferred
while there exists any arrearage in the payment of cumulative dividends
hereunder other than redemptions of stock from terminating employees pursuant to
contractual rights in favor of the Corporation.
8. Voting Rights. Except as provided herein or as provided for by law, the
6% Preferred shall have no voting rights.
9. Attorney's Fees. Any holder of 6% Preferred shall be entitled to recover
from the Corporation the reasonable attorneys' fees and expenses incurred by
such holder in connection with enforcement by such holder of any obligation of
the Corporation hereunder.
10. No Adverse Actions. The Corporation shall not in any manner, whether by
amendment of the Articles of Organization (including, without limitation, any
vote establishing a class or series of stock), merger, reorganization,
recapitalization, consolidation, sales of assets, sale of stock tender offer,
dissolution or otherwise, take any action, or permit any action to be taken,
solely or primarily for the purpose of increasing the value of any class of
stock of the Corporation if the effect of such action is to reduce the value or
security of the 6% Preferred.
- 6 -
EXHIBIT A to the Subscription Agreement
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON
STOCK PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March ___, 1998
1. Basic Terms. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the registered holder specified
below or its registered assigns ("Holder"), is the owner of warrants of PHC,
Inc., a Massachusetts corporation (the "Corporation"), and is entitled, subject
to the terms and conditions of this Warrant, including adjustments as provided
herein, to purchase ______ ( ) (number to be pro-rated for a total of 50,000
share) shares of the Common Stock (the "Common Stock") of the Corporation from
the Corporation at the price per share shown below (the "Exercise Price").
Holder:
Exercise Price per share: ______ Dollars and ______
Cents ($ )per share
[This amount will be the Closing Bid Price of the
Corporation's Common Stock on the Issue Date]
Except as specifically provided otherwise, all references in this Warrant
to the Exercise Price and the number of shares of Common Stock purchasable
hereunder shall be to the Exercise Price and number of shares after any
adjustments are made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The Corporation represents and
covenants that the shares of Common Stock issuable upon the exercise of this
Warrant shall at delivery be fully paid and non-assessable and free from taxes,
liens, encumbrances and charges with respect to their purchase. The Corporation
shall take any necessary actions to assure that the par value per share of the
Common Stock is at all times equal to or less than the then current Exercise
Price per share of Common Stock issuable pursuant to this Warrant. The
Corporation shall at all times reserve and hold available sufficient shares of
Common Stock to satisfy all conversion and purchase rights of outstanding
convertible securities, options and warrants of the Corporation, including this
Warrant.
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the issue date.
To exercise this Warrant, the Holder shall surrender this Warrant at the
principal office of the Corporation or that of the duly authorized and acting
transfer agent for its Common Stock, together with the executed exercise form
(substantially in the form of that attached hereto) and together with payment
for the Common Stock purchased under this Warrant. The principal office of the
Corporation is located at the address specified on the signature page of this
Warrant; provided, however, that the Corporation may change its principal office
upon notice to the Holder. At the option of the Holder payment shall be made
either in cash (by wire) or by certified or bank cashier's check payable to the
order of the Corporation or the Holder may elect to receive shares of Common
Stock calculated pursuant to paragraph 4. The Corporation shall, immediately
upon receipt of such notice, issue and deliver to or upon the order of such
Holder a certificate or certificates for the number of shares of Common Stock to
which such Holder shall be entitled and such certificate or certificates shall
not bear any restrictive legend; provided (A) the Common Stock evidenced thereby
are sold pursuant to an effective registration statement under the Act, (B) the
holder provides the Corporation with an opinion of counsel reasonably acceptable
to the Corporation to the effect that a public sale of such shares may be made
without registration under the Act, or (C) such holder provides the Corporation
with reasonable assurance that such shares can be sold free of any limitations
imposed by Rule 144, promulgated under the Act. The Corporation shall cause such
issuance and delivery to be effected within three (3) business days and shall
transmit the certificates by messenger or overnight delivery service to reach
the address designated by such holder within three (3) business days after the
receipt of such notice. This Warrant is not exercisable with respect to a
fraction of a share of Common Stock. In lieu of issuing a fraction of a share
remaining after exercise of this Warrant as to all full shares covered by this
Warrant the Corporation shall either at its option (a) pay for the fractional
share cash equal to the same fraction at the fair market price for such share;
or (b) issue scrip for the fraction in the registered or bearer form which shall
entitle the Holder to receive a certificate for a full share of Common Stock on
surrender of scrip aggregating a full share. As compensation to the Holder when
the Corporation has failed with respect to such Holder to comply with the
Corporation's obligations hereunder, and not as a penalty, the Corporation shall
pay to such holder liquidated damages of $500 per day until the certificates are
delivered as instructed. Such damages shall be paid to the Holder by cashiers
check or wire transfer in immediately available funds to such account as shall
be designated in writing by the Holder at the end of each month in which such
amounts have accrued. Holder shall be entitled to an injunction or injunctions
to prevent or cure breaches of the provisions of hereof and to enforce
specifically the terms and provisions hereof, this being in addition to any
other remedy to which Holder may be entitled by law or equity.
4. Cashless Exercise.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or
quoted in the NASDAQ System or the domestic over-the-counter market, the fair
market value shall be the higher of (i) the book value thereof, as determined by
any firm of independent public accountants of recognized standing selected by
the Corporation (which may be the Corporation's regular independent
accountants), as of the last day of any month ending within sixty days preceding
the date as of which the determination is to be made; or (ii) the fair market
value thereof, which shall be reasonably determined by the Corporation and the
Holder as of a date which is within fifteen days of the date as of which the
determination is to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that
price determined by multiplying the Exercise Price in effect immediately prior
to such event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number an kind of securities or other
property purchasable under this Warrant resulting from the event and settin
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until,
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant.All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the
Holder.
PHC, INC., a Massachusetts corporation
By: ________________________________
Authorized Officer
Printed Name: _______________________
Title: ______________________________
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ________________________________
________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________ ____________________________________
Signature
- 8 -
Incorporated by Reference into the Resolutions Establishing Right and
Preferences for Series B Convertible Preferred Stock.
PROMISSORY NOTE (the "Note")
Date: __________________, ________________________
Maker: PHC, Inc.
Maker's Mailing Address: 200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
Payee:
Place for Payment:
Principal Amount: $_________________________________
Annual Interest Rate on Unpaid Principal From Date: Eight percent (8%).
Annual Past Due Interest Rate on Unpaid Principal from Maturity to Payment:
Fifteen percent (15%).
Terms of Payment: Principal and interest shall be due and payable in six (6)
equal consecutive monthly payments of $ ________________ (based on a six (6)
month amortization) with the first payment being due and payable on the first
day of _____________________.
The Maker promises to pay to the order of Payee at the place for payment and
according to the terms of payment the outstanding principal and accrued interest
at the rates stated above. All unpaid amounts owing on this Note shall be due by
the final scheduled payment date of ________________________.
Additional Provisions:
If Maker defaults in the payment of this Note, or in any instrument securing or
collateral to it, then Payee may declare the unpaid principal balance of this
Note and all accrued interest immediately due and payable. Maker and each
surety, endorser, and guarantor or other party liable for the payment of any
sums of money payable on this Note severally waive all demands for payment,
presentations for payment, notices of dishonor, notices of intention to
accelerate maturity, notices of acceleration of maturity, protests, and notices
of protest, to the extent permitted by law.
If this Note or any instrument securing or collateral to it is given to an
attorney for collection or enforcement. or if suit is brought for collection or
enforcement or if it is collected or enforced through probate, bankruptcy, or
other judicial proceedings then Maker shall pay Payee all costs of collection
and enforcement, including reasonable attorneys fees and court costs, in
addition to other amounts due.
PHC. INC., PROMISSORY NOTE
Page 1
Interest that may be contracted for, taken, reserved, charged or received
under law; any interest in excess of that maximum amount shall be credited on
the principal of the debt or, if that has been paid, refunded. On any
acceleration or required or permitted prepayment, any such excess shall be
canceled automatically as of the acceleration or prepayment or, if already paid,
credited on the principal of the debt or, if the principal of the debt has been
paid, refunded. This provision overrides other provisions in this and all other
instruments concerning the debt.
When the context requires, singular nouns and pronouns include the plural.
This Note is to be governed and construed in accordance with the laws of
the State of Texas.
MAKER, FOR GOOD AND VALUABLE CONSIDERATION, THE RECEIPT AND SUFFICIENCY OF
WHICH ARE HEREBY ACKNOWLEDGED, (I) HEREBY IRREVOCABLY SUBMITS TO THE
JURISDICTION OF THE UNITED STATES DISTRICT COURT AND OTHER COURTS OF THE UNITED
STATES SITTING IN TEXAS FOR THE PURPOSES OF ANY SUIT, ACTION OR PROCEEDING
ARISING OUT OF OR RELATING TO THIS AGREEMENT AND (ii) HEREBY WAIVES, AND AGREES
NOT TO ASSERT IN ANY SUCH SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT
PERSONALLY SUBJECT TO THE JURISDICTION OF SUCH COURT, THAT THE SUIT, ACTION OR
PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR THAT THE VENUE OF THE SUIT,
ACTION OR PROCEEDING IS IMPROPER. MAKER CONSENTS TO PROCESS BEING SERVED IN ANY
SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF TO MAKER AT ITS MAIN
BUSINESS OFFICE AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND
SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING IN THIS PARAGRAPH
SHALL AFFECT OR LIMIT ANY RIGHT TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED
BY LAW.
Executed as of date first above written.
PHC Inc., a Massachusetts corporation
By: _______________________________________
Name of
Authorized Officer: __________________________
Title: ______________________________________
PHC. INC., PROMISSORY NOTE
Page 2
EXHIBIT B to the Subscription Agreement
Section 2.2(a): PHC, Inc. Subsidiaries:
PHC of Utah, Inc. Pioneer Counseling of Virginia, Inc.
D/B/A Highland Ridge Hospital (80% Owned)
4578 Highland Drive D/B/A Pioneer Counseling of Virginia
Salt Lake City, UT 94117 D/B/A Counseling Associates of Virginia
400 East Burwell street
Salem, VA 24153
PHC of Virginia, Inc. PHC of Kansas, Inc.
D/B/A Mount Regis Center D/B/A Total Concept EAP
D/B/A Changes 7451 Szwitzer, Suite 101
405 Kimball Avenue Shawnee Mission, KS 66203
Salem, VA 24153
Quality Care Centers of Mass, Inc. PHC of California, Inc.
D/B/A Franvale Nursing & Rehab Center D/B/A Marin Grove
20 Pond Street 42 Grove Street
Braintree, MA 02194 San Rafael, CA 94901
PHC of Nevada, Inc. Professional Health Associates
D/B/A Harmony Healthcare 94-19 59 Avenue
2340 Paseo del Prado, Bldg.D Elmhum NY 11373
Las Vegas, NV 89102
Northpoint - Pioneer, Inc. STL, Inc.
D/B/A Pioneer Counseling Center 200 Lake Street
31700 W. 13 Mile; Suite 201 Suite 102
Farmington Hills, MI 48334 Peabody, MA 0 1960
BSC-NY, Inc. Harmony Behavioral Health
D/B/A Behavioral Stress Center 2340 Paseo del Prado, Bldg.D
94-19 59 Avenue Las Vegas, NV 89102
Elmhurst, NY 11373
PHC of Michigan, Inc. PHC of Rhode island, Inc.
D/B/A Harbor Oaks Hospital D/B/A Good Hope Center
35031 23 Mile Road P.O. Box 1491
New Baltimore, MI 48047 Coventry, RI 02816-0029
EXHIBIT B (cont'd.)
Section 2.2(f):
The Company failed to file two years' of audited financial statements for
Behavioral Stress Centers, Inc. and Clinical Diagnostics and Clinical
Associates, as described in the December 18, 1996 letter from Choate, Hall &
Stewart to Mr. Robert Bayless of the Securities and Exchange Commission.
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns "Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Twenty Six Thousand Three Hundred Fifteen (26,315) shares of Class A
Common Stock (the "Common Stock") of the Corporation from the Corporation at the
price per share shown below (the "Exercise Price").
Holder: ProFutures Special Equities Fund, L.P.
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporations Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading shall be average of the
closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at he end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant,. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ______________________ _____________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________ __________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Seven Thousand Eight Hundred Ninety (7,890) shares of Class A Common
Stock (the "Common Stock") of the Corporation from the Corporation at the price
per share shown below (the "Exercise Price").
Holder: Gary D. Halbert
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock s at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDA", the average of the daily market prices of such stock on the ten
(10) trading days immediately preceeding the date as of which such value is to
be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restriction s on transfer contained herein, in the names designated by the
Holder at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement hall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
-6-
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ________________________ ________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________________
__________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Five Thousand Two Hundred Sixty (5,260) shares of Class A Common Stock
(the "Common Stock") of the Corporation from the Corporation at the price per
share shown below (the "Exercise Price").
Holder: John F. Mauldin
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. he Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashiers check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted t be given to the Holder shall
be in writing and shall be given by first class mail, postage repaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: _________________________ _____________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: _________________________ ____________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Ten Thousand Five Hundred Twenty Five (10,525) shares of Class A Common
Stock (the "Common Stock") of the Corporation from the Corporation at the price
per share shown below (the "Exercise Price").
Holder: Augustine Fund, L.P.
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDA"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of
1933, as amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ______________________ ________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: _________________________ _________________________________
Signature
- 8 -
Exhibit 10.133
ASSET PURCHASE AGREEMENT
This Asset Purchase Agreement is made and entered into as of the 2nd day of
February, 1998, by and between Lexington Healthcare Group, Inc., a Delaware
corporation having its principal place of business at 35 Park Place, New
Britain, Connecticut 06052 (together with its successors and assigns hereinafter
collectively referred to as the "Buyer"), and Quality Care Centers of
Massachusetts, a Massachusetts corporation having its principal place of
business at 200 Lake Street, Suite 102, Peabody, Massachusetts 01960 (together
with its successors and assigns hereinafter collectively referred to as the
"Seller").
W I T N E S S E T H:
WHEREAS, the Seller owns and leases certain assets in connection with, and
operates the 128-bed licensed skilled nursing care facility known as, Franvale
Nursing and Rehabilitation Center at 20 Pond Street, Braintree, Massachusetts
02184 (the "Facility"); and
WHEREAS, the Buyer desires to acquire from the Seller, and the Seller
desires to sell to the Buyer, certain of the assets of the Seller used in
connection with the operation of the Facility, all upoExhibit 4.28
SUBSCRIPTION AGREEMENT
PHC, INC.
THE SECURITIES WHICH ARE THE SUBJECT OF THIS SUBSCRIPTION AGREEMENT (AS IT MAY
BE AMENDED FROM TIME TO TIME, THE "AGREEMENT") HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR UNDER THE
APPLICABLE SECURITIES LAWS OF ANY STATE AND WILL BE OFFERED AND SOLD IN RELIANCE
ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THESE LAWS BY VIRTUE OF PHC,
INC.'S INTENDED COMPLIANCE WITH SECTIONS 3(b), 4(2) AND 4(6) OF THE SECURITIES
ACT, THE PROVISIONS OF REGULATION D UNDER SUCH ACT AND SIMILAR EXEMPTIONS UNDER
STATE LAW. THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE U.S.
SECURITIES AND EXCHANGE COMMISSION ("SEC"), ANY STATE SECURITIES COMMISSION OR
ANY OTHER REGULATORY AUTHORITY. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.
The undersigned purchaser (hereafter, the "Purchaser") hereby offers to
purchase certain Series B Convertible Preferred Stock (referred to herein as a
"Share" or collectively as "Shares") of PHC, Inc. (the "Company"), a publicly
held corporation formed under the laws of the Commonwealth of Massachusetts.
This offer to purchase may, for any reason whatsoever, be revoked by the
Purchaser or rejected by the Company prior to acceptance of this offer by the
Company.
Section 1.1 Purchase and Sale of Shares. Upon the following terms and
conditions, the Company shall issue and sell to the Purchaser, and the Purchaser
shall purchase from the Company, the number of Shares indicated herein, which
Shares shall have the rights, designations and preferences set forth in Schedule
I hereto.
Section 1.2 Purchase Price. The purchase price for the Shares (the
"Purchase Price") shall be $1,000 per Share.
Section 1.3 The Closing.
(a) The closing of the purchase and sale of the Shares (the "Closing"),
shall take place at the law offices of Arent, Fox, Kintner, Plotkin & Kahn, 1050
Connecticut Avenue, N.W., Washington, D.C. 20036, at 10:00 a.m., local
Washington, D.C. time, on the later of the following: (i) the date on which the
last to be fulfilled or waived of the conditions set forth in Section 4.1 and
4.2 hereof and applicable to the Closing shall be fulfilled or waived in
accordance herewith, or (ii) such other time and place and/or on such other date
as the Purchaser and the Company may agree. The date on which the Closing occurs
is referred to herein as the "Closing Date."
(b) On the Closing Date, the Company shall deliver to the Purchaser (i) a
certificate representing the Shares registered in the name of the Purchaser or
deposit such Shares into accounts designated by the Purchaser and (ii) the
Warrant for the number of shares of the Company's Common Stock indicated herein,
in the form attached hereto as Exhibit A, incorporated herein by reference. The
Purchaser shall on the Closing Date deliver to the Company the Purchase Price
for all the Shares by cashier's check or wire transfer in immediately available
funds to such account as shall be designated in writing by the Company. In
addition, each party shall deliver all documents, instruments and writings
required to be delivered by such party pursuant to this Agreement at or prior to
the Closing.
Section 1.4 Covenant to Register.
(a) For purposes of this Section, the following definitions shall apply:
The terms "register," "registered," and "registration" refer to a
registration under the Securities Act of 1933, as amended (the "Act"), effected
by preparing and filing a registration statement or similar document in
compliance with the Act, and the declaration or ordering of effectiveness of
such registration statement, document or amendment thereto.
(ii) The term "Registrable Securities" means the shares of the Company's
Class A Common Stock, par value $.01 per share (the "Common Stock"), issuable
upon conversion of shares of the Shares and upon exercise of the Warrant, or
upon conversion of any other stock issued in payment of dividends on the Shares
or otherwise issuable pursuant to this Agreement or the provisions of Schedule I
hereto, and any securities of the Company or securities of any successor
corporation issued as, or issuable upon the conversion or exercise of any
warrant right or other security that is issued as a dividend or other
distribution with respect to, or in exchange for, or in replacement of, the
Shares.
(iii) The term "holder of Registrable Securities" means the Purchaser and
any permitted assignee of registration rights pursuant to Section 1.4(h).
(b) (i) The Company shall as soon as possible file a registration statement
on Form SB-2 or Form S-3 covering at least 200% of the number of Registrable
Securities which would then be issuable upon conversion of the Shares at the
conversion price then in effect, and shall use its best efforts to cause such
registration statement to become effective on or before ninety (90) days after
the Closing Date (the "Initial Registration"). In the event such registration is
not so declared effective or does not include all Registrable Securities, a
holder of Registrable Securities shall have the right to require by notice in
writing that the Company register all or any part of the Registrable Securities
held by such holder (a "Demand Registration") and the Company shall thereupon
effect such registration in accordance herewith (which may include adding such
shares to an existing shelf registration). The parties agree that if the holder
of Registrable Securities demands registration of less than all of the
Registrable Securities, the Company, at its option, may nevertheless file a
registration statement covering all of the Registrable Securities. If such
registration statement is declared effective with respect to all Registrable
Securities and the Company is in compliance with its obligations under
Subsection (d) of this Section 1.4, the demand registration rights granted
pursuant to this Subsection (b)(i) shall cease. If such registration statement
is not declared effective with respect to all Registrable Securities or if the
Company is not in compliance with such obligations, the demand registration
rights described herein shall remain in effect.
(ii) The Company shall not be obligated to effect a Demand Registration
under Subsection (b)(i) above: (A) if all of the Registrable Securities held by
the holder of Registrable Securities which are demanded to be covered by the
Demand Registration are, at the time of such demand, included in an effective
registration statement and the Company is in compliance with its obligations
under Subsection (d) of this Section 1.4; (B) if all of the Registrable
Securities may be sold under Rule 144(k) of the Act and the Company's transfer
agent has accepted an instruction from the Company to such effect; or (C) at any
time after two (2) years from the Closing Date.
(iii) Subject to Subsection (iv)(B) hereof, the Company may suspend the
effectiveness of any such registration effected pursuant to this Subsection (b)
in the event and for such period of time as, such a suspension is required by
the rules and regulations of the Securities and Exchange Commission ("SEC"). The
Company will use its best efforts to cause such suspension to terminate at the
earliest possible date.
(iv) (A) If the Company is advised by the SEC that a registration statement
filed hereunder is subject to a "no-review" and such registration statement is
not declared effective within five (5) business days thereafter (an
"Acceleration Date") or, irrespective of the SEC review, a registration
statement is not declared effective by the ninety first (91st) day after the
Closing Date (the "Target Date"), the Company shall pay Purchaser as liquidated
damages an amount equal to two percent (2%) of the total Purchase Price of the
Shares for each thirty (30) day period following the earlier of the Acceleration
Date or Target Date, as applicable, until such time as the registration
statement is declared effective; provided, however, that such damages shall not
be payable if the failure to meet the Acceleration Date or Target Date, as
applicable, is due to action or inaction by Purchaser with respect to providing
information for the registration statement. The payment set forth above shall be
pro-rated daily as to any period of less than thirty (30) days. Such payment
shall be made to the Purchaser either (I) by cashier's check or wire transfer in
immediately available funds to such account as shall be designated in writing by
the Purchaser or (II) in Shares, the number of which shall be equal to the
amount due under this Subsection divided by $1,000 per Share. The foregoing
amount shall be paid irrespective of the amount of Registrable Securities then
held by Purchaser.
(B) If, following effectiveness of a registration, either the effectiveness
of the registration statement is suspended or a current prospectus meeting the
requirements of Section 10 of the Act is not available for delivery by the
Purchaser (either referred to herein as a "suspension"), the Company shall
thereupon pay to Purchaser as liquidated damages an amount equal to two percent
(2%) of the Purchase Price of the Shares for each thirty (30) day period of the
suspension. The payment set forth above shall be pro-rated daily as to periods
of less than thirty (30) days. Such payment shall be made to the Purchaser by
cashiers check or wire transfer in immediately available funds to such account
as shall be designated in writing by the Purchaser, and shall be paid
irrespective of the amount of Registrable Securities held by Purchaser on or
after the date following the suspension.
(C) Any amount payable pursuant to the foregoing provisions of this
Subsection (iv) shall be delivered on or before the fifth (5th) day following
the end of the calendar month in which such payment obligation arose. The
"Purchase Price" of Registrable Securities shall be (1) if derived from
conversion or substitution of Shares, the Purchase Price of the Shares, and (2)
if received in satisfaction of a Company obligation, the dollar amount of such
obligation.
(D) This Subsection is in addition to the provisions of Section 7.2(a)
hereof.
(c) If the Company proposes to register (including for this purpose a
registration effected by the Company for shareholders other than the Purchaser)
any of its stock or other securities under the Act in connection with a public
offering of such securities (other than a registration on Form S-4, Form S-8 or
other limited purpose form) and all Registrable Securities have not theretofore
been included in a registration statement under Subsection (b) of this Section
1.4 which remains effective, the Company shall, at such time, promptly give all
holders of Registrable Securities written notice of such registration. Upon the
written request of any holder of Registrable Securities given within twenty (20)
days after receipt of such notice by the holder of Registrable Securities, the
Company shall use its best efforts to cause to be registered under the Act all
Registrable Securities that such holder of Registrable Securities requests to be
registered. However, the Company shall have no obligation under this Subsection
(c) if (i) the Registrable Securities may be sold without registration under
Rule 144(k) and the Company's transfer agent has accepted an instruction from
the Company to such effect, (ii) the Registration Statement is filed more than
two (2) years after the Closing Date, or (iii) to the extent that, with respect
to any underwritten offering initiated by the Company later than one calendar
year following the Closing, the managing underwriter of such offering reasonably
notifies such holder(s) in writing of its determination that the Registrable
Securities or a portion thereof shall be excluded therefrom.
(d) Whenever required under this Section 1.4 to effect the registration of
any Registrable Securities including, without limitation, the Initial
Registration, the Company shall, as expeditiously as reasonably possible:
(i) Prepare and file with the SEC a registration statement with respect to
such Registrable Securities and use its best efforts to cause such registration
to become effective as provided in Section 1.4(b)(i), and keep such registration
statement effective for so long as any holder of Registrable Securities desires
to dispose of the securities covered by such registration statement; provided,
however, that in no event shall the Company be required to keep the Registration
Statement effective for a period greater than two (2) years from the Closing
Date;
(ii) Respond to comments made by the SEC with respect to a registration
statement filed pursuant to this Agreement within ten (10) business days after
the date of the comment letter, and prepare and file with the SEC such
amendments and supplements to such registration statement and the prospectus
used in connection with such registration statement as may be necessary to
comply with the provisions of the Act with respect to the disposition of all
securities covered by such registration statement and notify the holders of the
filing and effectiveness of such Registration Statement and any amendments or
supplements;
(iii) Furnish to each holder of Registrable Securities such numbers of
copies of a current prospectus, including a preliminary prospectus, conforming
with the requirements of the Act, copies of the registration statement any
amendment or supplement to any thereof and any documents incorporated by
reference therein and such other documents, all free of charge, as such holder
of Registrable Securities may reasonably require in order to facilitate the
disposition of Registrable Securities owned by such holder of Registrable
Securities;
(iv) Use its best efforts to register and qualify the securities covered by
such registration statement under such other securities or "Blue Sky" laws of
such jurisdictions as shall be reasonably requested by the holder of Registrable
Securities;
(v) Notify each holder of Registrable Securities immediately of the
happening of any event as a result of which the prospectus included in such
registration statement, as then in effect, includes an untrue statement of
material fact or omits to state a material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the
circumstances then existing, and use its best efforts to promptly update and/or
correct such prospectus;
(vi) Furnish, at the request of any holder of Registrable Securities in
connection with any underwritten public offering, (A) an opinion of counsel of
the Company, dated the effective date of the registration statement, in form and
substance reasonably satisfactory to the holder and its counsel and covering,
without limitation, such matters as the due authorization and issuance of the
securities being registered and certain matters pertaining to disclosure under
and compliance with securities laws by the Company in connection with the
registration thereof and/or (B) a "comfort" letter or letters of the Company's
independent public accountants provided at the Company's expense in form and
substance reasonably satisfactory to the holder and its counsel;
(vii) Use its best efforts to list the Registrable Securities covered by
such registration statement with any national market or securities exchange on
which such securities are then listed;
(viii) Make available for inspection by the holder of Registrable
Securities, upon request, all SEC Documents (as defined below) filed subsequent
to the Closing and require the Company's officers, directors and employees to
supply all information reasonably requested by any holder of Registrable
Securities in connection with such registration statement: and
(ix) Furnish to each holder of Registrable Securities prompt notice of the
commencement of any stop-order proceedings under the Act, together with copies
of all documents in connection therewith, and use its best efforts to obtain
withdrawal of any such stop order as soon as possible.
(e) Upon request of the Company, each holder of Registrable Securities will
furnish to the Company in connection with any registration under this Section
such information regarding itself, the Registrable Securities and other
securities of the Company held by it, and the intended method of disposition of
such securities as shall be reasonably required to effect the registration of
the Registrable Securities held by such holder of Registrable Securities. The
intended method of disposition (Plan of Distribution) of such securities as so
provided by Purchaser shall be included without alteration in the Registration
Statement covering the Registrable Securities and shall not be changed without
the prior written consent of the Purchaser.
(f) (i) The Company shall indemnify, defend and hold harmless each holder
of Registrable Securities which are included in a registration statement
pursuant to the provisions of Subsections (b) or (c) hereof and each of its
officers, directors, employees, agents, partners or controlling persons (within
the meaning of the Act) (each, an "indemnified party") from and against, and
shall reimburse such indemnified party with respect to, any and all claims,
suits, demands, causes of action, losses, damages, liabilities, costs or
expenses ("Liabilities") to which such indemnified party may become subject
under the Act or otherwise, arising from or relating to (A) any untrue statement
or alleged untrue statement of any material fact contained in such registration
statement, any prospectus contained therein or any amendment or supplement
thereto, or (B) the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances in which they were made, not misleading; provided,
however, that the Company shall not be liable in any such case to the extent
that any such Liability arises out of or is based upon an untrue statement or
omission so made in strict conformity with information furnished by such
indemnified party in writing specifically for use in a registration statement.
(ii) In the event of any registration under the Act of Registrable
Securities pursuant to Subsections (b) or (c), each holder of such Registrable
Securities hereby severally agrees to indemnity, defend and hold harmless the
Company, and its officers, directors, employees, agents, partners, or
controlling persons (within the meaning of the Act) (each, an "indemnified
party") from and against, and shall reimburse such indemnified party with
respect to, any and all Liabilities to which such indemnified party may become
subject under the Act or otherwise, arising from or relating to (A) any untrue
statement or alleged untrue statement of any material fact contained in such
registration statement, any prospectus contained therein or any amendment or
supplement thereto, or (B) the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances in which they were made, not misleading;
provided, that such holders will be liable in any such case to the extent and
only to the extent, that any such Liability arises out of or is based upon an
untrue statement or alleged untrue statement or omission or alleged omission
made in such registration statement, prospectus or amendment or supplement
thereto in reliance upon and in conformity with written information furnished by
such holder specifically for use in the preparation thereof.
(iii) Promptly after receipt by any indemnified party of notice of the
commencement of any action, such indemnified party shall, if a claim in respect
thereof is to be made against another party (the "indemnifying party")
hereunder, notify such party in writing thereof, but the omission so to notify
such party shall not relieve such party from any Liability which it may have to
the indemnified party other than under this Section and shall only relieve it
from any Liability which it may have to the indemnified party under this section
if and to the extent an indemnifying party is materially prejudiced by such
omission. In case any such action shall be brought against any indemnified party
and such indemnified party shall notify an indemnifying party of the
commencement thereof, the indemnifying party shall be entitled to participate in
and, to the extent it shall wish, to assume and undertake the defense thereof
with counsel reasonably satisfactory to such indemnified party, and, after
notice from the indemnifying party to the indemnified party of its election so
to assume and undertake the defense thereof, the indemnifying party shall not be
liable to the indemnified party under this section for any legal expenses
subsequently incurred by the indemnified party in connection with the defense
thereof other than reasonable costs of investigation and of liaison with counsel
so selected; provided however, that if the defendants in any such action include
both parties and the indemnified party shall have reasonably concluded that
there may be reasonable defenses available to them which are different from or
additional to those available to the indemnifying party or if the interests of
the indemnified party reasonably may be deemed to conflict with the interests of
the indemnifying party, the indemnified party shall have the right to select a
separate counsel and to assume such legal defenses and otherwise to participate
in the defense of such action, with the reasonable expenses and fees of one such
separate counsel and other reasonable expenses related to such participation to
be reimbursed by the indemnifying party as incurred.
(g) (i) With respect to the inclusion of Registrable Securities in a
registration statement pursuant to Subsections (b) or (c), all fees, costs and
expenses of and incidental to such registration, inclusion and public offering
shall be borne by the Company, provided, however, that any securityholders
participating in such registration shall bear their pro-rata share of the
underwriting discounts and commissions, if any, incurred by them in connection
with such registration.
(ii) The fees, costs and expenses of registration to be borne by the
Company as provided in this Subsection shall include, without limitation, all
registration, filing and NASD fees, printing expenses, fees and disbursements of
counsel and accountants for the Company, and all legal fees and disbursements
and other expenses of complying with state securities or Blue Sky laws of any
jurisdiction or jurisdictions in which securities to be offered are to be
registered and qualified. Subject to appropriate agreements as to
confidentiality, the Company shall make available to the holders of Registrable
Securities and their counsel its documents and personnel for due diligence
purposes. Except as otherwise provided herein, fees and disbursements of counsel
and accountants for the selling security holders shall be borne by the
respective selling security holders.
(h) The rights to cause the Company to register all or any portion of
Registrable Securities pursuant to this Section 1.4 may be assigned by Purchaser
to a transferee or assignee. Within a reasonable time after such transfer, the
Purchaser shall notify the Company of the name and address of such transferee or
assignee, and the securities with respect to which such registration rights are
being assigned. Such assignment shall be effective only if, immediately
following such transfer, the further disposition of such securities by the
transferee or assignee is restricted under the Act. Any transferee asserting
registration rights hereunder shall be bound by the applicable provisions of
this Agreement.
(i) The Company shall not agree to allow the holders of any securities of
the Company to include any of their securities in any registration statement
filed by the Company pursuant to Subsection (b) unless such inclusion will not
reduce the amount of the Registrable Securities included therein.
Section 1.5 Company Standoff, Except in a corporate reorganization,
business combination, stock or asset purchase, merger or consolidation, under
existing employee stock incentive or purchase plans or pursuant to this
Agreement, the Company shall not for its own account effect any public sale or
distribution of any securities similar to the Registrable Securities or any
securities exercisable for or convertible or changeable into the Registrable
Securities during the thirty (30) days prior to, and during the sixty (60) days
immediately following, the effective date of any registration statement filed or
amended pursuant to Section 1.4(b); provided, however, that the Company may
effect such public sale or distribution during the sixty (60) days immediately
following the effective date of such registration statement if such sale or
distribution of securities is at a price equal to or greater than 125% of the
last trade price of the Company's Common Stock on the day of Closing.
Section 2.1 Representations and Warranties of the Purchaser. The Purchaser
makes the following representations and warranties to the Company.
(a) Accredited Investor. The Purchaser is an "accredited investor", as such
term is defined in Rule 50 1 (a) of Regulation D, promulgated under the Act.
(b) Speculative Investment. The Purchaser is aware that an investment in
the Shares is highly speculative and subject to substantial risks. The Purchaser
is capable of bearing the high degree of economic risk and the burden of this
venture, including, but not limited to, the possibility of complete loss of the
Purchaser's investment in the Shares and underlying Common Stock which make
liquidation of this investment impossible for the indefinite future.
(c) Disposition. The Purchaser understands that (i) except as provided for
in Section 1.4, the Shares and underlying Common Stock of the Company (the
"Securities"), have not been and are not being registered under the Securities
Act or any applicable state securities laws, and may not be transferred unless
(A) subsequently registered thereunder, or (B) the Securities may be sold or
transferred pursuant to an exemption from securities registration under the
Securities Act and any applicable state securities laws or (C) sold pursuant to
Rule 144, promulgated under the Securities Act (or any successor Rule), or (ii)
any sale of such Securities made in reliance on Rule 144 may be made only in
accordance with the terms of such Rule and further, if such Rule is not
applicable, any resale of such Securities under circumstances in which the
seller (or the person through whom the sale is made) may be deemed to be an
underwriter (as that term is defined in the Securities Act) may require
compliance with another exemption under the Securities Act or the rules of the
SEC thereunder. Notwithstanding any provision to the contrary contained herein,
a holder may pledge such Securities as collateral for a revolving credit note
pursuant to a loan and security agreement with a lending institution.
(d) Privately Offered. The offer to acquire the Shares was directly
communicated to the Purchaser in such manner that the Purchaser was able to ask
questions of and receive answers concerning the terms and conditions of this
transaction. At no time was the Purchaser presented with or solicited by or
through any leaflet, public promotional meeting, television advertisement, or
any other form of general advertising.
(e) Purchase for Investment, The Securities are being acquired solely for
the Purchaser's own account, for investment, and are not being purchased with
view to the resale, distribution, subdivision or fractionalization thereof
without proper registration with applicable securities administrators.
Section 2.2 Representations and Warranties of the Company. The Company
hereby makes the following representations and warranties to the Purchaser:
(a) Organizations and Qualifications. The Company is a corporation duly
incorporated and existing in good standing under the laws of the Commonwealth of
Massachusetts and has the requisite corporate power to own its properties and to
carry on its business as now being conducted. The Company does not have any
subsidiaries except as listed in Exhibit B, attached hereto and incorporated
herein by reference. The Company and each such subsidiary, if any, is duly
qualified as a foreign corporation to do business and is in good standing in
every jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary other than those in which the
failure so to qualify would not have a Material Adverse Effect. "Material
Adverse Effect", for purposes of this Agreement, means any adverse effect on the
business operations, properties, prospects, or financial condition of the entity
with respect to which such term is used and which is material to such entity and
other entities controlled by such entity taken as a whole.
(b) Authorizations Enforcement. (i) The Company has the requisite corporate
power and authority to enter into and perform this Agreement and to issue the
Shares and Registrable Securities in accordance with the terms hereof, (ii) the
execution and delivery of this Agreement by the Company and the consummation by
it of the transactions contemplated hereby have been duly authorized by all
necessary corporate action, and no further consent or authorization of the
Company or its Board of Directors or stockholders is required, (iii) this
Agreement has been duly executed and delivered by the Company, (iv) this
Agreement constitutes a valid and binding obligation of the Company enforceable
against the Company in accordance with its terms (except as such enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally the enforcement
of, creditor' rights and remedies or by other equitable principles of general
application) and (v) prior to the Closing Date, any necessary Certificate of
Amendment to the Company's Charter authorizing Company to issue all of the
Shares and Registerable Securities, in accordance with Schedule 1, will have
been filed with the Massachusetts Secretary of State and will be in full force
and effect enforceable against the Company in accordance with the terms of such
amended Charter.
(c) Authorized Capital Rights or Commitments to Stock. The authorized
capital stock of the Company consists of 22,200,000 shares of Common Stock and
1,000,000 shares of Series B Preferred Stock; there are 4,704,956 shares of
Common Stock issued and 730,292 shares of Class B Common Stock outstanding;
there are no shares of such Preferred Stock issued and outstanding; and, upon
issuance of the Shares in accordance with the terms hereof, there will be
4,704,956 shares of Class B Common Stock and 950 shares of such Preferred Stock
issued and outstanding.
All of the outstanding shares of the Company's Common Stock have been
validly issued and are fully paid and nonassessable. Except as set forth in
Exhibit B hereto or as described in the SEC Documents, no shares of Common
Stock are entitled to preemptive rights or registration rights and there are
no outstanding options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company, or contracts,
commitments, understandings, or arrangements by which the Company is or may
become bound to issue additional shares of capital stock of the Company or
options, warrants, scrip, rights to subscribe to, or commitments to purchase
or acquire, any shares. or securities or rights convertible into shares, of
capital stock of the Company. The Company has furnished or made available to
the Purchaser true and correct copies of the Company's Articles of
Organization as in effect on the date hereof (the "Charter"), and the
Company's By-Laws, as in effect on the date hereof (the "By-Laws").
(d) Issuance of Shares. The issuance of the Shares has been duly authorized
and, when paid for and issued in accordance with the terms hereof, the shall be
validly issued, fully paid and non-assessable and entitled to the rights and
preferences set forth in Schedule I hereto. The Common Stock issuable upon
conversion of the Shares will be duly authorized and reserved for issuance and,
upon conversion, will be validly issued, fully paid and non-assessable and the
holders shall be entitled to all rights and preferences accorded to a holder of
Common Stock.
(e) No Conflicts. The execution, delivery and performance of this Agreement
by the Company and the consummation by the Company of the transactions
contemplated hereby do not and will not (i) result in a violation of the
Company's Charter or By-Laws or (ii) conflict with, or constitute a default (or
an event which with notice or lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Company or
any of its subsidiaries is a party, or result in a violation of any federal,
state, local or foreign law, rule, regulation, order, judgment or decree
(including Federal and state securities laws and regulations) applicable to the
Company or any of its subsidiaries or by which any property or assets of the
Company or any of its subsidiaries is bound or affected (except for such
conflicts, defaults, terminations, amendments, accelerations, cancellations and
violations as would not, individually or in the aggregate, have a Material
Adverse Effect); provided that, for purposes of such representation as to
Federal, state, local or foreign law, rule or regulation, no representation is
made herein with respect to any of the same applicable solely to the Purchaser
and not to the Company. The business of the Company is not being conducted in
violation of any law, ordinance or regulations of any governmental entity,
except for violations which either singly or in the aggregate do not and will
not have a Material Adverse Effect. The Company is not required under Federal,
state or local law, rule or regulation in the United States to obtain any
consent, authorization or order of, or make any filing (other than any filing of
a vote establishing a class or series of stock with the Massachusetts Secretary
of State) or registration with, any court or governmental agency in order for it
to execute, deliver or perform any of its obligations under this Agreement or
issue and sell the Shares in accordance with the terms hereof (other than any
SEC, NASD or state securities filings which may be required to be made by the
Company subsequent to the Closing, and any registration statement which may be
filed pursuant hereto); provided that, for purposes of the representation made
in this sentence, the Company is assuming and relying upon the accuracy of the
relevant representations and agreements of the Purchaser herein.
(f) SEC Documents, Financial Statements. The Common Stock of the Company is
registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as
amended (the "Exchange Act") and, except as set forth in Exhibit B, the Company
has filed on a timely basis all reports, schedules, forms, statements and other
documents required to be filed by it with the SEC pursuant to the reporting
requirements of the Exchange Act, including material filed pursuant to Section
13(a) or 15(d), in addition to one or more registration statements and
amendments thereto heretofore filed by the Company with the SEC under the Act
(all of the foregoing including filings incorporated by reference therein being
referred to herein as the "SEC Documents"). The Company directly or through its
agent has delivered to the Purchaser true and complete copies of the SEC
Documents except for the exhibits and incorporated documents. The Company has
not provided to the Purchaser any information which, according to applicable
law, rule or regulation, should have been disclosed publicly by the Company but
which has not been so disclosed, other than with respect to the transactions
contemplated by this Agreement.
Except as set forth in Exhibit B, as of their respective dates the SEC
Documents complied in all material respects with the requirements of the Act or
the Exchange Act as the case may be and the rules and regulations of the SEC
promulgated thereunder and other federal, state and local laws, rules and
regulations applicable to such SEC Documents, and none of the SEC Documents
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading. Except as set forth in Exhibit B, the financial statements of the
Company included in the SEC Documents comply as to form in all material respects
with applicable accounting requirements and the published rules and regulations
of the SEC or other applicable rules and regulations with respect thereto. Such
financial statements have been prepared in accordance with generally accepted
accounting principles applied on a consistent basis during the periods involved
(except (i) as may be otherwise indicated in such financial statements or the
notes thereto or (ii) in the case of unaudited interim statements, to the extent
they may not include footnotes or may be condensed or summary statements) and
fairly present in all material respects the financial position of the Company as
of the dates thereof and the results of operations and cash flows for the
periods then ended (subject, in the case of unaudited statements, to normal
year-end audit adjustments).
(g) No Material Adverse Change. Since the date through which the most
recent quarterly report of the Company on Form 10-Q has been prepared and filed
with the SEC, a copy of which is included in the SEC Documents, no Material
Adverse Effect has occurred or exists with respect to the Company or any of its
subsidiaries.
(h) No Undisclosed Liabilities. The Company and its subsidiaries have no
material liabilities or obligations not disclosed in the SEC Documents, other
than those incurred in the ordinary course of the Company's or any of its
subsidiaries' respective businesses since the date of the most recently filed
SEC Documents which, individually or in the aggregate, do not or would not have
a Material Adverse Effect on the Company or any of its subsidiaries.
(i) No Undisclosed Events or Circumstances. No event or circumstance has
occurred or exists with respect to the Company or any of its subsidiaries or
their respective businesses, properties, prospects, operations or financial
condition which, under applicable law, rule or regulation, requires public
disclosure or announcement by the Company but which has not been so publicly
announced or disclosed.
(j) No General Solicitation. Neither the Company, nor any of its
affiliates, or, to the best of its knowledge, any person acting on its or their
behalf, has engaged in any form of general solicitation or general advertising
(within the meaning of Regulation D under the Act) in connection with the offer
or sale of the Shares.
(k) No Integrated Offering. Neither the Company, nor any of its affiliates,
nor any person acting on its or their behalf has, directly or indirectly, made
any offers or sales of any security or solicited any offers to buy any security,
under circumstances that would require registration of the Shares under the Act.
Section 3.1 Securities Compliance. The Company shall notify the SEC and
NASD, in accordance with their requirements, of the transactions contemplated by
this Agreement, and shall take all other necessary action and proceedings as may
be required and permitted by applicable law, rule and regulation, for the legal
and valid issuance of the Shares, and the Common Stock issuable upon conversion
thereof, to the Purchaser.
Section 3.2 Registration and Listing. Until. at least two (2) years after
all Shares have been converted into Registrable Securities, the Company will
cause its Common Stock to continue to be registered under Sections 12(b) or
12(g) of the Exchange Act, will comply in all respects with its reporting and
filing obligations under such Exchange Act, will comply with all requirements
related to any registration statement filed pursuant to this Agreement and will
not take any action or file any document (whether or not permitted by the Act or
the Exchange Act or the rules thereunder) to terminate or suspend such
registration or to terminate or suspend its reporting and filing obligations
under said Acts, except as permitted herein. Until at least two (2) years after
all Shares have been converted into Common Stock the Company will take all
action within its power to continue the listing or trading of its Common Stock
on the NASDAQ Small Cap Market and will comply in all respects with the
Company's reporting, filing and other obligations under the bylaws or rules of
the NASD and NASDAQ. The covenants set forth in this Section 3.2 shall not be
deemed to prohibit a merger, sale of all assets or other corporate
reorganization if the entity surviving or succeeding to the Company is bound by
this Agreement with respect to its securities issued in exchange for or in
replacement of the Shares or Common Stock or the consideration received for or
in replacement of the Shares or Common Stock is cash.
Section 3.3 Right of First Refusal and Most-Favored-Nation Clause. If at
any time during the period beginning on the fifth (5th) day prior to (but not
including) the Closing Date and ending sixty (60) days immediately following the
effective date of the Initial Registration, the Company proposes to issue Common
Stock or securities convertible into or exercisable for Common Stock or other
convertible securities, pursuant to an offering exempt from registration under
the Act, the Company shall provide to Purchaser reasonable advance notice of all
the terms of such proposed issuance. The Purchaser shall have the right to
purchase or refuse to purchase all or any part of such securities proposed to be
issued in such offering, and shall have at least seventy two (72) hours after
receipt of such notice to review the terms of the proposed issuance.
If the Company issues Common Stock or securities convertible into or
exercisable for Common Stock or other convertible securities, at a time when any
of the Shares remain outstanding, at an effective price per share of Common
Stock which is lower than the conversion price of the Shares at that time, then
the Company shall, within five (5) business days, deliver to each holder upon
conversion an additional number of shares of Common Stock necessary to reduce
the effective conversion price to such lower issue price. This Section shall not
be applicable to issuances of Common Stock pursuant to (a) any business
combination, acquisition transaction, stock or asset purchase undertaken by the
Company or (b) any shareholder-approved option plan covering not more than 10%
of the Company's outstanding stock.
Section 4.1 Conditions Precedent to the Obligation of the Company to Sell
the Shares. The obligation hereunder of the Company to issue and/or sell the
Shares to the Purchaser is subject to the satisfaction, at or before the
Closing, of each of the conditions set forth below. These conditions may be
waived by the Company at any time in its sole discretion.
(a) Accuracy of the Purchaser's Representations and Warranting. The
representations and warranties of the Purchaser shall be true and correct in all
material respects as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
particular date).
(b) Performance by the Purchaser. The Purchaser shall have performed all
agreements and satisfied all conditions required to be performed or satisfied by
the Purchaser at or prior to the Closing.
(c) No Injunction. No statute, rule, regulation. executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits
the consummation of any of the transactions contemplated by this Agreement.
(d) Legal action. No legal action, suit or proceeding shall be pending or
threatened which seeks to restrain or prohibit the transactions contemplated by
this Agreement.
(e) Execution. The Purchaser shall have executed this Agreement, and
delivered such Agreement to the Company.
(f) Purchase Price. The Purchaser shall have delivered the Purchase Price
in accordance with Section 1.3(b) above.
Section 4.2 Conditions Precedent to the Obligation of the Purchaser to
Purchase the Shares. The obligation hereunder of the Purchaser to acquire and
pay for the Shares is subject to the satisfaction, at or before the Closing, of
each of the conditions set forth below. These conditions may be waived by the
Purchaser at any time in its sole discretion.
(a) Accuracy of the Company's Representations and Warranties. The
representations and warranties of the Company shall be true and correct in all
material respects as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
particular date).
(b) Performance by the Company. The Company shall have performed all
agreements and satisfied all conditions required to be performed or satisfied by
the Company at or prior to the Closing.
(c) NASDAO. From the date hereof to the Closing Date, trading in the
Company's Common Stock shall not have been suspended by the SEC or the NASDAQ
Small Cap Market (except for any suspension of trading of limited duration
agreed to between the Company and the NASDAQ Small Cap Market solely to permit
dissemination of material information regarding the Company), and trading in
securities generally as reported by NASDAQ shall not have been suspended or
limited or minimum prices shall not have been established on
securities whose trades are reported by NASDAQ.
(d) No Injunction. No statute, rule, regulation, executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits
the consummation of any of the transactions contemplated by this Agreement.
(e) Opinion of Counsel Etc. The Purchaser shall have received before or at
the Closing an opinion of counsel to the Company (covering, without limitation,
such of the matters set forth in Section 2.2(a) through (e)), as are in form and
substance reasonably satisfactory to the Purchaser and its counsel, and such
other certificates and documents as the Purchaser or its counsel shall
reasonably require incident to the Closing.
(f) Execution. The Company shall have executed this Agreement, and
delivered such Agreement to the Purchaser.
Section 5.1 Legend on Stock. Each certificate representing the Shares and,
if necessary, Common Stock issued upon conversion thereof, shall be stamped or
otherwise imprinted with a legend substantially in the following form:
THESE SECURITIES [AND THE SHARES OF COMMON STOCK ISSUABLE UPON THE CONVERSION
HEREOF] HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD OR OFFERED FOR SALE UNLESS
THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND ANY APPLICABLE
STATE SECURITIES LAW OR, IN THE OPINION OF COUNSEL, REGISTRATION UNDER SUCH ACT
OR APPLICABLE STATE SECURITIES LAW IS NOT REQUIRED IN CONNECTION WITH SUCH SALE
OR OFFER, AND SUCH OPINION IS REASONABLY SATISFACTORY TO THE COMPANY.
The Company agrees to reissue certificates representing the Shares or, if
applicable, the Common Stock issued upon conversion thereof, without the legend
set forth above at such time as (a) the holder thereof is permitted to dispose
of such Shares (or securities issued upon conversion thereof) pursuant to Rule
144(k) under the Act, (b) the securities are sold to a purchaser or purchasers
who (in the opinion of counsel to such holders, in form and substance reasonably
satisfactory to the Company and its counsel) are able to dispose of such
securities publicly without registration under the Act, or (iii) such securities
are registered under the Act
Section 6.1 Termination by Mutual Consent. This Agreement may be terminated
at any time prior to the Closing by the mutual written consent of the Company,
and the Purchaser.
Section 6.2 Other Termination. This Agreement may be terminated by action
of the Board of Directors or other governing body of the Purchaser or the
Company at any time if the Closing shall not have been consummated by the fifth
(5th) business day following the date of this Agreement, provided that the party
seeking to terminate the Agreement is not in breach of the Agreement.
Section 6.3 Automatic Termination. This Agreement shall automatically
terminate without any further action of either party hereto if the Closing shall
not have occurred by the seventh (7th) business day following the date of this
Agreement, provided, however, that any such termination shall not terminate the
liability of any party which is then in breach of the Agreement.
Section 7.1 Fees and Expenses. Except as otherwise set forth in Section 1.4
hereof with respect to the registration of Registrable Securities, the Company
shall pay the fees, commissions and expenses of its advisers, brokers, finders,
counsel, accountants and other experts, if any, and all other expenses
associated therewith, and shall on the Closing Date reimburse ProFutures Special
Equities Fund, L.P. up to $5,000 for fees and expenses of its counsel in
connection with the preparation, negotiation and coordination of this Agreement.
The Company shall pay all stamp and other taxes and duties levied in connection
with the issuance of the Shares and Common Stock pursuant hereto.
Section 7.2 Specific Enforcement, Consent to Jurisdiction.
(a) The Company and the Purchaser acknowledge and agree that irreparable
damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that the parties shall be entitled to an
injunction or injunctions to prevent or cure breaches of the provisions of this
Agreement and to enforce specifically the terms and provisions hereof, this
being in addition to any other remedy to which either of them may be entitled by
law or equity.
(b) The Company and the Purchaser each (i) hereby irrevocably submits to
the jurisdiction of the United States District Court and other courts of the
United States sitting in the State of Texas for the purposes of any suit, action
or proceeding arising out of or relating to this Agreement and (ii) hereby
waives, and agrees not to assert in any such suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of such court, that
the suit, action or proceeding is brought in an inconvenient forum or that the
venue of the suit, action or proceeding is improper. The Company and the
Purchaser each consents to process being served in any such suit, action or
proceeding by mailing a copy thereof to such party at the address in effect for
notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing in this
paragraph shall affect or limit any right to serve process in any other manner
permitted by law.
Section 7.3 Entire Agreement: Amendment. This Agreement contains the entire
understanding of the parties with respect to the matters covered hereby and,
except as specifically set forth herein, neither the Company nor the Purchaser
makes any representation, warranty, covenant or undertaking with respect to such
matters. No provision of this Agreement may be waived or amended other than by a
written instrument signed by the party against whom enforcement of any such
amendment or waiver is sought.
Section 7.4 Notices. Any notice or other communication required or
permitted to be given hereunder shall be in writing and shall be effective (a)
upon hand delivery or delivery by telex (with correct answer back received),
telecopy or facsimile at the address or number designated below (if delivered on
a business day during normal business hours where such notice is to be
received), or the first business day following such delivery (if delivered other
than on a business day during normal business hours where such notice is to be
received) or (b) on the second (2nd) business day following the date of mailing
by express courier service, fully prepaid, addressed to such address, or upon
actual receipt of such mailing, whichever shall first occur.
The addresses for such communications shall be:
to the Company: Bruce A. Shear, President and Chief Executive Officer
PHC, Inc.
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
to the Purchaser: At the address set forth at the foot of this Agreement or
as specified in writing by Purchaser.
Any party hereto may from time to time change its address for notices by giving
at least ten (10) days' written notice of such changed address to the other
party hereto.
Section 7.5 Waivers. No waiver by either party of any default with respect
to any provision, condition or requirement of this Agreement shall be deemed to
be a continuing waiver in the future or a waiver of any other provision,
condition or requirement hereof, nor shall any delay or omission of either party
to exercise any right hereunder in any manner impair the exercise of any such
right accruing to it thereafter.
Section 7.6 Headings. The headings herein are for convenience only, do not
constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.
Section 7.7 Governing Law. This Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the present state
of incorporation of the Company without regard to such state's principles of
conflict of laws.
Section 7.8 Survival. The representations and warranties of the Company and
the Purchaser contained in herein and the agreements and covenants set forth in
Sections 1.1 through 1.5, 3.1 through 3.3 and 7.1 through 7.16 shall survive the
Closing for a period of two (2) years.
Section 7.9 Publicity. The Company agrees that it will not disclose, and
will not include in any public announcement, the name of the Purchaser without
its consent, unless and until such disclosure is required by law or applicable
regulation, and then only to the extent of such requirement.
Section 7.10 NASDAO. The term "NASDAQ" or "NASDAQ Small Cap Market" herein
refers to the principal market on which the Common Stock of the Company is
traded. If the Common Stock is listed on a securities exchange. or if another
market becomes the principal market on which the Common Stock is traded or
through which price quotations for the Common Stock are reported, the term
"NASDAQ" or "NASDAQ Small Cap Market" shall be deemed to refer to such exchange
or other principal market.
Section 7.11 Acceptance. Execution and delivery of this Agreement shall
constitute an offer to purchase the Shares, which offer, unless previously
revoked by the Purchaser, may be accepted or rejected by the Company, in its
sole discretion for any cause or for no cause and without liability to the
Purchaser. The Company shall indicate acceptance of this Agreement by signing as
indicated on the signature page hereof.
Section 7.12 Binding Agreement. Upon acceptance of this Agreement by the
Company, the Purchaser agrees that he may not cancel, terminate or revoke any
agreement of the Purchaser made hereunder, and that this Agreement shall survive
the death or disability of the Purchaser and shall be binding upon heirs,
successors, assigns, executors, administrators, guardians, conservators or
personal representatives of the Purchaser.
Section 7.13 Incorporation by Reference. All information set forth on the
signature page is incorporated as integral terms of this Agreement.
Section 7.14 Counterparts. This Agreement may be signed in multiple
counterparts, which counterparts shall constitute one and the same original
instrument.
Section 7.15 Severability. If any portion of this Agreement shall be held
illegal, unenforceable, void or voidable by any court each of the remaining
terms hereof shall nevertheless remain in full force and effect as a separate
contract.
Section 7.16 Successors and Assigns. This Agreement shall be binding upon
and inure to the benefit of the parties hereto and their respective successors
and permitted assigns.
[This space has been left blank intentionally. The signature page follows.]
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$500,000 (500 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
26,315 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
ProFutures Special Equities Fund, L.P.
Address of Purchaser: % ProFutures Fund Management, Inc.
1030 Highway 620 South - Suite 200
Austin, TX 78734
Social Security or IRS Employer Identification Number(s):
74-2786952
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
______________________________________________
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: ProFutures Special Equities Fund, L.P.
By ProFutures Fund Management, Inc., a General Partner
By: ______________________________________
(Signature)
Name: /s/ Gary D. Halbert
Title: President
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$150,000 (150 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
7,890 shares
The exact name(s)(Including correct,legible spelling) and the information under
which title to the Shares will be taken is as follows (Please print or type):
Gary D. Halbert
Address of Purchaser: 1030 Highway 620 South - Suite 200
Austin, TX 78734
Social Security or IRS Employer Identification Number(s):
451-96-0684
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
/s/ Gary D. Halbert
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: _______________________________________
By: ______________________________________
(Signature)
Name: ____________________________________________
Title: ____________________________________________
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$100,000 (100 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
5,260 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
John F. Mauldin
Address of Purchaser: 1000 Ballpark in Arlington - Suite 216
Arlington, TX 76011
Social Security or IRS Employer Identification Number(s):
459-84-6606
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
/s/ John F. Mauldin
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: ________________________________
By: ______________________________________
(Signature)
Name: _________________________________
Title: _________________________________
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$200,000 (200 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
10,525 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
Augustine Fund, L.P.
Address of Purchaser: 141 West Jackson Boulevard - Suite 2182
Chicago, IL 60604
Social Security or IRS Employer Identification Number(s):
36-418-6782
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
______________________________________________
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: Augustine Fund, L.P.
By Augustine Capital Management, Inc., the General Partner
By: ______________________________________
(Signature)
Name: /s/ Thomas Duszynski
Title: Chief Operating Officer
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
SCHEDULE I
PHC, INC.
RESOLUTIONS ESTABLISHING RIGHTS AND PREFERENCES
FOR SERIES B CONVERTIBLE PREFERRED STOCK
RESOLVED, that there shall be a series of shares of the Corporation
designated "Series B Convertible Preferred Stock"; that the number of shares of
such series shall be 1,000, that the Corporation issue such shares, and that the
rights and preferences of such series (the "6% Preferred") and the limitations
or restrictions thereon, shall be as set forth herein.
The following terms and conditions shall be adopted and incorporated by
reference into the foregoing resolutions as if fully set forth therein:
1. Dividends.
(a) The holders of the 6% Preferred shall be entitled to receive out of any
assets legally available therefor cumulative dividends at the rate of $60 per
share per annum, accrued daily and payable quarterly in arrears on March 31,
June 30, September 30 and December 31 of each year, in preference and priority
to any payment of any dividend on the Common Stock or any other class or series
of stock of the Corporation. Such dividends shall accrue on any given share from
the day of original issuance of such share and shall accrue from day to day
whether or not earned or declared. If at any time dividends on the outstanding
6% Preferred at the rate set forth above shall not have been paid or declared
and set apart for payment with respect to all preceding periods, the amount of
the deficiency shall be fully paid or declared and set apart for payment, but
without interest, before any distribution, whether by way of dividend or
otherwise, shall be declared or paid upon or set apart for the shares of any
other class or series of stock of the Corporation.
(b) Any dividend payable on a dividend payment date may be paid, at the
option of the Corporation, either (i) in cash or (ii) in shares of 6% Preferred
valued at $1,000 per share, if the Common Stock issuable upon conversion of such
shares has been registered for resale under the Securities Act of 1933, as
amended (the "Act"), and the registration statement including a current
prospectus with respect thereto remains in effect at the date of delivery of
such shares, and if the Corporation shall have given written notice of its
intention to pay such dividend in stock to all holders of the 6% Preferred at
least ten (10) days before the record date for such dividend.
2. Liquidation Preference, Redemption.
(a) In the event of any liquidation, dissolution or winding up of the
Corporation, either voluntary or involuntary, the holders of the 6% Preferred
shall be entitled to receive, prior and in preference to any distribution of any
assets of the Corporation to the holders of any other class or series of shares,
the amount of $1,000 per share plus any accrued but unpaid dividends (the
"Liquidation Preference").
(b) A consolidation or merger of the Corporation with or into any other
corporation or corporations, or a sale of all or substantially all of the assets
of the Corporation (other than a sale or transfer to a wholly-owned subsidiary
of the Corporation), shall, at the option of the holders of the 6% Preferred, be
deemed a liquidation, dissolution or winding up within the meaning of this
Section 2 if the shares of stock of the Corporation outstanding immediately
prior to such transaction represent immediately after such transaction less than
a majority of the voting power of the surviving corporation (or of the acquirer
of the Corporation's assets in the case of a sale of assets). Such option may be
exercised by the vote or written consent of holders of a majority of the 6%
Preferred at any time within thirty (30) days after written notice (which shall
be given promptly) of the essential terms of such transaction shall have been
given to the holders of the 6% Preferred in the manner provided by law for the
giving of notice of meetings of shareholders.
- 1 -
(c) The Corporation may, at its option, cause all outstanding shares of the
6% Preferred to be redeemed after the date on which a registration statement
under the Act ("Registration Statement") has been declared effective (the
"effective date"); provided the Corporation has given notice of its intention to
redeem to the holders of the 6% Preferred at least five (5) days prior to the
redemption date. In addition, if any conversion of 6% Preferred, when aggregated
with all prior conversions, will cause the Company to issue a number of shares
of Common Stock which exceeds twenty percent (20%) of the shares of Common Stock
then issued and outstanding, the Company shall redeem such number of shares of
6% Preferred as is necessary to limit such issuance of Common Stock to twenty
percent (20%) of the shares of Common Stock then issued and outstanding, unless
the Company has previously obtained stockholder approval to issue in excess of
twenty percent (20%) of the shares of Common Stock then issued and outstanding.
If a redemption will occur under either of the preceding sentences, on the
redemption date, the Corporation shall pay such holders by cashiers check or
wire transfer in immediately available funds the amount of $1,300 per share of
6% Preferred plus all accrued but unpaid dividends. Promptly thereafter, the
holders shall surrender the certificate or certificates representing the 6%
Preferred, duly endorsed, at the office of the Corporation or of any transfer
agent for such shares, or at such other place designated by the Corporation.
3. 6% Preferred - Forced Conversion.
(a) The Corporation may, at its option, cause all outstanding shares of the
6% Preferred to be converted into Common Stock at any time beginning one (1)
year after the date of issuance, on at least twenty (20) days' advance notice,
at a conversion price determined as set forth in Section 4 hereof (the
"Conversion Price") as of the date specified in such notice (the "Conversion
Date") and otherwise on the terms set forth in Section 4 hereof, provided, that
the Corporation may not exercise such right of conversion unless (i) the Closing
Price (last trade price) of the Common Stock as reported by NASDAQ for the
twenty (20) consecutive trading days prior to the date the Conversion Notice is
mailed has not on any day been less than one hundred forty percent (140%) of the
last trade price of the Company's Common Stock on the day of Closing (subject to
adjustment for stock dividends, stock splits and reverse stock splits), and (ii)
the shares issuable upon conversion of the 6% Preferred are registered for
resale by an effective Registration Statement which became effective not more
than one hundred twenty (120) days after the date of issuance of the 6%
Preferred, and a current prospectus meeting the requirements of Section 10 of
the Act is available for delivery at the Conversion Date.
(b) At least twenty (20) days prior to the Conversion Date, written notice
(the "Conversion Notice") shall be mailed, first class postage prepaid, by the
Corporation to each holder of record of the 6% Preferred, at the address last
shown on the records of the Corporation for such holder, notifying such holder
of the conversion which is to be effected, specifying the Conversion Date and
calling upon each such holder to surrender to the Corporation, in the manner and
at the place designated, a certificate or certificates representing the number
of shares of 6% Preferred held by such holder. Subject to the provisions of the
following subsection (c), on or after the Conversion Date, each holder of 6%
Preferred shall surrender to the Corporation the certificate or certificates
representing the shares of 6% Preferred owned by such holder as of the
Conversion Date, in the manner and at the place designated in the Conversion
Notice, and thereupon the shares issuable upon such conversion shall be
delivered as provided in Section 4(b) hereof.
(c) If, on the Conversion Date, the registration condition specified in
clause (ii) of subsection (a) shall not be satisfied, then no shares shall be
converted and the Conversion Notice shall be deemed to be withdrawn. In such
event, any certificates for 6% Preferred which have been surrendered for
conversion shall be returned to the persons surrendering the same; provided,
however, that if a holder has received shares of Common Stock upon conversion of
6% Preferred after the Conversion Notice was given but before the Conversion
Date, such holder may elect either to retain such Common Stock or rescind such
conversion by tendering such shares of Common Stock to the Corporation.
(d) On the second anniversary of the issuance of the 6% Preferred, all then
outstanding shares of 6% Preferred shall be automatically converted into Common
Stock at the Conversion Price and otherwise pursuant to the applicable
provisions set forth in Section 4 hereof.
- 2 -
4. 6% Preferred - Optional Conversion. The holders of the 6% Preferred
shall have optional conversion rights as follows:
(a) Right to Convert. At any time after the earlier of (i) the date on
which a Registration Statement has been declared effective, or (ii) the close of
business on the ninety first (91st) day following the date of issuance of the 6%
Preferred, shares of 6% Preferred shall become convertible, at the option of the
holder thereof, into such number of fully paid and nonassessable shares of
Common Stock as is determined by dividing (A) the Liquidation Preference of the
6% Preferred determined pursuant to Section 2 hereof on the date the notice of
conversion is given, by (B) the Conversion Price determined as hereinafter
provided in effect on the applicable conversion date.
(b) Mechanics of Conversion. To convert shares of 6% Preferred into shares
of Common Stock, the holder shall give written notice to the Corporation (which
notice may be given by facsimile transmission) that such holder elects to
convert the shares and shall state therein date of the conversion, the number of
shares to be converted and the name or names in which such holder wishes the
certificate or certificates for shares of Common Stock to be issued. Promptly
thereafter, the holder shall surrender the certificate or certificates
representing the shares to be converted, duly endorsed, at the office of the
Corporation or of any transfer agent for such shares, or at such other place
designated by the Corporation; provided that the holder shall not be required to
deliver the certificates representing such shares if the holder is waiting to
receive all or part of such certificates from the Corporation. The Corporation
shall, immediately upon receipt of such notice, issue and deliver to or upon the
order of such holder, against delivery of the certificates representing the
shares which have been converted, a certificate or certificates for the number
of shares of Common Stock to which such holder shall be entitled and such
certificate or certificates shall not bear any restrictive legend; provided (A)
the Common Stock evidenced thereby are sold pursuant to an effective
registration statement under the Act, (B) the holder provides the Corporation
with an opinion of counsel reasonably acceptable to the Corporation to the
effect that a public sale of such shares may be made without registration under
the Act, or (C) such holder provides the Corporation with reasonable assurance
that such shares can be sold free of any limitations imposed by Rule 144,
promulgated under the Act. The Corporation shall cause such issuance and
delivery to be effected within three (3) business days and shall transmit the
certificates by messenger or overnight delivery service to reach the address
designated by such holder within three (3) business days after the receipt of
such notice. The notice of conversion may be given by a holder at any time
during the day up to 5:00 p.m. Boston, Massachusetts time and such conversion
shall be deemed to have been made immediately prior to the close of business on
the date such notice of conversion is given (a "conversion date"). The person or
persons entitled to receive the shares of Common Stock issuable upon such
conversion shall be treated for all purposes as the record holder or holders of
such shares of Common Stock at the close of business on such date.
(c) Conversion, Redemption and Note Delivery Required. The Corporation
acknowledges and understands that a delay in the issuance of the Common Stock
upon conversion or pursuant to a redemption according to the provisions hereof,
or a delay in delivering the Promissory Note set forth in Subsection (d) hereof,
could result in economic loss to the holders of the 6% Preferred. As
compensation to any holder when the Corporation has failed with respect to such
holder to comply with the Corporation's obligations hereunder, and not as a
penalty, the Corporation shall pay to such holder liquidated damages of $500 per
day plus an amount equal to: (i) two percent (2%) of the total Purchase Price of
Shares for the first thirty (30) day period after the date on which the Common
Stock should have been issued by the Corporation (i.e., the end of the three (3)
business day period described in Subsection (b)), shares of 6% Preferred
redeemed by the Corporation or Promissory Note delivered to holder (i.e., the
end of the three (3) business day period described in Subsection (d)), as
applicable; plus (ii) an amount equal to three percent (3%) of the total
Purchase Price of Shares for each subsequent thirty (30) day period thereafter.
Amounts payable shall be pro-rated daily as to a periods of less than thirty
(30) days. Such amounts shall be paid to the holder at the end of each month in
which such amounts have accrued. Payment shall be made immediately by cashier's
check or wire transfer in immediately available funds to such account as shall
be designated in writing by the holder. Each holder shall be entitled to an
injunction or injunctions to prevent or cure breaches of the provisions of
hereof and. to enforce specifically the terms and provisions hereof, this being,
in addition to any other remedy to which a holder may be entitled by law or
equity.
- 3 -
(d) Determination of Conversion Price:
(i )The "Conversion Price" for purposes of hereof shall be equal to eighty
percent (80%) of the average of the closing bid prices of the Common Stock as
reported by NASDAQ during the five (5) consecutive trading days preceding the
conversion date (but not including such date); provided, however, that in no
event may the Conversion Price be more than three dollars and twenty cents
($3.20) (the "Maximum Conversion Price") or less than an amount equal to the
closing bid price per share of the Common Stock on the date of issuance minus
fifty cents ($0.50) (the "Minimum Conversion Price"). If, but for this Section
4(d)(i), the Conversion Price would have been below Minimum Conversion Price,
the Company shall pay the holder by delivering to holder a Promissory Note, the
form which has been delivered to the Corporation and is incorporated herein by
reference, bearing the principal amount equal to the difference between (A) the
number of shares of Common Stock that would have been issued at the amount the
Conversion Price would have been but for this Section 4(d)(i) multiplied by 100%
of the closing bid price of the Common Stock on the conversion date as
determined in accordance with the Subsection (d) (the latter amount being
referred to herein as the "Conversion Date Price"), minus (B) the number of
shares of Common Stock actually issued pursuant to the conversion multiplied by
the Conversion Date Price. Such Promissory Note shall be delivered to holder by
the third (3rd) day following the applicable conversion date.
(ii) The "closing bid price" of the Common Stock on a trading day shall be
the closing bid price of the Common Stock on the NASDAQ Small Cap Market or any
other principal securities price quotation system or market on which prices of
the Common Stock are reported. The term "trading day" means a day on which
trading is reported on the principal quotation system or market on which prices
of the Common Stock are reported.
(iii) If, during the period of consecutive trading days provided for above,
the Corporation shall declare or pay any dividend on the Common Stock payable in
Common Stock or in rights to acquire Common Stock, or shall effect a stock split
or reverse stock split, or a combination, consolidation or reclassification of
the Common Stock, the Conversion Price, Maximum Conversion Price and Minimum
Conversion Price shall be proportionately decreased or increased, as
appropriate, to give effect to such event.
(e) Distributions. If the Corporation shall at any time or from time to
time make or issue, or fix a record date for the determination of holders of
Common Stock entitled to receive, a dividend or other distribution payable in
securities of the Corporation or any of its subsidiaries other than additional
shares of Common Stock, then in each such event provision shall be made so that
the holders of 6% Preferred shall receive, upon the conversion thereof, the
securities of the Corporation which they would have received had they been the
owners on the date of such event of the number of shares of Common Stock
issuable to them upon conversion.
(f) Certificates as to Adjustments. Upon the occurrence of any adjustment
or readjustment of the Conversion Price, the Maximum Conversion Price and
Minimum Conversion Price pursuant to this Section 4, the Corporation at its
expense shall promptly compute such adjustment or readjustment in accordance
with the terms hereof and cause the independent public accountants regularly
employed to audit the financial statements of the Corporation to verify such
computation and prepare and furnish to each holder of 6% Preferred a certificate
setting forth such adjustment or readjustment and showing in detail the facts
upon which such adjustment or readjustment is based. The Corporation shall, upon
the written request at any time of any holder of 6%. Preferred, furnish or cause
to be furnished to such holder a like certificate prepared by the Corporation
setting forth (i) such adjustments and readjustments, and (ii) the number of
other securities and the amount, if any, of other property which at the time
would be received upon the conversion of 6% Preferred with respect to each share
of Common Stock received upon such conversion.
(g) Notice of Record Date. In the event of any taking by the Corporation of
a record of the holders of any class of securities for the purpose of
determining the holders thereof who are entitled to receive any dividend (other
than a cash dividend) or other distribution, any security or right convertible
into or entitling the holder thereof to receive additional shares of Common
Stock, or any right to subscribe for, purchase or otherwise acquire any shares
of stock of any class or any other securities or property, or to receive any
other right, the Corporation shall mail to each holder of 6% Preferred at least
ten (10) days prior to the date specified therein, a notice specifying the date
on which any such record is to be taken for the purpose of such dividend,
distribution, security or right and the amount and character of such dividend,
distribution, security or right.
- 4 -
(h) Issue Taxes. The Corporation shall pay any and all issue and other
taxes, excluding any income, franchise or similar taxes, that may be payable in
respect of any issue or delivery of shares of Common Stock on conversion of
shares of 6% Preferred pursuant hereto; provided, however, that the Corporation
shall not be obligated to pay any transfer taxes resulting from any transfer
requested by any holder in connection with any such conversion.
(i) Reservation of Stock Issuable Upon Conversion. The Corporation shall at
all times reserve and keep available out of its authorized but unissued shares
of Common Stock, solely for the purpose of effecting the conversion of the
shares of the 6% Preferred, such number of its shares of Common Stock as shall
from time to time be sufficient to effect the conversion of all outstanding
shares of the 6% Preferred, and if at any time the number of authorized but
unissued shares of Common Stock shall not be sufficient to effect the conversion
of all then outstanding shares of the 6% Preferred, the Corporation will take
such corporate action as may be necessary to increase its authorized but
unissued shares of Common Stock to such number of shares as shall be sufficient
for such purpose, including, without limitation, engaging in best efforts to
obtain any requisite shareholder approval.
(j) Fractional Shares. No fractional shares shall be issued upon the
conversion of any share or shares of 6% Preferred. All shares of Common Stock
(including fractions thereof) issuable upon conversion of more than one share of
6% Preferred by a holder thereof shall be aggregated for purposes of determining
whether the conversion would result in the issuance of any fractional share. If,
after the aforementioned aggregation, the conversion would result in the
issuance of a fraction of a share of Common Stock, the Corporation shall, in
lieu of issuing any fractional share, pay the holder otherwise entitled to such
fraction a sum in cash equal to the fair market value of such fraction on the
date of conversion (as determined in good faith by the Board of Directors of the
Corporation or an authorized Committee thereof).
(k) Notices. Any notice required by the provisions of this Section to be
given to the holders of shares of 6% Preferred shall be deemed given if
deposited in the United States mail, postage prepaid, and addressed to each
holder of record at its address appearing on the books of the Corporation.
(1) Reorganization or Merger. In case of any reorganization or any
reclassification of the capital stock of the Corporation or any consolidation or
merger of the Corporation with or into any other corporation or corporations or
a sale of all or substantially all of the assets of the Corporation to any other
person (other than a sale or transfer to a wholly owned subsidiary of the
Corporation), and the holders of 6% Preferred do not elect to treat such
transaction as a liquidation, dissolution or winding up as provided in Section 2
hereof, then, as part of such reorganization, consolidation, merger or sale,
provision shall be made so that each share of 6% Preferred shall thereafter be
convertible into the number of shares of stock or other securities or property
(including cash) to which a holder of the number of shares of Common Stock
deliverable upon conversion of such share of 6% Preferred would have been
entitled upon the record date of (or date of, if no record date is fixed) such
event and, in any case, appropriate adjustment (as determined by the Board of
Directors) shall be made in the application of the provisions herein set forth
with respect to the rights and interests thereafter of the holders of the 6%
Preferred, to the end that the provisions set forth herein shall thereafter be
applicable, as nearly as equivalent as is practicable, in relation to any shares
of stock or the securities or property (including cash) thereafter deliverable
upon the conversion of the shares of 6% Preferred.
5. Re-issuance of Certificates. In the event of a conversion (or, if
applicable, redemption) of 6% Preferred in which less than all of the shares of
6% Preferred of a particular certificate are converted or redeemed, as the case
may be, the Corporation shall promptly without delay cause to be issued and
delivered to the holder of such certificate, a certificate representing the
remaining shares of 6% Preferred which have not been so
converted or redeemed.
- 5 -
6. Other Provisions. For all purposes of this Resolution, the term "date of
issuance" and the terms "Closing" or "Closing Date" shall mean the day on which
shares of the 6% Preferred are first issued by the Corporation. Any provision
herein which conflicts with or violates any applicable usury law shall be deemed
modified to the extent necessary to avoid such conflict or violation. The term
"NASDAQ" herein refers to the principal market on which the Common Stock of the
Corporation is traded. If the Common Stock is listed on a securities exchange,
or if another market becomes the principal market on which the Common Stock is
traded or through which price quotations for the Common Stock are reported, the
term "NASDAQ" shall be deemed to refer to such exchange or other principal
market.
7. Restrictions and Limitations. The Corporation shall not undertake the
following actions without the consent of the holders of a majority of the 6%
Preferred: (i) modify its Articles of Organization or Bylaws so as to amend or
change any of the rights, preferences, or privileges of the 6% Preferred, (ii)
authorize or issue any other preferred equity security senior to or on a parity
with the 6% Preferred as to dividends, liquidation preferences, conversion
rights, redemption rights or other rights, preferences or privileges for a
period of thirty (30) days after Closing, as applicable or (iii), purchase or
otherwise acquire for value any Common Stock or other equity security of the
Corporation either junior or senior to or on a parity with the 6% Preferred
while there exists any arrearage in the payment of cumulative dividends
hereunder other than redemptions of stock from terminating employees pursuant to
contractual rights in favor of the Corporation.
8. Voting Rights. Except as provided herein or as provided for by law, the
6% Preferred shall have no voting rights.
9. Attorney's Fees. Any holder of 6% Preferred shall be entitled to recover
from the Corporation the reasonable attorneys' fees and expenses incurred by
such holder in connection with enforcement by such holder of any obligation of
the Corporation hereunder.
10. No Adverse Actions. The Corporation shall not in any manner, whether by
amendment of the Articles of Organization (including, without limitation, any
vote establishing a class or series of stock), merger, reorganization,
recapitalization, consolidation, sales of assets, sale of stock tender offer,
dissolution or otherwise, take any action, or permit any action to be taken,
solely or primarily for the purpose of increasing the value of any class of
stock of the Corporation if the effect of such action is to reduce the value or
security of the 6% Preferred.
- 6 -
EXHIBIT A to the Subscription Agreement
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON
STOCK PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March ___, 1998
1. Basic Terms. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the registered holder specified
below or its registered assigns ("Holder"), is the owner of warrants of PHC,
Inc., a Massachusetts corporation (the "Corporation"), and is entitled, subject
to the terms and conditions of this Warrant, including adjustments as provided
herein, to purchase ______ ( ) (number to be pro-rated for a total of 50,000
share) shares of the Common Stock (the "Common Stock") of the Corporation from
the Corporation at the price per share shown below (the "Exercise Price").
Holder:
Exercise Price per share: ______ Dollars and ______
Cents ($ )per share
[This amount will be the Closing Bid Price of the
Corporation's Common Stock on the Issue Date]
Except as specifically provided otherwise, all references in this Warrant
to the Exercise Price and the number of shares of Common Stock purchasable
hereunder shall be to the Exercise Price and number of shares after any
adjustments are made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The Corporation represents and
covenants that the shares of Common Stock issuable upon the exercise of this
Warrant shall at delivery be fully paid and non-assessable and free from taxes,
liens, encumbrances and charges with respect to their purchase. The Corporation
shall take any necessary actions to assure that the par value per share of the
Common Stock is at all times equal to or less than the then current Exercise
Price per share of Common Stock issuable pursuant to this Warrant. The
Corporation shall at all times reserve and hold available sufficient shares of
Common Stock to satisfy all conversion and purchase rights of outstanding
convertible securities, options and warrants of the Corporation, including this
Warrant.
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the issue date.
To exercise this Warrant, the Holder shall surrender this Warrant at the
principal office of the Corporation or that of the duly authorized and acting
transfer agent for its Common Stock, together with the executed exercise form
(substantially in the form of that attached hereto) and together with payment
for the Common Stock purchased under this Warrant. The principal office of the
Corporation is located at the address specified on the signature page of this
Warrant; provided, however, that the Corporation may change its principal office
upon notice to the Holder. At the option of the Holder payment shall be made
either in cash (by wire) or by certified or bank cashier's check payable to the
order of the Corporation or the Holder may elect to receive shares of Common
Stock calculated pursuant to paragraph 4. The Corporation shall, immediately
upon receipt of such notice, issue and deliver to or upon the order of such
Holder a certificate or certificates for the number of shares of Common Stock to
which such Holder shall be entitled and such certificate or certificates shall
not bear any restrictive legend; provided (A) the Common Stock evidenced thereby
are sold pursuant to an effective registration statement under the Act, (B) the
holder provides the Corporation with an opinion of counsel reasonably acceptable
to the Corporation to the effect that a public sale of such shares may be made
without registration under the Act, or (C) such holder provides the Corporation
with reasonable assurance that such shares can be sold free of any limitations
imposed by Rule 144, promulgated under the Act. The Corporation shall cause such
issuance and delivery to be effected within three (3) business days and shall
transmit the certificates by messenger or overnight delivery service to reach
the address designated by such holder within three (3) business days after the
receipt of such notice. This Warrant is not exercisable with respect to a
fraction of a share of Common Stock. In lieu of issuing a fraction of a share
remaining after exercise of this Warrant as to all full shares covered by this
Warrant the Corporation shall either at its option (a) pay for the fractional
share cash equal to the same fraction at the fair market price for such share;
or (b) issue scrip for the fraction in the registered or bearer form which shall
entitle the Holder to receive a certificate for a full share of Common Stock on
surrender of scrip aggregating a full share. As compensation to the Holder when
the Corporation has failed with respect to such Holder to comply with the
Corporation's obligations hereunder, and not as a penalty, the Corporation shall
pay to such holder liquidated damages of $500 per day until the certificates are
delivered as instructed. Such damages shall be paid to the Holder by cashiers
check or wire transfer in immediately available funds to such account as shall
be designated in writing by the Holder at the end of each month in which such
amounts have accrued. Holder shall be entitled to an injunction or injunctions
to prevent or cure breaches of the provisions of hereof and to enforce
specifically the terms and provisions hereof, this being in addition to any
other remedy to which Holder may be entitled by law or equity.
4. Cashless Exercise.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or
quoted in the NASDAQ System or the domestic over-the-counter market, the fair
market value shall be the higher of (i) the book value thereof, as determined by
any firm of independent public accountants of recognized standing selected by
the Corporation (which may be the Corporation's regular independent
accountants), as of the last day of any month ending within sixty days preceding
the date as of which the determination is to be made; or (ii) the fair market
value thereof, which shall be reasonably determined by the Corporation and the
Holder as of a date which is within fifteen days of the date as of which the
determination is to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that
price determined by multiplying the Exercise Price in effect immediately prior
to such event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number an kind of securities or other
property purchasable under this Warrant resulting from the event and settin
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until,
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant.All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the
Holder.
PHC, INC., a Massachusetts corporation
By: ________________________________
Authorized Officer
Printed Name: _______________________
Title: ______________________________
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ________________________________
________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________ ____________________________________
Signature
- 8 -
Incorporated by Reference into the Resolutions Establishing Right and
Preferences for Series B Convertible Preferred Stock.
PROMISSORY NOTE (the "Note")
Date: __________________, ________________________
Maker: PHC, Inc.
Maker's Mailing Address: 200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
Payee:
Place for Payment:
Principal Amount: $_________________________________
Annual Interest Rate on Unpaid Principal From Date: Eight percent (8%).
Annual Past Due Interest Rate on Unpaid Principal from Maturity to Payment:
Fifteen percent (15%).
Terms of Payment: Principal and interest shall be due and payable in six (6)
equal consecutive monthly payments of $ ________________ (based on a six (6)
month amortization) with the first payment being due and payable on the first
day of _____________________.
The Maker promises to pay to the order of Payee at the place for payment and
according to the terms of payment the outstanding principal and accrued interest
at the rates stated above. All unpaid amounts owing on this Note shall be due by
the final scheduled payment date of ________________________.
Additional Provisions:
If Maker defaults in the payment of this Note, or in any instrument securing or
collateral to it, then Payee may declare the unpaid principal balance of this
Note and all accrued interest immediately due and payable. Maker and each
surety, endorser, and guarantor or other party liable for the payment of any
sums of money payable on this Note severally waive all demands for payment,
presentations for payment, notices of dishonor, notices of intention to
accelerate maturity, notices of acceleration of maturity, protests, and notices
of protest, to the extent permitted by law.
If this Note or any instrument securing or collateral to it is given to an
attorney for collection or enforcement. or if suit is brought for collection or
enforcement or if it is collected or enforced through probate, bankruptcy, or
other judicial proceedings then Maker shall pay Payee all costs of collection
and enforcement, including reasonable attorneys fees and court costs, in
addition to other amounts due.
PHC. INC., PROMISSORY NOTE
Page 1
Interest that may be contracted for, taken, reserved, charged or received
under law; any interest in excess of that maximum amount shall be credited on
the principal of the debt or, if that has been paid, refunded. On any
acceleration or required or permitted prepayment, any such excess shall be
canceled automatically as of the acceleration or prepayment or, if already paid,
credited on the principal of the debt or, if the principal of the debt has been
paid, refunded. This provision overrides other provisions in this and all other
instruments concerning the debt.
When the context requires, singular nouns and pronouns include the plural.
This Note is to be governed and construed in accordance with the laws of
the State of Texas.
MAKER, FOR GOOD AND VALUABLE CONSIDERATION, THE RECEIPT AND SUFFICIENCY OF
WHICH ARE HEREBY ACKNOWLEDGED, (I) HEREBY IRREVOCABLY SUBMITS TO THE
JURISDICTION OF THE UNITED STATES DISTRICT COURT AND OTHER COURTS OF THE UNITED
STATES SITTING IN TEXAS FOR THE PURPOSES OF ANY SUIT, ACTION OR PROCEEDING
ARISING OUT OF OR RELATING TO THIS AGREEMENT AND (ii) HEREBY WAIVES, AND AGREES
NOT TO ASSERT IN ANY SUCH SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT
PERSONALLY SUBJECT TO THE JURISDICTION OF SUCH COURT, THAT THE SUIT, ACTION OR
PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR THAT THE VENUE OF THE SUIT,
ACTION OR PROCEEDING IS IMPROPER. MAKER CONSENTS TO PROCESS BEING SERVED IN ANY
SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF TO MAKER AT ITS MAIN
BUSINESS OFFICE AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND
SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING IN THIS PARAGRAPH
SHALL AFFECT OR LIMIT ANY RIGHT TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED
BY LAW.
Executed as of date first above written.
PHC Inc., a Massachusetts corporation
By: _______________________________________
Name of
Authorized Officer: __________________________
Title: ______________________________________
PHC. INC., PROMISSORY NOTE
Page 2
EXHIBIT B to the Subscription Agreement
Section 2.2(a): PHC, Inc. Subsidiaries:
PHC of Utah, Inc. Pioneer Counseling of Virginia, Inc.
D/B/A Highland Ridge Hospital (80% Owned)
4578 Highland Drive D/B/A Pioneer Counseling of Virginia
Salt Lake City, UT 94117 D/B/A Counseling Associates of Virginia
400 East Burwell street
Salem, VA 24153
PHC of Virginia, Inc. PHC of Kansas, Inc.
D/B/A Mount Regis Center D/B/A Total Concept EAP
D/B/A Changes 7451 Szwitzer, Suite 101
405 Kimball Avenue Shawnee Mission, KS 66203
Salem, VA 24153
Quality Care Centers of Mass, Inc. PHC of California, Inc.
D/B/A Franvale Nursing & Rehab Center D/B/A Marin Grove
20 Pond Street 42 Grove Street
Braintree, MA 02194 San Rafael, CA 94901
PHC of Nevada, Inc. Professional Health Associates
D/B/A Harmony Healthcare 94-19 59 Avenue
2340 Paseo del Prado, Bldg.D Elmhum NY 11373
Las Vegas, NV 89102
Northpoint - Pioneer, Inc. STL, Inc.
D/B/A Pioneer Counseling Center 200 Lake Street
31700 W. 13 Mile; Suite 201 Suite 102
Farmington Hills, MI 48334 Peabody, MA 0 1960
BSC-NY, Inc. Harmony Behavioral Health
D/B/A Behavioral Stress Center 2340 Paseo del Prado, Bldg.D
94-19 59 Avenue Las Vegas, NV 89102
Elmhurst, NY 11373
PHC of Michigan, Inc. PHC of Rhode island, Inc.
D/B/A Harbor Oaks Hospital D/B/A Good Hope Center
35031 23 Mile Road P.O. Box 1491
New Baltimore, MI 48047 Coventry, RI 02816-0029
EXHIBIT B (cont'd.)
Section 2.2(f):
The Company failed to file two years' of audited financial statements for
Behavioral Stress Centers, Inc. and Clinical Diagnostics and Clinical
Associates, as described in the December 18, 1996 letter from Choate, Hall &
Stewart to Mr. Robert Bayless of the Securities and Exchange Commission.
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns "Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Twenty Six Thousand Three Hundred Fifteen (26,315) shares of Class A
Common Stock (the "Common Stock") of the Corporation from the Corporation at the
price per share shown below (the "Exercise Price").
Holder: ProFutures Special Equities Fund, L.P.
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporations Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading shall be average of the
closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at he end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant,. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ______________________ _____________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________ __________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Seven Thousand Eight Hundred Ninety (7,890) shares of Class A Common
Stock (the "Common Stock") of the Corporation from the Corporation at the price
per share shown below (the "Exercise Price").
Holder: Gary D. Halbert
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock s at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDA", the average of the daily market prices of such stock on the ten
(10) trading days immediately preceeding the date as of which such value is to
be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restriction s on transfer contained herein, in the names designated by the
Holder at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement hall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
-6-
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ________________________ ________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________________
__________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Five Thousand Two Hundred Sixty (5,260) shares of Class A Common Stock
(the "Common Stock") of the Corporation from the Corporation at the price per
share shown below (the "Exercise Price").
Holder: John F. Mauldin
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. he Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashiers check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted t be given to the Holder shall
be in writing and shall be given by first class mail, postage repaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: _________________________ _____________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: _________________________ ____________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Ten Thousand Five Hundred Twenty Five (10,525) shares of Class A Common
Stock (the "Common Stock") of the Corporation from the Corporation at the price
per share shown below (the "Exercise Price").
Holder: Augustine Fund, L.P.
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDA"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of
1933, as amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ______________________ ________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: _________________________ _________________________________
Signature
- 8 -
Exhibit 10.133
ASSET PURCHASE AGREEMENT
This Asset Purchase Agreement is made and entered into as of the 2nd day of
February, 1998, by and between Lexington Healthcare Group, Inc., a Delaware
corporation having its principal place of business at 35 Park Place, New
Britain, Connecticut 06052 (together with its successors and assigns hereinafter
collectively referred to as the "Buyer"), and Quality Care Centers of
Massachusetts, a Massachusetts corporation having its principal place of
business at 200 Lake Street, Suite 102, Peabody, Massachusetts 01960 (together
with its successors and assigns hereinafter collectively referred to as the
"Seller").
W I T N E S S E T H:
WHEREAS, the Seller owns and leases certain assets in connection with, and
operates the 128-bed licensed skilled nursing care facility known as, Franvale
Nursing and Rehabilitation Center at 20 Pond Street, Braintree, Massachusetts
02184 (the "Facility"); and
WHEREAS, the Buyer desires to acquire from the Seller, and the Seller
desires to sell to the Buyer, certain of the assets of the Seller used in
connection with the operation of the Facility, all upon Exhibit 4.28
SUBSCRIPTION AGREEMENT
PHC, INC.
THE SECURITIES WHICH ARE THE SUBJECT OF THIS SUBSCRIPTION AGREEMENT (AS IT MAY
BE AMENDED FROM TIME TO TIME, THE "AGREEMENT") HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR UNDER THE
APPLICABLE SECURITIES LAWS OF ANY STATE AND WILL BE OFFERED AND SOLD IN RELIANCE
ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THESE LAWS BY VIRTUE OF PHC,
INC.'S INTENDED COMPLIANCE WITH SECTIONS 3(b), 4(2) AND 4(6) OF THE SECURITIES
ACT, THE PROVISIONS OF REGULATION D UNDER SUCH ACT AND SIMILAR EXEMPTIONS UNDER
STATE LAW. THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE U.S.
SECURITIES AND EXCHANGE COMMISSION ("SEC"), ANY STATE SECURITIES COMMISSION OR
ANY OTHER REGULATORY AUTHORITY. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.
The undersigned purchaser (hereafter, the "Purchaser") hereby offers to
purchase certain Series B Convertible Preferred Stock (referred to herein as a
"Share" or collectively as "Shares") of PHC, Inc. (the "Company"), a publicly
held corporation formed under the laws of the Commonwealth of Massachusetts.
This offer to purchase may, for any reason whatsoever, be revoked by the
Purchaser or rejected by the Company prior to acceptance of this offer by the
Company.
Section 1.1 Purchase and Sale of Shares. Upon the following terms and
conditions, the Company shall issue and sell to the Purchaser, and the Purchaser
shall purchase from the Company, the number of Shares indicated herein, which
Shares shall have the rights, designations and preferences set forth in Schedule
I hereto.
Section 1.2 Purchase Price. The purchase price for the Shares (the
"Purchase Price") shall be $1,000 per Share.
Section 1.3 The Closing.
(a) The closing of the purchase and sale of the Shares (the "Closing"),
shall take place at the law offices of Arent, Fox, Kintner, Plotkin & Kahn, 1050
Connecticut Avenue, N.W., Washington, D.C. 20036, at 10:00 a.m., local
Washington, D.C. time, on the later of the following: (i) the date on which the
last to be fulfilled or waived of the conditions set forth in Section 4.1 and
4.2 hereof and applicable to the Closing shall be fulfilled or waived in
accordance herewith, or (ii) such other time and place and/or on such other date
as the Purchaser and the Company may agree. The date on which the Closing occurs
is referred to herein as the "Closing Date."
(b) On the Closing Date, the Company shall deliver to the Purchaser (i) a
certificate representing the Shares registered in the name of the Purchaser or
deposit such Shares into accounts designated by the Purchaser and (ii) the
Warrant for the number of shares of the Company's Common Stock indicated herein,
in the form attached hereto as Exhibit A, incorporated herein by reference. The
Purchaser shall on the Closing Date deliver to the Company the Purchase Price
for all the Shares by cashier's check or wire transfer in immediately available
funds to such account as shall be designated in writing by the Company. In
addition, each party shall deliver all documents, instruments and writings
required to be delivered by such party pursuant to this Agreement at or prior to
the Closing.
Section 1.4 Covenant to Register.
(a) For purposes of this Section, the following definitions shall apply:
The terms "register," "registered," and "registration" refer to a
registration under the Securities Act of 1933, as amended (the "Act"), effected
by preparing and filing a registration statement or similar document in
compliance with the Act, and the declaration or ordering of effectiveness of
such registration statement, document or amendment thereto.
(ii) The term "Registrable Securities" means the shares of the Company's
Class A Common Stock, par value $.01 per share (the "Common Stock"), issuable
upon conversion of shares of the Shares and upon exercise of the Warrant, or
upon conversion of any other stock issued in payment of dividends on the Shares
or otherwise issuable pursuant to this Agreement or the provisions of Schedule I
hereto, and any securities of the Company or securities of any successor
corporation issued as, or issuable upon the conversion or exercise of any
warrant right or other security that is issued as a dividend or other
distribution with respect to, or in exchange for, or in replacement of, the
Shares.
(iii) The term "holder of Registrable Securities" means the Purchaser and
any permitted assignee of registration rights pursuant to Section 1.4(h).
(b) (i) The Company shall as soon as possible file a registration statement
on Form SB-2 or Form S-3 covering at least 200% of the number of Registrable
Securities which would then be issuable upon conversion of the Shares at the
conversion price then in effect, and shall use its best efforts to cause such
registration statement to become effective on or before ninety (90) days after
the Closing Date (the "Initial Registration"). In the event such registration is
not so declared effective or does not include all Registrable Securities, a
holder of Registrable Securities shall have the right to require by notice in
writing that the Company register all or any part of the Registrable Securities
held by such holder (a "Demand Registration") and the Company shall thereupon
effect such registration in accordance herewith (which may include adding such
shares to an existing shelf registration). The parties agree that if the holder
of Registrable Securities demands registration of less than all of the
Registrable Securities, the Company, at its option, may nevertheless file a
registration statement covering all of the Registrable Securities. If such
registration statement is declared effective with respect to all Registrable
Securities and the Company is in compliance with its obligations under
Subsection (d) of this Section 1.4, the demand registration rights granted
pursuant to this Subsection (b)(i) shall cease. If such registration statement
is not declared effective with respect to all Registrable Securities or if the
Company is not in compliance with such obligations, the demand registration
rights described herein shall remain in effect.
(ii) The Company shall not be obligated to effect a Demand Registration
under Subsection (b)(i) above: (A) if all of the Registrable Securities held by
the holder of Registrable Securities which are demanded to be covered by the
Demand Registration are, at the time of such demand, included in an effective
registration statement and the Company is in compliance with its obligations
under Subsection (d) of this Section 1.4; (B) if all of the Registrable
Securities may be sold under Rule 144(k) of the Act and the Company's transfer
agent has accepted an instruction from the Company to such effect; or (C) at any
time after two (2) years from the Closing Date.
(iii) Subject to Subsection (iv)(B) hereof, the Company may suspend the
effectiveness of any such registration effected pursuant to this Subsection (b)
in the event and for such period of time as, such a suspension is required by
the rules and regulations of the Securities and Exchange Commission ("SEC"). The
Company will use its best efforts to cause such suspension to terminate at the
earliest possible date.
(iv) (A) If the Company is advised by the SEC that a registration statement
filed hereunder is subject to a "no-review" and such registration statement is
not declared effective within five (5) business days thereafter (an
"Acceleration Date") or, irrespective of the SEC review, a registration
statement is not declared effective by the ninety first (91st) day after the
Closing Date (the "Target Date"), the Company shall pay Purchaser as liquidated
damages an amount equal to two percent (2%) of the total Purchase Price of the
Shares for each thirty (30) day period following the earlier of the Acceleration
Date or Target Date, as applicable, until such time as the registration
statement is declared effective; provided, however, that such damages shall not
be payable if the failure to meet the Acceleration Date or Target Date, as
applicable, is due to action or inaction by Purchaser with respect to providing
information for the registration statement. The payment set forth above shall be
pro-rated daily as to any period of less than thirty (30) days. Such payment
shall be made to the Purchaser either (I) by cashier's check or wire transfer in
immediately available funds to such account as shall be designated in writing by
the Purchaser or (II) in Shares, the number of which shall be equal to the
amount due under this Subsection divided by $1,000 per Share. The foregoing
amount shall be paid irrespective of the amount of Registrable Securities then
held by Purchaser.
(B) If, following effectiveness of a registration, either the effectiveness
of the registration statement is suspended or a current prospectus meeting the
requirements of Section 10 of the Act is not available for delivery by the
Purchaser (either referred to herein as a "suspension"), the Company shall
thereupon pay to Purchaser as liquidated damages an amount equal to two percent
(2%) of the Purchase Price of the Shares for each thirty (30) day period of the
suspension. The payment set forth above shall be pro-rated daily as to periods
of less than thirty (30) days. Such payment shall be made to the Purchaser by
cashiers check or wire transfer in immediately available funds to such account
as shall be designated in writing by the Purchaser, and shall be paid
irrespective of the amount of Registrable Securities held by Purchaser on or
after the date following the suspension.
(C) Any amount payable pursuant to the foregoing provisions of this
Subsection (iv) shall be delivered on or before the fifth (5th) day following
the end of the calendar month in which such payment obligation arose. The
"Purchase Price" of Registrable Securities shall be (1) if derived from
conversion or substitution of Shares, the Purchase Price of the Shares, and (2)
if received in satisfaction of a Company obligation, the dollar amount of such
obligation.
(D) This Subsection is in addition to the provisions of Section 7.2(a)
hereof.
(c) If the Company proposes to register (including for this purpose a
registration effected by the Company for shareholders other than the Purchaser)
any of its stock or other securities under the Act in connection with a public
offering of such securities (other than a registration on Form S-4, Form S-8 or
other limited purpose form) and all Registrable Securities have not theretofore
been included in a registration statement under Subsection (b) of this Section
1.4 which remains effective, the Company shall, at such time, promptly give all
holders of Registrable Securities written notice of such registration. Upon the
written request of any holder of Registrable Securities given within twenty (20)
days after receipt of such notice by the holder of Registrable Securities, the
Company shall use its best efforts to cause to be registered under the Act all
Registrable Securities that such holder of Registrable Securities requests to be
registered. However, the Company shall have no obligation under this Subsection
(c) if (i) the Registrable Securities may be sold without registration under
Rule 144(k) and the Company's transfer agent has accepted an instruction from
the Company to such effect, (ii) the Registration Statement is filed more than
two (2) years after the Closing Date, or (iii) to the extent that, with respect
to any underwritten offering initiated by the Company later than one calendar
year following the Closing, the managing underwriter of such offering reasonably
notifies such holder(s) in writing of its determination that the Registrable
Securities or a portion thereof shall be excluded therefrom.
(d) Whenever required under this Section 1.4 to effect the registration of
any Registrable Securities including, without limitation, the Initial
Registration, the Company shall, as expeditiously as reasonably possible:
(i) Prepare and file with the SEC a registration statement with respect to
such Registrable Securities and use its best efforts to cause such registration
to become effective as provided in Section 1.4(b)(i), and keep such registration
statement effective for so long as any holder of Registrable Securities desires
to dispose of the securities covered by such registration statement; provided,
however, that in no event shall the Company be required to keep the Registration
Statement effective for a period greater than two (2) years from the Closing
Date;
(ii) Respond to comments made by the SEC with respect to a registration
statement filed pursuant to this Agreement within ten (10) business days after
the date of the comment letter, and prepare and file with the SEC such
amendments and supplements to such registration statement and the prospectus
used in connection with such registration statement as may be necessary to
comply with the provisions of the Act with respect to the disposition of all
securities covered by such registration statement and notify the holders of the
filing and effectiveness of such Registration Statement and any amendments or
supplements;
(iii) Furnish to each holder of Registrable Securities such numbers of
copies of a current prospectus, including a preliminary prospectus, conforming
with the requirements of the Act, copies of the registration statement any
amendment or supplement to any thereof and any documents incorporated by
reference therein and such other documents, all free of charge, as such holder
of Registrable Securities may reasonably require in order to facilitate the
disposition of Registrable Securities owned by such holder of Registrable
Securities;
(iv) Use its best efforts to register and qualify the securities covered by
such registration statement under such other securities or "Blue Sky" laws of
such jurisdictions as shall be reasonably requested by the holder of Registrable
Securities;
(v) Notify each holder of Registrable Securities immediately of the
happening of any event as a result of which the prospectus included in such
registration statement, as then in effect, includes an untrue statement of
material fact or omits to state a material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the
circumstances then existing, and use its best efforts to promptly update and/or
correct such prospectus;
(vi) Furnish, at the request of any holder of Registrable Securities in
connection with any underwritten public offering, (A) an opinion of counsel of
the Company, dated the effective date of the registration statement, in form and
substance reasonably satisfactory to the holder and its counsel and covering,
without limitation, such matters as the due authorization and issuance of the
securities being registered and certain matters pertaining to disclosure under
and compliance with securities laws by the Company in connection with the
registration thereof and/or (B) a "comfort" letter or letters of the Company's
independent public accountants provided at the Company's expense in form and
substance reasonably satisfactory to the holder and its counsel;
(vii) Use its best efforts to list the Registrable Securities covered by
such registration statement with any national market or securities exchange on
which such securities are then listed;
(viii) Make available for inspection by the holder of Registrable
Securities, upon request, all SEC Documents (as defined below) filed subsequent
to the Closing and require the Company's officers, directors and employees to
supply all information reasonably requested by any holder of Registrable
Securities in connection with such registration statement: and
(ix) Furnish to each holder of Registrable Securities prompt notice of the
commencement of any stop-order proceedings under the Act, together with copies
of all documents in connection therewith, and use its best efforts to obtain
withdrawal of any such stop order as soon as possible.
(e) Upon request of the Company, each holder of Registrable Securities will
furnish to the Company in connection with any registration under this Section
such information regarding itself, the Registrable Securities and other
securities of the Company held by it, and the intended method of disposition of
such securities as shall be reasonably required to effect the registration of
the Registrable Securities held by such holder of Registrable Securities. The
intended method of disposition (Plan of Distribution) of such securities as so
provided by Purchaser shall be included without alteration in the Registration
Statement covering the Registrable Securities and shall not be changed without
the prior written consent of the Purchaser.
(f) (i) The Company shall indemnify, defend and hold harmless each holder
of Registrable Securities which are included in a registration statement
pursuant to the provisions of Subsections (b) or (c) hereof and each of its
officers, directors, employees, agents, partners or controlling persons (within
the meaning of the Act) (each, an "indemnified party") from and against, and
shall reimburse such indemnified party with respect to, any and all claims,
suits, demands, causes of action, losses, damages, liabilities, costs or
expenses ("Liabilities") to which such indemnified party may become subject
under the Act or otherwise, arising from or relating to (A) any untrue statement
or alleged untrue statement of any material fact contained in such registration
statement, any prospectus contained therein or any amendment or supplement
thereto, or (B) the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances in which they were made, not misleading; provided,
however, that the Company shall not be liable in any such case to the extent
that any such Liability arises out of or is based upon an untrue statement or
omission so made in strict conformity with information furnished by such
indemnified party in writing specifically for use in a registration statement.
(ii) In the event of any registration under the Act of Registrable
Securities pursuant to Subsections (b) or (c), each holder of such Registrable
Securities hereby severally agrees to indemnity, defend and hold harmless the
Company, and its officers, directors, employees, agents, partners, or
controlling persons (within the meaning of the Act) (each, an "indemnified
party") from and against, and shall reimburse such indemnified party with
respect to, any and all Liabilities to which such indemnified party may become
subject under the Act or otherwise, arising from or relating to (A) any untrue
statement or alleged untrue statement of any material fact contained in such
registration statement, any prospectus contained therein or any amendment or
supplement thereto, or (B) the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances in which they were made, not misleading;
provided, that such holders will be liable in any such case to the extent and
only to the extent, that any such Liability arises out of or is based upon an
untrue statement or alleged untrue statement or omission or alleged omission
made in such registration statement, prospectus or amendment or supplement
thereto in reliance upon and in conformity with written information furnished by
such holder specifically for use in the preparation thereof.
(iii) Promptly after receipt by any indemnified party of notice of the
commencement of any action, such indemnified party shall, if a claim in respect
thereof is to be made against another party (the "indemnifying party")
hereunder, notify such party in writing thereof, but the omission so to notify
such party shall not relieve such party from any Liability which it may have to
the indemnified party other than under this Section and shall only relieve it
from any Liability which it may have to the indemnified party under this section
if and to the extent an indemnifying party is materially prejudiced by such
omission. In case any such action shall be brought against any indemnified party
and such indemnified party shall notify an indemnifying party of the
commencement thereof, the indemnifying party shall be entitled to participate in
and, to the extent it shall wish, to assume and undertake the defense thereof
with counsel reasonably satisfactory to such indemnified party, and, after
notice from the indemnifying party to the indemnified party of its election so
to assume and undertake the defense thereof, the indemnifying party shall not be
liable to the indemnified party under this section for any legal expenses
subsequently incurred by the indemnified party in connection with the defense
thereof other than reasonable costs of investigation and of liaison with counsel
so selected; provided however, that if the defendants in any such action include
both parties and the indemnified party shall have reasonably concluded that
there may be reasonable defenses available to them which are different from or
additional to those available to the indemnifying party or if the interests of
the indemnified party reasonably may be deemed to conflict with the interests of
the indemnifying party, the indemnified party shall have the right to select a
separate counsel and to assume such legal defenses and otherwise to participate
in the defense of such action, with the reasonable expenses and fees of one such
separate counsel and other reasonable expenses related to such participation to
be reimbursed by the indemnifying party as incurred.
(g) (i) With respect to the inclusion of Registrable Securities in a
registration statement pursuant to Subsections (b) or (c), all fees, costs and
expenses of and incidental to such registration, inclusion and public offering
shall be borne by the Company, provided, however, that any securityholders
participating in such registration shall bear their pro-rata share of the
underwriting discounts and commissions, if any, incurred by them in connection
with such registration.
(ii) The fees, costs and expenses of registration to be borne by the
Company as provided in this Subsection shall include, without limitation, all
registration, filing and NASD fees, printing expenses, fees and disbursements of
counsel and accountants for the Company, and all legal fees and disbursements
and other expenses of complying with state securities or Blue Sky laws of any
jurisdiction or jurisdictions in which securities to be offered are to be
registered and qualified. Subject to appropriate agreements as to
confidentiality, the Company shall make available to the holders of Registrable
Securities and their counsel its documents and personnel for due diligence
purposes. Except as otherwise provided herein, fees and disbursements of counsel
and accountants for the selling security holders shall be borne by the
respective selling security holders.
(h) The rights to cause the Company to register all or any portion of
Registrable Securities pursuant to this Section 1.4 may be assigned by Purchaser
to a transferee or assignee. Within a reasonable time after such transfer, the
Purchaser shall notify the Company of the name and address of such transferee or
assignee, and the securities with respect to which such registration rights are
being assigned. Such assignment shall be effective only if, immediately
following such transfer, the further disposition of such securities by the
transferee or assignee is restricted under the Act. Any transferee asserting
registration rights hereunder shall be bound by the applicable provisions of
this Agreement.
(i) The Company shall not agree to allow the holders of any securities of
the Company to include any of their securities in any registration statement
filed by the Company pursuant to Subsection (b) unless such inclusion will not
reduce the amount of the Registrable Securities included therein.
Section 1.5 Company Standoff, Except in a corporate reorganization,
business combination, stock or asset purchase, merger or consolidation, under
existing employee stock incentive or purchase plans or pursuant to this
Agreement, the Company shall not for its own account effect any public sale or
distribution of any securities similar to the Registrable Securities or any
securities exercisable for or convertible or changeable into the Registrable
Securities during the thirty (30) days prior to, and during the sixty (60) days
immediately following, the effective date of any registration statement filed or
amended pursuant to Section 1.4(b); provided, however, that the Company may
effect such public sale or distribution during the sixty (60) days immediately
following the effective date of such registration statement if such sale or
distribution of securities is at a price equal to or greater than 125% of the
last trade price of the Company's Common Stock on the day of Closing.
Section 2.1 Representations and Warranties of the Purchaser. The Purchaser
makes the following representations and warranties to the Company.
(a) Accredited Investor. The Purchaser is an "accredited investor", as such
term is defined in Rule 50 1 (a) of Regulation D, promulgated under the Act.
(b) Speculative Investment. The Purchaser is aware that an investment in
the Shares is highly speculative and subject to substantial risks. The Purchaser
is capable of bearing the high degree of economic risk and the burden of this
venture, including, but not limited to, the possibility of complete loss of the
Purchaser's investment in the Shares and underlying Common Stock which make
liquidation of this investment impossible for the indefinite future.
(c) Disposition. The Purchaser understands that (i) except as provided for
in Section 1.4, the Shares and underlying Common Stock of the Company (the
"Securities"), have not been and are not being registered under the Securities
Act or any applicable state securities laws, and may not be transferred unless
(A) subsequently registered thereunder, or (B) the Securities may be sold or
transferred pursuant to an exemption from securities registration under the
Securities Act and any applicable state securities laws or (C) sold pursuant to
Rule 144, promulgated under the Securities Act (or any successor Rule), or (ii)
any sale of such Securities made in reliance on Rule 144 may be made only in
accordance with the terms of such Rule and further, if such Rule is not
applicable, any resale of such Securities under circumstances in which the
seller (or the person through whom the sale is made) may be deemed to be an
underwriter (as that term is defined in the Securities Act) may require
compliance with another exemption under the Securities Act or the rules of the
SEC thereunder. Notwithstanding any provision to the contrary contained herein,
a holder may pledge such Securities as collateral for a revolving credit note
pursuant to a loan and security agreement with a lending institution.
(d) Privately Offered. The offer to acquire the Shares was directly
communicated to the Purchaser in such manner that the Purchaser was able to ask
questions of and receive answers concerning the terms and conditions of this
transaction. At no time was the Purchaser presented with or solicited by or
through any leaflet, public promotional meeting, television advertisement, or
any other form of general advertising.
(e) Purchase for Investment, The Securities are being acquired solely for
the Purchaser's own account, for investment, and are not being purchased with
view to the resale, distribution, subdivision or fractionalization thereof
without proper registration with applicable securities administrators.
Section 2.2 Representations and Warranties of the Company. The Company
hereby makes the following representations and warranties to the Purchaser:
(a) Organizations and Qualifications. The Company is a corporation duly
incorporated and existing in good standing under the laws of the Commonwealth of
Massachusetts and has the requisite corporate power to own its properties and to
carry on its business as now being conducted. The Company does not have any
subsidiaries except as listed in Exhibit B, attached hereto and incorporated
herein by reference. The Company and each such subsidiary, if any, is duly
qualified as a foreign corporation to do business and is in good standing in
every jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary other than those in which the
failure so to qualify would not have a Material Adverse Effect. "Material
Adverse Effect", for purposes of this Agreement, means any adverse effect on the
business operations, properties, prospects, or financial condition of the entity
with respect to which such term is used and which is material to such entity and
other entities controlled by such entity taken as a whole.
(b) Authorizations Enforcement. (i) The Company has the requisite corporate
power and authority to enter into and perform this Agreement and to issue the
Shares and Registrable Securities in accordance with the terms hereof, (ii) the
execution and delivery of this Agreement by the Company and the consummation by
it of the transactions contemplated hereby have been duly authorized by all
necessary corporate action, and no further consent or authorization of the
Company or its Board of Directors or stockholders is required, (iii) this
Agreement has been duly executed and delivered by the Company, (iv) this
Agreement constitutes a valid and binding obligation of the Company enforceable
against the Company in accordance with its terms (except as such enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally the enforcement
of, creditor' rights and remedies or by other equitable principles of general
application) and (v) prior to the Closing Date, any necessary Certificate of
Amendment to the Company's Charter authorizing Company to issue all of the
Shares and Registerable Securities, in accordance with Schedule 1, will have
been filed with the Massachusetts Secretary of State and will be in full force
and effect enforceable against the Company in accordance with the terms of such
amended Charter.
(c) Authorized Capital Rights or Commitments to Stock. The authorized
capital stock of the Company consists of 22,200,000 shares of Common Stock and
1,000,000 shares of Series B Preferred Stock; there are 4,704,956 shares of
Common Stock issued and 730,292 shares of Class B Common Stock outstanding;
there are no shares of such Preferred Stock issued and outstanding; and, upon
issuance of the Shares in accordance with the terms hereof, there will be
4,704,956 shares of Class B Common Stock and 950 shares of such Preferred Stock
issued and outstanding.
All of the outstanding shares of the Company's Common Stock have been
validly issued and are fully paid and nonassessable. Except as set forth in
Exhibit B hereto or as described in the SEC Documents, no shares of Common
Stock are entitled to preemptive rights or registration rights and there are
no outstanding options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company, or contracts,
commitments, understandings, or arrangements by which the Company is or may
become bound to issue additional shares of capital stock of the Company or
options, warrants, scrip, rights to subscribe to, or commitments to purchase
or acquire, any shares. or securities or rights convertible into shares, of
capital stock of the Company. The Company has furnished or made available to
the Purchaser true and correct copies of the Company's Articles of
Organization as in effect on the date hereof (the "Charter"), and the
Company's By-Laws, as in effect on the date hereof (the "By-Laws").
(d) Issuance of Shares. The issuance of the Shares has been duly authorized
and, when paid for and issued in accordance with the terms hereof, the shall be
validly issued, fully paid and non-assessable and entitled to the rights and
preferences set forth in Schedule I hereto. The Common Stock issuable upon
conversion of the Shares will be duly authorized and reserved for issuance and,
upon conversion, will be validly issued, fully paid and non-assessable and the
holders shall be entitled to all rights and preferences accorded to a holder of
Common Stock.
(e) No Conflicts. The execution, delivery and performance of this Agreement
by the Company and the consummation by the Company of the transactions
contemplated hereby do not and will not (i) result in a violation of the
Company's Charter or By-Laws or (ii) conflict with, or constitute a default (or
an event which with notice or lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Company or
any of its subsidiaries is a party, or result in a violation of any federal,
state, local or foreign law, rule, regulation, order, judgment or decree
(including Federal and state securities laws and regulations) applicable to the
Company or any of its subsidiaries or by which any property or assets of the
Company or any of its subsidiaries is bound or affected (except for such
conflicts, defaults, terminations, amendments, accelerations, cancellations and
violations as would not, individually or in the aggregate, have a Material
Adverse Effect); provided that, for purposes of such representation as to
Federal, state, local or foreign law, rule or regulation, no representation is
made herein with respect to any of the same applicable solely to the Purchaser
and not to the Company. The business of the Company is not being conducted in
violation of any law, ordinance or regulations of any governmental entity,
except for violations which either singly or in the aggregate do not and will
not have a Material Adverse Effect. The Company is not required under Federal,
state or local law, rule or regulation in the United States to obtain any
consent, authorization or order of, or make any filing (other than any filing of
a vote establishing a class or series of stock with the Massachusetts Secretary
of State) or registration with, any court or governmental agency in order for it
to execute, deliver or perform any of its obligations under this Agreement or
issue and sell the Shares in accordance with the terms hereof (other than any
SEC, NASD or state securities filings which may be required to be made by the
Company subsequent to the Closing, and any registration statement which may be
filed pursuant hereto); provided that, for purposes of the representation made
in this sentence, the Company is assuming and relying upon the accuracy of the
relevant representations and agreements of the Purchaser herein.
(f) SEC Documents, Financial Statements. The Common Stock of the Company is
registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as
amended (the "Exchange Act") and, except as set forth in Exhibit B, the Company
has filed on a timely basis all reports, schedules, forms, statements and other
documents required to be filed by it with the SEC pursuant to the reporting
requirements of the Exchange Act, including material filed pursuant to Section
13(a) or 15(d), in addition to one or more registration statements and
amendments thereto heretofore filed by the Company with the SEC under the Act
(all of the foregoing including filings incorporated by reference therein being
referred to herein as the "SEC Documents"). The Company directly or through its
agent has delivered to the Purchaser true and complete copies of the SEC
Documents except for the exhibits and incorporated documents. The Company has
not provided to the Purchaser any information which, according to applicable
law, rule or regulation, should have been disclosed publicly by the Company but
which has not been so disclosed, other than with respect to the transactions
contemplated by this Agreement.
Except as set forth in Exhibit B, as of their respective dates the SEC
Documents complied in all material respects with the requirements of the Act or
the Exchange Act as the case may be and the rules and regulations of the SEC
promulgated thereunder and other federal, state and local laws, rules and
regulations applicable to such SEC Documents, and none of the SEC Documents
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading. Except as set forth in Exhibit B, the financial statements of the
Company included in the SEC Documents comply as to form in all material respects
with applicable accounting requirements and the published rules and regulations
of the SEC or other applicable rules and regulations with respect thereto. Such
financial statements have been prepared in accordance with generally accepted
accounting principles applied on a consistent basis during the periods involved
(except (i) as may be otherwise indicated in such financial statements or the
notes thereto or (ii) in the case of unaudited interim statements, to the extent
they may not include footnotes or may be condensed or summary statements) and
fairly present in all material respects the financial position of the Company as
of the dates thereof and the results of operations and cash flows for the
periods then ended (subject, in the case of unaudited statements, to normal
year-end audit adjustments).
(g) No Material Adverse Change. Since the date through which the most
recent quarterly report of the Company on Form 10-Q has been prepared and filed
with the SEC, a copy of which is included in the SEC Documents, no Material
Adverse Effect has occurred or exists with respect to the Company or any of its
subsidiaries.
(h) No Undisclosed Liabilities. The Company and its subsidiaries have no
material liabilities or obligations not disclosed in the SEC Documents, other
than those incurred in the ordinary course of the Company's or any of its
subsidiaries' respective businesses since the date of the most recently filed
SEC Documents which, individually or in the aggregate, do not or would not have
a Material Adverse Effect on the Company or any of its subsidiaries.
(i) No Undisclosed Events or Circumstances. No event or circumstance has
occurred or exists with respect to the Company or any of its subsidiaries or
their respective businesses, properties, prospects, operations or financial
condition which, under applicable law, rule or regulation, requires public
disclosure or announcement by the Company but which has not been so publicly
announced or disclosed.
(j) No General Solicitation. Neither the Company, nor any of its
affiliates, or, to the best of its knowledge, any person acting on its or their
behalf, has engaged in any form of general solicitation or general advertising
(within the meaning of Regulation D under the Act) in connection with the offer
or sale of the Shares.
(k) No Integrated Offering. Neither the Company, nor any of its affiliates,
nor any person acting on its or their behalf has, directly or indirectly, made
any offers or sales of any security or solicited any offers to buy any security,
under circumstances that would require registration of the Shares under the Act.
Section 3.1 Securities Compliance. The Company shall notify the SEC and
NASD, in accordance with their requirements, of the transactions contemplated by
this Agreement, and shall take all other necessary action and proceedings as may
be required and permitted by applicable law, rule and regulation, for the legal
and valid issuance of the Shares, and the Common Stock issuable upon conversion
thereof, to the Purchaser.
Section 3.2 Registration and Listing. Until. at least two (2) years after
all Shares have been converted into Registrable Securities, the Company will
cause its Common Stock to continue to be registered under Sections 12(b) or
12(g) of the Exchange Act, will comply in all respects with its reporting and
filing obligations under such Exchange Act, will comply with all requirements
related to any registration statement filed pursuant to this Agreement and will
not take any action or file any document (whether or not permitted by the Act or
the Exchange Act or the rules thereunder) to terminate or suspend such
registration or to terminate or suspend its reporting and filing obligations
under said Acts, except as permitted herein. Until at least two (2) years after
all Shares have been converted into Common Stock the Company will take all
action within its power to continue the listing or trading of its Common Stock
on the NASDAQ Small Cap Market and will comply in all respects with the
Company's reporting, filing and other obligations under the bylaws or rules of
the NASD and NASDAQ. The covenants set forth in this Section 3.2 shall not be
deemed to prohibit a merger, sale of all assets or other corporate
reorganization if the entity surviving or succeeding to the Company is bound by
this Agreement with respect to its securities issued in exchange for or in
replacement of the Shares or Common Stock or the consideration received for or
in replacement of the Shares or Common Stock is cash.
Section 3.3 Right of First Refusal and Most-Favored-Nation Clause. If at
any time during the period beginning on the fifth (5th) day prior to (but not
including) the Closing Date and ending sixty (60) days immediately following the
effective date of the Initial Registration, the Company proposes to issue Common
Stock or securities convertible into or exercisable for Common Stock or other
convertible securities, pursuant to an offering exempt from registration under
the Act, the Company shall provide to Purchaser reasonable advance notice of all
the terms of such proposed issuance. The Purchaser shall have the right to
purchase or refuse to purchase all or any part of such securities proposed to be
issued in such offering, and shall have at least seventy two (72) hours after
receipt of such notice to review the terms of the proposed issuance.
If the Company issues Common Stock or securities convertible into or
exercisable for Common Stock or other convertible securities, at a time when any
of the Shares remain outstanding, at an effective price per share of Common
Stock which is lower than the conversion price of the Shares at that time, then
the Company shall, within five (5) business days, deliver to each holder upon
conversion an additional number of shares of Common Stock necessary to reduce
the effective conversion price to such lower issue price. This Section shall not
be applicable to issuances of Common Stock pursuant to (a) any business
combination, acquisition transaction, stock or asset purchase undertaken by the
Company or (b) any shareholder-approved option plan covering not more than 10%
of the Company's outstanding stock.
Section 4.1 Conditions Precedent to the Obligation of the Company to Sell
the Shares. The obligation hereunder of the Company to issue and/or sell the
Shares to the Purchaser is subject to the satisfaction, at or before the
Closing, of each of the conditions set forth below. These conditions may be
waived by the Company at any time in its sole discretion.
(a) Accuracy of the Purchaser's Representations and Warranting. The
representations and warranties of the Purchaser shall be true and correct in all
material respects as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
particular date).
(b) Performance by the Purchaser. The Purchaser shall have performed all
agreements and satisfied all conditions required to be performed or satisfied by
the Purchaser at or prior to the Closing.
(c) No Injunction. No statute, rule, regulation. executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits
the consummation of any of the transactions contemplated by this Agreement.
(d) Legal action. No legal action, suit or proceeding shall be pending or
threatened which seeks to restrain or prohibit the transactions contemplated by
this Agreement.
(e) Execution. The Purchaser shall have executed this Agreement, and
delivered such Agreement to the Company.
(f) Purchase Price. The Purchaser shall have delivered the Purchase Price
in accordance with Section 1.3(b) above.
Section 4.2 Conditions Precedent to the Obligation of the Purchaser to
Purchase the Shares. The obligation hereunder of the Purchaser to acquire and
pay for the Shares is subject to the satisfaction, at or before the Closing, of
each of the conditions set forth below. These conditions may be waived by the
Purchaser at any time in its sole discretion.
(a) Accuracy of the Company's Representations and Warranties. The
representations and warranties of the Company shall be true and correct in all
material respects as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
particular date).
(b) Performance by the Company. The Company shall have performed all
agreements and satisfied all conditions required to be performed or satisfied by
the Company at or prior to the Closing.
(c) NASDAO. From the date hereof to the Closing Date, trading in the
Company's Common Stock shall not have been suspended by the SEC or the NASDAQ
Small Cap Market (except for any suspension of trading of limited duration
agreed to between the Company and the NASDAQ Small Cap Market solely to permit
dissemination of material information regarding the Company), and trading in
securities generally as reported by NASDAQ shall not have been suspended or
limited or minimum prices shall not have been established on
securities whose trades are reported by NASDAQ.
(d) No Injunction. No statute, rule, regulation, executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits
the consummation of any of the transactions contemplated by this Agreement.
(e) Opinion of Counsel Etc. The Purchaser shall have received before or at
the Closing an opinion of counsel to the Company (covering, without limitation,
such of the matters set forth in Section 2.2(a) through (e)), as are in form and
substance reasonably satisfactory to the Purchaser and its counsel, and such
other certificates and documents as the Purchaser or its counsel shall
reasonably require incident to the Closing.
(f) Execution. The Company shall have executed this Agreement, and
delivered such Agreement to the Purchaser.
Section 5.1 Legend on Stock. Each certificate representing the Shares and,
if necessary, Common Stock issued upon conversion thereof, shall be stamped or
otherwise imprinted with a legend substantially in the following form:
THESE SECURITIES [AND THE SHARES OF COMMON STOCK ISSUABLE UPON THE CONVERSION
HEREOF] HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD OR OFFERED FOR SALE UNLESS
THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND ANY APPLICABLE
STATE SECURITIES LAW OR, IN THE OPINION OF COUNSEL, REGISTRATION UNDER SUCH ACT
OR APPLICABLE STATE SECURITIES LAW IS NOT REQUIRED IN CONNECTION WITH SUCH SALE
OR OFFER, AND SUCH OPINION IS REASONABLY SATISFACTORY TO THE COMPANY.
The Company agrees to reissue certificates representing the Shares or, if
applicable, the Common Stock issued upon conversion thereof, without the legend
set forth above at such time as (a) the holder thereof is permitted to dispose
of such Shares (or securities issued upon conversion thereof) pursuant to Rule
144(k) under the Act, (b) the securities are sold to a purchaser or purchasers
who (in the opinion of counsel to such holders, in form and substance reasonably
satisfactory to the Company and its counsel) are able to dispose of such
securities publicly without registration under the Act, or (iii) such securities
are registered under the Act
Section 6.1 Termination by Mutual Consent. This Agreement may be terminated
at any time prior to the Closing by the mutual written consent of the Company,
and the Purchaser.
Section 6.2 Other Termination. This Agreement may be terminated by action
of the Board of Directors or other governing body of the Purchaser or the
Company at any time if the Closing shall not have been consummated by the fifth
(5th) business day following the date of this Agreement, provided that the party
seeking to terminate the Agreement is not in breach of the Agreement.
Section 6.3 Automatic Termination. This Agreement shall automatically
terminate without any further action of either party hereto if the Closing shall
not have occurred by the seventh (7th) business day following the date of this
Agreement, provided, however, that any such termination shall not terminate the
liability of any party which is then in breach of the Agreement.
Section 7.1 Fees and Expenses. Except as otherwise set forth in Section 1.4
hereof with respect to the registration of Registrable Securities, the Company
shall pay the fees, commissions and expenses of its advisers, brokers, finders,
counsel, accountants and other experts, if any, and all other expenses
associated therewith, and shall on the Closing Date reimburse ProFutures Special
Equities Fund, L.P. up to $5,000 for fees and expenses of its counsel in
connection with the preparation, negotiation and coordination of this Agreement.
The Company shall pay all stamp and other taxes and duties levied in connection
with the issuance of the Shares and Common Stock pursuant hereto.
Section 7.2 Specific Enforcement, Consent to Jurisdiction.
(a) The Company and the Purchaser acknowledge and agree that irreparable
damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that the parties shall be entitled to an
injunction or injunctions to prevent or cure breaches of the provisions of this
Agreement and to enforce specifically the terms and provisions hereof, this
being in addition to any other remedy to which either of them may be entitled by
law or equity.
(b) The Company and the Purchaser each (i) hereby irrevocably submits to
the jurisdiction of the United States District Court and other courts of the
United States sitting in the State of Texas for the purposes of any suit, action
or proceeding arising out of or relating to this Agreement and (ii) hereby
waives, and agrees not to assert in any such suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of such court, that
the suit, action or proceeding is brought in an inconvenient forum or that the
venue of the suit, action or proceeding is improper. The Company and the
Purchaser each consents to process being served in any such suit, action or
proceeding by mailing a copy thereof to such party at the address in effect for
notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing in this
paragraph shall affect or limit any right to serve process in any other manner
permitted by law.
Section 7.3 Entire Agreement: Amendment. This Agreement contains the entire
understanding of the parties with respect to the matters covered hereby and,
except as specifically set forth herein, neither the Company nor the Purchaser
makes any representation, warranty, covenant or undertaking with respect to such
matters. No provision of this Agreement may be waived or amended other than by a
written instrument signed by the party against whom enforcement of any such
amendment or waiver is sought.
Section 7.4 Notices. Any notice or other communication required or
permitted to be given hereunder shall be in writing and shall be effective (a)
upon hand delivery or delivery by telex (with correct answer back received),
telecopy or facsimile at the address or number designated below (if delivered on
a business day during normal business hours where such notice is to be
received), or the first business day following such delivery (if delivered other
than on a business day during normal business hours where such notice is to be
received) or (b) on the second (2nd) business day following the date of mailing
by express courier service, fully prepaid, addressed to such address, or upon
actual receipt of such mailing, whichever shall first occur.
The addresses for such communications shall be:
to the Company: Bruce A. Shear, President and Chief Executive Officer
PHC, Inc.
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
to the Purchaser: At the address set forth at the foot of this Agreement or
as specified in writing by Purchaser.
Any party hereto may from time to time change its address for notices by giving
at least ten (10) days' written notice of such changed address to the other
party hereto.
Section 7.5 Waivers. No waiver by either party of any default with respect
to any provision, condition or requirement of this Agreement shall be deemed to
be a continuing waiver in the future or a waiver of any other provision,
condition or requirement hereof, nor shall any delay or omission of either party
to exercise any right hereunder in any manner impair the exercise of any such
right accruing to it thereafter.
Section 7.6 Headings. The headings herein are for convenience only, do not
constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.
Section 7.7 Governing Law. This Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the present state
of incorporation of the Company without regard to such state's principles of
conflict of laws.
Section 7.8 Survival. The representations and warranties of the Company and
the Purchaser contained in herein and the agreements and covenants set forth in
Sections 1.1 through 1.5, 3.1 through 3.3 and 7.1 through 7.16 shall survive the
Closing for a period of two (2) years.
Section 7.9 Publicity. The Company agrees that it will not disclose, and
will not include in any public announcement, the name of the Purchaser without
its consent, unless and until such disclosure is required by law or applicable
regulation, and then only to the extent of such requirement.
Section 7.10 NASDAO. The term "NASDAQ" or "NASDAQ Small Cap Market" herein
refers to the principal market on which the Common Stock of the Company is
traded. If the Common Stock is listed on a securities exchange. or if another
market becomes the principal market on which the Common Stock is traded or
through which price quotations for the Common Stock are reported, the term
"NASDAQ" or "NASDAQ Small Cap Market" shall be deemed to refer to such exchange
or other principal market.
Section 7.11 Acceptance. Execution and delivery of this Agreement shall
constitute an offer to purchase the Shares, which offer, unless previously
revoked by the Purchaser, may be accepted or rejected by the Company, in its
sole discretion for any cause or for no cause and without liability to the
Purchaser. The Company shall indicate acceptance of this Agreement by signing as
indicated on the signature page hereof.
Section 7.12 Binding Agreement. Upon acceptance of this Agreement by the
Company, the Purchaser agrees that he may not cancel, terminate or revoke any
agreement of the Purchaser made hereunder, and that this Agreement shall survive
the death or disability of the Purchaser and shall be binding upon heirs,
successors, assigns, executors, administrators, guardians, conservators or
personal representatives of the Purchaser.
Section 7.13 Incorporation by Reference. All information set forth on the
signature page is incorporated as integral terms of this Agreement.
Section 7.14 Counterparts. This Agreement may be signed in multiple
counterparts, which counterparts shall constitute one and the same original
instrument.
Section 7.15 Severability. If any portion of this Agreement shall be held
illegal, unenforceable, void or voidable by any court each of the remaining
terms hereof shall nevertheless remain in full force and effect as a separate
contract.
Section 7.16 Successors and Assigns. This Agreement shall be binding upon
and inure to the benefit of the parties hereto and their respective successors
and permitted assigns.
[This space has been left blank intentionally. The signature page follows.]
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$500,000 (500 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
26,315 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
ProFutures Special Equities Fund, L.P.
Address of Purchaser: % ProFutures Fund Management, Inc.
1030 Highway 620 South - Suite 200
Austin, TX 78734
Social Security or IRS Employer Identification Number(s):
74-2786952
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
______________________________________________
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: ProFutures Special Equities Fund, L.P.
By ProFutures Fund Management, Inc., a General Partner
By: ______________________________________
(Signature)
Name: /s/ Gary D. Halbert
Title: President
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$150,000 (150 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
7,890 shares
The exact name(s)(Including correct,legible spelling) and the information under
which title to the Shares will be taken is as follows (Please print or type):
Gary D. Halbert
Address of Purchaser: 1030 Highway 620 South - Suite 200
Austin, TX 78734
Social Security or IRS Employer Identification Number(s):
451-96-0684
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
/s/ Gary D. Halbert
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: _______________________________________
By: ______________________________________
(Signature)
Name: ____________________________________________
Title: ____________________________________________
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$100,000 (100 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
5,260 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
John F. Mauldin
Address of Purchaser: 1000 Ballpark in Arlington - Suite 216
Arlington, TX 76011
Social Security or IRS Employer Identification Number(s):
459-84-6606
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
/s/ John F. Mauldin
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: ________________________________
By: ______________________________________
(Signature)
Name: _________________________________
Title: _________________________________
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$200,000 (200 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
10,525 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
Augustine Fund, L.P.
Address of Purchaser: 141 West Jackson Boulevard - Suite 2182
Chicago, IL 60604
Social Security or IRS Employer Identification Number(s):
36-418-6782
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
______________________________________________
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: Augustine Fund, L.P.
By Augustine Capital Management, Inc., the General Partner
By: ______________________________________
(Signature)
Name: /s/ Thomas Duszynski
Title: Chief Operating Officer
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
SCHEDULE I
PHC, INC.
RESOLUTIONS ESTABLISHING RIGHTS AND PREFERENCES
FOR SERIES B CONVERTIBLE PREFERRED STOCK
RESOLVED, that there shall be a series of shares of the Corporation
designated "Series B Convertible Preferred Stock"; that the number of shares of
such series shall be 1,000, that the Corporation issue such shares, and that the
rights and preferences of such series (the "6% Preferred") and the limitations
or restrictions thereon, shall be as set forth herein.
The following terms and conditions shall be adopted and incorporated by
reference into the foregoing resolutions as if fully set forth therein:
1. Dividends.
(a) The holders of the 6% Preferred shall be entitled to receive out of any
assets legally available therefor cumulative dividends at the rate of $60 per
share per annum, accrued daily and payable quarterly in arrears on March 31,
June 30, September 30 and December 31 of each year, in preference and priority
to any payment of any dividend on the Common Stock or any other class or series
of stock of the Corporation. Such dividends shall accrue on any given share from
the day of original issuance of such share and shall accrue from day to day
whether or not earned or declared. If at any time dividends on the outstanding
6% Preferred at the rate set forth above shall not have been paid or declared
and set apart for payment with respect to all preceding periods, the amount of
the deficiency shall be fully paid or declared and set apart for payment, but
without interest, before any distribution, whether by way of dividend or
otherwise, shall be declared or paid upon or set apart for the shares of any
other class or series of stock of the Corporation.
(b) Any dividend payable on a dividend payment date may be paid, at the
option of the Corporation, either (i) in cash or (ii) in shares of 6% Preferred
valued at $1,000 per share, if the Common Stock issuable upon conversion of such
shares has been registered for resale under the Securities Act of 1933, as
amended (the "Act"), and the registration statement including a current
prospectus with respect thereto remains in effect at the date of delivery of
such shares, and if the Corporation shall have given written notice of its
intention to pay such dividend in stock to all holders of the 6% Preferred at
least ten (10) days before the record date for such dividend.
2. Liquidation Preference, Redemption.
(a) In the event of any liquidation, dissolution or winding up of the
Corporation, either voluntary or involuntary, the holders of the 6% Preferred
shall be entitled to receive, prior and in preference to any distribution of any
assets of the Corporation to the holders of any other class or series of shares,
the amount of $1,000 per share plus any accrued but unpaid dividends (the
"Liquidation Preference").
(b) A consolidation or merger of the Corporation with or into any other
corporation or corporations, or a sale of all or substantially all of the assets
of the Corporation (other than a sale or transfer to a wholly-owned subsidiary
of the Corporation), shall, at the option of the holders of the 6% Preferred, be
deemed a liquidation, dissolution or winding up within the meaning of this
Section 2 if the shares of stock of the Corporation outstanding immediately
prior to such transaction represent immediately after such transaction less than
a majority of the voting power of the surviving corporation (or of the acquirer
of the Corporation's assets in the case of a sale of assets). Such option may be
exercised by the vote or written consent of holders of a majority of the 6%
Preferred at any time within thirty (30) days after written notice (which shall
be given promptly) of the essential terms of such transaction shall have been
given to the holders of the 6% Preferred in the manner provided by law for the
giving of notice of meetings of shareholders.
- 1 -
(c) The Corporation may, at its option, cause all outstanding shares of the
6% Preferred to be redeemed after the date on which a registration statement
under the Act ("Registration Statement") has been declared effective (the
"effective date"); provided the Corporation has given notice of its intention to
redeem to the holders of the 6% Preferred at least five (5) days prior to the
redemption date. In addition, if any conversion of 6% Preferred, when aggregated
with all prior conversions, will cause the Company to issue a number of shares
of Common Stock which exceeds twenty percent (20%) of the shares of Common Stock
then issued and outstanding, the Company shall redeem such number of shares of
6% Preferred as is necessary to limit such issuance of Common Stock to twenty
percent (20%) of the shares of Common Stock then issued and outstanding, unless
the Company has previously obtained stockholder approval to issue in excess of
twenty percent (20%) of the shares of Common Stock then issued and outstanding.
If a redemption will occur under either of the preceding sentences, on the
redemption date, the Corporation shall pay such holders by cashiers check or
wire transfer in immediately available funds the amount of $1,300 per share of
6% Preferred plus all accrued but unpaid dividends. Promptly thereafter, the
holders shall surrender the certificate or certificates representing the 6%
Preferred, duly endorsed, at the office of the Corporation or of any transfer
agent for such shares, or at such other place designated by the Corporation.
3. 6% Preferred - Forced Conversion.
(a) The Corporation may, at its option, cause all outstanding shares of the
6% Preferred to be converted into Common Stock at any time beginning one (1)
year after the date of issuance, on at least twenty (20) days' advance notice,
at a conversion price determined as set forth in Section 4 hereof (the
"Conversion Price") as of the date specified in such notice (the "Conversion
Date") and otherwise on the terms set forth in Section 4 hereof, provided, that
the Corporation may not exercise such right of conversion unless (i) the Closing
Price (last trade price) of the Common Stock as reported by NASDAQ for the
twenty (20) consecutive trading days prior to the date the Conversion Notice is
mailed has not on any day been less than one hundred forty percent (140%) of the
last trade price of the Company's Common Stock on the day of Closing (subject to
adjustment for stock dividends, stock splits and reverse stock splits), and (ii)
the shares issuable upon conversion of the 6% Preferred are registered for
resale by an effective Registration Statement which became effective not more
than one hundred twenty (120) days after the date of issuance of the 6%
Preferred, and a current prospectus meeting the requirements of Section 10 of
the Act is available for delivery at the Conversion Date.
(b) At least twenty (20) days prior to the Conversion Date, written notice
(the "Conversion Notice") shall be mailed, first class postage prepaid, by the
Corporation to each holder of record of the 6% Preferred, at the address last
shown on the records of the Corporation for such holder, notifying such holder
of the conversion which is to be effected, specifying the Conversion Date and
calling upon each such holder to surrender to the Corporation, in the manner and
at the place designated, a certificate or certificates representing the number
of shares of 6% Preferred held by such holder. Subject to the provisions of the
following subsection (c), on or after the Conversion Date, each holder of 6%
Preferred shall surrender to the Corporation the certificate or certificates
representing the shares of 6% Preferred owned by such holder as of the
Conversion Date, in the manner and at the place designated in the Conversion
Notice, and thereupon the shares issuable upon such conversion shall be
delivered as provided in Section 4(b) hereof.
(c) If, on the Conversion Date, the registration condition specified in
clause (ii) of subsection (a) shall not be satisfied, then no shares shall be
converted and the Conversion Notice shall be deemed to be withdrawn. In such
event, any certificates for 6% Preferred which have been surrendered for
conversion shall be returned to the persons surrendering the same; provided,
however, that if a holder has received shares of Common Stock upon conversion of
6% Preferred after the Conversion Notice was given but before the Conversion
Date, such holder may elect either to retain such Common Stock or rescind such
conversion by tendering such shares of Common Stock to the Corporation.
(d) On the second anniversary of the issuance of the 6% Preferred, all then
outstanding shares of 6% Preferred shall be automatically converted into Common
Stock at the Conversion Price and otherwise pursuant to the applicable
provisions set forth in Section 4 hereof.
- 2 -
4. 6% Preferred - Optional Conversion. The holders of the 6% Preferred
shall have optional conversion rights as follows:
(a) Right to Convert. At any time after the earlier of (i) the date on
which a Registration Statement has been declared effective, or (ii) the close of
business on the ninety first (91st) day following the date of issuance of the 6%
Preferred, shares of 6% Preferred shall become convertible, at the option of the
holder thereof, into such number of fully paid and nonassessable shares of
Common Stock as is determined by dividing (A) the Liquidation Preference of the
6% Preferred determined pursuant to Section 2 hereof on the date the notice of
conversion is given, by (B) the Conversion Price determined as hereinafter
provided in effect on the applicable conversion date.
(b) Mechanics of Conversion. To convert shares of 6% Preferred into shares
of Common Stock, the holder shall give written notice to the Corporation (which
notice may be given by facsimile transmission) that such holder elects to
convert the shares and shall state therein date of the conversion, the number of
shares to be converted and the name or names in which such holder wishes the
certificate or certificates for shares of Common Stock to be issued. Promptly
thereafter, the holder shall surrender the certificate or certificates
representing the shares to be converted, duly endorsed, at the office of the
Corporation or of any transfer agent for such shares, or at such other place
designated by the Corporation; provided that the holder shall not be required to
deliver the certificates representing such shares if the holder is waiting to
receive all or part of such certificates from the Corporation. The Corporation
shall, immediately upon receipt of such notice, issue and deliver to or upon the
order of such holder, against delivery of the certificates representing the
shares which have been converted, a certificate or certificates for the number
of shares of Common Stock to which such holder shall be entitled and such
certificate or certificates shall not bear any restrictive legend; provided (A)
the Common Stock evidenced thereby are sold pursuant to an effective
registration statement under the Act, (B) the holder provides the Corporation
with an opinion of counsel reasonably acceptable to the Corporation to the
effect that a public sale of such shares may be made without registration under
the Act, or (C) such holder provides the Corporation with reasonable assurance
that such shares can be sold free of any limitations imposed by Rule 144,
promulgated under the Act. The Corporation shall cause such issuance and
delivery to be effected within three (3) business days and shall transmit the
certificates by messenger or overnight delivery service to reach the address
designated by such holder within three (3) business days after the receipt of
such notice. The notice of conversion may be given by a holder at any time
during the day up to 5:00 p.m. Boston, Massachusetts time and such conversion
shall be deemed to have been made immediately prior to the close of business on
the date such notice of conversion is given (a "conversion date"). The person or
persons entitled to receive the shares of Common Stock issuable upon such
conversion shall be treated for all purposes as the record holder or holders of
such shares of Common Stock at the close of business on such date.
(c) Conversion, Redemption and Note Delivery Required. The Corporation
acknowledges and understands that a delay in the issuance of the Common Stock
upon conversion or pursuant to a redemption according to the provisions hereof,
or a delay in delivering the Promissory Note set forth in Subsection (d) hereof,
could result in economic loss to the holders of the 6% Preferred. As
compensation to any holder when the Corporation has failed with respect to such
holder to comply with the Corporation's obligations hereunder, and not as a
penalty, the Corporation shall pay to such holder liquidated damages of $500 per
day plus an amount equal to: (i) two percent (2%) of the total Purchase Price of
Shares for the first thirty (30) day period after the date on which the Common
Stock should have been issued by the Corporation (i.e., the end of the three (3)
business day period described in Subsection (b)), shares of 6% Preferred
redeemed by the Corporation or Promissory Note delivered to holder (i.e., the
end of the three (3) business day period described in Subsection (d)), as
applicable; plus (ii) an amount equal to three percent (3%) of the total
Purchase Price of Shares for each subsequent thirty (30) day period thereafter.
Amounts payable shall be pro-rated daily as to a periods of less than thirty
(30) days. Such amounts shall be paid to the holder at the end of each month in
which such amounts have accrued. Payment shall be made immediately by cashier's
check or wire transfer in immediately available funds to such account as shall
be designated in writing by the holder. Each holder shall be entitled to an
injunction or injunctions to prevent or cure breaches of the provisions of
hereof and. to enforce specifically the terms and provisions hereof, this being,
in addition to any other remedy to which a holder may be entitled by law or
equity.
- 3 -
(d) Determination of Conversion Price:
(i )The "Conversion Price" for purposes of hereof shall be equal to eighty
percent (80%) of the average of the closing bid prices of the Common Stock as
reported by NASDAQ during the five (5) consecutive trading days preceding the
conversion date (but not including such date); provided, however, that in no
event may the Conversion Price be more than three dollars and twenty cents
($3.20) (the "Maximum Conversion Price") or less than an amount equal to the
closing bid price per share of the Common Stock on the date of issuance minus
fifty cents ($0.50) (the "Minimum Conversion Price"). If, but for this Section
4(d)(i), the Conversion Price would have been below Minimum Conversion Price,
the Company shall pay the holder by delivering to holder a Promissory Note, the
form which has been delivered to the Corporation and is incorporated herein by
reference, bearing the principal amount equal to the difference between (A) the
number of shares of Common Stock that would have been issued at the amount the
Conversion Price would have been but for this Section 4(d)(i) multiplied by 100%
of the closing bid price of the Common Stock on the conversion date as
determined in accordance with the Subsection (d) (the latter amount being
referred to herein as the "Conversion Date Price"), minus (B) the number of
shares of Common Stock actually issued pursuant to the conversion multiplied by
the Conversion Date Price. Such Promissory Note shall be delivered to holder by
the third (3rd) day following the applicable conversion date.
(ii) The "closing bid price" of the Common Stock on a trading day shall be
the closing bid price of the Common Stock on the NASDAQ Small Cap Market or any
other principal securities price quotation system or market on which prices of
the Common Stock are reported. The term "trading day" means a day on which
trading is reported on the principal quotation system or market on which prices
of the Common Stock are reported.
(iii) If, during the period of consecutive trading days provided for above,
the Corporation shall declare or pay any dividend on the Common Stock payable in
Common Stock or in rights to acquire Common Stock, or shall effect a stock split
or reverse stock split, or a combination, consolidation or reclassification of
the Common Stock, the Conversion Price, Maximum Conversion Price and Minimum
Conversion Price shall be proportionately decreased or increased, as
appropriate, to give effect to such event.
(e) Distributions. If the Corporation shall at any time or from time to
time make or issue, or fix a record date for the determination of holders of
Common Stock entitled to receive, a dividend or other distribution payable in
securities of the Corporation or any of its subsidiaries other than additional
shares of Common Stock, then in each such event provision shall be made so that
the holders of 6% Preferred shall receive, upon the conversion thereof, the
securities of the Corporation which they would have received had they been the
owners on the date of such event of the number of shares of Common Stock
issuable to them upon conversion.
(f) Certificates as to Adjustments. Upon the occurrence of any adjustment
or readjustment of the Conversion Price, the Maximum Conversion Price and
Minimum Conversion Price pursuant to this Section 4, the Corporation at its
expense shall promptly compute such adjustment or readjustment in accordance
with the terms hereof and cause the independent public accountants regularly
employed to audit the financial statements of the Corporation to verify such
computation and prepare and furnish to each holder of 6% Preferred a certificate
setting forth such adjustment or readjustment and showing in detail the facts
upon which such adjustment or readjustment is based. The Corporation shall, upon
the written request at any time of any holder of 6%. Preferred, furnish or cause
to be furnished to such holder a like certificate prepared by the Corporation
setting forth (i) such adjustments and readjustments, and (ii) the number of
other securities and the amount, if any, of other property which at the time
would be received upon the conversion of 6% Preferred with respect to each share
of Common Stock received upon such conversion.
(g) Notice of Record Date. In the event of any taking by the Corporation of
a record of the holders of any class of securities for the purpose of
determining the holders thereof who are entitled to receive any dividend (other
than a cash dividend) or other distribution, any security or right convertible
into or entitling the holder thereof to receive additional shares of Common
Stock, or any right to subscribe for, purchase or otherwise acquire any shares
of stock of any class or any other securities or property, or to receive any
other right, the Corporation shall mail to each holder of 6% Preferred at least
ten (10) days prior to the date specified therein, a notice specifying the date
on which any such record is to be taken for the purpose of such dividend,
distribution, security or right and the amount and character of such dividend,
distribution, security or right.
- 4 -
(h) Issue Taxes. The Corporation shall pay any and all issue and other
taxes, excluding any income, franchise or similar taxes, that may be payable in
respect of any issue or delivery of shares of Common Stock on conversion of
shares of 6% Preferred pursuant hereto; provided, however, that the Corporation
shall not be obligated to pay any transfer taxes resulting from any transfer
requested by any holder in connection with any such conversion.
(i) Reservation of Stock Issuable Upon Conversion. The Corporation shall at
all times reserve and keep available out of its authorized but unissued shares
of Common Stock, solely for the purpose of effecting the conversion of the
shares of the 6% Preferred, such number of its shares of Common Stock as shall
from time to time be sufficient to effect the conversion of all outstanding
shares of the 6% Preferred, and if at any time the number of authorized but
unissued shares of Common Stock shall not be sufficient to effect the conversion
of all then outstanding shares of the 6% Preferred, the Corporation will take
such corporate action as may be necessary to increase its authorized but
unissued shares of Common Stock to such number of shares as shall be sufficient
for such purpose, including, without limitation, engaging in best efforts to
obtain any requisite shareholder approval.
(j) Fractional Shares. No fractional shares shall be issued upon the
conversion of any share or shares of 6% Preferred. All shares of Common Stock
(including fractions thereof) issuable upon conversion of more than one share of
6% Preferred by a holder thereof shall be aggregated for purposes of determining
whether the conversion would result in the issuance of any fractional share. If,
after the aforementioned aggregation, the conversion would result in the
issuance of a fraction of a share of Common Stock, the Corporation shall, in
lieu of issuing any fractional share, pay the holder otherwise entitled to such
fraction a sum in cash equal to the fair market value of such fraction on the
date of conversion (as determined in good faith by the Board of Directors of the
Corporation or an authorized Committee thereof).
(k) Notices. Any notice required by the provisions of this Section to be
given to the holders of shares of 6% Preferred shall be deemed given if
deposited in the United States mail, postage prepaid, and addressed to each
holder of record at its address appearing on the books of the Corporation.
(1) Reorganization or Merger. In case of any reorganization or any
reclassification of the capital stock of the Corporation or any consolidation or
merger of the Corporation with or into any other corporation or corporations or
a sale of all or substantially all of the assets of the Corporation to any other
person (other than a sale or transfer to a wholly owned subsidiary of the
Corporation), and the holders of 6% Preferred do not elect to treat such
transaction as a liquidation, dissolution or winding up as provided in Section 2
hereof, then, as part of such reorganization, consolidation, merger or sale,
provision shall be made so that each share of 6% Preferred shall thereafter be
convertible into the number of shares of stock or other securities or property
(including cash) to which a holder of the number of shares of Common Stock
deliverable upon conversion of such share of 6% Preferred would have been
entitled upon the record date of (or date of, if no record date is fixed) such
event and, in any case, appropriate adjustment (as determined by the Board of
Directors) shall be made in the application of the provisions herein set forth
with respect to the rights and interests thereafter of the holders of the 6%
Preferred, to the end that the provisions set forth herein shall thereafter be
applicable, as nearly as equivalent as is practicable, in relation to any shares
of stock or the securities or property (including cash) thereafter deliverable
upon the conversion of the shares of 6% Preferred.
5. Re-issuance of Certificates. In the event of a conversion (or, if
applicable, redemption) of 6% Preferred in which less than all of the shares of
6% Preferred of a particular certificate are converted or redeemed, as the case
may be, the Corporation shall promptly without delay cause to be issued and
delivered to the holder of such certificate, a certificate representing the
remaining shares of 6% Preferred which have not been so
converted or redeemed.
- 5 -
6. Other Provisions. For all purposes of this Resolution, the term "date of
issuance" and the terms "Closing" or "Closing Date" shall mean the day on which
shares of the 6% Preferred are first issued by the Corporation. Any provision
herein which conflicts with or violates any applicable usury law shall be deemed
modified to the extent necessary to avoid such conflict or violation. The term
"NASDAQ" herein refers to the principal market on which the Common Stock of the
Corporation is traded. If the Common Stock is listed on a securities exchange,
or if another market becomes the principal market on which the Common Stock is
traded or through which price quotations for the Common Stock are reported, the
term "NASDAQ" shall be deemed to refer to such exchange or other principal
market.
7. Restrictions and Limitations. The Corporation shall not undertake the
following actions without the consent of the holders of a majority of the 6%
Preferred: (i) modify its Articles of Organization or Bylaws so as to amend or
change any of the rights, preferences, or privileges of the 6% Preferred, (ii)
authorize or issue any other preferred equity security senior to or on a parity
with the 6% Preferred as to dividends, liquidation preferences, conversion
rights, redemption rights or other rights, preferences or privileges for a
period of thirty (30) days after Closing, as applicable or (iii), purchase or
otherwise acquire for value any Common Stock or other equity security of the
Corporation either junior or senior to or on a parity with the 6% Preferred
while there exists any arrearage in the payment of cumulative dividends
hereunder other than redemptions of stock from terminating employees pursuant to
contractual rights in favor of the Corporation.
8. Voting Rights. Except as provided herein or as provided for by law, the
6% Preferred shall have no voting rights.
9. Attorney's Fees. Any holder of 6% Preferred shall be entitled to recover
from the Corporation the reasonable attorneys' fees and expenses incurred by
such holder in connection with enforcement by such holder of any obligation of
the Corporation hereunder.
10. No Adverse Actions. The Corporation shall not in any manner, whether by
amendment of the Articles of Organization (including, without limitation, any
vote establishing a class or series of stock), merger, reorganization,
recapitalization, consolidation, sales of assets, sale of stock tender offer,
dissolution or otherwise, take any action, or permit any action to be taken,
solely or primarily for the purpose of increasing the value of any class of
stock of the Corporation if the effect of such action is to reduce the value or
security of the 6% Preferred.
- 6 -
EXHIBIT A to the Subscription Agreement
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON
STOCK PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March ___, 1998
1. Basic Terms. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the registered holder specified
below or its registered assigns ("Holder"), is the owner of warrants of PHC,
Inc., a Massachusetts corporation (the "Corporation"), and is entitled, subject
to the terms and conditions of this Warrant, including adjustments as provided
herein, to purchase ______ ( ) (number to be pro-rated for a total of 50,000
share) shares of the Common Stock (the "Common Stock") of the Corporation from
the Corporation at the price per share shown below (the "Exercise Price").
Holder:
Exercise Price per share: ______ Dollars and ______
Cents ($ )per share
[This amount will be the Closing Bid Price of the
Corporation's Common Stock on the Issue Date]
Except as specifically provided otherwise, all references in this Warrant
to the Exercise Price and the number of shares of Common Stock purchasable
hereunder shall be to the Exercise Price and number of shares after any
adjustments are made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The Corporation represents and
covenants that the shares of Common Stock issuable upon the exercise of this
Warrant shall at delivery be fully paid and non-assessable and free from taxes,
liens, encumbrances and charges with respect to their purchase. The Corporation
shall take any necessary actions to assure that the par value per share of the
Common Stock is at all times equal to or less than the then current Exercise
Price per share of Common Stock issuable pursuant to this Warrant. The
Corporation shall at all times reserve and hold available sufficient shares of
Common Stock to satisfy all conversion and purchase rights of outstanding
convertible securities, options and warrants of the Corporation, including this
Warrant.
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the issue date.
To exercise this Warrant, the Holder shall surrender this Warrant at the
principal office of the Corporation or that of the duly authorized and acting
transfer agent for its Common Stock, together with the executed exercise form
(substantially in the form of that attached hereto) and together with payment
for the Common Stock purchased under this Warrant. The principal office of the
Corporation is located at the address specified on the signature page of this
Warrant; provided, however, that the Corporation may change its principal office
upon notice to the Holder. At the option of the Holder payment shall be made
either in cash (by wire) or by certified or bank cashier's check payable to the
order of the Corporation or the Holder may elect to receive shares of Common
Stock calculated pursuant to paragraph 4. The Corporation shall, immediately
upon receipt of such notice, issue and deliver to or upon the order of such
Holder a certificate or certificates for the number of shares of Common Stock to
which such Holder shall be entitled and such certificate or certificates shall
not bear any restrictive legend; provided (A) the Common Stock evidenced thereby
are sold pursuant to an effective registration statement under the Act, (B) the
holder provides the Corporation with an opinion of counsel reasonably acceptable
to the Corporation to the effect that a public sale of such shares may be made
without registration under the Act, or (C) such holder provides the Corporation
with reasonable assurance that such shares can be sold free of any limitations
imposed by Rule 144, promulgated under the Act. The Corporation shall cause such
issuance and delivery to be effected within three (3) business days and shall
transmit the certificates by messenger or overnight delivery service to reach
the address designated by such holder within three (3) business days after the
receipt of such notice. This Warrant is not exercisable with respect to a
fraction of a share of Common Stock. In lieu of issuing a fraction of a share
remaining after exercise of this Warrant as to all full shares covered by this
Warrant the Corporation shall either at its option (a) pay for the fractional
share cash equal to the same fraction at the fair market price for such share;
or (b) issue scrip for the fraction in the registered or bearer form which shall
entitle the Holder to receive a certificate for a full share of Common Stock on
surrender of scrip aggregating a full share. As compensation to the Holder when
the Corporation has failed with respect to such Holder to comply with the
Corporation's obligations hereunder, and not as a penalty, the Corporation shall
pay to such holder liquidated damages of $500 per day until the certificates are
delivered as instructed. Such damages shall be paid to the Holder by cashiers
check or wire transfer in immediately available funds to such account as shall
be designated in writing by the Holder at the end of each month in which such
amounts have accrued. Holder shall be entitled to an injunction or injunctions
to prevent or cure breaches of the provisions of hereof and to enforce
specifically the terms and provisions hereof, this being in addition to any
other remedy to which Holder may be entitled by law or equity.
4. Cashless Exercise.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or
quoted in the NASDAQ System or the domestic over-the-counter market, the fair
market value shall be the higher of (i) the book value thereof, as determined by
any firm of independent public accountants of recognized standing selected by
the Corporation (which may be the Corporation's regular independent
accountants), as of the last day of any month ending within sixty days preceding
the date as of which the determination is to be made; or (ii) the fair market
value thereof, which shall be reasonably determined by the Corporation and the
Holder as of a date which is within fifteen days of the date as of which the
determination is to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that
price determined by multiplying the Exercise Price in effect immediately prior
to such event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number an kind of securities or other
property purchasable under this Warrant resulting from the event and settin
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until,
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant.All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the
Holder.
PHC, INC., a Massachusetts corporation
By: ________________________________
Authorized Officer
Printed Name: _______________________
Title: ______________________________
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ________________________________
________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________ ____________________________________
Signature
- 8 -
Incorporated by Reference into the Resolutions Establishing Right and
Preferences for Series B Convertible Preferred Stock.
PROMISSORY NOTE (the "Note")
Date: __________________, ________________________
Maker: PHC, Inc.
Maker's Mailing Address: 200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
Payee:
Place for Payment:
Principal Amount: $_________________________________
Annual Interest Rate on Unpaid Principal From Date: Eight percent (8%).
Annual Past Due Interest Rate on Unpaid Principal from Maturity to Payment:
Fifteen percent (15%).
Terms of Payment: Principal and interest shall be due and payable in six (6)
equal consecutive monthly payments of $ ________________ (based on a six (6)
month amortization) with the first payment being due and payable on the first
day of _____________________.
The Maker promises to pay to the order of Payee at the place for payment and
according to the terms of payment the outstanding principal and accrued interest
at the rates stated above. All unpaid amounts owing on this Note shall be due by
the final scheduled payment date of ________________________.
Additional Provisions:
If Maker defaults in the payment of this Note, or in any instrument securing or
collateral to it, then Payee may declare the unpaid principal balance of this
Note and all accrued interest immediately due and payable. Maker and each
surety, endorser, and guarantor or other party liable for the payment of any
sums of money payable on this Note severally waive all demands for payment,
presentations for payment, notices of dishonor, notices of intention to
accelerate maturity, notices of acceleration of maturity, protests, and notices
of protest, to the extent permitted by law.
If this Note or any instrument securing or collateral to it is given to an
attorney for collection or enforcement. or if suit is brought for collection or
enforcement or if it is collected or enforced through probate, bankruptcy, or
other judicial proceedings then Maker shall pay Payee all costs of collection
and enforcement, including reasonable attorneys fees and court costs, in
addition to other amounts due.
PHC. INC., PROMISSORY NOTE
Page 1
Interest that may be contracted for, taken, reserved, charged or received
under law; any interest in excess of that maximum amount shall be credited on
the principal of the debt or, if that has been paid, refunded. On any
acceleration or required or permitted prepayment, any such excess shall be
canceled automatically as of the acceleration or prepayment or, if already paid,
credited on the principal of the debt or, if the principal of the debt has been
paid, refunded. This provision overrides other provisions in this and all other
instruments concerning the debt.
When the context requires, singular nouns and pronouns include the plural.
This Note is to be governed and construed in accordance with the laws of
the State of Texas.
MAKER, FOR GOOD AND VALUABLE CONSIDERATION, THE RECEIPT AND SUFFICIENCY OF
WHICH ARE HEREBY ACKNOWLEDGED, (I) HEREBY IRREVOCABLY SUBMITS TO THE
JURISDICTION OF THE UNITED STATES DISTRICT COURT AND OTHER COURTS OF THE UNITED
STATES SITTING IN TEXAS FOR THE PURPOSES OF ANY SUIT, ACTION OR PROCEEDING
ARISING OUT OF OR RELATING TO THIS AGREEMENT AND (ii) HEREBY WAIVES, AND AGREES
NOT TO ASSERT IN ANY SUCH SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT
PERSONALLY SUBJECT TO THE JURISDICTION OF SUCH COURT, THAT THE SUIT, ACTION OR
PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR THAT THE VENUE OF THE SUIT,
ACTION OR PROCEEDING IS IMPROPER. MAKER CONSENTS TO PROCESS BEING SERVED IN ANY
SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF TO MAKER AT ITS MAIN
BUSINESS OFFICE AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND
SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING IN THIS PARAGRAPH
SHALL AFFECT OR LIMIT ANY RIGHT TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED
BY LAW.
Executed as of date first above written.
PHC Inc., a Massachusetts corporation
By: _______________________________________
Name of
Authorized Officer: __________________________
Title: ______________________________________
PHC. INC., PROMISSORY NOTE
Page 2
EXHIBIT B to the Subscription Agreement
Section 2.2(a): PHC, Inc. Subsidiaries:
PHC of Utah, Inc. Pioneer Counseling of Virginia, Inc.
D/B/A Highland Ridge Hospital (80% Owned)
4578 Highland Drive D/B/A Pioneer Counseling of Virginia
Salt Lake City, UT 94117 D/B/A Counseling Associates of Virginia
400 East Burwell street
Salem, VA 24153
PHC of Virginia, Inc. PHC of Kansas, Inc.
D/B/A Mount Regis Center D/B/A Total Concept EAP
D/B/A Changes 7451 Szwitzer, Suite 101
405 Kimball Avenue Shawnee Mission, KS 66203
Salem, VA 24153
Quality Care Centers of Mass, Inc. PHC of California, Inc.
D/B/A Franvale Nursing & Rehab Center D/B/A Marin Grove
20 Pond Street 42 Grove Street
Braintree, MA 02194 San Rafael, CA 94901
PHC of Nevada, Inc. Professional Health Associates
D/B/A Harmony Healthcare 94-19 59 Avenue
2340 Paseo del Prado, Bldg.D Elmhum NY 11373
Las Vegas, NV 89102
Northpoint - Pioneer, Inc. STL, Inc.
D/B/A Pioneer Counseling Center 200 Lake Street
31700 W. 13 Mile; Suite 201 Suite 102
Farmington Hills, MI 48334 Peabody, MA 0 1960
BSC-NY, Inc. Harmony Behavioral Health
D/B/A Behavioral Stress Center 2340 Paseo del Prado, Bldg.D
94-19 59 Avenue Las Vegas, NV 89102
Elmhurst, NY 11373
PHC of Michigan, Inc. PHC of Rhode island, Inc.
D/B/A Harbor Oaks Hospital D/B/A Good Hope Center
35031 23 Mile Road P.O. Box 1491
New Baltimore, MI 48047 Coventry, RI 02816-0029
EXHIBIT B (cont'd.)
Section 2.2(f):
The Company failed to file two years' of audited financial statements for
Behavioral Stress Centers, Inc. and Clinical Diagnostics and Clinical
Associates, as described in the December 18, 1996 letter from Choate, Hall &
Stewart to Mr. Robert Bayless of the Securities and Exchange Commission.
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns "Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Twenty Six Thousand Three Hundred Fifteen (26,315) shares of Class A
Common Stock (the "Common Stock") of the Corporation from the Corporation at the
price per share shown below (the "Exercise Price").
Holder: ProFutures Special Equities Fund, L.P.
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporations Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading shall be average of the
closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at he end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant,. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ______________________ _____________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________ __________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Seven Thousand Eight Hundred Ninety (7,890) shares of Class A Common
Stock (the "Common Stock") of the Corporation from the Corporation at the price
per share shown below (the "Exercise Price").
Holder: Gary D. Halbert
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock s at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDA", the average of the daily market prices of such stock on the ten
(10) trading days immediately preceeding the date as of which such value is to
be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restriction s on transfer contained herein, in the names designated by the
Holder at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement hall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
-6-
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ________________________ ________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________________
__________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Five Thousand Two Hundred Sixty (5,260) shares of Class A Common Stock
(the "Common Stock") of the Corporation from the Corporation at the price per
share shown below (the "Exercise Price").
Holder: John F. Mauldin
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. he Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashiers check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted t be given to the Holder shall
be in writing and shall be given by first class mail, postage repaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: _________________________ _____________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: _________________________ ____________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Ten Thousand Five Hundred Twenty Five (10,525) shares of Class A Common
Stock (the "Common Stock") of the Corporation from the Corporation at the price
per share shown below (the "Exercise Price").
Holder: Augustine Fund, L.P.
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDA"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of
1933, as amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ______________________ ________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: _________________________ _________________________________
Signature
- 8 -
Exhibit 10.133
ASSET PURCHASE AGREEMENT
This Asset Purchase Agreement is made and entered into as of the 2nd day of
February, 1998, by and between Lexington Healthcare Group, Inc., a Delaware
corporation having its principal place of business at 35 Park Place, New
Britain, Connecticut 06052 (together with its successors and assigns hereinafter
collectively referred to as the "Buyer"), and Quality Care Centers of
Massachusetts, a Massachusetts corporation having its principal place of
business at 200 Lake Street, Suite 102, Peabody, Massachusetts 01960 (together
with its successors and assigns hereinafter collectively referred to as the
"Seller").
W I T N E S S E T H:
WHEREAS, the Seller owns and leases certain assets in connection with, and
operates the 128-bed licensed skilled nursing care facility known as, Franvale
Nursing and Rehabilitation Center at 20 Pond Street, Braintree, Massachusetts
02184 (the "Facility"); and
WHEREAS, the Buyer desires to acquire from the Seller, and the Seller
desires to sell to the Buyer, certain of the assets of the Seller used in
connection with the operation of the Facility, all upoExhibit 4.28
SUBSCRIPTION AGREEMENT
PHC, INC.
THE SECURITIES WHICH ARE THE SUBJECT OF THIS SUBSCRIPTION AGREEMENT (AS IT MAY
BE AMENDED FROM TIME TO TIME, THE "AGREEMENT") HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR UNDER THE
APPLICABLE SECURITIES LAWS OF ANY STATE AND WILL BE OFFERED AND SOLD IN RELIANCE
ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THESE LAWS BY VIRTUE OF PHC,
INC.'S INTENDED COMPLIANCE WITH SECTIONS 3(b), 4(2) AND 4(6) OF THE SECURITIES
ACT, THE PROVISIONS OF REGULATION D UNDER SUCH ACT AND SIMILAR EXEMPTIONS UNDER
STATE LAW. THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE U.S.
SECURITIES AND EXCHANGE COMMISSION ("SEC"), ANY STATE SECURITIES COMMISSION OR
ANY OTHER REGULATORY AUTHORITY. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.
The undersigned purchaser (hereafter, the "Purchaser") hereby offers to
purchase certain Series B Convertible Preferred Stock (referred to herein as a
"Share" or collectively as "Shares") of PHC, Inc. (the "Company"), a publicly
held corporation formed under the laws of the Commonwealth of Massachusetts.
This offer to purchase may, for any reason whatsoever, be revoked by the
Purchaser or rejected by the Company prior to acceptance of this offer by the
Company.
Section 1.1 Purchase and Sale of Shares. Upon the following terms and
conditions, the Company shall issue and sell to the Purchaser, and the Purchaser
shall purchase from the Company, the number of Shares indicated herein, which
Shares shall have the rights, designations and preferences set forth in Schedule
I hereto.
Section 1.2 Purchase Price. The purchase price for the Shares (the
"Purchase Price") shall be $1,000 per Share.
Section 1.3 The Closing.
(a) The closing of the purchase and sale of the Shares (the "Closing"),
shall take place at the law offices of Arent, Fox, Kintner, Plotkin & Kahn, 1050
Connecticut Avenue, N.W., Washington, D.C. 20036, at 10:00 a.m., local
Washington, D.C. time, on the later of the following: (i) the date on which the
last to be fulfilled or waived of the conditions set forth in Section 4.1 and
4.2 hereof and applicable to the Closing shall be fulfilled or waived in
accordance herewith, or (ii) such other time and place and/or on such other date
as the Purchaser and the Company may agree. The date on which the Closing occurs
is referred to herein as the "Closing Date."
(b) On the Closing Date, the Company shall deliver to the Purchaser (i) a
certificate representing the Shares registered in the name of the Purchaser or
deposit such Shares into accounts designated by the Purchaser and (ii) the
Warrant for the number of shares of the Company's Common Stock indicated herein,
in the form attached hereto as Exhibit A, incorporated herein by reference. The
Purchaser shall on the Closing Date deliver to the Company the Purchase Price
for all the Shares by cashier's check or wire transfer in immediately available
funds to such account as shall be designated in writing by the Company. In
addition, each party shall deliver all documents, instruments and writings
required to be delivered by such party pursuant to this Agreement at or prior to
the Closing.
Section 1.4 Covenant to Register.
(a) For purposes of this Section, the following definitions shall apply:
The terms "register," "registered," and "registration" refer to a
registration under the Securities Act of 1933, as amended (the "Act"), effected
by preparing and filing a registration statement or similar document in
compliance with the Act, and the declaration or ordering of effectiveness of
such registration statement, document or amendment thereto.
(ii) The term "Registrable Securities" means the shares of the Company's
Class A Common Stock, par value $.01 per share (the "Common Stock"), issuable
upon conversion of shares of the Shares and upon exercise of the Warrant, or
upon conversion of any other stock issued in payment of dividends on the Shares
or otherwise issuable pursuant to this Agreement or the provisions of Schedule I
hereto, and any securities of the Company or securities of any successor
corporation issued as, or issuable upon the conversion or exercise of any
warrant right or other security that is issued as a dividend or other
distribution with respect to, or in exchange for, or in replacement of, the
Shares.
(iii) The term "holder of Registrable Securities" means the Purchaser and
any permitted assignee of registration rights pursuant to Section 1.4(h).
(b) (i) The Company shall as soon as possible file a registration statement
on Form SB-2 or Form S-3 covering at least 200% of the number of Registrable
Securities which would then be issuable upon conversion of the Shares at the
conversion price then in effect, and shall use its best efforts to cause such
registration statement to become effective on or before ninety (90) days after
the Closing Date (the "Initial Registration"). In the event such registration is
not so declared effective or does not include all Registrable Securities, a
holder of Registrable Securities shall have the right to require by notice in
writing that the Company register all or any part of the Registrable Securities
held by such holder (a "Demand Registration") and the Company shall thereupon
effect such registration in accordance herewith (which may include adding such
shares to an existing shelf registration). The parties agree that if the holder
of Registrable Securities demands registration of less than all of the
Registrable Securities, the Company, at its option, may nevertheless file a
registration statement covering all of the Registrable Securities. If such
registration statement is declared effective with respect to all Registrable
Securities and the Company is in compliance with its obligations under
Subsection (d) of this Section 1.4, the demand registration rights granted
pursuant to this Subsection (b)(i) shall cease. If such registration statement
is not declared effective with respect to all Registrable Securities or if the
Company is not in compliance with such obligations, the demand registration
rights described herein shall remain in effect.
(ii) The Company shall not be obligated to effect a Demand Registration
under Subsection (b)(i) above: (A) if all of the Registrable Securities held by
the holder of Registrable Securities which are demanded to be covered by the
Demand Registration are, at the time of such demand, included in an effective
registration statement and the Company is in compliance with its obligations
under Subsection (d) of this Section 1.4; (B) if all of the Registrable
Securities may be sold under Rule 144(k) of the Act and the Company's transfer
agent has accepted an instruction from the Company to such effect; or (C) at any
time after two (2) years from the Closing Date.
(iii) Subject to Subsection (iv)(B) hereof, the Company may suspend the
effectiveness of any such registration effected pursuant to this Subsection (b)
in the event and for such period of time as, such a suspension is required by
the rules and regulations of the Securities and Exchange Commission ("SEC"). The
Company will use its best efforts to cause such suspension to terminate at the
earliest possible date.
(iv) (A) If the Company is advised by the SEC that a registration statement
filed hereunder is subject to a "no-review" and such registration statement is
not declared effective within five (5) business days thereafter (an
"Acceleration Date") or, irrespective of the SEC review, a registration
statement is not declared effective by the ninety first (91st) day after the
Closing Date (the "Target Date"), the Company shall pay Purchaser as liquidated
damages an amount equal to two percent (2%) of the total Purchase Price of the
Shares for each thirty (30) day period following the earlier of the Acceleration
Date or Target Date, as applicable, until such time as the registration
statement is declared effective; provided, however, that such damages shall not
be payable if the failure to meet the Acceleration Date or Target Date, as
applicable, is due to action or inaction by Purchaser with respect to providing
information for the registration statement. The payment set forth above shall be
pro-rated daily as to any period of less than thirty (30) days. Such payment
shall be made to the Purchaser either (I) by cashier's check or wire transfer in
immediately available funds to such account as shall be designated in writing by
the Purchaser or (II) in Shares, the number of which shall be equal to the
amount due under this Subsection divided by $1,000 per Share. The foregoing
amount shall be paid irrespective of the amount of Registrable Securities then
held by Purchaser.
(B) If, following effectiveness of a registration, either the effectiveness
of the registration statement is suspended or a current prospectus meeting the
requirements of Section 10 of the Act is not available for delivery by the
Purchaser (either referred to herein as a "suspension"), the Company shall
thereupon pay to Purchaser as liquidated damages an amount equal to two percent
(2%) of the Purchase Price of the Shares for each thirty (30) day period of the
suspension. The payment set forth above shall be pro-rated daily as to periods
of less than thirty (30) days. Such payment shall be made to the Purchaser by
cashiers check or wire transfer in immediately available funds to such account
as shall be designated in writing by the Purchaser, and shall be paid
irrespective of the amount of Registrable Securities held by Purchaser on or
after the date following the suspension.
(C) Any amount payable pursuant to the foregoing provisions of this
Subsection (iv) shall be delivered on or before the fifth (5th) day following
the end of the calendar month in which such payment obligation arose. The
"Purchase Price" of Registrable Securities shall be (1) if derived from
conversion or substitution of Shares, the Purchase Price of the Shares, and (2)
if received in satisfaction of a Company obligation, the dollar amount of such
obligation.
(D) This Subsection is in addition to the provisions of Section 7.2(a)
hereof.
(c) If the Company proposes to register (including for this purpose a
registration effected by the Company for shareholders other than the Purchaser)
any of its stock or other securities under the Act in connection with a public
offering of such securities (other than a registration on Form S-4, Form S-8 or
other limited purpose form) and all Registrable Securities have not theretofore
been included in a registration statement under Subsection (b) of this Section
1.4 which remains effective, the Company shall, at such time, promptly give all
holders of Registrable Securities written notice of such registration. Upon the
written request of any holder of Registrable Securities given within twenty (20)
days after receipt of such notice by the holder of Registrable Securities, the
Company shall use its best efforts to cause to be registered under the Act all
Registrable Securities that such holder of Registrable Securities requests to be
registered. However, the Company shall have no obligation under this Subsection
(c) if (i) the Registrable Securities may be sold without registration under
Rule 144(k) and the Company's transfer agent has accepted an instruction from
the Company to such effect, (ii) the Registration Statement is filed more than
two (2) years after the Closing Date, or (iii) to the extent that, with respect
to any underwritten offering initiated by the Company later than one calendar
year following the Closing, the managing underwriter of such offering reasonably
notifies such holder(s) in writing of its determination that the Registrable
Securities or a portion thereof shall be excluded therefrom.
(d) Whenever required under this Section 1.4 to effect the registration of
any Registrable Securities including, without limitation, the Initial
Registration, the Company shall, as expeditiously as reasonably possible:
(i) Prepare and file with the SEC a registration statement with respect to
such Registrable Securities and use its best efforts to cause such registration
to become effective as provided in Section 1.4(b)(i), and keep such registration
statement effective for so long as any holder of Registrable Securities desires
to dispose of the securities covered by such registration statement; provided,
however, that in no event shall the Company be required to keep the Registration
Statement effective for a period greater than two (2) years from the Closing
Date;
(ii) Respond to comments made by the SEC with respect to a registration
statement filed pursuant to this Agreement within ten (10) business days after
the date of the comment letter, and prepare and file with the SEC such
amendments and supplements to such registration statement and the prospectus
used in connection with such registration statement as may be necessary to
comply with the provisions of the Act with respect to the disposition of all
securities covered by such registration statement and notify the holders of the
filing and effectiveness of such Registration Statement and any amendments or
supplements;
(iii) Furnish to each holder of Registrable Securities such numbers of
copies of a current prospectus, including a preliminary prospectus, conforming
with the requirements of the Act, copies of the registration statement any
amendment or supplement to any thereof and any documents incorporated by
reference therein and such other documents, all free of charge, as such holder
of Registrable Securities may reasonably require in order to facilitate the
disposition of Registrable Securities owned by such holder of Registrable
Securities;
(iv) Use its best efforts to register and qualify the securities covered by
such registration statement under such other securities or "Blue Sky" laws of
such jurisdictions as shall be reasonably requested by the holder of Registrable
Securities;
(v) Notify each holder of Registrable Securities immediately of the
happening of any event as a result of which the prospectus included in such
registration statement, as then in effect, includes an untrue statement of
material fact or omits to state a material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the
circumstances then existing, and use its best efforts to promptly update and/or
correct such prospectus;
(vi) Furnish, at the request of any holder of Registrable Securities in
connection with any underwritten public offering, (A) an opinion of counsel of
the Company, dated the effective date of the registration statement, in form and
substance reasonably satisfactory to the holder and its counsel and covering,
without limitation, such matters as the due authorization and issuance of the
securities being registered and certain matters pertaining to disclosure under
and compliance with securities laws by the Company in connection with the
registration thereof and/or (B) a "comfort" letter or letters of the Company's
independent public accountants provided at the Company's expense in form and
substance reasonably satisfactory to the holder and its counsel;
(vii) Use its best efforts to list the Registrable Securities covered by
such registration statement with any national market or securities exchange on
which such securities are then listed;
(viii) Make available for inspection by the holder of Registrable
Securities, upon request, all SEC Documents (as defined below) filed subsequent
to the Closing and require the Company's officers, directors and employees to
supply all information reasonably requested by any holder of Registrable
Securities in connection with such registration statement: and
(ix) Furnish to each holder of Registrable Securities prompt notice of the
commencement of any stop-order proceedings under the Act, together with copies
of all documents in connection therewith, and use its best efforts to obtain
withdrawal of any such stop order as soon as possible.
(e) Upon request of the Company, each holder of Registrable Securities will
furnish to the Company in connection with any registration under this Section
such information regarding itself, the Registrable Securities and other
securities of the Company held by it, and the intended method of disposition of
such securities as shall be reasonably required to effect the registration of
the Registrable Securities held by such holder of Registrable Securities. The
intended method of disposition (Plan of Distribution) of such securities as so
provided by Purchaser shall be included without alteration in the Registration
Statement covering the Registrable Securities and shall not be changed without
the prior written consent of the Purchaser.
(f) (i) The Company shall indemnify, defend and hold harmless each holder
of Registrable Securities which are included in a registration statement
pursuant to the provisions of Subsections (b) or (c) hereof and each of its
officers, directors, employees, agents, partners or controlling persons (within
the meaning of the Act) (each, an "indemnified party") from and against, and
shall reimburse such indemnified party with respect to, any and all claims,
suits, demands, causes of action, losses, damages, liabilities, costs or
expenses ("Liabilities") to which such indemnified party may become subject
under the Act or otherwise, arising from or relating to (A) any untrue statement
or alleged untrue statement of any material fact contained in such registration
statement, any prospectus contained therein or any amendment or supplement
thereto, or (B) the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances in which they were made, not misleading; provided,
however, that the Company shall not be liable in any such case to the extent
that any such Liability arises out of or is based upon an untrue statement or
omission so made in strict conformity with information furnished by such
indemnified party in writing specifically for use in a registration statement.
(ii) In the event of any registration under the Act of Registrable
Securities pursuant to Subsections (b) or (c), each holder of such Registrable
Securities hereby severally agrees to indemnity, defend and hold harmless the
Company, and its officers, directors, employees, agents, partners, or
controlling persons (within the meaning of the Act) (each, an "indemnified
party") from and against, and shall reimburse such indemnified party with
respect to, any and all Liabilities to which such indemnified party may become
subject under the Act or otherwise, arising from or relating to (A) any untrue
statement or alleged untrue statement of any material fact contained in such
registration statement, any prospectus contained therein or any amendment or
supplement thereto, or (B) the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances in which they were made, not misleading;
provided, that such holders will be liable in any such case to the extent and
only to the extent, that any such Liability arises out of or is based upon an
untrue statement or alleged untrue statement or omission or alleged omission
made in such registration statement, prospectus or amendment or supplement
thereto in reliance upon and in conformity with written information furnished by
such holder specifically for use in the preparation thereof.
(iii) Promptly after receipt by any indemnified party of notice of the
commencement of any action, such indemnified party shall, if a claim in respect
thereof is to be made against another party (the "indemnifying party")
hereunder, notify such party in writing thereof, but the omission so to notify
such party shall not relieve such party from any Liability which it may have to
the indemnified party other than under this Section and shall only relieve it
from any Liability which it may have to the indemnified party under this section
if and to the extent an indemnifying party is materially prejudiced by such
omission. In case any such action shall be brought against any indemnified party
and such indemnified party shall notify an indemnifying party of the
commencement thereof, the indemnifying party shall be entitled to participate in
and, to the extent it shall wish, to assume and undertake the defense thereof
with counsel reasonably satisfactory to such indemnified party, and, after
notice from the indemnifying party to the indemnified party of its election so
to assume and undertake the defense thereof, the indemnifying party shall not be
liable to the indemnified party under this section for any legal expenses
subsequently incurred by the indemnified party in connection with the defense
thereof other than reasonable costs of investigation and of liaison with counsel
so selected; provided however, that if the defendants in any such action include
both parties and the indemnified party shall have reasonably concluded that
there may be reasonable defenses available to them which are different from or
additional to those available to the indemnifying party or if the interests of
the indemnified party reasonably may be deemed to conflict with the interests of
the indemnifying party, the indemnified party shall have the right to select a
separate counsel and to assume such legal defenses and otherwise to participate
in the defense of such action, with the reasonable expenses and fees of one such
separate counsel and other reasonable expenses related to such participation to
be reimbursed by the indemnifying party as incurred.
(g) (i) With respect to the inclusion of Registrable Securities in a
registration statement pursuant to Subsections (b) or (c), all fees, costs and
expenses of and incidental to such registration, inclusion and public offering
shall be borne by the Company, provided, however, that any securityholders
participating in such registration shall bear their pro-rata share of the
underwriting discounts and commissions, if any, incurred by them in connection
with such registration.
(ii) The fees, costs and expenses of registration to be borne by the
Company as provided in this Subsection shall include, without limitation, all
registration, filing and NASD fees, printing expenses, fees and disbursements of
counsel and accountants for the Company, and all legal fees and disbursements
and other expenses of complying with state securities or Blue Sky laws of any
jurisdiction or jurisdictions in which securities to be offered are to be
registered and qualified. Subject to appropriate agreements as to
confidentiality, the Company shall make available to the holders of Registrable
Securities and their counsel its documents and personnel for due diligence
purposes. Except as otherwise provided herein, fees and disbursements of counsel
and accountants for the selling security holders shall be borne by the
respective selling security holders.
(h) The rights to cause the Company to register all or any portion of
Registrable Securities pursuant to this Section 1.4 may be assigned by Purchaser
to a transferee or assignee. Within a reasonable time after such transfer, the
Purchaser shall notify the Company of the name and address of such transferee or
assignee, and the securities with respect to which such registration rights are
being assigned. Such assignment shall be effective only if, immediately
following such transfer, the further disposition of such securities by the
transferee or assignee is restricted under the Act. Any transferee asserting
registration rights hereunder shall be bound by the applicable provisions of
this Agreement.
(i) The Company shall not agree to allow the holders of any securities of
the Company to include any of their securities in any registration statement
filed by the Company pursuant to Subsection (b) unless such inclusion will not
reduce the amount of the Registrable Securities included therein.
Section 1.5 Company Standoff, Except in a corporate reorganization,
business combination, stock or asset purchase, merger or consolidation, under
existing employee stock incentive or purchase plans or pursuant to this
Agreement, the Company shall not for its own account effect any public sale or
distribution of any securities similar to the Registrable Securities or any
securities exercisable for or convertible or changeable into the Registrable
Securities during the thirty (30) days prior to, and during the sixty (60) days
immediately following, the effective date of any registration statement filed or
amended pursuant to Section 1.4(b); provided, however, that the Company may
effect such public sale or distribution during the sixty (60) days immediately
following the effective date of such registration statement if such sale or
distribution of securities is at a price equal to or greater than 125% of the
last trade price of the Company's Common Stock on the day of Closing.
Section 2.1 Representations and Warranties of the Purchaser. The Purchaser
makes the following representations and warranties to the Company.
(a) Accredited Investor. The Purchaser is an "accredited investor", as such
term is defined in Rule 50 1 (a) of Regulation D, promulgated under the Act.
(b) Speculative Investment. The Purchaser is aware that an investment in
the Shares is highly speculative and subject to substantial risks. The Purchaser
is capable of bearing the high degree of economic risk and the burden of this
venture, including, but not limited to, the possibility of complete loss of the
Purchaser's investment in the Shares and underlying Common Stock which make
liquidation of this investment impossible for the indefinite future.
(c) Disposition. The Purchaser understands that (i) except as provided for
in Section 1.4, the Shares and underlying Common Stock of the Company (the
"Securities"), have not been and are not being registered under the Securities
Act or any applicable state securities laws, and may not be transferred unless
(A) subsequently registered thereunder, or (B) the Securities may be sold or
transferred pursuant to an exemption from securities registration under the
Securities Act and any applicable state securities laws or (C) sold pursuant to
Rule 144, promulgated under the Securities Act (or any successor Rule), or (ii)
any sale of such Securities made in reliance on Rule 144 may be made only in
accordance with the terms of such Rule and further, if such Rule is not
applicable, any resale of such Securities under circumstances in which the
seller (or the person through whom the sale is made) may be deemed to be an
underwriter (as that term is defined in the Securities Act) may require
compliance with another exemption under the Securities Act or the rules of the
SEC thereunder. Notwithstanding any provision to the contrary contained herein,
a holder may pledge such Securities as collateral for a revolving credit note
pursuant to a loan and security agreement with a lending institution.
(d) Privately Offered. The offer to acquire the Shares was directly
communicated to the Purchaser in such manner that the Purchaser was able to ask
questions of and receive answers concerning the terms and conditions of this
transaction. At no time was the Purchaser presented with or solicited by or
through any leaflet, public promotional meeting, television advertisement, or
any other form of general advertising.
(e) Purchase for Investment, The Securities are being acquired solely for
the Purchaser's own account, for investment, and are not being purchased with
view to the resale, distribution, subdivision or fractionalization thereof
without proper registration with applicable securities administrators.
Section 2.2 Representations and Warranties of the Company. The Company
hereby makes the following representations and warranties to the Purchaser:
(a) Organizations and Qualifications. The Company is a corporation duly
incorporated and existing in good standing under the laws of the Commonwealth of
Massachusetts and has the requisite corporate power to own its properties and to
carry on its business as now being conducted. The Company does not have any
subsidiaries except as listed in Exhibit B, attached hereto and incorporated
herein by reference. The Company and each such subsidiary, if any, is duly
qualified as a foreign corporation to do business and is in good standing in
every jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary other than those in which the
failure so to qualify would not have a Material Adverse Effect. "Material
Adverse Effect", for purposes of this Agreement, means any adverse effect on the
business operations, properties, prospects, or financial condition of the entity
with respect to which such term is used and which is material to such entity and
other entities controlled by such entity taken as a whole.
(b) Authorizations Enforcement. (i) The Company has the requisite corporate
power and authority to enter into and perform this Agreement and to issue the
Shares and Registrable Securities in accordance with the terms hereof, (ii) the
execution and delivery of this Agreement by the Company and the consummation by
it of the transactions contemplated hereby have been duly authorized by all
necessary corporate action, and no further consent or authorization of the
Company or its Board of Directors or stockholders is required, (iii) this
Agreement has been duly executed and delivered by the Company, (iv) this
Agreement constitutes a valid and binding obligation of the Company enforceable
against the Company in accordance with its terms (except as such enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally the enforcement
of, creditor' rights and remedies or by other equitable principles of general
application) and (v) prior to the Closing Date, any necessary Certificate of
Amendment to the Company's Charter authorizing Company to issue all of the
Shares and Registerable Securities, in accordance with Schedule 1, will have
been filed with the Massachusetts Secretary of State and will be in full force
and effect enforceable against the Company in accordance with the terms of such
amended Charter.
(c) Authorized Capital Rights or Commitments to Stock. The authorized
capital stock of the Company consists of 22,200,000 shares of Common Stock and
1,000,000 shares of Series B Preferred Stock; there are 4,704,956 shares of
Common Stock issued and 730,292 shares of Class B Common Stock outstanding;
there are no shares of such Preferred Stock issued and outstanding; and, upon
issuance of the Shares in accordance with the terms hereof, there will be
4,704,956 shares of Class B Common Stock and 950 shares of such Preferred Stock
issued and outstanding.
All of the outstanding shares of the Company's Common Stock have been
validly issued and are fully paid and nonassessable. Except as set forth in
Exhibit B hereto or as described in the SEC Documents, no shares of Common
Stock are entitled to preemptive rights or registration rights and there are
no outstanding options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company, or contracts,
commitments, understandings, or arrangements by which the Company is or may
become bound to issue additional shares of capital stock of the Company or
options, warrants, scrip, rights to subscribe to, or commitments to purchase
or acquire, any shares. or securities or rights convertible into shares, of
capital stock of the Company. The Company has furnished or made available to
the Purchaser true and correct copies of the Company's Articles of
Organization as in effect on the date hereof (the "Charter"), and the
Company's By-Laws, as in effect on the date hereof (the "By-Laws").
(d) Issuance of Shares. The issuance of the Shares has been duly authorized
and, when paid for and issued in accordance with the terms hereof, the shall be
validly issued, fully paid and non-assessable and entitled to the rights and
preferences set forth in Schedule I hereto. The Common Stock issuable upon
conversion of the Shares will be duly authorized and reserved for issuance and,
upon conversion, will be validly issued, fully paid and non-assessable and the
holders shall be entitled to all rights and preferences accorded to a holder of
Common Stock.
(e) No Conflicts. The execution, delivery and performance of this Agreement
by the Company and the consummation by the Company of the transactions
contemplated hereby do not and will not (i) result in a violation of the
Company's Charter or By-Laws or (ii) conflict with, or constitute a default (or
an event which with notice or lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Company or
any of its subsidiaries is a party, or result in a violation of any federal,
state, local or foreign law, rule, regulation, order, judgment or decree
(including Federal and state securities laws and regulations) applicable to the
Company or any of its subsidiaries or by which any property or assets of the
Company or any of its subsidiaries is bound or affected (except for such
conflicts, defaults, terminations, amendments, accelerations, cancellations and
violations as would not, individually or in the aggregate, have a Material
Adverse Effect); provided that, for purposes of such representation as to
Federal, state, local or foreign law, rule or regulation, no representation is
made herein with respect to any of the same applicable solely to the Purchaser
and not to the Company. The business of the Company is not being conducted in
violation of any law, ordinance or regulations of any governmental entity,
except for violations which either singly or in the aggregate do not and will
not have a Material Adverse Effect. The Company is not required under Federal,
state or local law, rule or regulation in the United States to obtain any
consent, authorization or order of, or make any filing (other than any filing of
a vote establishing a class or series of stock with the Massachusetts Secretary
of State) or registration with, any court or governmental agency in order for it
to execute, deliver or perform any of its obligations under this Agreement or
issue and sell the Shares in accordance with the terms hereof (other than any
SEC, NASD or state securities filings which may be required to be made by the
Company subsequent to the Closing, and any registration statement which may be
filed pursuant hereto); provided that, for purposes of the representation made
in this sentence, the Company is assuming and relying upon the accuracy of the
relevant representations and agreements of the Purchaser herein.
(f) SEC Documents, Financial Statements. The Common Stock of the Company is
registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as
amended (the "Exchange Act") and, except as set forth in Exhibit B, the Company
has filed on a timely basis all reports, schedules, forms, statements and other
documents required to be filed by it with the SEC pursuant to the reporting
requirements of the Exchange Act, including material filed pursuant to Section
13(a) or 15(d), in addition to one or more registration statements and
amendments thereto heretofore filed by the Company with the SEC under the Act
(all of the foregoing including filings incorporated by reference therein being
referred to herein as the "SEC Documents"). The Company directly or through its
agent has delivered to the Purchaser true and complete copies of the SEC
Documents except for the exhibits and incorporated documents. The Company has
not provided to the Purchaser any information which, according to applicable
law, rule or regulation, should have been disclosed publicly by the Company but
which has not been so disclosed, other than with respect to the transactions
contemplated by this Agreement.
Except as set forth in Exhibit B, as of their respective dates the SEC
Documents complied in all material respects with the requirements of the Act or
the Exchange Act as the case may be and the rules and regulations of the SEC
promulgated thereunder and other federal, state and local laws, rules and
regulations applicable to such SEC Documents, and none of the SEC Documents
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading. Except as set forth in Exhibit B, the financial statements of the
Company included in the SEC Documents comply as to form in all material respects
with applicable accounting requirements and the published rules and regulations
of the SEC or other applicable rules and regulations with respect thereto. Such
financial statements have been prepared in accordance with generally accepted
accounting principles applied on a consistent basis during the periods involved
(except (i) as may be otherwise indicated in such financial statements or the
notes thereto or (ii) in the case of unaudited interim statements, to the extent
they may not include footnotes or may be condensed or summary statements) and
fairly present in all material respects the financial position of the Company as
of the dates thereof and the results of operations and cash flows for the
periods then ended (subject, in the case of unaudited statements, to normal
year-end audit adjustments).
(g) No Material Adverse Change. Since the date through which the most
recent quarterly report of the Company on Form 10-Q has been prepared and filed
with the SEC, a copy of which is included in the SEC Documents, no Material
Adverse Effect has occurred or exists with respect to the Company or any of its
subsidiaries.
(h) No Undisclosed Liabilities. The Company and its subsidiaries have no
material liabilities or obligations not disclosed in the SEC Documents, other
than those incurred in the ordinary course of the Company's or any of its
subsidiaries' respective businesses since the date of the most recently filed
SEC Documents which, individually or in the aggregate, do not or would not have
a Material Adverse Effect on the Company or any of its subsidiaries.
(i) No Undisclosed Events or Circumstances. No event or circumstance has
occurred or exists with respect to the Company or any of its subsidiaries or
their respective businesses, properties, prospects, operations or financial
condition which, under applicable law, rule or regulation, requires public
disclosure or announcement by the Company but which has not been so publicly
announced or disclosed.
(j) No General Solicitation. Neither the Company, nor any of its
affiliates, or, to the best of its knowledge, any person acting on its or their
behalf, has engaged in any form of general solicitation or general advertising
(within the meaning of Regulation D under the Act) in connection with the offer
or sale of the Shares.
(k) No Integrated Offering. Neither the Company, nor any of its affiliates,
nor any person acting on its or their behalf has, directly or indirectly, made
any offers or sales of any security or solicited any offers to buy any security,
under circumstances that would require registration of the Shares under the Act.
Section 3.1 Securities Compliance. The Company shall notify the SEC and
NASD, in accordance with their requirements, of the transactions contemplated by
this Agreement, and shall take all other necessary action and proceedings as may
be required and permitted by applicable law, rule and regulation, for the legal
and valid issuance of the Shares, and the Common Stock issuable upon conversion
thereof, to the Purchaser.
Section 3.2 Registration and Listing. Until. at least two (2) years after
all Shares have been converted into Registrable Securities, the Company will
cause its Common Stock to continue to be registered under Sections 12(b) or
12(g) of the Exchange Act, will comply in all respects with its reporting and
filing obligations under such Exchange Act, will comply with all requirements
related to any registration statement filed pursuant to this Agreement and will
not take any action or file any document (whether or not permitted by the Act or
the Exchange Act or the rules thereunder) to terminate or suspend such
registration or to terminate or suspend its reporting and filing obligations
under said Acts, except as permitted herein. Until at least two (2) years after
all Shares have been converted into Common Stock the Company will take all
action within its power to continue the listing or trading of its Common Stock
on the NASDAQ Small Cap Market and will comply in all respects with the
Company's reporting, filing and other obligations under the bylaws or rules of
the NASD and NASDAQ. The covenants set forth in this Section 3.2 shall not be
deemed to prohibit a merger, sale of all assets or other corporate
reorganization if the entity surviving or succeeding to the Company is bound by
this Agreement with respect to its securities issued in exchange for or in
replacement of the Shares or Common Stock or the consideration received for or
in replacement of the Shares or Common Stock is cash.
Section 3.3 Right of First Refusal and Most-Favored-Nation Clause. If at
any time during the period beginning on the fifth (5th) day prior to (but not
including) the Closing Date and ending sixty (60) days immediately following the
effective date of the Initial Registration, the Company proposes to issue Common
Stock or securities convertible into or exercisable for Common Stock or other
convertible securities, pursuant to an offering exempt from registration under
the Act, the Company shall provide to Purchaser reasonable advance notice of all
the terms of such proposed issuance. The Purchaser shall have the right to
purchase or refuse to purchase all or any part of such securities proposed to be
issued in such offering, and shall have at least seventy two (72) hours after
receipt of such notice to review the terms of the proposed issuance.
If the Company issues Common Stock or securities convertible into or
exercisable for Common Stock or other convertible securities, at a time when any
of the Shares remain outstanding, at an effective price per share of Common
Stock which is lower than the conversion price of the Shares at that time, then
the Company shall, within five (5) business days, deliver to each holder upon
conversion an additional number of shares of Common Stock necessary to reduce
the effective conversion price to such lower issue price. This Section shall not
be applicable to issuances of Common Stock pursuant to (a) any business
combination, acquisition transaction, stock or asset purchase undertaken by the
Company or (b) any shareholder-approved option plan covering not more than 10%
of the Company's outstanding stock.
Section 4.1 Conditions Precedent to the Obligation of the Company to Sell
the Shares. The obligation hereunder of the Company to issue and/or sell the
Shares to the Purchaser is subject to the satisfaction, at or before the
Closing, of each of the conditions set forth below. These conditions may be
waived by the Company at any time in its sole discretion.
(a) Accuracy of the Purchaser's Representations and Warranting. The
representations and warranties of the Purchaser shall be true and correct in all
material respects as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
particular date).
(b) Performance by the Purchaser. The Purchaser shall have performed all
agreements and satisfied all conditions required to be performed or satisfied by
the Purchaser at or prior to the Closing.
(c) No Injunction. No statute, rule, regulation. executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits
the consummation of any of the transactions contemplated by this Agreement.
(d) Legal action. No legal action, suit or proceeding shall be pending or
threatened which seeks to restrain or prohibit the transactions contemplated by
this Agreement.
(e) Execution. The Purchaser shall have executed this Agreement, and
delivered such Agreement to the Company.
(f) Purchase Price. The Purchaser shall have delivered the Purchase Price
in accordance with Section 1.3(b) above.
Section 4.2 Conditions Precedent to the Obligation of the Purchaser to
Purchase the Shares. The obligation hereunder of the Purchaser to acquire and
pay for the Shares is subject to the satisfaction, at or before the Closing, of
each of the conditions set forth below. These conditions may be waived by the
Purchaser at any time in its sole discretion.
(a) Accuracy of the Company's Representations and Warranties. The
representations and warranties of the Company shall be true and correct in all
material respects as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
particular date).
(b) Performance by the Company. The Company shall have performed all
agreements and satisfied all conditions required to be performed or satisfied by
the Company at or prior to the Closing.
(c) NASDAO. From the date hereof to the Closing Date, trading in the
Company's Common Stock shall not have been suspended by the SEC or the NASDAQ
Small Cap Market (except for any suspension of trading of limited duration
agreed to between the Company and the NASDAQ Small Cap Market solely to permit
dissemination of material information regarding the Company), and trading in
securities generally as reported by NASDAQ shall not have been suspended or
limited or minimum prices shall not have been established on
securities whose trades are reported by NASDAQ.
(d) No Injunction. No statute, rule, regulation, executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits
the consummation of any of the transactions contemplated by this Agreement.
(e) Opinion of Counsel Etc. The Purchaser shall have received before or at
the Closing an opinion of counsel to the Company (covering, without limitation,
such of the matters set forth in Section 2.2(a) through (e)), as are in form and
substance reasonably satisfactory to the Purchaser and its counsel, and such
other certificates and documents as the Purchaser or its counsel shall
reasonably require incident to the Closing.
(f) Execution. The Company shall have executed this Agreement, and
delivered such Agreement to the Purchaser.
Section 5.1 Legend on Stock. Each certificate representing the Shares and,
if necessary, Common Stock issued upon conversion thereof, shall be stamped or
otherwise imprinted with a legend substantially in the following form:
THESE SECURITIES [AND THE SHARES OF COMMON STOCK ISSUABLE UPON THE CONVERSION
HEREOF] HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD OR OFFERED FOR SALE UNLESS
THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND ANY APPLICABLE
STATE SECURITIES LAW OR, IN THE OPINION OF COUNSEL, REGISTRATION UNDER SUCH ACT
OR APPLICABLE STATE SECURITIES LAW IS NOT REQUIRED IN CONNECTION WITH SUCH SALE
OR OFFER, AND SUCH OPINION IS REASONABLY SATISFACTORY TO THE COMPANY.
The Company agrees to reissue certificates representing the Shares or, if
applicable, the Common Stock issued upon conversion thereof, without the legend
set forth above at such time as (a) the holder thereof is permitted to dispose
of such Shares (or securities issued upon conversion thereof) pursuant to Rule
144(k) under the Act, (b) the securities are sold to a purchaser or purchasers
who (in the opinion of counsel to such holders, in form and substance reasonably
satisfactory to the Company and its counsel) are able to dispose of such
securities publicly without registration under the Act, or (iii) such securities
are registered under the Act
Section 6.1 Termination by Mutual Consent. This Agreement may be terminated
at any time prior to the Closing by the mutual written consent of the Company,
and the Purchaser.
Section 6.2 Other Termination. This Agreement may be terminated by action
of the Board of Directors or other governing body of the Purchaser or the
Company at any time if the Closing shall not have been consummated by the fifth
(5th) business day following the date of this Agreement, provided that the party
seeking to terminate the Agreement is not in breach of the Agreement.
Section 6.3 Automatic Termination. This Agreement shall automatically
terminate without any further action of either party hereto if the Closing shall
not have occurred by the seventh (7th) business day following the date of this
Agreement, provided, however, that any such termination shall not terminate the
liability of any party which is then in breach of the Agreement.
Section 7.1 Fees and Expenses. Except as otherwise set forth in Section 1.4
hereof with respect to the registration of Registrable Securities, the Company
shall pay the fees, commissions and expenses of its advisers, brokers, finders,
counsel, accountants and other experts, if any, and all other expenses
associated therewith, and shall on the Closing Date reimburse ProFutures Special
Equities Fund, L.P. up to $5,000 for fees and expenses of its counsel in
connection with the preparation, negotiation and coordination of this Agreement.
The Company shall pay all stamp and other taxes and duties levied in connection
with the issuance of the Shares and Common Stock pursuant hereto.
Section 7.2 Specific Enforcement, Consent to Jurisdiction.
(a) The Company and the Purchaser acknowledge and agree that irreparable
damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that the parties shall be entitled to an
injunction or injunctions to prevent or cure breaches of the provisions of this
Agreement and to enforce specifically the terms and provisions hereof, this
being in addition to any other remedy to which either of them may be entitled by
law or equity.
(b) The Company and the Purchaser each (i) hereby irrevocably submits to
the jurisdiction of the United States District Court and other courts of the
United States sitting in the State of Texas for the purposes of any suit, action
or proceeding arising out of or relating to this Agreement and (ii) hereby
waives, and agrees not to assert in any such suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of such court, that
the suit, action or proceeding is brought in an inconvenient forum or that the
venue of the suit, action or proceeding is improper. The Company and the
Purchaser each consents to process being served in any such suit, action or
proceeding by mailing a copy thereof to such party at the address in effect for
notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing in this
paragraph shall affect or limit any right to serve process in any other manner
permitted by law.
Section 7.3 Entire Agreement: Amendment. This Agreement contains the entire
understanding of the parties with respect to the matters covered hereby and,
except as specifically set forth herein, neither the Company nor the Purchaser
makes any representation, warranty, covenant or undertaking with respect to such
matters. No provision of this Agreement may be waived or amended other than by a
written instrument signed by the party against whom enforcement of any such
amendment or waiver is sought.
Section 7.4 Notices. Any notice or other communication required or
permitted to be given hereunder shall be in writing and shall be effective (a)
upon hand delivery or delivery by telex (with correct answer back received),
telecopy or facsimile at the address or number designated below (if delivered on
a business day during normal business hours where such notice is to be
received), or the first business day following such delivery (if delivered other
than on a business day during normal business hours where such notice is to be
received) or (b) on the second (2nd) business day following the date of mailing
by express courier service, fully prepaid, addressed to such address, or upon
actual receipt of such mailing, whichever shall first occur.
The addresses for such communications shall be:
to the Company: Bruce A. Shear, President and Chief Executive Officer
PHC, Inc.
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
to the Purchaser: At the address set forth at the foot of this Agreement or
as specified in writing by Purchaser.
Any party hereto may from time to time change its address for notices by giving
at least ten (10) days' written notice of such changed address to the other
party hereto.
Section 7.5 Waivers. No waiver by either party of any default with respect
to any provision, condition or requirement of this Agreement shall be deemed to
be a continuing waiver in the future or a waiver of any other provision,
condition or requirement hereof, nor shall any delay or omission of either party
to exercise any right hereunder in any manner impair the exercise of any such
right accruing to it thereafter.
Section 7.6 Headings. The headings herein are for convenience only, do not
constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.
Section 7.7 Governing Law. This Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the present state
of incorporation of the Company without regard to such state's principles of
conflict of laws.
Section 7.8 Survival. The representations and warranties of the Company and
the Purchaser contained in herein and the agreements and covenants set forth in
Sections 1.1 through 1.5, 3.1 through 3.3 and 7.1 through 7.16 shall survive the
Closing for a period of two (2) years.
Section 7.9 Publicity. The Company agrees that it will not disclose, and
will not include in any public announcement, the name of the Purchaser without
its consent, unless and until such disclosure is required by law or applicable
regulation, and then only to the extent of such requirement.
Section 7.10 NASDAO. The term "NASDAQ" or "NASDAQ Small Cap Market" herein
refers to the principal market on which the Common Stock of the Company is
traded. If the Common Stock is listed on a securities exchange. or if another
market becomes the principal market on which the Common Stock is traded or
through which price quotations for the Common Stock are reported, the term
"NASDAQ" or "NASDAQ Small Cap Market" shall be deemed to refer to such exchange
or other principal market.
Section 7.11 Acceptance. Execution and delivery of this Agreement shall
constitute an offer to purchase the Shares, which offer, unless previously
revoked by the Purchaser, may be accepted or rejected by the Company, in its
sole discretion for any cause or for no cause and without liability to the
Purchaser. The Company shall indicate acceptance of this Agreement by signing as
indicated on the signature page hereof.
Section 7.12 Binding Agreement. Upon acceptance of this Agreement by the
Company, the Purchaser agrees that he may not cancel, terminate or revoke any
agreement of the Purchaser made hereunder, and that this Agreement shall survive
the death or disability of the Purchaser and shall be binding upon heirs,
successors, assigns, executors, administrators, guardians, conservators or
personal representatives of the Purchaser.
Section 7.13 Incorporation by Reference. All information set forth on the
signature page is incorporated as integral terms of this Agreement.
Section 7.14 Counterparts. This Agreement may be signed in multiple
counterparts, which counterparts shall constitute one and the same original
instrument.
Section 7.15 Severability. If any portion of this Agreement shall be held
illegal, unenforceable, void or voidable by any court each of the remaining
terms hereof shall nevertheless remain in full force and effect as a separate
contract.
Section 7.16 Successors and Assigns. This Agreement shall be binding upon
and inure to the benefit of the parties hereto and their respective successors
and permitted assigns.
[This space has been left blank intentionally. The signature page follows.]
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$500,000 (500 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
26,315 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
ProFutures Special Equities Fund, L.P.
Address of Purchaser: % ProFutures Fund Management, Inc.
1030 Highway 620 South - Suite 200
Austin, TX 78734
Social Security or IRS Employer Identification Number(s):
74-2786952
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
______________________________________________
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: ProFutures Special Equities Fund, L.P.
By ProFutures Fund Management, Inc., a General Partner
By: ______________________________________
(Signature)
Name: /s/ Gary D. Halbert
Title: President
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$150,000 (150 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
7,890 shares
The exact name(s)(Including correct,legible spelling) and the information under
which title to the Shares will be taken is as follows (Please print or type):
Gary D. Halbert
Address of Purchaser: 1030 Highway 620 South - Suite 200
Austin, TX 78734
Social Security or IRS Employer Identification Number(s):
451-96-0684
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
/s/ Gary D. Halbert
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: _______________________________________
By: ______________________________________
(Signature)
Name: ____________________________________________
Title: ____________________________________________
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$100,000 (100 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
5,260 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
John F. Mauldin
Address of Purchaser: 1000 Ballpark in Arlington - Suite 216
Arlington, TX 76011
Social Security or IRS Employer Identification Number(s):
459-84-6606
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
/s/ John F. Mauldin
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: ________________________________
By: ______________________________________
(Signature)
Name: _________________________________
Title: _________________________________
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$200,000 (200 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
10,525 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
Augustine Fund, L.P.
Address of Purchaser: 141 West Jackson Boulevard - Suite 2182
Chicago, IL 60604
Social Security or IRS Employer Identification Number(s):
36-418-6782
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
______________________________________________
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: Augustine Fund, L.P.
By Augustine Capital Management, Inc., the General Partner
By: ______________________________________
(Signature)
Name: /s/ Thomas Duszynski
Title: Chief Operating Officer
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
SCHEDULE I
PHC, INC.
RESOLUTIONS ESTABLISHING RIGHTS AND PREFERENCES
FOR SERIES B CONVERTIBLE PREFERRED STOCK
RESOLVED, that there shall be a series of shares of the Corporation
designated "Series B Convertible Preferred Stock"; that the number of shares of
such series shall be 1,000, that the Corporation issue such shares, and that the
rights and preferences of such series (the "6% Preferred") and the limitations
or restrictions thereon, shall be as set forth herein.
The following terms and conditions shall be adopted and incorporated by
reference into the foregoing resolutions as if fully set forth therein:
1. Dividends.
(a) The holders of the 6% Preferred shall be entitled to receive out of any
assets legally available therefor cumulative dividends at the rate of $60 per
share per annum, accrued daily and payable quarterly in arrears on March 31,
June 30, September 30 and December 31 of each year, in preference and priority
to any payment of any dividend on the Common Stock or any other class or series
of stock of the Corporation. Such dividends shall accrue on any given share from
the day of original issuance of such share and shall accrue from day to day
whether or not earned or declared. If at any time dividends on the outstanding
6% Preferred at the rate set forth above shall not have been paid or declared
and set apart for payment with respect to all preceding periods, the amount of
the deficiency shall be fully paid or declared and set apart for payment, but
without interest, before any distribution, whether by way of dividend or
otherwise, shall be declared or paid upon or set apart for the shares of any
other class or series of stock of the Corporation.
(b) Any dividend payable on a dividend payment date may be paid, at the
option of the Corporation, either (i) in cash or (ii) in shares of 6% Preferred
valued at $1,000 per share, if the Common Stock issuable upon conversion of such
shares has been registered for resale under the Securities Act of 1933, as
amended (the "Act"), and the registration statement including a current
prospectus with respect thereto remains in effect at the date of delivery of
such shares, and if the Corporation shall have given written notice of its
intention to pay such dividend in stock to all holders of the 6% Preferred at
least ten (10) days before the record date for such dividend.
2. Liquidation Preference, Redemption.
(a) In the event of any liquidation, dissolution or winding up of the
Corporation, either voluntary or involuntary, the holders of the 6% Preferred
shall be entitled to receive, prior and in preference to any distribution of any
assets of the Corporation to the holders of any other class or series of shares,
the amount of $1,000 per share plus any accrued but unpaid dividends (the
"Liquidation Preference").
(b) A consolidation or merger of the Corporation with or into any other
corporation or corporations, or a sale of all or substantially all of the assets
of the Corporation (other than a sale or transfer to a wholly-owned subsidiary
of the Corporation), shall, at the option of the holders of the 6% Preferred, be
deemed a liquidation, dissolution or winding up within the meaning of this
Section 2 if the shares of stock of the Corporation outstanding immediately
prior to such transaction represent immediately after such transaction less than
a majority of the voting power of the surviving corporation (or of the acquirer
of the Corporation's assets in the case of a sale of assets). Such option may be
exercised by the vote or written consent of holders of a majority of the 6%
Preferred at any time within thirty (30) days after written notice (which shall
be given promptly) of the essential terms of such transaction shall have been
given to the holders of the 6% Preferred in the manner provided by law for the
giving of notice of meetings of shareholders.
- 1 -
(c) The Corporation may, at its option, cause all outstanding shares of the
6% Preferred to be redeemed after the date on which a registration statement
under the Act ("Registration Statement") has been declared effective (the
"effective date"); provided the Corporation has given notice of its intention to
redeem to the holders of the 6% Preferred at least five (5) days prior to the
redemption date. In addition, if any conversion of 6% Preferred, when aggregated
with all prior conversions, will cause the Company to issue a number of shares
of Common Stock which exceeds twenty percent (20%) of the shares of Common Stock
then issued and outstanding, the Company shall redeem such number of shares of
6% Preferred as is necessary to limit such issuance of Common Stock to twenty
percent (20%) of the shares of Common Stock then issued and outstanding, unless
the Company has previously obtained stockholder approval to issue in excess of
twenty percent (20%) of the shares of Common Stock then issued and outstanding.
If a redemption will occur under either of the preceding sentences, on the
redemption date, the Corporation shall pay such holders by cashiers check or
wire transfer in immediately available funds the amount of $1,300 per share of
6% Preferred plus all accrued but unpaid dividends. Promptly thereafter, the
holders shall surrender the certificate or certificates representing the 6%
Preferred, duly endorsed, at the office of the Corporation or of any transfer
agent for such shares, or at such other place designated by the Corporation.
3. 6% Preferred - Forced Conversion.
(a) The Corporation may, at its option, cause all outstanding shares of the
6% Preferred to be converted into Common Stock at any time beginning one (1)
year after the date of issuance, on at least twenty (20) days' advance notice,
at a conversion price determined as set forth in Section 4 hereof (the
"Conversion Price") as of the date specified in such notice (the "Conversion
Date") and otherwise on the terms set forth in Section 4 hereof, provided, that
the Corporation may not exercise such right of conversion unless (i) the Closing
Price (last trade price) of the Common Stock as reported by NASDAQ for the
twenty (20) consecutive trading days prior to the date the Conversion Notice is
mailed has not on any day been less than one hundred forty percent (140%) of the
last trade price of the Company's Common Stock on the day of Closing (subject to
adjustment for stock dividends, stock splits and reverse stock splits), and (ii)
the shares issuable upon conversion of the 6% Preferred are registered for
resale by an effective Registration Statement which became effective not more
than one hundred twenty (120) days after the date of issuance of the 6%
Preferred, and a current prospectus meeting the requirements of Section 10 of
the Act is available for delivery at the Conversion Date.
(b) At least twenty (20) days prior to the Conversion Date, written notice
(the "Conversion Notice") shall be mailed, first class postage prepaid, by the
Corporation to each holder of record of the 6% Preferred, at the address last
shown on the records of the Corporation for such holder, notifying such holder
of the conversion which is to be effected, specifying the Conversion Date and
calling upon each such holder to surrender to the Corporation, in the manner and
at the place designated, a certificate or certificates representing the number
of shares of 6% Preferred held by such holder. Subject to the provisions of the
following subsection (c), on or after the Conversion Date, each holder of 6%
Preferred shall surrender to the Corporation the certificate or certificates
representing the shares of 6% Preferred owned by such holder as of the
Conversion Date, in the manner and at the place designated in the Conversion
Notice, and thereupon the shares issuable upon such conversion shall be
delivered as provided in Section 4(b) hereof.
(c) If, on the Conversion Date, the registration condition specified in
clause (ii) of subsection (a) shall not be satisfied, then no shares shall be
converted and the Conversion Notice shall be deemed to be withdrawn. In such
event, any certificates for 6% Preferred which have been surrendered for
conversion shall be returned to the persons surrendering the same; provided,
however, that if a holder has received shares of Common Stock upon conversion of
6% Preferred after the Conversion Notice was given but before the Conversion
Date, such holder may elect either to retain such Common Stock or rescind such
conversion by tendering such shares of Common Stock to the Corporation.
(d) On the second anniversary of the issuance of the 6% Preferred, all then
outstanding shares of 6% Preferred shall be automatically converted into Common
Stock at the Conversion Price and otherwise pursuant to the applicable
provisions set forth in Section 4 hereof.
- 2 -
4. 6% Preferred - Optional Conversion. The holders of the 6% Preferred
shall have optional conversion rights as follows:
(a) Right to Convert. At any time after the earlier of (i) the date on
which a Registration Statement has been declared effective, or (ii) the close of
business on the ninety first (91st) day following the date of issuance of the 6%
Preferred, shares of 6% Preferred shall become convertible, at the option of the
holder thereof, into such number of fully paid and nonassessable shares of
Common Stock as is determined by dividing (A) the Liquidation Preference of the
6% Preferred determined pursuant to Section 2 hereof on the date the notice of
conversion is given, by (B) the Conversion Price determined as hereinafter
provided in effect on the applicable conversion date.
(b) Mechanics of Conversion. To convert shares of 6% Preferred into shares
of Common Stock, the holder shall give written notice to the Corporation (which
notice may be given by facsimile transmission) that such holder elects to
convert the shares and shall state therein date of the conversion, the number of
shares to be converted and the name or names in which such holder wishes the
certificate or certificates for shares of Common Stock to be issued. Promptly
thereafter, the holder shall surrender the certificate or certificates
representing the shares to be converted, duly endorsed, at the office of the
Corporation or of any transfer agent for such shares, or at such other place
designated by the Corporation; provided that the holder shall not be required to
deliver the certificates representing such shares if the holder is waiting to
receive all or part of such certificates from the Corporation. The Corporation
shall, immediately upon receipt of such notice, issue and deliver to or upon the
order of such holder, against delivery of the certificates representing the
shares which have been converted, a certificate or certificates for the number
of shares of Common Stock to which such holder shall be entitled and such
certificate or certificates shall not bear any restrictive legend; provided (A)
the Common Stock evidenced thereby are sold pursuant to an effective
registration statement under the Act, (B) the holder provides the Corporation
with an opinion of counsel reasonably acceptable to the Corporation to the
effect that a public sale of such shares may be made without registration under
the Act, or (C) such holder provides the Corporation with reasonable assurance
that such shares can be sold free of any limitations imposed by Rule 144,
promulgated under the Act. The Corporation shall cause such issuance and
delivery to be effected within three (3) business days and shall transmit the
certificates by messenger or overnight delivery service to reach the address
designated by such holder within three (3) business days after the receipt of
such notice. The notice of conversion may be given by a holder at any time
during the day up to 5:00 p.m. Boston, Massachusetts time and such conversion
shall be deemed to have been made immediately prior to the close of business on
the date such notice of conversion is given (a "conversion date"). The person or
persons entitled to receive the shares of Common Stock issuable upon such
conversion shall be treated for all purposes as the record holder or holders of
such shares of Common Stock at the close of business on such date.
(c) Conversion, Redemption and Note Delivery Required. The Corporation
acknowledges and understands that a delay in the issuance of the Common Stock
upon conversion or pursuant to a redemption according to the provisions hereof,
or a delay in delivering the Promissory Note set forth in Subsection (d) hereof,
could result in economic loss to the holders of the 6% Preferred. As
compensation to any holder when the Corporation has failed with respect to such
holder to comply with the Corporation's obligations hereunder, and not as a
penalty, the Corporation shall pay to such holder liquidated damages of $500 per
day plus an amount equal to: (i) two percent (2%) of the total Purchase Price of
Shares for the first thirty (30) day period after the date on which the Common
Stock should have been issued by the Corporation (i.e., the end of the three (3)
business day period described in Subsection (b)), shares of 6% Preferred
redeemed by the Corporation or Promissory Note delivered to holder (i.e., the
end of the three (3) business day period described in Subsection (d)), as
applicable; plus (ii) an amount equal to three percent (3%) of the total
Purchase Price of Shares for each subsequent thirty (30) day period thereafter.
Amounts payable shall be pro-rated daily as to a periods of less than thirty
(30) days. Such amounts shall be paid to the holder at the end of each month in
which such amounts have accrued. Payment shall be made immediately by cashier's
check or wire transfer in immediately available funds to such account as shall
be designated in writing by the holder. Each holder shall be entitled to an
injunction or injunctions to prevent or cure breaches of the provisions of
hereof and. to enforce specifically the terms and provisions hereof, this being,
in addition to any other remedy to which a holder may be entitled by law or
equity.
- 3 -
(d) Determination of Conversion Price:
(i )The "Conversion Price" for purposes of hereof shall be equal to eighty
percent (80%) of the average of the closing bid prices of the Common Stock as
reported by NASDAQ during the five (5) consecutive trading days preceding the
conversion date (but not including such date); provided, however, that in no
event may the Conversion Price be more than three dollars and twenty cents
($3.20) (the "Maximum Conversion Price") or less than an amount equal to the
closing bid price per share of the Common Stock on the date of issuance minus
fifty cents ($0.50) (the "Minimum Conversion Price"). If, but for this Section
4(d)(i), the Conversion Price would have been below Minimum Conversion Price,
the Company shall pay the holder by delivering to holder a Promissory Note, the
form which has been delivered to the Corporation and is incorporated herein by
reference, bearing the principal amount equal to the difference between (A) the
number of shares of Common Stock that would have been issued at the amount the
Conversion Price would have been but for this Section 4(d)(i) multiplied by 100%
of the closing bid price of the Common Stock on the conversion date as
determined in accordance with the Subsection (d) (the latter amount being
referred to herein as the "Conversion Date Price"), minus (B) the number of
shares of Common Stock actually issued pursuant to the conversion multiplied by
the Conversion Date Price. Such Promissory Note shall be delivered to holder by
the third (3rd) day following the applicable conversion date.
(ii) The "closing bid price" of the Common Stock on a trading day shall be
the closing bid price of the Common Stock on the NASDAQ Small Cap Market or any
other principal securities price quotation system or market on which prices of
the Common Stock are reported. The term "trading day" means a day on which
trading is reported on the principal quotation system or market on which prices
of the Common Stock are reported.
(iii) If, during the period of consecutive trading days provided for above,
the Corporation shall declare or pay any dividend on the Common Stock payable in
Common Stock or in rights to acquire Common Stock, or shall effect a stock split
or reverse stock split, or a combination, consolidation or reclassification of
the Common Stock, the Conversion Price, Maximum Conversion Price and Minimum
Conversion Price shall be proportionately decreased or increased, as
appropriate, to give effect to such event.
(e) Distributions. If the Corporation shall at any time or from time to
time make or issue, or fix a record date for the determination of holders of
Common Stock entitled to receive, a dividend or other distribution payable in
securities of the Corporation or any of its subsidiaries other than additional
shares of Common Stock, then in each such event provision shall be made so that
the holders of 6% Preferred shall receive, upon the conversion thereof, the
securities of the Corporation which they would have received had they been the
owners on the date of such event of the number of shares of Common Stock
issuable to them upon conversion.
(f) Certificates as to Adjustments. Upon the occurrence of any adjustment
or readjustment of the Conversion Price, the Maximum Conversion Price and
Minimum Conversion Price pursuant to this Section 4, the Corporation at its
expense shall promptly compute such adjustment or readjustment in accordance
with the terms hereof and cause the independent public accountants regularly
employed to audit the financial statements of the Corporation to verify such
computation and prepare and furnish to each holder of 6% Preferred a certificate
setting forth such adjustment or readjustment and showing in detail the facts
upon which such adjustment or readjustment is based. The Corporation shall, upon
the written request at any time of any holder of 6%. Preferred, furnish or cause
to be furnished to such holder a like certificate prepared by the Corporation
setting forth (i) such adjustments and readjustments, and (ii) the number of
other securities and the amount, if any, of other property which at the time
would be received upon the conversion of 6% Preferred with respect to each share
of Common Stock received upon such conversion.
(g) Notice of Record Date. In the event of any taking by the Corporation of
a record of the holders of any class of securities for the purpose of
determining the holders thereof who are entitled to receive any dividend (other
than a cash dividend) or other distribution, any security or right convertible
into or entitling the holder thereof to receive additional shares of Common
Stock, or any right to subscribe for, purchase or otherwise acquire any shares
of stock of any class or any other securities or property, or to receive any
other right, the Corporation shall mail to each holder of 6% Preferred at least
ten (10) days prior to the date specified therein, a notice specifying the date
on which any such record is to be taken for the purpose of such dividend,
distribution, security or right and the amount and character of such dividend,
distribution, security or right.
- 4 -
(h) Issue Taxes. The Corporation shall pay any and all issue and other
taxes, excluding any income, franchise or similar taxes, that may be payable in
respect of any issue or delivery of shares of Common Stock on conversion of
shares of 6% Preferred pursuant hereto; provided, however, that the Corporation
shall not be obligated to pay any transfer taxes resulting from any transfer
requested by any holder in connection with any such conversion.
(i) Reservation of Stock Issuable Upon Conversion. The Corporation shall at
all times reserve and keep available out of its authorized but unissued shares
of Common Stock, solely for the purpose of effecting the conversion of the
shares of the 6% Preferred, such number of its shares of Common Stock as shall
from time to time be sufficient to effect the conversion of all outstanding
shares of the 6% Preferred, and if at any time the number of authorized but
unissued shares of Common Stock shall not be sufficient to effect the conversion
of all then outstanding shares of the 6% Preferred, the Corporation will take
such corporate action as may be necessary to increase its authorized but
unissued shares of Common Stock to such number of shares as shall be sufficient
for such purpose, including, without limitation, engaging in best efforts to
obtain any requisite shareholder approval.
(j) Fractional Shares. No fractional shares shall be issued upon the
conversion of any share or shares of 6% Preferred. All shares of Common Stock
(including fractions thereof) issuable upon conversion of more than one share of
6% Preferred by a holder thereof shall be aggregated for purposes of determining
whether the conversion would result in the issuance of any fractional share. If,
after the aforementioned aggregation, the conversion would result in the
issuance of a fraction of a share of Common Stock, the Corporation shall, in
lieu of issuing any fractional share, pay the holder otherwise entitled to such
fraction a sum in cash equal to the fair market value of such fraction on the
date of conversion (as determined in good faith by the Board of Directors of the
Corporation or an authorized Committee thereof).
(k) Notices. Any notice required by the provisions of this Section to be
given to the holders of shares of 6% Preferred shall be deemed given if
deposited in the United States mail, postage prepaid, and addressed to each
holder of record at its address appearing on the books of the Corporation.
(1) Reorganization or Merger. In case of any reorganization or any
reclassification of the capital stock of the Corporation or any consolidation or
merger of the Corporation with or into any other corporation or corporations or
a sale of all or substantially all of the assets of the Corporation to any other
person (other than a sale or transfer to a wholly owned subsidiary of the
Corporation), and the holders of 6% Preferred do not elect to treat such
transaction as a liquidation, dissolution or winding up as provided in Section 2
hereof, then, as part of such reorganization, consolidation, merger or sale,
provision shall be made so that each share of 6% Preferred shall thereafter be
convertible into the number of shares of stock or other securities or property
(including cash) to which a holder of the number of shares of Common Stock
deliverable upon conversion of such share of 6% Preferred would have been
entitled upon the record date of (or date of, if no record date is fixed) such
event and, in any case, appropriate adjustment (as determined by the Board of
Directors) shall be made in the application of the provisions herein set forth
with respect to the rights and interests thereafter of the holders of the 6%
Preferred, to the end that the provisions set forth herein shall thereafter be
applicable, as nearly as equivalent as is practicable, in relation to any shares
of stock or the securities or property (including cash) thereafter deliverable
upon the conversion of the shares of 6% Preferred.
5. Re-issuance of Certificates. In the event of a conversion (or, if
applicable, redemption) of 6% Preferred in which less than all of the shares of
6% Preferred of a particular certificate are converted or redeemed, as the case
may be, the Corporation shall promptly without delay cause to be issued and
delivered to the holder of such certificate, a certificate representing the
remaining shares of 6% Preferred which have not been so
converted or redeemed.
- 5 -
6. Other Provisions. For all purposes of this Resolution, the term "date of
issuance" and the terms "Closing" or "Closing Date" shall mean the day on which
shares of the 6% Preferred are first issued by the Corporation. Any provision
herein which conflicts with or violates any applicable usury law shall be deemed
modified to the extent necessary to avoid such conflict or violation. The term
"NASDAQ" herein refers to the principal market on which the Common Stock of the
Corporation is traded. If the Common Stock is listed on a securities exchange,
or if another market becomes the principal market on which the Common Stock is
traded or through which price quotations for the Common Stock are reported, the
term "NASDAQ" shall be deemed to refer to such exchange or other principal
market.
7. Restrictions and Limitations. The Corporation shall not undertake the
following actions without the consent of the holders of a majority of the 6%
Preferred: (i) modify its Articles of Organization or Bylaws so as to amend or
change any of the rights, preferences, or privileges of the 6% Preferred, (ii)
authorize or issue any other preferred equity security senior to or on a parity
with the 6% Preferred as to dividends, liquidation preferences, conversion
rights, redemption rights or other rights, preferences or privileges for a
period of thirty (30) days after Closing, as applicable or (iii), purchase or
otherwise acquire for value any Common Stock or other equity security of the
Corporation either junior or senior to or on a parity with the 6% Preferred
while there exists any arrearage in the payment of cumulative dividends
hereunder other than redemptions of stock from terminating employees pursuant to
contractual rights in favor of the Corporation.
8. Voting Rights. Except as provided herein or as provided for by law, the
6% Preferred shall have no voting rights.
9. Attorney's Fees. Any holder of 6% Preferred shall be entitled to recover
from the Corporation the reasonable attorneys' fees and expenses incurred by
such holder in connection with enforcement by such holder of any obligation of
the Corporation hereunder.
10. No Adverse Actions. The Corporation shall not in any manner, whether by
amendment of the Articles of Organization (including, without limitation, any
vote establishing a class or series of stock), merger, reorganization,
recapitalization, consolidation, sales of assets, sale of stock tender offer,
dissolution or otherwise, take any action, or permit any action to be taken,
solely or primarily for the purpose of increasing the value of any class of
stock of the Corporation if the effect of such action is to reduce the value or
security of the 6% Preferred.
- 6 -
EXHIBIT A to the Subscription Agreement
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON
STOCK PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March ___, 1998
1. Basic Terms. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the registered holder specified
below or its registered assigns ("Holder"), is the owner of warrants of PHC,
Inc., a Massachusetts corporation (the "Corporation"), and is entitled, subject
to the terms and conditions of this Warrant, including adjustments as provided
herein, to purchase ______ ( ) (number to be pro-rated for a total of 50,000
share) shares of the Common Stock (the "Common Stock") of the Corporation from
the Corporation at the price per share shown below (the "Exercise Price").
Holder:
Exercise Price per share: ______ Dollars and ______
Cents ($ )per share
[This amount will be the Closing Bid Price of the
Corporation's Common Stock on the Issue Date]
Except as specifically provided otherwise, all references in this Warrant
to the Exercise Price and the number of shares of Common Stock purchasable
hereunder shall be to the Exercise Price and number of shares after any
adjustments are made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The Corporation represents and
covenants that the shares of Common Stock issuable upon the exercise of this
Warrant shall at delivery be fully paid and non-assessable and free from taxes,
liens, encumbrances and charges with respect to their purchase. The Corporation
shall take any necessary actions to assure that the par value per share of the
Common Stock is at all times equal to or less than the then current Exercise
Price per share of Common Stock issuable pursuant to this Warrant. The
Corporation shall at all times reserve and hold available sufficient shares of
Common Stock to satisfy all conversion and purchase rights of outstanding
convertible securities, options and warrants of the Corporation, including this
Warrant.
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the issue date.
To exercise this Warrant, the Holder shall surrender this Warrant at the
principal office of the Corporation or that of the duly authorized and acting
transfer agent for its Common Stock, together with the executed exercise form
(substantially in the form of that attached hereto) and together with payment
for the Common Stock purchased under this Warrant. The principal office of the
Corporation is located at the address specified on the signature page of this
Warrant; provided, however, that the Corporation may change its principal office
upon notice to the Holder. At the option of the Holder payment shall be made
either in cash (by wire) or by certified or bank cashier's check payable to the
order of the Corporation or the Holder may elect to receive shares of Common
Stock calculated pursuant to paragraph 4. The Corporation shall, immediately
upon receipt of such notice, issue and deliver to or upon the order of such
Holder a certificate or certificates for the number of shares of Common Stock to
which such Holder shall be entitled and such certificate or certificates shall
not bear any restrictive legend; provided (A) the Common Stock evidenced thereby
are sold pursuant to an effective registration statement under the Act, (B) the
holder provides the Corporation with an opinion of counsel reasonably acceptable
to the Corporation to the effect that a public sale of such shares may be made
without registration under the Act, or (C) such holder provides the Corporation
with reasonable assurance that such shares can be sold free of any limitations
imposed by Rule 144, promulgated under the Act. The Corporation shall cause such
issuance and delivery to be effected within three (3) business days and shall
transmit the certificates by messenger or overnight delivery service to reach
the address designated by such holder within three (3) business days after the
receipt of such notice. This Warrant is not exercisable with respect to a
fraction of a share of Common Stock. In lieu of issuing a fraction of a share
remaining after exercise of this Warrant as to all full shares covered by this
Warrant the Corporation shall either at its option (a) pay for the fractional
share cash equal to the same fraction at the fair market price for such share;
or (b) issue scrip for the fraction in the registered or bearer form which shall
entitle the Holder to receive a certificate for a full share of Common Stock on
surrender of scrip aggregating a full share. As compensation to the Holder when
the Corporation has failed with respect to such Holder to comply with the
Corporation's obligations hereunder, and not as a penalty, the Corporation shall
pay to such holder liquidated damages of $500 per day until the certificates are
delivered as instructed. Such damages shall be paid to the Holder by cashiers
check or wire transfer in immediately available funds to such account as shall
be designated in writing by the Holder at the end of each month in which such
amounts have accrued. Holder shall be entitled to an injunction or injunctions
to prevent or cure breaches of the provisions of hereof and to enforce
specifically the terms and provisions hereof, this being in addition to any
other remedy to which Holder may be entitled by law or equity.
4. Cashless Exercise.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or
quoted in the NASDAQ System or the domestic over-the-counter market, the fair
market value shall be the higher of (i) the book value thereof, as determined by
any firm of independent public accountants of recognized standing selected by
the Corporation (which may be the Corporation's regular independent
accountants), as of the last day of any month ending within sixty days preceding
the date as of which the determination is to be made; or (ii) the fair market
value thereof, which shall be reasonably determined by the Corporation and the
Holder as of a date which is within fifteen days of the date as of which the
determination is to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that
price determined by multiplying the Exercise Price in effect immediately prior
to such event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number an kind of securities or other
property purchasable under this Warrant resulting from the event and settin
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until,
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant.All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the
Holder.
PHC, INC., a Massachusetts corporation
By: ________________________________
Authorized Officer
Printed Name: _______________________
Title: ______________________________
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ________________________________
________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________ ____________________________________
Signature
- 8 -
Incorporated by Reference into the Resolutions Establishing Right and
Preferences for Series B Convertible Preferred Stock.
PROMISSORY NOTE (the "Note")
Date: __________________, ________________________
Maker: PHC, Inc.
Maker's Mailing Address: 200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
Payee:
Place for Payment:
Principal Amount: $_________________________________
Annual Interest Rate on Unpaid Principal From Date: Eight percent (8%).
Annual Past Due Interest Rate on Unpaid Principal from Maturity to Payment:
Fifteen percent (15%).
Terms of Payment: Principal and interest shall be due and payable in six (6)
equal consecutive monthly payments of $ ________________ (based on a six (6)
month amortization) with the first payment being due and payable on the first
day of _____________________.
The Maker promises to pay to the order of Payee at the place for payment and
according to the terms of payment the outstanding principal and accrued interest
at the rates stated above. All unpaid amounts owing on this Note shall be due by
the final scheduled payment date of ________________________.
Additional Provisions:
If Maker defaults in the payment of this Note, or in any instrument securing or
collateral to it, then Payee may declare the unpaid principal balance of this
Note and all accrued interest immediately due and payable. Maker and each
surety, endorser, and guarantor or other party liable for the payment of any
sums of money payable on this Note severally waive all demands for payment,
presentations for payment, notices of dishonor, notices of intention to
accelerate maturity, notices of acceleration of maturity, protests, and notices
of protest, to the extent permitted by law.
If this Note or any instrument securing or collateral to it is given to an
attorney for collection or enforcement. or if suit is brought for collection or
enforcement or if it is collected or enforced through probate, bankruptcy, or
other judicial proceedings then Maker shall pay Payee all costs of collection
and enforcement, including reasonable attorneys fees and court costs, in
addition to other amounts due.
PHC. INC., PROMISSORY NOTE
Page 1
Interest that may be contracted for, taken, reserved, charged or received
under law; any interest in excess of that maximum amount shall be credited on
the principal of the debt or, if that has been paid, refunded. On any
acceleration or required or permitted prepayment, any such excess shall be
canceled automatically as of the acceleration or prepayment or, if already paid,
credited on the principal of the debt or, if the principal of the debt has been
paid, refunded. This provision overrides other provisions in this and all other
instruments concerning the debt.
When the context requires, singular nouns and pronouns include the plural.
This Note is to be governed and construed in accordance with the laws of
the State of Texas.
MAKER, FOR GOOD AND VALUABLE CONSIDERATION, THE RECEIPT AND SUFFICIENCY OF
WHICH ARE HEREBY ACKNOWLEDGED, (I) HEREBY IRREVOCABLY SUBMITS TO THE
JURISDICTION OF THE UNITED STATES DISTRICT COURT AND OTHER COURTS OF THE UNITED
STATES SITTING IN TEXAS FOR THE PURPOSES OF ANY SUIT, ACTION OR PROCEEDING
ARISING OUT OF OR RELATING TO THIS AGREEMENT AND (ii) HEREBY WAIVES, AND AGREES
NOT TO ASSERT IN ANY SUCH SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT
PERSONALLY SUBJECT TO THE JURISDICTION OF SUCH COURT, THAT THE SUIT, ACTION OR
PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR THAT THE VENUE OF THE SUIT,
ACTION OR PROCEEDING IS IMPROPER. MAKER CONSENTS TO PROCESS BEING SERVED IN ANY
SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF TO MAKER AT ITS MAIN
BUSINESS OFFICE AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND
SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING IN THIS PARAGRAPH
SHALL AFFECT OR LIMIT ANY RIGHT TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED
BY LAW.
Executed as of date first above written.
PHC Inc., a Massachusetts corporation
By: _______________________________________
Name of
Authorized Officer: __________________________
Title: ______________________________________
PHC. INC., PROMISSORY NOTE
Page 2
EXHIBIT B to the Subscription Agreement
Section 2.2(a): PHC, Inc. Subsidiaries:
PHC of Utah, Inc. Pioneer Counseling of Virginia, Inc.
D/B/A Highland Ridge Hospital (80% Owned)
4578 Highland Drive D/B/A Pioneer Counseling of Virginia
Salt Lake City, UT 94117 D/B/A Counseling Associates of Virginia
400 East Burwell street
Salem, VA 24153
PHC of Virginia, Inc. PHC of Kansas, Inc.
D/B/A Mount Regis Center D/B/A Total Concept EAP
D/B/A Changes 7451 Szwitzer, Suite 101
405 Kimball Avenue Shawnee Mission, KS 66203
Salem, VA 24153
Quality Care Centers of Mass, Inc. PHC of California, Inc.
D/B/A Franvale Nursing & Rehab Center D/B/A Marin Grove
20 Pond Street 42 Grove Street
Braintree, MA 02194 San Rafael, CA 94901
PHC of Nevada, Inc. Professional Health Associates
D/B/A Harmony Healthcare 94-19 59 Avenue
2340 Paseo del Prado, Bldg.D Elmhum NY 11373
Las Vegas, NV 89102
Northpoint - Pioneer, Inc. STL, Inc.
D/B/A Pioneer Counseling Center 200 Lake Street
31700 W. 13 Mile; Suite 201 Suite 102
Farmington Hills, MI 48334 Peabody, MA 0 1960
BSC-NY, Inc. Harmony Behavioral Health
D/B/A Behavioral Stress Center 2340 Paseo del Prado, Bldg.D
94-19 59 Avenue Las Vegas, NV 89102
Elmhurst, NY 11373
PHC of Michigan, Inc. PHC of Rhode island, Inc.
D/B/A Harbor Oaks Hospital D/B/A Good Hope Center
35031 23 Mile Road P.O. Box 1491
New Baltimore, MI 48047 Coventry, RI 02816-0029
EXHIBIT B (cont'd.)
Section 2.2(f):
The Company failed to file two years' of audited financial statements for
Behavioral Stress Centers, Inc. and Clinical Diagnostics and Clinical
Associates, as described in the December 18, 1996 letter from Choate, Hall &
Stewart to Mr. Robert Bayless of the Securities and Exchange Commission.
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns "Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Twenty Six Thousand Three Hundred Fifteen (26,315) shares of Class A
Common Stock (the "Common Stock") of the Corporation from the Corporation at the
price per share shown below (the "Exercise Price").
Holder: ProFutures Special Equities Fund, L.P.
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporations Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading shall be average of the
closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at he end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant,. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ______________________ _____________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________ __________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Seven Thousand Eight Hundred Ninety (7,890) shares of Class A Common
Stock (the "Common Stock") of the Corporation from the Corporation at the price
per share shown below (the "Exercise Price").
Holder: Gary D. Halbert
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock s at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDA", the average of the daily market prices of such stock on the ten
(10) trading days immediately preceeding the date as of which such value is to
be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restriction s on transfer contained herein, in the names designated by the
Holder at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement hall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
-6-
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ________________________ ________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________________
__________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Five Thousand Two Hundred Sixty (5,260) shares of Class A Common Stock
(the "Common Stock") of the Corporation from the Corporation at the price per
share shown below (the "Exercise Price").
Holder: John F. Mauldin
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. he Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashiers check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted t be given to the Holder shall
be in writing and shall be given by first class mail, postage repaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: _________________________ _____________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: _________________________ ____________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Ten Thousand Five Hundred Twenty Five (10,525) shares of Class A Common
Stock (the "Common Stock") of the Corporation from the Corporation at the price
per share shown below (the "Exercise Price").
Holder: Augustine Fund, L.P.
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDA"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of
1933, as amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ______________________ ________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: _________________________ _________________________________
Signature
- 8 -
Exhibit 10.133
ASSET PURCHASE AGREEMENT
This Asset Purchase Agreement is made and entered into as of the 2nd day of
February, 1998, by and between Lexington Healthcare Group, Inc., a Delaware
corporation having its principal place of business at 35 Park Place, New
Britain, Connecticut 06052 (together with its successors and assigns hereinafter
collectively referred to as the "Buyer"), and Quality Care Centers of
Massachusetts, a Massachusetts corporation having its principal place of
business at 200 Lake Street, Suite 102, Peabody, Massachusetts 01960 (together
with its successors and assigns hereinafter collectively referred to as the
"Seller").
W I T N E S S E T H:
WHEREAS, the Seller owns and leases certain assets in connection with, and
operates the 128-bed licensed skilled nursing care facility known as, Franvale
Nursing and Rehabilitation Center at 20 Pond Street, Braintree, Massachusetts
02184 (the "Facility"); and
WHEREAS, the Buyer desires to acquire from the Seller, and the Seller
desires to sell to the Buyer, certain of the assets of the Seller used in
connection with the operation of the Facility, all upoExhibit 4.28
SUBSCRIPTION AGREEMENT
PHC, INC.
THE SECURITIES WHICH ARE THE SUBJECT OF THIS SUBSCRIPTION AGREEMENT (AS IT MAY
BE AMENDED FROM TIME TO TIME, THE "AGREEMENT") HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR UNDER THE
APPLICABLE SECURITIES LAWS OF ANY STATE AND WILL BE OFFERED AND SOLD IN RELIANCE
ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THESE LAWS BY VIRTUE OF PHC,
INC.'S INTENDED COMPLIANCE WITH SECTIONS 3(b), 4(2) AND 4(6) OF THE SECURITIES
ACT, THE PROVISIONS OF REGULATION D UNDER SUCH ACT AND SIMILAR EXEMPTIONS UNDER
STATE LAW. THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE U.S.
SECURITIES AND EXCHANGE COMMISSION ("SEC"), ANY STATE SECURITIES COMMISSION OR
ANY OTHER REGULATORY AUTHORITY. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.
The undersigned purchaser (hereafter, the "Purchaser") hereby offers to
purchase certain Series B Convertible Preferred Stock (referred to herein as a
"Share" or collectively as "Shares") of PHC, Inc. (the "Company"), a publicly
held corporation formed under the laws of the Commonwealth of Massachusetts.
This offer to purchase may, for any reason whatsoever, be revoked by the
Purchaser or rejected by the Company prior to acceptance of this offer by the
Company.
Section 1.1 Purchase and Sale of Shares. Upon the following terms and
conditions, the Company shall issue and sell to the Purchaser, and the Purchaser
shall purchase from the Company, the number of Shares indicated herein, which
Shares shall have the rights, designations and preferences set forth in Schedule
I hereto.
Section 1.2 Purchase Price. The purchase price for the Shares (the
"Purchase Price") shall be $1,000 per Share.
Section 1.3 The Closing.
(a) The closing of the purchase and sale of the Shares (the "Closing"),
shall take place at the law offices of Arent, Fox, Kintner, Plotkin & Kahn, 1050
Connecticut Avenue, N.W., Washington, D.C. 20036, at 10:00 a.m., local
Washington, D.C. time, on the later of the following: (i) the date on which the
last to be fulfilled or waived of the conditions set forth in Section 4.1 and
4.2 hereof and applicable to the Closing shall be fulfilled or waived in
accordance herewith, or (ii) such other time and place and/or on such other date
as the Purchaser and the Company may agree. The date on which the Closing occurs
is referred to herein as the "Closing Date."
(b) On the Closing Date, the Company shall deliver to the Purchaser (i) a
certificate representing the Shares registered in the name of the Purchaser or
deposit such Shares into accounts designated by the Purchaser and (ii) the
Warrant for the number of shares of the Company's Common Stock indicated herein,
in the form attached hereto as Exhibit A, incorporated herein by reference. The
Purchaser shall on the Closing Date deliver to the Company the Purchase Price
for all the Shares by cashier's check or wire transfer in immediately available
funds to such account as shall be designated in writing by the Company. In
addition, each party shall deliver all documents, instruments and writings
required to be delivered by such party pursuant to this Agreement at or prior to
the Closing.
Section 1.4 Covenant to Register.
(a) For purposes of this Section, the following definitions shall apply:
The terms "register," "registered," and "registration" refer to a
registration under the Securities Act of 1933, as amended (the "Act"), effected
by preparing and filing a registration statement or similar document in
compliance with the Act, and the declaration or ordering of effectiveness of
such registration statement, document or amendment thereto.
(ii) The term "Registrable Securities" means the shares of the Company's
Class A Common Stock, par value $.01 per share (the "Common Stock"), issuable
upon conversion of shares of the Shares and upon exercise of the Warrant, or
upon conversion of any other stock issued in payment of dividends on the Shares
or otherwise issuable pursuant to this Agreement or the provisions of Schedule I
hereto, and any securities of the Company or securities of any successor
corporation issued as, or issuable upon the conversion or exercise of any
warrant right or other security that is issued as a dividend or other
distribution with respect to, or in exchange for, or in replacement of, the
Shares.
(iii) The term "holder of Registrable Securities" means the Purchaser and
any permitted assignee of registration rights pursuant to Section 1.4(h).
(b) (i) The Company shall as soon as possible file a registration statement
on Form SB-2 or Form S-3 covering at least 200% of the number of Registrable
Securities which would then be issuable upon conversion of the Shares at the
conversion price then in effect, and shall use its best efforts to cause such
registration statement to become effective on or before ninety (90) days after
the Closing Date (the "Initial Registration"). In the event such registration is
not so declared effective or does not include all Registrable Securities, a
holder of Registrable Securities shall have the right to require by notice in
writing that the Company register all or any part of the Registrable Securities
held by such holder (a "Demand Registration") and the Company shall thereupon
effect such registration in accordance herewith (which may include adding such
shares to an existing shelf registration). The parties agree that if the holder
of Registrable Securities demands registration of less than all of the
Registrable Securities, the Company, at its option, may nevertheless file a
registration statement covering all of the Registrable Securities. If such
registration statement is declared effective with respect to all Registrable
Securities and the Company is in compliance with its obligations under
Subsection (d) of this Section 1.4, the demand registration rights granted
pursuant to this Subsection (b)(i) shall cease. If such registration statement
is not declared effective with respect to all Registrable Securities or if the
Company is not in compliance with such obligations, the demand registration
rights described herein shall remain in effect.
(ii) The Company shall not be obligated to effect a Demand Registration
under Subsection (b)(i) above: (A) if all of the Registrable Securities held by
the holder of Registrable Securities which are demanded to be covered by the
Demand Registration are, at the time of such demand, included in an effective
registration statement and the Company is in compliance with its obligations
under Subsection (d) of this Section 1.4; (B) if all of the Registrable
Securities may be sold under Rule 144(k) of the Act and the Company's transfer
agent has accepted an instruction from the Company to such effect; or (C) at any
time after two (2) years from the Closing Date.
(iii) Subject to Subsection (iv)(B) hereof, the Company may suspend the
effectiveness of any such registration effected pursuant to this Subsection (b)
in the event and for such period of time as, such a suspension is required by
the rules and regulations of the Securities and Exchange Commission ("SEC"). The
Company will use its best efforts to cause such suspension to terminate at the
earliest possible date.
(iv) (A) If the Company is advised by the SEC that a registration statement
filed hereunder is subject to a "no-review" and such registration statement is
not declared effective within five (5) business days thereafter (an
"Acceleration Date") or, irrespective of the SEC review, a registration
statement is not declared effective by the ninety first (91st) day after the
Closing Date (the "Target Date"), the Company shall pay Purchaser as liquidated
damages an amount equal to two percent (2%) of the total Purchase Price of the
Shares for each thirty (30) day period following the earlier of the Acceleration
Date or Target Date, as applicable, until such time as the registration
statement is declared effective; provided, however, that such damages shall not
be payable if the failure to meet the Acceleration Date or Target Date, as
applicable, is due to action or inaction by Purchaser with respect to providing
information for the registration statement. The payment set forth above shall be
pro-rated daily as to any period of less than thirty (30) days. Such payment
shall be made to the Purchaser either (I) by cashier's check or wire transfer in
immediately available funds to such account as shall be designated in writing by
the Purchaser or (II) in Shares, the number of which shall be equal to the
amount due under this Subsection divided by $1,000 per Share. The foregoing
amount shall be paid irrespective of the amount of Registrable Securities then
held by Purchaser.
(B) If, following effectiveness of a registration, either the effectiveness
of the registration statement is suspended or a current prospectus meeting the
requirements of Section 10 of the Act is not available for delivery by the
Purchaser (either referred to herein as a "suspension"), the Company shall
thereupon pay to Purchaser as liquidated damages an amount equal to two percent
(2%) of the Purchase Price of the Shares for each thirty (30) day period of the
suspension. The payment set forth above shall be pro-rated daily as to periods
of less than thirty (30) days. Such payment shall be made to the Purchaser by
cashiers check or wire transfer in immediately available funds to such account
as shall be designated in writing by the Purchaser, and shall be paid
irrespective of the amount of Registrable Securities held by Purchaser on or
after the date following the suspension.
(C) Any amount payable pursuant to the foregoing provisions of this
Subsection (iv) shall be delivered on or before the fifth (5th) day following
the end of the calendar month in which such payment obligation arose. The
"Purchase Price" of Registrable Securities shall be (1) if derived from
conversion or substitution of Shares, the Purchase Price of the Shares, and (2)
if received in satisfaction of a Company obligation, the dollar amount of such
obligation.
(D) This Subsection is in addition to the provisions of Section 7.2(a)
hereof.
(c) If the Company proposes to register (including for this purpose a
registration effected by the Company for shareholders other than the Purchaser)
any of its stock or other securities under the Act in connection with a public
offering of such securities (other than a registration on Form S-4, Form S-8 or
other limited purpose form) and all Registrable Securities have not theretofore
been included in a registration statement under Subsection (b) of this Section
1.4 which remains effective, the Company shall, at such time, promptly give all
holders of Registrable Securities written notice of such registration. Upon the
written request of any holder of Registrable Securities given within twenty (20)
days after receipt of such notice by the holder of Registrable Securities, the
Company shall use its best efforts to cause to be registered under the Act all
Registrable Securities that such holder of Registrable Securities requests to be
registered. However, the Company shall have no obligation under this Subsection
(c) if (i) the Registrable Securities may be sold without registration under
Rule 144(k) and the Company's transfer agent has accepted an instruction from
the Company to such effect, (ii) the Registration Statement is filed more than
two (2) years after the Closing Date, or (iii) to the extent that, with respect
to any underwritten offering initiated by the Company later than one calendar
year following the Closing, the managing underwriter of such offering reasonably
notifies such holder(s) in writing of its determination that the Registrable
Securities or a portion thereof shall be excluded therefrom.
(d) Whenever required under this Section 1.4 to effect the registration of
any Registrable Securities including, without limitation, the Initial
Registration, the Company shall, as expeditiously as reasonably possible:
(i) Prepare and file with the SEC a registration statement with respect to
such Registrable Securities and use its best efforts to cause such registration
to become effective as provided in Section 1.4(b)(i), and keep such registration
statement effective for so long as any holder of Registrable Securities desires
to dispose of the securities covered by such registration statement; provided,
however, that in no event shall the Company be required to keep the Registration
Statement effective for a period greater than two (2) years from the Closing
Date;
(ii) Respond to comments made by the SEC with respect to a registration
statement filed pursuant to this Agreement within ten (10) business days after
the date of the comment letter, and prepare and file with the SEC such
amendments and supplements to such registration statement and the prospectus
used in connection with such registration statement as may be necessary to
comply with the provisions of the Act with respect to the disposition of all
securities covered by such registration statement and notify the holders of the
filing and effectiveness of such Registration Statement and any amendments or
supplements;
(iii) Furnish to each holder of Registrable Securities such numbers of
copies of a current prospectus, including a preliminary prospectus, conforming
with the requirements of the Act, copies of the registration statement any
amendment or supplement to any thereof and any documents incorporated by
reference therein and such other documents, all free of charge, as such holder
of Registrable Securities may reasonably require in order to facilitate the
disposition of Registrable Securities owned by such holder of Registrable
Securities;
(iv) Use its best efforts to register and qualify the securities covered by
such registration statement under such other securities or "Blue Sky" laws of
such jurisdictions as shall be reasonably requested by the holder of Registrable
Securities;
(v) Notify each holder of Registrable Securities immediately of the
happening of any event as a result of which the prospectus included in such
registration statement, as then in effect, includes an untrue statement of
material fact or omits to state a material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the
circumstances then existing, and use its best efforts to promptly update and/or
correct such prospectus;
(vi) Furnish, at the request of any holder of Registrable Securities in
connection with any underwritten public offering, (A) an opinion of counsel of
the Company, dated the effective date of the registration statement, in form and
substance reasonably satisfactory to the holder and its counsel and covering,
without limitation, such matters as the due authorization and issuance of the
securities being registered and certain matters pertaining to disclosure under
and compliance with securities laws by the Company in connection with the
registration thereof and/or (B) a "comfort" letter or letters of the Company's
independent public accountants provided at the Company's expense in form and
substance reasonably satisfactory to the holder and its counsel;
(vii) Use its best efforts to list the Registrable Securities covered by
such registration statement with any national market or securities exchange on
which such securities are then listed;
(viii) Make available for inspection by the holder of Registrable
Securities, upon request, all SEC Documents (as defined below) filed subsequent
to the Closing and require the Company's officers, directors and employees to
supply all information reasonably requested by any holder of Registrable
Securities in connection with such registration statement: and
(ix) Furnish to each holder of Registrable Securities prompt notice of the
commencement of any stop-order proceedings under the Act, together with copies
of all documents in connection therewith, and use its best efforts to obtain
withdrawal of any such stop order as soon as possible.
(e) Upon request of the Company, each holder of Registrable Securities will
furnish to the Company in connection with any registration under this Section
such information regarding itself, the Registrable Securities and other
securities of the Company held by it, and the intended method of disposition of
such securities as shall be reasonably required to effect the registration of
the Registrable Securities held by such holder of Registrable Securities. The
intended method of disposition (Plan of Distribution) of such securities as so
provided by Purchaser shall be included without alteration in the Registration
Statement covering the Registrable Securities and shall not be changed without
the prior written consent of the Purchaser.
(f) (i) The Company shall indemnify, defend and hold harmless each holder
of Registrable Securities which are included in a registration statement
pursuant to the provisions of Subsections (b) or (c) hereof and each of its
officers, directors, employees, agents, partners or controlling persons (within
the meaning of the Act) (each, an "indemnified party") from and against, and
shall reimburse such indemnified party with respect to, any and all claims,
suits, demands, causes of action, losses, damages, liabilities, costs or
expenses ("Liabilities") to which such indemnified party may become subject
under the Act or otherwise, arising from or relating to (A) any untrue statement
or alleged untrue statement of any material fact contained in such registration
statement, any prospectus contained therein or any amendment or supplement
thereto, or (B) the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances in which they were made, not misleading; provided,
however, that the Company shall not be liable in any such case to the extent
that any such Liability arises out of or is based upon an untrue statement or
omission so made in strict conformity with information furnished by such
indemnified party in writing specifically for use in a registration statement.
(ii) In the event of any registration under the Act of Registrable
Securities pursuant to Subsections (b) or (c), each holder of such Registrable
Securities hereby severally agrees to indemnity, defend and hold harmless the
Company, and its officers, directors, employees, agents, partners, or
controlling persons (within the meaning of the Act) (each, an "indemnified
party") from and against, and shall reimburse such indemnified party with
respect to, any and all Liabilities to which such indemnified party may become
subject under the Act or otherwise, arising from or relating to (A) any untrue
statement or alleged untrue statement of any material fact contained in such
registration statement, any prospectus contained therein or any amendment or
supplement thereto, or (B) the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances in which they were made, not misleading;
provided, that such holders will be liable in any such case to the extent and
only to the extent, that any such Liability arises out of or is based upon an
untrue statement or alleged untrue statement or omission or alleged omission
made in such registration statement, prospectus or amendment or supplement
thereto in reliance upon and in conformity with written information furnished by
such holder specifically for use in the preparation thereof.
(iii) Promptly after receipt by any indemnified party of notice of the
commencement of any action, such indemnified party shall, if a claim in respect
thereof is to be made against another party (the "indemnifying party")
hereunder, notify such party in writing thereof, but the omission so to notify
such party shall not relieve such party from any Liability which it may have to
the indemnified party other than under this Section and shall only relieve it
from any Liability which it may have to the indemnified party under this section
if and to the extent an indemnifying party is materially prejudiced by such
omission. In case any such action shall be brought against any indemnified party
and such indemnified party shall notify an indemnifying party of the
commencement thereof, the indemnifying party shall be entitled to participate in
and, to the extent it shall wish, to assume and undertake the defense thereof
with counsel reasonably satisfactory to such indemnified party, and, after
notice from the indemnifying party to the indemnified party of its election so
to assume and undertake the defense thereof, the indemnifying party shall not be
liable to the indemnified party under this section for any legal expenses
subsequently incurred by the indemnified party in connection with the defense
thereof other than reasonable costs of investigation and of liaison with counsel
so selected; provided however, that if the defendants in any such action include
both parties and the indemnified party shall have reasonably concluded that
there may be reasonable defenses available to them which are different from or
additional to those available to the indemnifying party or if the interests of
the indemnified party reasonably may be deemed to conflict with the interests of
the indemnifying party, the indemnified party shall have the right to select a
separate counsel and to assume such legal defenses and otherwise to participate
in the defense of such action, with the reasonable expenses and fees of one such
separate counsel and other reasonable expenses related to such participation to
be reimbursed by the indemnifying party as incurred.
(g) (i) With respect to the inclusion of Registrable Securities in a
registration statement pursuant to Subsections (b) or (c), all fees, costs and
expenses of and incidental to such registration, inclusion and public offering
shall be borne by the Company, provided, however, that any securityholders
participating in such registration shall bear their pro-rata share of the
underwriting discounts and commissions, if any, incurred by them in connection
with such registration.
(ii) The fees, costs and expenses of registration to be borne by the
Company as provided in this Subsection shall include, without limitation, all
registration, filing and NASD fees, printing expenses, fees and disbursements of
counsel and accountants for the Company, and all legal fees and disbursements
and other expenses of complying with state securities or Blue Sky laws of any
jurisdiction or jurisdictions in which securities to be offered are to be
registered and qualified. Subject to appropriate agreements as to
confidentiality, the Company shall make available to the holders of Registrable
Securities and their counsel its documents and personnel for due diligence
purposes. Except as otherwise provided herein, fees and disbursements of counsel
and accountants for the selling security holders shall be borne by the
respective selling security holders.
(h) The rights to cause the Company to register all or any portion of
Registrable Securities pursuant to this Section 1.4 may be assigned by Purchaser
to a transferee or assignee. Within a reasonable time after such transfer, the
Purchaser shall notify the Company of the name and address of such transferee or
assignee, and the securities with respect to which such registration rights are
being assigned. Such assignment shall be effective only if, immediately
following such transfer, the further disposition of such securities by the
transferee or assignee is restricted under the Act. Any transferee asserting
registration rights hereunder shall be bound by the applicable provisions of
this Agreement.
(i) The Company shall not agree to allow the holders of any securities of
the Company to include any of their securities in any registration statement
filed by the Company pursuant to Subsection (b) unless such inclusion will not
reduce the amount of the Registrable Securities included therein.
Section 1.5 Company Standoff, Except in a corporate reorganization,
business combination, stock or asset purchase, merger or consolidation, under
existing employee stock incentive or purchase plans or pursuant to this
Agreement, the Company shall not for its own account effect any public sale or
distribution of any securities similar to the Registrable Securities or any
securities exercisable for or convertible or changeable into the Registrable
Securities during the thirty (30) days prior to, and during the sixty (60) days
immediately following, the effective date of any registration statement filed or
amended pursuant to Section 1.4(b); provided, however, that the Company may
effect such public sale or distribution during the sixty (60) days immediately
following the effective date of such registration statement if such sale or
distribution of securities is at a price equal to or greater than 125% of the
last trade price of the Company's Common Stock on the day of Closing.
Section 2.1 Representations and Warranties of the Purchaser. The Purchaser
makes the following representations and warranties to the Company.
(a) Accredited Investor. The Purchaser is an "accredited investor", as such
term is defined in Rule 50 1 (a) of Regulation D, promulgated under the Act.
(b) Speculative Investment. The Purchaser is aware that an investment in
the Shares is highly speculative and subject to substantial risks. The Purchaser
is capable of bearing the high degree of economic risk and the burden of this
venture, including, but not limited to, the possibility of complete loss of the
Purchaser's investment in the Shares and underlying Common Stock which make
liquidation of this investment impossible for the indefinite future.
(c) Disposition. The Purchaser understands that (i) except as provided for
in Section 1.4, the Shares and underlying Common Stock of the Company (the
"Securities"), have not been and are not being registered under the Securities
Act or any applicable state securities laws, and may not be transferred unless
(A) subsequently registered thereunder, or (B) the Securities may be sold or
transferred pursuant to an exemption from securities registration under the
Securities Act and any applicable state securities laws or (C) sold pursuant to
Rule 144, promulgated under the Securities Act (or any successor Rule), or (ii)
any sale of such Securities made in reliance on Rule 144 may be made only in
accordance with the terms of such Rule and further, if such Rule is not
applicable, any resale of such Securities under circumstances in which the
seller (or the person through whom the sale is made) may be deemed to be an
underwriter (as that term is defined in the Securities Act) may require
compliance with another exemption under the Securities Act or the rules of the
SEC thereunder. Notwithstanding any provision to the contrary contained herein,
a holder may pledge such Securities as collateral for a revolving credit note
pursuant to a loan and security agreement with a lending institution.
(d) Privately Offered. The offer to acquire the Shares was directly
communicated to the Purchaser in such manner that the Purchaser was able to ask
questions of and receive answers concerning the terms and conditions of this
transaction. At no time was the Purchaser presented with or solicited by or
through any leaflet, public promotional meeting, television advertisement, or
any other form of general advertising.
(e) Purchase for Investment, The Securities are being acquired solely for
the Purchaser's own account, for investment, and are not being purchased with
view to the resale, distribution, subdivision or fractionalization thereof
without proper registration with applicable securities administrators.
Section 2.2 Representations and Warranties of the Company. The Company
hereby makes the following representations and warranties to the Purchaser:
(a) Organizations and Qualifications. The Company is a corporation duly
incorporated and existing in good standing under the laws of the Commonwealth of
Massachusetts and has the requisite corporate power to own its properties and to
carry on its business as now being conducted. The Company does not have any
subsidiaries except as listed in Exhibit B, attached hereto and incorporated
herein by reference. The Company and each such subsidiary, if any, is duly
qualified as a foreign corporation to do business and is in good standing in
every jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary other than those in which the
failure so to qualify would not have a Material Adverse Effect. "Material
Adverse Effect", for purposes of this Agreement, means any adverse effect on the
business operations, properties, prospects, or financial condition of the entity
with respect to which such term is used and which is material to such entity and
other entities controlled by such entity taken as a whole.
(b) Authorizations Enforcement. (i) The Company has the requisite corporate
power and authority to enter into and perform this Agreement and to issue the
Shares and Registrable Securities in accordance with the terms hereof, (ii) the
execution and delivery of this Agreement by the Company and the consummation by
it of the transactions contemplated hereby have been duly authorized by all
necessary corporate action, and no further consent or authorization of the
Company or its Board of Directors or stockholders is required, (iii) this
Agreement has been duly executed and delivered by the Company, (iv) this
Agreement constitutes a valid and binding obligation of the Company enforceable
against the Company in accordance with its terms (except as such enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally the enforcement
of, creditor' rights and remedies or by other equitable principles of general
application) and (v) prior to the Closing Date, any necessary Certificate of
Amendment to the Company's Charter authorizing Company to issue all of the
Shares and Registerable Securities, in accordance with Schedule 1, will have
been filed with the Massachusetts Secretary of State and will be in full force
and effect enforceable against the Company in accordance with the terms of such
amended Charter.
(c) Authorized Capital Rights or Commitments to Stock. The authorized
capital stock of the Company consists of 22,200,000 shares of Common Stock and
1,000,000 shares of Series B Preferred Stock; there are 4,704,956 shares of
Common Stock issued and 730,292 shares of Class B Common Stock outstanding;
there are no shares of such Preferred Stock issued and outstanding; and, upon
issuance of the Shares in accordance with the terms hereof, there will be
4,704,956 shares of Class B Common Stock and 950 shares of such Preferred Stock
issued and outstanding.
All of the outstanding shares of the Company's Common Stock have been
validly issued and are fully paid and nonassessable. Except as set forth in
Exhibit B hereto or as described in the SEC Documents, no shares of Common
Stock are entitled to preemptive rights or registration rights and there are
no outstanding options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company, or contracts,
commitments, understandings, or arrangements by which the Company is or may
become bound to issue additional shares of capital stock of the Company or
options, warrants, scrip, rights to subscribe to, or commitments to purchase
or acquire, any shares. or securities or rights convertible into shares, of
capital stock of the Company. The Company has furnished or made available to
the Purchaser true and correct copies of the Company's Articles of
Organization as in effect on the date hereof (the "Charter"), and the
Company's By-Laws, as in effect on the date hereof (the "By-Laws").
(d) Issuance of Shares. The issuance of the Shares has been duly authorized
and, when paid for and issued in accordance with the terms hereof, the shall be
validly issued, fully paid and non-assessable and entitled to the rights and
preferences set forth in Schedule I hereto. The Common Stock issuable upon
conversion of the Shares will be duly authorized and reserved for issuance and,
upon conversion, will be validly issued, fully paid and non-assessable and the
holders shall be entitled to all rights and preferences accorded to a holder of
Common Stock.
(e) No Conflicts. The execution, delivery and performance of this Agreement
by the Company and the consummation by the Company of the transactions
contemplated hereby do not and will not (i) result in a violation of the
Company's Charter or By-Laws or (ii) conflict with, or constitute a default (or
an event which with notice or lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Company or
any of its subsidiaries is a party, or result in a violation of any federal,
state, local or foreign law, rule, regulation, order, judgment or decree
(including Federal and state securities laws and regulations) applicable to the
Company or any of its subsidiaries or by which any property or assets of the
Company or any of its subsidiaries is bound or affected (except for such
conflicts, defaults, terminations, amendments, accelerations, cancellations and
violations as would not, individually or in the aggregate, have a Material
Adverse Effect); provided that, for purposes of such representation as to
Federal, state, local or foreign law, rule or regulation, no representation is
made herein with respect to any of the same applicable solely to the Purchaser
and not to the Company. The business of the Company is not being conducted in
violation of any law, ordinance or regulations of any governmental entity,
except for violations which either singly or in the aggregate do not and will
not have a Material Adverse Effect. The Company is not required under Federal,
state or local law, rule or regulation in the United States to obtain any
consent, authorization or order of, or make any filing (other than any filing of
a vote establishing a class or series of stock with the Massachusetts Secretary
of State) or registration with, any court or governmental agency in order for it
to execute, deliver or perform any of its obligations under this Agreement or
issue and sell the Shares in accordance with the terms hereof (other than any
SEC, NASD or state securities filings which may be required to be made by the
Company subsequent to the Closing, and any registration statement which may be
filed pursuant hereto); provided that, for purposes of the representation made
in this sentence, the Company is assuming and relying upon the accuracy of the
relevant representations and agreements of the Purchaser herein.
(f) SEC Documents, Financial Statements. The Common Stock of the Company is
registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as
amended (the "Exchange Act") and, except as set forth in Exhibit B, the Company
has filed on a timely basis all reports, schedules, forms, statements and other
documents required to be filed by it with the SEC pursuant to the reporting
requirements of the Exchange Act, including material filed pursuant to Section
13(a) or 15(d), in addition to one or more registration statements and
amendments thereto heretofore filed by the Company with the SEC under the Act
(all of the foregoing including filings incorporated by reference therein being
referred to herein as the "SEC Documents"). The Company directly or through its
agent has delivered to the Purchaser true and complete copies of the SEC
Documents except for the exhibits and incorporated documents. The Company has
not provided to the Purchaser any information which, according to applicable
law, rule or regulation, should have been disclosed publicly by the Company but
which has not been so disclosed, other than with respect to the transactions
contemplated by this Agreement.
Except as set forth in Exhibit B, as of their respective dates the SEC
Documents complied in all material respects with the requirements of the Act or
the Exchange Act as the case may be and the rules and regulations of the SEC
promulgated thereunder and other federal, state and local laws, rules and
regulations applicable to such SEC Documents, and none of the SEC Documents
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading. Except as set forth in Exhibit B, the financial statements of the
Company included in the SEC Documents comply as to form in all material respects
with applicable accounting requirements and the published rules and regulations
of the SEC or other applicable rules and regulations with respect thereto. Such
financial statements have been prepared in accordance with generally accepted
accounting principles applied on a consistent basis during the periods involved
(except (i) as may be otherwise indicated in such financial statements or the
notes thereto or (ii) in the case of unaudited interim statements, to the extent
they may not include footnotes or may be condensed or summary statements) and
fairly present in all material respects the financial position of the Company as
of the dates thereof and the results of operations and cash flows for the
periods then ended (subject, in the case of unaudited statements, to normal
year-end audit adjustments).
(g) No Material Adverse Change. Since the date through which the most
recent quarterly report of the Company on Form 10-Q has been prepared and filed
with the SEC, a copy of which is included in the SEC Documents, no Material
Adverse Effect has occurred or exists with respect to the Company or any of its
subsidiaries.
(h) No Undisclosed Liabilities. The Company and its subsidiaries have no
material liabilities or obligations not disclosed in the SEC Documents, other
than those incurred in the ordinary course of the Company's or any of its
subsidiaries' respective businesses since the date of the most recently filed
SEC Documents which, individually or in the aggregate, do not or would not have
a Material Adverse Effect on the Company or any of its subsidiaries.
(i) No Undisclosed Events or Circumstances. No event or circumstance has
occurred or exists with respect to the Company or any of its subsidiaries or
their respective businesses, properties, prospects, operations or financial
condition which, under applicable law, rule or regulation, requires public
disclosure or announcement by the Company but which has not been so publicly
announced or disclosed.
(j) No General Solicitation. Neither the Company, nor any of its
affiliates, or, to the best of its knowledge, any person acting on its or their
behalf, has engaged in any form of general solicitation or general advertising
(within the meaning of Regulation D under the Act) in connection with the offer
or sale of the Shares.
(k) No Integrated Offering. Neither the Company, nor any of its affiliates,
nor any person acting on its or their behalf has, directly or indirectly, made
any offers or sales of any security or solicited any offers to buy any security,
under circumstances that would require registration of the Shares under the Act.
Section 3.1 Securities Compliance. The Company shall notify the SEC and
NASD, in accordance with their requirements, of the transactions contemplated by
this Agreement, and shall take all other necessary action and proceedings as may
be required and permitted by applicable law, rule and regulation, for the legal
and valid issuance of the Shares, and the Common Stock issuable upon conversion
thereof, to the Purchaser.
Section 3.2 Registration and Listing. Until. at least two (2) years after
all Shares have been converted into Registrable Securities, the Company will
cause its Common Stock to continue to be registered under Sections 12(b) or
12(g) of the Exchange Act, will comply in all respects with its reporting and
filing obligations under such Exchange Act, will comply with all requirements
related to any registration statement filed pursuant to this Agreement and will
not take any action or file any document (whether or not permitted by the Act or
the Exchange Act or the rules thereunder) to terminate or suspend such
registration or to terminate or suspend its reporting and filing obligations
under said Acts, except as permitted herein. Until at least two (2) years after
all Shares have been converted into Common Stock the Company will take all
action within its power to continue the listing or trading of its Common Stock
on the NASDAQ Small Cap Market and will comply in all respects with the
Company's reporting, filing and other obligations under the bylaws or rules of
the NASD and NASDAQ. The covenants set forth in this Section 3.2 shall not be
deemed to prohibit a merger, sale of all assets or other corporate
reorganization if the entity surviving or succeeding to the Company is bound by
this Agreement with respect to its securities issued in exchange for or in
replacement of the Shares or Common Stock or the consideration received for or
in replacement of the Shares or Common Stock is cash.
Section 3.3 Right of First Refusal and Most-Favored-Nation Clause. If at
any time during the period beginning on the fifth (5th) day prior to (but not
including) the Closing Date and ending sixty (60) days immediately following the
effective date of the Initial Registration, the Company proposes to issue Common
Stock or securities convertible into or exercisable for Common Stock or other
convertible securities, pursuant to an offering exempt from registration under
the Act, the Company shall provide to Purchaser reasonable advance notice of all
the terms of such proposed issuance. The Purchaser shall have the right to
purchase or refuse to purchase all or any part of such securities proposed to be
issued in such offering, and shall have at least seventy two (72) hours after
receipt of such notice to review the terms of the proposed issuance.
If the Company issues Common Stock or securities convertible into or
exercisable for Common Stock or other convertible securities, at a time when any
of the Shares remain outstanding, at an effective price per share of Common
Stock which is lower than the conversion price of the Shares at that time, then
the Company shall, within five (5) business days, deliver to each holder upon
conversion an additional number of shares of Common Stock necessary to reduce
the effective conversion price to such lower issue price. This Section shall not
be applicable to issuances of Common Stock pursuant to (a) any business
combination, acquisition transaction, stock or asset purchase undertaken by the
Company or (b) any shareholder-approved option plan covering not more than 10%
of the Company's outstanding stock.
Section 4.1 Conditions Precedent to the Obligation of the Company to Sell
the Shares. The obligation hereunder of the Company to issue and/or sell the
Shares to the Purchaser is subject to the satisfaction, at or before the
Closing, of each of the conditions set forth below. These conditions may be
waived by the Company at any time in its sole discretion.
(a) Accuracy of the Purchaser's Representations and Warranting. The
representations and warranties of the Purchaser shall be true and correct in all
material respects as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
particular date).
(b) Performance by the Purchaser. The Purchaser shall have performed all
agreements and satisfied all conditions required to be performed or satisfied by
the Purchaser at or prior to the Closing.
(c) No Injunction. No statute, rule, regulation. executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits
the consummation of any of the transactions contemplated by this Agreement.
(d) Legal action. No legal action, suit or proceeding shall be pending or
threatened which seeks to restrain or prohibit the transactions contemplated by
this Agreement.
(e) Execution. The Purchaser shall have executed this Agreement, and
delivered such Agreement to the Company.
(f) Purchase Price. The Purchaser shall have delivered the Purchase Price
in accordance with Section 1.3(b) above.
Section 4.2 Conditions Precedent to the Obligation of the Purchaser to
Purchase the Shares. The obligation hereunder of the Purchaser to acquire and
pay for the Shares is subject to the satisfaction, at or before the Closing, of
each of the conditions set forth below. These conditions may be waived by the
Purchaser at any time in its sole discretion.
(a) Accuracy of the Company's Representations and Warranties. The
representations and warranties of the Company shall be true and correct in all
material respects as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
particular date).
(b) Performance by the Company. The Company shall have performed all
agreements and satisfied all conditions required to be performed or satisfied by
the Company at or prior to the Closing.
(c) NASDAO. From the date hereof to the Closing Date, trading in the
Company's Common Stock shall not have been suspended by the SEC or the NASDAQ
Small Cap Market (except for any suspension of trading of limited duration
agreed to between the Company and the NASDAQ Small Cap Market solely to permit
dissemination of material information regarding the Company), and trading in
securities generally as reported by NASDAQ shall not have been suspended or
limited or minimum prices shall not have been established on
securities whose trades are reported by NASDAQ.
(d) No Injunction. No statute, rule, regulation, executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits
the consummation of any of the transactions contemplated by this Agreement.
(e) Opinion of Counsel Etc. The Purchaser shall have received before or at
the Closing an opinion of counsel to the Company (covering, without limitation,
such of the matters set forth in Section 2.2(a) through (e)), as are in form and
substance reasonably satisfactory to the Purchaser and its counsel, and such
other certificates and documents as the Purchaser or its counsel shall
reasonably require incident to the Closing.
(f) Execution. The Company shall have executed this Agreement, and
delivered such Agreement to the Purchaser.
Section 5.1 Legend on Stock. Each certificate representing the Shares and,
if necessary, Common Stock issued upon conversion thereof, shall be stamped or
otherwise imprinted with a legend substantially in the following form:
THESE SECURITIES [AND THE SHARES OF COMMON STOCK ISSUABLE UPON THE CONVERSION
HEREOF] HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD OR OFFERED FOR SALE UNLESS
THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND ANY APPLICABLE
STATE SECURITIES LAW OR, IN THE OPINION OF COUNSEL, REGISTRATION UNDER SUCH ACT
OR APPLICABLE STATE SECURITIES LAW IS NOT REQUIRED IN CONNECTION WITH SUCH SALE
OR OFFER, AND SUCH OPINION IS REASONABLY SATISFACTORY TO THE COMPANY.
The Company agrees to reissue certificates representing the Shares or, if
applicable, the Common Stock issued upon conversion thereof, without the legend
set forth above at such time as (a) the holder thereof is permitted to dispose
of such Shares (or securities issued upon conversion thereof) pursuant to Rule
144(k) under the Act, (b) the securities are sold to a purchaser or purchasers
who (in the opinion of counsel to such holders, in form and substance reasonably
satisfactory to the Company and its counsel) are able to dispose of such
securities publicly without registration under the Act, or (iii) such securities
are registered under the Act
Section 6.1 Termination by Mutual Consent. This Agreement may be terminated
at any time prior to the Closing by the mutual written consent of the Company,
and the Purchaser.
Section 6.2 Other Termination. This Agreement may be terminated by action
of the Board of Directors or other governing body of the Purchaser or the
Company at any time if the Closing shall not have been consummated by the fifth
(5th) business day following the date of this Agreement, provided that the party
seeking to terminate the Agreement is not in breach of the Agreement.
Section 6.3 Automatic Termination. This Agreement shall automatically
terminate without any further action of either party hereto if the Closing shall
not have occurred by the seventh (7th) business day following the date of this
Agreement, provided, however, that any such termination shall not terminate the
liability of any party which is then in breach of the Agreement.
Section 7.1 Fees and Expenses. Except as otherwise set forth in Section 1.4
hereof with respect to the registration of Registrable Securities, the Company
shall pay the fees, commissions and expenses of its advisers, brokers, finders,
counsel, accountants and other experts, if any, and all other expenses
associated therewith, and shall on the Closing Date reimburse ProFutures Special
Equities Fund, L.P. up to $5,000 for fees and expenses of its counsel in
connection with the preparation, negotiation and coordination of this Agreement.
The Company shall pay all stamp and other taxes and duties levied in connection
with the issuance of the Shares and Common Stock pursuant hereto.
Section 7.2 Specific Enforcement, Consent to Jurisdiction.
(a) The Company and the Purchaser acknowledge and agree that irreparable
damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that the parties shall be entitled to an
injunction or injunctions to prevent or cure breaches of the provisions of this
Agreement and to enforce specifically the terms and provisions hereof, this
being in addition to any other remedy to which either of them may be entitled by
law or equity.
(b) The Company and the Purchaser each (i) hereby irrevocably submits to
the jurisdiction of the United States District Court and other courts of the
United States sitting in the State of Texas for the purposes of any suit, action
or proceeding arising out of or relating to this Agreement and (ii) hereby
waives, and agrees not to assert in any such suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of such court, that
the suit, action or proceeding is brought in an inconvenient forum or that the
venue of the suit, action or proceeding is improper. The Company and the
Purchaser each consents to process being served in any such suit, action or
proceeding by mailing a copy thereof to such party at the address in effect for
notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing in this
paragraph shall affect or limit any right to serve process in any other manner
permitted by law.
Section 7.3 Entire Agreement: Amendment. This Agreement contains the entire
understanding of the parties with respect to the matters covered hereby and,
except as specifically set forth herein, neither the Company nor the Purchaser
makes any representation, warranty, covenant or undertaking with respect to such
matters. No provision of this Agreement may be waived or amended other than by a
written instrument signed by the party against whom enforcement of any such
amendment or waiver is sought.
Section 7.4 Notices. Any notice or other communication required or
permitted to be given hereunder shall be in writing and shall be effective (a)
upon hand delivery or delivery by telex (with correct answer back received),
telecopy or facsimile at the address or number designated below (if delivered on
a business day during normal business hours where such notice is to be
received), or the first business day following such delivery (if delivered other
than on a business day during normal business hours where such notice is to be
received) or (b) on the second (2nd) business day following the date of mailing
by express courier service, fully prepaid, addressed to such address, or upon
actual receipt of such mailing, whichever shall first occur.
The addresses for such communications shall be:
to the Company: Bruce A. Shear, President and Chief Executive Officer
PHC, Inc.
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
to the Purchaser: At the address set forth at the foot of this Agreement or
as specified in writing by Purchaser.
Any party hereto may from time to time change its address for notices by giving
at least ten (10) days' written notice of such changed address to the other
party hereto.
Section 7.5 Waivers. No waiver by either party of any default with respect
to any provision, condition or requirement of this Agreement shall be deemed to
be a continuing waiver in the future or a waiver of any other provision,
condition or requirement hereof, nor shall any delay or omission of either party
to exercise any right hereunder in any manner impair the exercise of any such
right accruing to it thereafter.
Section 7.6 Headings. The headings herein are for convenience only, do not
constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.
Section 7.7 Governing Law. This Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the present state
of incorporation of the Company without regard to such state's principles of
conflict of laws.
Section 7.8 Survival. The representations and warranties of the Company and
the Purchaser contained in herein and the agreements and covenants set forth in
Sections 1.1 through 1.5, 3.1 through 3.3 and 7.1 through 7.16 shall survive the
Closing for a period of two (2) years.
Section 7.9 Publicity. The Company agrees that it will not disclose, and
will not include in any public announcement, the name of the Purchaser without
its consent, unless and until such disclosure is required by law or applicable
regulation, and then only to the extent of such requirement.
Section 7.10 NASDAO. The term "NASDAQ" or "NASDAQ Small Cap Market" herein
refers to the principal market on which the Common Stock of the Company is
traded. If the Common Stock is listed on a securities exchange. or if another
market becomes the principal market on which the Common Stock is traded or
through which price quotations for the Common Stock are reported, the term
"NASDAQ" or "NASDAQ Small Cap Market" shall be deemed to refer to such exchange
or other principal market.
Section 7.11 Acceptance. Execution and delivery of this Agreement shall
constitute an offer to purchase the Shares, which offer, unless previously
revoked by the Purchaser, may be accepted or rejected by the Company, in its
sole discretion for any cause or for no cause and without liability to the
Purchaser. The Company shall indicate acceptance of this Agreement by signing as
indicated on the signature page hereof.
Section 7.12 Binding Agreement. Upon acceptance of this Agreement by the
Company, the Purchaser agrees that he may not cancel, terminate or revoke any
agreement of the Purchaser made hereunder, and that this Agreement shall survive
the death or disability of the Purchaser and shall be binding upon heirs,
successors, assigns, executors, administrators, guardians, conservators or
personal representatives of the Purchaser.
Section 7.13 Incorporation by Reference. All information set forth on the
signature page is incorporated as integral terms of this Agreement.
Section 7.14 Counterparts. This Agreement may be signed in multiple
counterparts, which counterparts shall constitute one and the same original
instrument.
Section 7.15 Severability. If any portion of this Agreement shall be held
illegal, unenforceable, void or voidable by any court each of the remaining
terms hereof shall nevertheless remain in full force and effect as a separate
contract.
Section 7.16 Successors and Assigns. This Agreement shall be binding upon
and inure to the benefit of the parties hereto and their respective successors
and permitted assigns.
[This space has been left blank intentionally. The signature page follows.]
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$500,000 (500 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
26,315 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
ProFutures Special Equities Fund, L.P.
Address of Purchaser: % ProFutures Fund Management, Inc.
1030 Highway 620 South - Suite 200
Austin, TX 78734
Social Security or IRS Employer Identification Number(s):
74-2786952
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
______________________________________________
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: ProFutures Special Equities Fund, L.P.
By ProFutures Fund Management, Inc., a General Partner
By: ______________________________________
(Signature)
Name: /s/ Gary D. Halbert
Title: President
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$150,000 (150 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
7,890 shares
The exact name(s)(Including correct,legible spelling) and the information under
which title to the Shares will be taken is as follows (Please print or type):
Gary D. Halbert
Address of Purchaser: 1030 Highway 620 South - Suite 200
Austin, TX 78734
Social Security or IRS Employer Identification Number(s):
451-96-0684
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
/s/ Gary D. Halbert
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: _______________________________________
By: ______________________________________
(Signature)
Name: ____________________________________________
Title: ____________________________________________
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$100,000 (100 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
5,260 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
John F. Mauldin
Address of Purchaser: 1000 Ballpark in Arlington - Suite 216
Arlington, TX 76011
Social Security or IRS Employer Identification Number(s):
459-84-6606
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
/s/ John F. Mauldin
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: ________________________________
By: ______________________________________
(Signature)
Name: _________________________________
Title: _________________________________
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
IN WITNESS THEREOF, the Purchaser has executed this Agreement on the date set
forth below.
For the purchase price of $1,000 per Share, the Purchaser tenders herewith the
full purchase price of:
$200,000 (200 shares)
Number of Shares of Common Stock to be issuable under the Warrant:
10,525 shares
The exact name(s) (Including correct, legible spelling) and the information
under which title to the Shares will be taken is as follows (Please print or
type):
Augustine Fund, L.P.
Address of Purchaser: 141 West Jackson Boulevard - Suite 2182
Chicago, IL 60604
Social Security or IRS Employer Identification Number(s):
36-418-6782
Signature of Purchaser: Dated March 13, 1998
IF PURCHASER IS AN INDIVIDUAL OR JOINT PURCHASE:
______________________________________________
(Signature)
_______________________________________________
(Signature of Joint Owner, if any)
IF PURCHASER IS AN ENTITY:
Name of Entity: Augustine Fund, L.P.
By Augustine Capital Management, Inc., the General Partner
By: ______________________________________
(Signature)
Name: /s/ Thomas Duszynski
Title: Chief Operating Officer
Accepted by:
PHC, INC., a Massachusetts corporation
By: ___________________________________
(Signature)
Name: /s/ Bruce A. Shear
Title: President
SCHEDULE I
PHC, INC.
RESOLUTIONS ESTABLISHING RIGHTS AND PREFERENCES
FOR SERIES B CONVERTIBLE PREFERRED STOCK
RESOLVED, that there shall be a series of shares of the Corporation
designated "Series B Convertible Preferred Stock"; that the number of shares of
such series shall be 1,000, that the Corporation issue such shares, and that the
rights and preferences of such series (the "6% Preferred") and the limitations
or restrictions thereon, shall be as set forth herein.
The following terms and conditions shall be adopted and incorporated by
reference into the foregoing resolutions as if fully set forth therein:
1. Dividends.
(a) The holders of the 6% Preferred shall be entitled to receive out of any
assets legally available therefor cumulative dividends at the rate of $60 per
share per annum, accrued daily and payable quarterly in arrears on March 31,
June 30, September 30 and December 31 of each year, in preference and priority
to any payment of any dividend on the Common Stock or any other class or series
of stock of the Corporation. Such dividends shall accrue on any given share from
the day of original issuance of such share and shall accrue from day to day
whether or not earned or declared. If at any time dividends on the outstanding
6% Preferred at the rate set forth above shall not have been paid or declared
and set apart for payment with respect to all preceding periods, the amount of
the deficiency shall be fully paid or declared and set apart for payment, but
without interest, before any distribution, whether by way of dividend or
otherwise, shall be declared or paid upon or set apart for the shares of any
other class or series of stock of the Corporation.
(b) Any dividend payable on a dividend payment date may be paid, at the
option of the Corporation, either (i) in cash or (ii) in shares of 6% Preferred
valued at $1,000 per share, if the Common Stock issuable upon conversion of such
shares has been registered for resale under the Securities Act of 1933, as
amended (the "Act"), and the registration statement including a current
prospectus with respect thereto remains in effect at the date of delivery of
such shares, and if the Corporation shall have given written notice of its
intention to pay such dividend in stock to all holders of the 6% Preferred at
least ten (10) days before the record date for such dividend.
2. Liquidation Preference, Redemption.
(a) In the event of any liquidation, dissolution or winding up of the
Corporation, either voluntary or involuntary, the holders of the 6% Preferred
shall be entitled to receive, prior and in preference to any distribution of any
assets of the Corporation to the holders of any other class or series of shares,
the amount of $1,000 per share plus any accrued but unpaid dividends (the
"Liquidation Preference").
(b) A consolidation or merger of the Corporation with or into any other
corporation or corporations, or a sale of all or substantially all of the assets
of the Corporation (other than a sale or transfer to a wholly-owned subsidiary
of the Corporation), shall, at the option of the holders of the 6% Preferred, be
deemed a liquidation, dissolution or winding up within the meaning of this
Section 2 if the shares of stock of the Corporation outstanding immediately
prior to such transaction represent immediately after such transaction less than
a majority of the voting power of the surviving corporation (or of the acquirer
of the Corporation's assets in the case of a sale of assets). Such option may be
exercised by the vote or written consent of holders of a majority of the 6%
Preferred at any time within thirty (30) days after written notice (which shall
be given promptly) of the essential terms of such transaction shall have been
given to the holders of the 6% Preferred in the manner provided by law for the
giving of notice of meetings of shareholders.
- 1 -
(c) The Corporation may, at its option, cause all outstanding shares of the
6% Preferred to be redeemed after the date on which a registration statement
under the Act ("Registration Statement") has been declared effective (the
"effective date"); provided the Corporation has given notice of its intention to
redeem to the holders of the 6% Preferred at least five (5) days prior to the
redemption date. In addition, if any conversion of 6% Preferred, when aggregated
with all prior conversions, will cause the Company to issue a number of shares
of Common Stock which exceeds twenty percent (20%) of the shares of Common Stock
then issued and outstanding, the Company shall redeem such number of shares of
6% Preferred as is necessary to limit such issuance of Common Stock to twenty
percent (20%) of the shares of Common Stock then issued and outstanding, unless
the Company has previously obtained stockholder approval to issue in excess of
twenty percent (20%) of the shares of Common Stock then issued and outstanding.
If a redemption will occur under either of the preceding sentences, on the
redemption date, the Corporation shall pay such holders by cashiers check or
wire transfer in immediately available funds the amount of $1,300 per share of
6% Preferred plus all accrued but unpaid dividends. Promptly thereafter, the
holders shall surrender the certificate or certificates representing the 6%
Preferred, duly endorsed, at the office of the Corporation or of any transfer
agent for such shares, or at such other place designated by the Corporation.
3. 6% Preferred - Forced Conversion.
(a) The Corporation may, at its option, cause all outstanding shares of the
6% Preferred to be converted into Common Stock at any time beginning one (1)
year after the date of issuance, on at least twenty (20) days' advance notice,
at a conversion price determined as set forth in Section 4 hereof (the
"Conversion Price") as of the date specified in such notice (the "Conversion
Date") and otherwise on the terms set forth in Section 4 hereof, provided, that
the Corporation may not exercise such right of conversion unless (i) the Closing
Price (last trade price) of the Common Stock as reported by NASDAQ for the
twenty (20) consecutive trading days prior to the date the Conversion Notice is
mailed has not on any day been less than one hundred forty percent (140%) of the
last trade price of the Company's Common Stock on the day of Closing (subject to
adjustment for stock dividends, stock splits and reverse stock splits), and (ii)
the shares issuable upon conversion of the 6% Preferred are registered for
resale by an effective Registration Statement which became effective not more
than one hundred twenty (120) days after the date of issuance of the 6%
Preferred, and a current prospectus meeting the requirements of Section 10 of
the Act is available for delivery at the Conversion Date.
(b) At least twenty (20) days prior to the Conversion Date, written notice
(the "Conversion Notice") shall be mailed, first class postage prepaid, by the
Corporation to each holder of record of the 6% Preferred, at the address last
shown on the records of the Corporation for such holder, notifying such holder
of the conversion which is to be effected, specifying the Conversion Date and
calling upon each such holder to surrender to the Corporation, in the manner and
at the place designated, a certificate or certificates representing the number
of shares of 6% Preferred held by such holder. Subject to the provisions of the
following subsection (c), on or after the Conversion Date, each holder of 6%
Preferred shall surrender to the Corporation the certificate or certificates
representing the shares of 6% Preferred owned by such holder as of the
Conversion Date, in the manner and at the place designated in the Conversion
Notice, and thereupon the shares issuable upon such conversion shall be
delivered as provided in Section 4(b) hereof.
(c) If, on the Conversion Date, the registration condition specified in
clause (ii) of subsection (a) shall not be satisfied, then no shares shall be
converted and the Conversion Notice shall be deemed to be withdrawn. In such
event, any certificates for 6% Preferred which have been surrendered for
conversion shall be returned to the persons surrendering the same; provided,
however, that if a holder has received shares of Common Stock upon conversion of
6% Preferred after the Conversion Notice was given but before the Conversion
Date, such holder may elect either to retain such Common Stock or rescind such
conversion by tendering such shares of Common Stock to the Corporation.
(d) On the second anniversary of the issuance of the 6% Preferred, all then
outstanding shares of 6% Preferred shall be automatically converted into Common
Stock at the Conversion Price and otherwise pursuant to the applicable
provisions set forth in Section 4 hereof.
- 2 -
4. 6% Preferred - Optional Conversion. The holders of the 6% Preferred
shall have optional conversion rights as follows:
(a) Right to Convert. At any time after the earlier of (i) the date on
which a Registration Statement has been declared effective, or (ii) the close of
business on the ninety first (91st) day following the date of issuance of the 6%
Preferred, shares of 6% Preferred shall become convertible, at the option of the
holder thereof, into such number of fully paid and nonassessable shares of
Common Stock as is determined by dividing (A) the Liquidation Preference of the
6% Preferred determined pursuant to Section 2 hereof on the date the notice of
conversion is given, by (B) the Conversion Price determined as hereinafter
provided in effect on the applicable conversion date.
(b) Mechanics of Conversion. To convert shares of 6% Preferred into shares
of Common Stock, the holder shall give written notice to the Corporation (which
notice may be given by facsimile transmission) that such holder elects to
convert the shares and shall state therein date of the conversion, the number of
shares to be converted and the name or names in which such holder wishes the
certificate or certificates for shares of Common Stock to be issued. Promptly
thereafter, the holder shall surrender the certificate or certificates
representing the shares to be converted, duly endorsed, at the office of the
Corporation or of any transfer agent for such shares, or at such other place
designated by the Corporation; provided that the holder shall not be required to
deliver the certificates representing such shares if the holder is waiting to
receive all or part of such certificates from the Corporation. The Corporation
shall, immediately upon receipt of such notice, issue and deliver to or upon the
order of such holder, against delivery of the certificates representing the
shares which have been converted, a certificate or certificates for the number
of shares of Common Stock to which such holder shall be entitled and such
certificate or certificates shall not bear any restrictive legend; provided (A)
the Common Stock evidenced thereby are sold pursuant to an effective
registration statement under the Act, (B) the holder provides the Corporation
with an opinion of counsel reasonably acceptable to the Corporation to the
effect that a public sale of such shares may be made without registration under
the Act, or (C) such holder provides the Corporation with reasonable assurance
that such shares can be sold free of any limitations imposed by Rule 144,
promulgated under the Act. The Corporation shall cause such issuance and
delivery to be effected within three (3) business days and shall transmit the
certificates by messenger or overnight delivery service to reach the address
designated by such holder within three (3) business days after the receipt of
such notice. The notice of conversion may be given by a holder at any time
during the day up to 5:00 p.m. Boston, Massachusetts time and such conversion
shall be deemed to have been made immediately prior to the close of business on
the date such notice of conversion is given (a "conversion date"). The person or
persons entitled to receive the shares of Common Stock issuable upon such
conversion shall be treated for all purposes as the record holder or holders of
such shares of Common Stock at the close of business on such date.
(c) Conversion, Redemption and Note Delivery Required. The Corporation
acknowledges and understands that a delay in the issuance of the Common Stock
upon conversion or pursuant to a redemption according to the provisions hereof,
or a delay in delivering the Promissory Note set forth in Subsection (d) hereof,
could result in economic loss to the holders of the 6% Preferred. As
compensation to any holder when the Corporation has failed with respect to such
holder to comply with the Corporation's obligations hereunder, and not as a
penalty, the Corporation shall pay to such holder liquidated damages of $500 per
day plus an amount equal to: (i) two percent (2%) of the total Purchase Price of
Shares for the first thirty (30) day period after the date on which the Common
Stock should have been issued by the Corporation (i.e., the end of the three (3)
business day period described in Subsection (b)), shares of 6% Preferred
redeemed by the Corporation or Promissory Note delivered to holder (i.e., the
end of the three (3) business day period described in Subsection (d)), as
applicable; plus (ii) an amount equal to three percent (3%) of the total
Purchase Price of Shares for each subsequent thirty (30) day period thereafter.
Amounts payable shall be pro-rated daily as to a periods of less than thirty
(30) days. Such amounts shall be paid to the holder at the end of each month in
which such amounts have accrued. Payment shall be made immediately by cashier's
check or wire transfer in immediately available funds to such account as shall
be designated in writing by the holder. Each holder shall be entitled to an
injunction or injunctions to prevent or cure breaches of the provisions of
hereof and. to enforce specifically the terms and provisions hereof, this being,
in addition to any other remedy to which a holder may be entitled by law or
equity.
- 3 -
(d) Determination of Conversion Price:
(i )The "Conversion Price" for purposes of hereof shall be equal to eighty
percent (80%) of the average of the closing bid prices of the Common Stock as
reported by NASDAQ during the five (5) consecutive trading days preceding the
conversion date (but not including such date); provided, however, that in no
event may the Conversion Price be more than three dollars and twenty cents
($3.20) (the "Maximum Conversion Price") or less than an amount equal to the
closing bid price per share of the Common Stock on the date of issuance minus
fifty cents ($0.50) (the "Minimum Conversion Price"). If, but for this Section
4(d)(i), the Conversion Price would have been below Minimum Conversion Price,
the Company shall pay the holder by delivering to holder a Promissory Note, the
form which has been delivered to the Corporation and is incorporated herein by
reference, bearing the principal amount equal to the difference between (A) the
number of shares of Common Stock that would have been issued at the amount the
Conversion Price would have been but for this Section 4(d)(i) multiplied by 100%
of the closing bid price of the Common Stock on the conversion date as
determined in accordance with the Subsection (d) (the latter amount being
referred to herein as the "Conversion Date Price"), minus (B) the number of
shares of Common Stock actually issued pursuant to the conversion multiplied by
the Conversion Date Price. Such Promissory Note shall be delivered to holder by
the third (3rd) day following the applicable conversion date.
(ii) The "closing bid price" of the Common Stock on a trading day shall be
the closing bid price of the Common Stock on the NASDAQ Small Cap Market or any
other principal securities price quotation system or market on which prices of
the Common Stock are reported. The term "trading day" means a day on which
trading is reported on the principal quotation system or market on which prices
of the Common Stock are reported.
(iii) If, during the period of consecutive trading days provided for above,
the Corporation shall declare or pay any dividend on the Common Stock payable in
Common Stock or in rights to acquire Common Stock, or shall effect a stock split
or reverse stock split, or a combination, consolidation or reclassification of
the Common Stock, the Conversion Price, Maximum Conversion Price and Minimum
Conversion Price shall be proportionately decreased or increased, as
appropriate, to give effect to such event.
(e) Distributions. If the Corporation shall at any time or from time to
time make or issue, or fix a record date for the determination of holders of
Common Stock entitled to receive, a dividend or other distribution payable in
securities of the Corporation or any of its subsidiaries other than additional
shares of Common Stock, then in each such event provision shall be made so that
the holders of 6% Preferred shall receive, upon the conversion thereof, the
securities of the Corporation which they would have received had they been the
owners on the date of such event of the number of shares of Common Stock
issuable to them upon conversion.
(f) Certificates as to Adjustments. Upon the occurrence of any adjustment
or readjustment of the Conversion Price, the Maximum Conversion Price and
Minimum Conversion Price pursuant to this Section 4, the Corporation at its
expense shall promptly compute such adjustment or readjustment in accordance
with the terms hereof and cause the independent public accountants regularly
employed to audit the financial statements of the Corporation to verify such
computation and prepare and furnish to each holder of 6% Preferred a certificate
setting forth such adjustment or readjustment and showing in detail the facts
upon which such adjustment or readjustment is based. The Corporation shall, upon
the written request at any time of any holder of 6%. Preferred, furnish or cause
to be furnished to such holder a like certificate prepared by the Corporation
setting forth (i) such adjustments and readjustments, and (ii) the number of
other securities and the amount, if any, of other property which at the time
would be received upon the conversion of 6% Preferred with respect to each share
of Common Stock received upon such conversion.
(g) Notice of Record Date. In the event of any taking by the Corporation of
a record of the holders of any class of securities for the purpose of
determining the holders thereof who are entitled to receive any dividend (other
than a cash dividend) or other distribution, any security or right convertible
into or entitling the holder thereof to receive additional shares of Common
Stock, or any right to subscribe for, purchase or otherwise acquire any shares
of stock of any class or any other securities or property, or to receive any
other right, the Corporation shall mail to each holder of 6% Preferred at least
ten (10) days prior to the date specified therein, a notice specifying the date
on which any such record is to be taken for the purpose of such dividend,
distribution, security or right and the amount and character of such dividend,
distribution, security or right.
- 4 -
(h) Issue Taxes. The Corporation shall pay any and all issue and other
taxes, excluding any income, franchise or similar taxes, that may be payable in
respect of any issue or delivery of shares of Common Stock on conversion of
shares of 6% Preferred pursuant hereto; provided, however, that the Corporation
shall not be obligated to pay any transfer taxes resulting from any transfer
requested by any holder in connection with any such conversion.
(i) Reservation of Stock Issuable Upon Conversion. The Corporation shall at
all times reserve and keep available out of its authorized but unissued shares
of Common Stock, solely for the purpose of effecting the conversion of the
shares of the 6% Preferred, such number of its shares of Common Stock as shall
from time to time be sufficient to effect the conversion of all outstanding
shares of the 6% Preferred, and if at any time the number of authorized but
unissued shares of Common Stock shall not be sufficient to effect the conversion
of all then outstanding shares of the 6% Preferred, the Corporation will take
such corporate action as may be necessary to increase its authorized but
unissued shares of Common Stock to such number of shares as shall be sufficient
for such purpose, including, without limitation, engaging in best efforts to
obtain any requisite shareholder approval.
(j) Fractional Shares. No fractional shares shall be issued upon the
conversion of any share or shares of 6% Preferred. All shares of Common Stock
(including fractions thereof) issuable upon conversion of more than one share of
6% Preferred by a holder thereof shall be aggregated for purposes of determining
whether the conversion would result in the issuance of any fractional share. If,
after the aforementioned aggregation, the conversion would result in the
issuance of a fraction of a share of Common Stock, the Corporation shall, in
lieu of issuing any fractional share, pay the holder otherwise entitled to such
fraction a sum in cash equal to the fair market value of such fraction on the
date of conversion (as determined in good faith by the Board of Directors of the
Corporation or an authorized Committee thereof).
(k) Notices. Any notice required by the provisions of this Section to be
given to the holders of shares of 6% Preferred shall be deemed given if
deposited in the United States mail, postage prepaid, and addressed to each
holder of record at its address appearing on the books of the Corporation.
(1) Reorganization or Merger. In case of any reorganization or any
reclassification of the capital stock of the Corporation or any consolidation or
merger of the Corporation with or into any other corporation or corporations or
a sale of all or substantially all of the assets of the Corporation to any other
person (other than a sale or transfer to a wholly owned subsidiary of the
Corporation), and the holders of 6% Preferred do not elect to treat such
transaction as a liquidation, dissolution or winding up as provided in Section 2
hereof, then, as part of such reorganization, consolidation, merger or sale,
provision shall be made so that each share of 6% Preferred shall thereafter be
convertible into the number of shares of stock or other securities or property
(including cash) to which a holder of the number of shares of Common Stock
deliverable upon conversion of such share of 6% Preferred would have been
entitled upon the record date of (or date of, if no record date is fixed) such
event and, in any case, appropriate adjustment (as determined by the Board of
Directors) shall be made in the application of the provisions herein set forth
with respect to the rights and interests thereafter of the holders of the 6%
Preferred, to the end that the provisions set forth herein shall thereafter be
applicable, as nearly as equivalent as is practicable, in relation to any shares
of stock or the securities or property (including cash) thereafter deliverable
upon the conversion of the shares of 6% Preferred.
5. Re-issuance of Certificates. In the event of a conversion (or, if
applicable, redemption) of 6% Preferred in which less than all of the shares of
6% Preferred of a particular certificate are converted or redeemed, as the case
may be, the Corporation shall promptly without delay cause to be issued and
delivered to the holder of such certificate, a certificate representing the
remaining shares of 6% Preferred which have not been so
converted or redeemed.
- 5 -
6. Other Provisions. For all purposes of this Resolution, the term "date of
issuance" and the terms "Closing" or "Closing Date" shall mean the day on which
shares of the 6% Preferred are first issued by the Corporation. Any provision
herein which conflicts with or violates any applicable usury law shall be deemed
modified to the extent necessary to avoid such conflict or violation. The term
"NASDAQ" herein refers to the principal market on which the Common Stock of the
Corporation is traded. If the Common Stock is listed on a securities exchange,
or if another market becomes the principal market on which the Common Stock is
traded or through which price quotations for the Common Stock are reported, the
term "NASDAQ" shall be deemed to refer to such exchange or other principal
market.
7. Restrictions and Limitations. The Corporation shall not undertake the
following actions without the consent of the holders of a majority of the 6%
Preferred: (i) modify its Articles of Organization or Bylaws so as to amend or
change any of the rights, preferences, or privileges of the 6% Preferred, (ii)
authorize or issue any other preferred equity security senior to or on a parity
with the 6% Preferred as to dividends, liquidation preferences, conversion
rights, redemption rights or other rights, preferences or privileges for a
period of thirty (30) days after Closing, as applicable or (iii), purchase or
otherwise acquire for value any Common Stock or other equity security of the
Corporation either junior or senior to or on a parity with the 6% Preferred
while there exists any arrearage in the payment of cumulative dividends
hereunder other than redemptions of stock from terminating employees pursuant to
contractual rights in favor of the Corporation.
8. Voting Rights. Except as provided herein or as provided for by law, the
6% Preferred shall have no voting rights.
9. Attorney's Fees. Any holder of 6% Preferred shall be entitled to recover
from the Corporation the reasonable attorneys' fees and expenses incurred by
such holder in connection with enforcement by such holder of any obligation of
the Corporation hereunder.
10. No Adverse Actions. The Corporation shall not in any manner, whether by
amendment of the Articles of Organization (including, without limitation, any
vote establishing a class or series of stock), merger, reorganization,
recapitalization, consolidation, sales of assets, sale of stock tender offer,
dissolution or otherwise, take any action, or permit any action to be taken,
solely or primarily for the purpose of increasing the value of any class of
stock of the Corporation if the effect of such action is to reduce the value or
security of the 6% Preferred.
- 6 -
EXHIBIT A to the Subscription Agreement
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON
STOCK PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March ___, 1998
1. Basic Terms. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the registered holder specified
below or its registered assigns ("Holder"), is the owner of warrants of PHC,
Inc., a Massachusetts corporation (the "Corporation"), and is entitled, subject
to the terms and conditions of this Warrant, including adjustments as provided
herein, to purchase ______ ( ) (number to be pro-rated for a total of 50,000
share) shares of the Common Stock (the "Common Stock") of the Corporation from
the Corporation at the price per share shown below (the "Exercise Price").
Holder:
Exercise Price per share: ______ Dollars and ______
Cents ($ )per share
[This amount will be the Closing Bid Price of the
Corporation's Common Stock on the Issue Date]
Except as specifically provided otherwise, all references in this Warrant
to the Exercise Price and the number of shares of Common Stock purchasable
hereunder shall be to the Exercise Price and number of shares after any
adjustments are made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The Corporation represents and
covenants that the shares of Common Stock issuable upon the exercise of this
Warrant shall at delivery be fully paid and non-assessable and free from taxes,
liens, encumbrances and charges with respect to their purchase. The Corporation
shall take any necessary actions to assure that the par value per share of the
Common Stock is at all times equal to or less than the then current Exercise
Price per share of Common Stock issuable pursuant to this Warrant. The
Corporation shall at all times reserve and hold available sufficient shares of
Common Stock to satisfy all conversion and purchase rights of outstanding
convertible securities, options and warrants of the Corporation, including this
Warrant.
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the issue date.
To exercise this Warrant, the Holder shall surrender this Warrant at the
principal office of the Corporation or that of the duly authorized and acting
transfer agent for its Common Stock, together with the executed exercise form
(substantially in the form of that attached hereto) and together with payment
for the Common Stock purchased under this Warrant. The principal office of the
Corporation is located at the address specified on the signature page of this
Warrant; provided, however, that the Corporation may change its principal office
upon notice to the Holder. At the option of the Holder payment shall be made
either in cash (by wire) or by certified or bank cashier's check payable to the
order of the Corporation or the Holder may elect to receive shares of Common
Stock calculated pursuant to paragraph 4. The Corporation shall, immediately
upon receipt of such notice, issue and deliver to or upon the order of such
Holder a certificate or certificates for the number of shares of Common Stock to
which such Holder shall be entitled and such certificate or certificates shall
not bear any restrictive legend; provided (A) the Common Stock evidenced thereby
are sold pursuant to an effective registration statement under the Act, (B) the
holder provides the Corporation with an opinion of counsel reasonably acceptable
to the Corporation to the effect that a public sale of such shares may be made
without registration under the Act, or (C) such holder provides the Corporation
with reasonable assurance that such shares can be sold free of any limitations
imposed by Rule 144, promulgated under the Act. The Corporation shall cause such
issuance and delivery to be effected within three (3) business days and shall
transmit the certificates by messenger or overnight delivery service to reach
the address designated by such holder within three (3) business days after the
receipt of such notice. This Warrant is not exercisable with respect to a
fraction of a share of Common Stock. In lieu of issuing a fraction of a share
remaining after exercise of this Warrant as to all full shares covered by this
Warrant the Corporation shall either at its option (a) pay for the fractional
share cash equal to the same fraction at the fair market price for such share;
or (b) issue scrip for the fraction in the registered or bearer form which shall
entitle the Holder to receive a certificate for a full share of Common Stock on
surrender of scrip aggregating a full share. As compensation to the Holder when
the Corporation has failed with respect to such Holder to comply with the
Corporation's obligations hereunder, and not as a penalty, the Corporation shall
pay to such holder liquidated damages of $500 per day until the certificates are
delivered as instructed. Such damages shall be paid to the Holder by cashiers
check or wire transfer in immediately available funds to such account as shall
be designated in writing by the Holder at the end of each month in which such
amounts have accrued. Holder shall be entitled to an injunction or injunctions
to prevent or cure breaches of the provisions of hereof and to enforce
specifically the terms and provisions hereof, this being in addition to any
other remedy to which Holder may be entitled by law or equity.
4. Cashless Exercise.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or
quoted in the NASDAQ System or the domestic over-the-counter market, the fair
market value shall be the higher of (i) the book value thereof, as determined by
any firm of independent public accountants of recognized standing selected by
the Corporation (which may be the Corporation's regular independent
accountants), as of the last day of any month ending within sixty days preceding
the date as of which the determination is to be made; or (ii) the fair market
value thereof, which shall be reasonably determined by the Corporation and the
Holder as of a date which is within fifteen days of the date as of which the
determination is to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that
price determined by multiplying the Exercise Price in effect immediately prior
to such event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number an kind of securities or other
property purchasable under this Warrant resulting from the event and settin
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until,
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant.All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the
Holder.
PHC, INC., a Massachusetts corporation
By: ________________________________
Authorized Officer
Printed Name: _______________________
Title: ______________________________
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ________________________________
________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________ ____________________________________
Signature
- 8 -
Incorporated by Reference into the Resolutions Establishing Right and
Preferences for Series B Convertible Preferred Stock.
PROMISSORY NOTE (the "Note")
Date: __________________, ________________________
Maker: PHC, Inc.
Maker's Mailing Address: 200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
Payee:
Place for Payment:
Principal Amount: $_________________________________
Annual Interest Rate on Unpaid Principal From Date: Eight percent (8%).
Annual Past Due Interest Rate on Unpaid Principal from Maturity to Payment:
Fifteen percent (15%).
Terms of Payment: Principal and interest shall be due and payable in six (6)
equal consecutive monthly payments of $ ________________ (based on a six (6)
month amortization) with the first payment being due and payable on the first
day of _____________________.
The Maker promises to pay to the order of Payee at the place for payment and
according to the terms of payment the outstanding principal and accrued interest
at the rates stated above. All unpaid amounts owing on this Note shall be due by
the final scheduled payment date of ________________________.
Additional Provisions:
If Maker defaults in the payment of this Note, or in any instrument securing or
collateral to it, then Payee may declare the unpaid principal balance of this
Note and all accrued interest immediately due and payable. Maker and each
surety, endorser, and guarantor or other party liable for the payment of any
sums of money payable on this Note severally waive all demands for payment,
presentations for payment, notices of dishonor, notices of intention to
accelerate maturity, notices of acceleration of maturity, protests, and notices
of protest, to the extent permitted by law.
If this Note or any instrument securing or collateral to it is given to an
attorney for collection or enforcement. or if suit is brought for collection or
enforcement or if it is collected or enforced through probate, bankruptcy, or
other judicial proceedings then Maker shall pay Payee all costs of collection
and enforcement, including reasonable attorneys fees and court costs, in
addition to other amounts due.
PHC. INC., PROMISSORY NOTE
Page 1
Interest that may be contracted for, taken, reserved, charged or received
under law; any interest in excess of that maximum amount shall be credited on
the principal of the debt or, if that has been paid, refunded. On any
acceleration or required or permitted prepayment, any such excess shall be
canceled automatically as of the acceleration or prepayment or, if already paid,
credited on the principal of the debt or, if the principal of the debt has been
paid, refunded. This provision overrides other provisions in this and all other
instruments concerning the debt.
When the context requires, singular nouns and pronouns include the plural.
This Note is to be governed and construed in accordance with the laws of
the State of Texas.
MAKER, FOR GOOD AND VALUABLE CONSIDERATION, THE RECEIPT AND SUFFICIENCY OF
WHICH ARE HEREBY ACKNOWLEDGED, (I) HEREBY IRREVOCABLY SUBMITS TO THE
JURISDICTION OF THE UNITED STATES DISTRICT COURT AND OTHER COURTS OF THE UNITED
STATES SITTING IN TEXAS FOR THE PURPOSES OF ANY SUIT, ACTION OR PROCEEDING
ARISING OUT OF OR RELATING TO THIS AGREEMENT AND (ii) HEREBY WAIVES, AND AGREES
NOT TO ASSERT IN ANY SUCH SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT
PERSONALLY SUBJECT TO THE JURISDICTION OF SUCH COURT, THAT THE SUIT, ACTION OR
PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR THAT THE VENUE OF THE SUIT,
ACTION OR PROCEEDING IS IMPROPER. MAKER CONSENTS TO PROCESS BEING SERVED IN ANY
SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF TO MAKER AT ITS MAIN
BUSINESS OFFICE AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND
SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING IN THIS PARAGRAPH
SHALL AFFECT OR LIMIT ANY RIGHT TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED
BY LAW.
Executed as of date first above written.
PHC Inc., a Massachusetts corporation
By: _______________________________________
Name of
Authorized Officer: __________________________
Title: ______________________________________
PHC. INC., PROMISSORY NOTE
Page 2
EXHIBIT B to the Subscription Agreement
Section 2.2(a): PHC, Inc. Subsidiaries:
PHC of Utah, Inc. Pioneer Counseling of Virginia, Inc.
D/B/A Highland Ridge Hospital (80% Owned)
4578 Highland Drive D/B/A Pioneer Counseling of Virginia
Salt Lake City, UT 94117 D/B/A Counseling Associates of Virginia
400 East Burwell street
Salem, VA 24153
PHC of Virginia, Inc. PHC of Kansas, Inc.
D/B/A Mount Regis Center D/B/A Total Concept EAP
D/B/A Changes 7451 Szwitzer, Suite 101
405 Kimball Avenue Shawnee Mission, KS 66203
Salem, VA 24153
Quality Care Centers of Mass, Inc. PHC of California, Inc.
D/B/A Franvale Nursing & Rehab Center D/B/A Marin Grove
20 Pond Street 42 Grove Street
Braintree, MA 02194 San Rafael, CA 94901
PHC of Nevada, Inc. Professional Health Associates
D/B/A Harmony Healthcare 94-19 59 Avenue
2340 Paseo del Prado, Bldg.D Elmhum NY 11373
Las Vegas, NV 89102
Northpoint - Pioneer, Inc. STL, Inc.
D/B/A Pioneer Counseling Center 200 Lake Street
31700 W. 13 Mile; Suite 201 Suite 102
Farmington Hills, MI 48334 Peabody, MA 0 1960
BSC-NY, Inc. Harmony Behavioral Health
D/B/A Behavioral Stress Center 2340 Paseo del Prado, Bldg.D
94-19 59 Avenue Las Vegas, NV 89102
Elmhurst, NY 11373
PHC of Michigan, Inc. PHC of Rhode island, Inc.
D/B/A Harbor Oaks Hospital D/B/A Good Hope Center
35031 23 Mile Road P.O. Box 1491
New Baltimore, MI 48047 Coventry, RI 02816-0029
EXHIBIT B (cont'd.)
Section 2.2(f):
The Company failed to file two years' of audited financial statements for
Behavioral Stress Centers, Inc. and Clinical Diagnostics and Clinical
Associates, as described in the December 18, 1996 letter from Choate, Hall &
Stewart to Mr. Robert Bayless of the Securities and Exchange Commission.
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns "Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Twenty Six Thousand Three Hundred Fifteen (26,315) shares of Class A
Common Stock (the "Common Stock") of the Corporation from the Corporation at the
price per share shown below (the "Exercise Price").
Holder: ProFutures Special Equities Fund, L.P.
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporations Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading shall be average of the
closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at he end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant,. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ______________________ _____________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________ __________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Seven Thousand Eight Hundred Ninety (7,890) shares of Class A Common
Stock (the "Common Stock") of the Corporation from the Corporation at the price
per share shown below (the "Exercise Price").
Holder: Gary D. Halbert
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock s at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDA", the average of the daily market prices of such stock on the ten
(10) trading days immediately preceeding the date as of which such value is to
be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restriction s on transfer contained herein, in the names designated by the
Holder at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement hall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
-6-
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ________________________ ________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: __________________________________
__________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Five Thousand Two Hundred Sixty (5,260) shares of Class A Common Stock
(the "Common Stock") of the Corporation from the Corporation at the price per
share shown below (the "Exercise Price").
Holder: John F. Mauldin
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. he Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashiers check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDAQ"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted t be given to the Holder shall
be in writing and shall be given by first class mail, postage repaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of 1933, as
amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: _________________________ _____________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: _________________________ ____________________________________
Signature
- 8 -
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE ON EXERCISE OF THIS
WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY OTHER SECURITIES
LAWS (THE "ACTS"). NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK
PURCHASABLE HEREUNDER MAY BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE
ABSENCE OF (A) AN REGISTRATION STATEMENT FOR THIS WARRANT OR COMMON STOCK
PURCHASABLE HEREUNDER, AS APPLICABLE, UNDER THE ACTS, OR (B) AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACTS.
PHC, INC.
WARRANT
Issue Date: March 16, 1998
1. Basic Term. This Warrant (as it may be amended from time to time, the
"Warrant") certifies that, for value received, the holder specified below or its
assigns ("Holder"), is the owner of warrants of PHC, Inc., a Massachusetts
corporation (the "Corporation"), and is entitled, subject to the terms and
conditions of this Warrant, including adjustments as provided herein, to
purchase Ten Thousand Five Hundred Twenty Five (10,525) shares of Class A Common
Stock (the "Common Stock") of the Corporation from the Corporation at the price
per share shown below (the "Exercise Price").
Holder: Augustine Fund, L.P.
Exercise Price per share: Two Dollars and Five-Sixteenths Cents ($2 5/16)
per share
Except as specifically provided otherwise, all references in this Warrant to the
Exercise Price and the number of shares of Common Stock purchasable hereunder
shall be to the Exercise Price and number of shares after any adjustments are
made thereto pursuant to this Warrant.
2. Corporation's Representations/Covenants. The corporation and covenants
that the shares of Common Stock issuable upon the exercise of this Warrant shall
at delivery be fully paid and nonasseble and free from taxes, liens,
encumbrances and charges with respect to their purchase. The Corporation shall
take any necessary actions to assure that the par value per share of the Common
Stock is at all times equal to or less than the then current Exercise Price per
share of Common Stock issuable pursuant to this Warrant. The Corporation shall
at all times reserve and hold available sufficient shares of Common Stock to
satisfy all conversion and purchase rights of outstanding convertible
securities, options and warrants of the Corporation, including this Warrant
- 1 -
3. Method of Exercise: Fractional Shares. This Warrant is exercisable at
the option of the Holder in whole at any time or in part from time to time by
surrendering this Warrant, on any business day during the period (the "Exercise
Period") beginning on the issue date of this Warrant specified above and ending
at 5:00 p.m. (Boston, Massachusetts time) three (3) years after the Late date.
To exercise this Warrant, the Holder shall surrender this Warrant at the office
of the Corporation or that of the duly authorized and acting transfer agent for
its Common Stock, together with the executed exercise form (substantially in the
form of that attached hereto) and together with payment for the Common Stock
purchased under this Warrant the principal office of the Corporation is located
at the address specified on the signature page of this Warrant; provided,
however, that the Corporation may change its principal office upon notice to the
Holder. At the option of the Holder payment shall be made either in cash (by
wire) or by certified or bank cashier's check payable to the order of the
Corporation or the Holder may elect to move shares of Common Stock calculated
pursuant to paragraph 4. The Corporation shall, immediately upon receipt of such
notice, issue and deliver to or upon the order of such Holder a certificate or
certificates for the number of shares of Common Stock to which such Holder shall
be entitled and such certificate or certificates shall not bear any restrictive
legend; provided (A) the Common Stock evidenced thereby are sold pursuant to an
effective registration statement under the Act, (B) the holder provides the
Corporation with an opinion of counsel reasonably acceptable to the Corporation
to the effect that a public sale of such shares may be made on under the Act, or
(C) such holder provides the Corporation with reasonable assurance that such
shares can be sold free of any limitations imposed by Rule 144, promulgated
under the Act. The Corporation shall cause such issuance and delivery to be
effected within three (3) business days and shall transmit the certificates by
messenger or overnight delivery service to reach the address designated by such
holder within three (3) business days after the receipt of such notice. This
Warrant is not exercisable with respect to a fraction of a share of Common
Stock. In lieu of issuing a fraction of a share remaining after exercise of this
Warrant as to all full shares covered by this Warrant, the Corporation shall
either at its option (a) pay for the fractional share cash equal to the same
fraction at the fair market price for such share; or (b) issue scrip for the
fraction in the registered or bearer form which shall entitle the Holder to
receive a certificate for a full share of Common Stock on surrender of scrip
aggregating a full share. As compensation to the Holder when the Corporation has
failed with respect to such Holder to comply with the Corporation's obligations
hereunder, and not as a penalty, the Corporation shall pay to such holder
liquidated damages of $500 per day until the certificates are delivered as
instructed. Such damages shall be paid to the Holder by cashier's check or wire
transfer in immediately available funds to such account as shall be designated
in writing by the Holder at the end of each month in which such amounts have
accrued. Holder shall be entitled to an injunction or injunctions to prevent or
cure breaches of the provisions of hereof and to enforce specifically the
transfer and provisions hereof, this being in addition to any other remedy to
which Holder may be entitled by law or equity.
(a) The Holder may, upon any full or partial exercise of this Warrant, pay
the Exercise Price applicable to such exercise by delivering this Warrant and
receiving from the Corporation in return therefor the number of shares of Common
Stock as to which the Warrant is being exercised which have a fair market value
on the date of exercise equal to the fair market value of the Warrant as
established in paragraph 4(b).
(b) The fair market value of this Warrant shall mean the fair market value
of the Common Stock purchasable under this Warrant minus the Exercise Price of
this Warrant.
(c) The fair market value of the Common Stock is, if the Common Stock is
traded on a national securities exchange or in the over-the-counter market as
reported by the National Association of Securities Dealers Automated Quotation
System ("NASDA"), the average of the daily market prices of such stock on the
ten (10) trading days immediately preceding the date as of which such value is
to be determined. The market price for each such trading day shall be average of
the closing prices on such day of the Common Stock on all domestic exchanges on
which the Common Stock is then listed, or if there have not been sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of such day, or, if the Common Stock is
not so listed, the average of the representative bid and asked prices quoted in
the NASDAQ National Market System as of 3:30 p.m., EST time, on such day, or, if
the Common Stock is not quoted in the NASDAQ System, the average of the high and
low bid and asked prices on such day in the domestic over-the-counter market as
reported by the National Quotation Bureau, Incorporated, or any similar
successor organization.
- 2 -
If at any time the Common Stock is not listed on any domestic exchange or quoted
in the NASDAQ System or the domestic over-the-counter market, the fair market
value shall be the higher of (i) the book value thereof, as determined by any
firm of independent public accountants of recognized standing selected by the
Corporation (which may be the Corporation's regular independent accountants), as
of the last day of any month ending within sixty days preceding the date as of
which the determination is to be made; or (ii) the fair market value thereof,
which shall be reasonably determined by the Corporation and the Holder as of a
date which is within fifteen days of the date as of which the determination is
to be made.
5. Protection Against Dilution. The number of shares of Common Stock
purchasable under this Warrant, and the Exercise Price, shall be adjusted as set
forth below. If at any time or from time to time after the date of this Warrant,
the Corporation:
(a) takes a record of the holders of its outstanding shares of Common Stock
for the purposes of entitling them to receive a dividend payable in, or other
distribution of, Common Stock,
(b) subdivides its outstanding shares of Common Stock into a larger number
of shares of Common Stock; or
(c) combines its outstanding shares of Common Stock into a smaller number
of shares of Common Stock;
then, and in each such case, the Exercise Price shall be adjusted to that price
determined by multiplying the Exercise Price in effect immediately prior to such
event by a fraction (A) the numerator of which is the total number of
outstanding shares of Common Stock immediately prior to such event and (B) the
denominator of which is the total number of outstanding shares of Common Stock
immediately after such event. Upon each adjustment in the Exercise Price under
this Warrant such number of shares of Common Stock purchasable under this
Warrant shall be adjusted by multiplying the number of shares of Common Stock by
a fraction, the numerator of which is the Exercise Price immediately prior to
such adjustment and the denominator of which is the Exercise Price in effect
upon such adjustment.
6. Adjustment for Reorganization, Consolidation, Merger, Etc.
(a) During the Exercise Period, the Corporation shall, prior to
consummation of a consolidation with or merger into another corporation, or
conveyance of all or substantially all of its assets to any other corporation or
corporations, whether affiliated or unaffiliated (any such corporation being
included within the meaning of the term "successor corporation"), or agreement
to so consolidate, merge or convey assets, require the successor corporation to
assume, by written instrument delivered to the Holder, the obligation to issue
and deliver to such Holder such shares of stock, securities or property as the
Holder shall be entitled to purchase or receive in accordance with the
provisions of paragraph 6(b) hereof.
(b) In the case of any capital reorganization or reclassification of the
Common Stock of the Corporation (or any other corporation the stock or other
securities of which are at the time receivable on the exercise of this Warrant)
during the Exercise Period or in case, during the Exercise Period, the
Corporation (or any such other corporation) shall consolidate with or merge into
another corporation or convey all or substantially all its assets to another
corporation, the Holder, upon exercise, at any time after the consummation of
such reorganization, consolidation, merger or conveyance, shall be entitled to
receive, in lieu of the Common Stock of the Corporation (or such other
corporation), the proportionate share of all stock, securities or other property
issued, paid or delivered for or on all of the Common Stock of the Corporation
(or such other corporation) as is allocable to the shares of Common Stock then
called for by this Warrant as if the Holder had exercised the Warrant
immediately prior thereto, all subject to further adjustment as provided in
paragraph 4 of this Warrant.
- 3 -
7. Notice of Adjustment. On the happening of an event requiring an
adjustment of the Exercise Price or the shares purchasable under this Warrant,
the Corporation shall immediately give written notice to the Holder stating the
adjusted Exercise Price and the adjusted number and kind of securities or other
property purchasable under this Warrant resulting from the event and setting
forth in reasonable detail the method of calculation and the facts upon which
the calculation is based.
8. Dissolution, Liquidation. In case the voluntary or involuntary
dissolution, liquidation or winding up of the Corporation (other than in
connection with a reorganization, consolidation, merger, or other transaction
covered by paragraph 5 above) is at any time proposed, the Corporation shall
give at least thirty days prior written notice to the Holder. Such notice shall
contain: (a) the date on which the transaction is to take place; (b) the record
date (which shall be at least thirty (30) days after the giving of the notice)
as of which holders of Common Stock will be entitled to receive distributions as
a result of the transaction; (c) a brief description of the transaction, (d) a
brief description of the distributions to be made to holders of Common Stock as
a result of the transaction; and (d) an estimate of the fair value of the
distributions. On the date of the transaction, if it actually occurs, this
Warrant and all rights under this Warrant shall terminate.
9. Rights of Holder. The Corporation shall deliver to the Holder all
notices and other information provided to its holders of shares of Common Stock
or other securities which may be issuable hereunder concurrently with the
delivery of such information to the holders. This Warrant does not entitle the
Holder to any voting rights or, except for the foregoing notice provisions, any
other rights as a shareholder of the Corporation. No dividends are payable or
will accrue on this Warrant or the Shares purchasable under this Warrant until.
and except to the extent that, this Warrant is exercised. Upon the surrender of
this Warrant and payment of the Exercise Price as provided above, the person or
entity entitled to receive the shares of Common Stock issuable upon such
exercise shall be treated for all purposes as the record holder of such shares
as of the close of business on the date of the surrender of this Warrant for
exercise as provided above. Upon the exercise of this Warrant the Holder shall
have all of the rights of a shareholder in the Corporation.
10. Exchange for Other Denominations. This Warrant is exchangeable, on its
surrender by the Holder to the Corporation, for a new Warrant of like tenor and
date representing in the aggregate the right to purchase the balance of the
number of shares Purchasable under this Warrant in denominations and subject to
restrictions on transfer contained herein, in the names designated by the Holder
at the time of surrender.
11. Substitution. Upon receipt by the Corporation of evidence satisfactory
(in the exercise of reasonable discretion) to it of the ownership of and the
loss, theft or destruction or mutilation of the Warrant, and (in the case or
loss, theft or destruction) of indemnity satisfactory (in the exercise of
reasonable discretion) to it, and (in the case of mutilation) upon the surrender
and cancellation thereof, the Corporation will issue and deliver, in lieu
thereof, a new Warrant of like tenor.
- 4 -
12. Restrictions on Transfer. Neither this Warrant nor the shares of Common
Stock issuable on exercise of this Warrant have been registered under the
Securities Act or any other securities laws (the "Acts"). Neither this Warrant
nor the shares of Common Stock purchasable hereunder may be sold, transferred,
pledged or hypothecated in the absence of (a) an effective registration
statement for this Warrant or Common Stock purchasable hereunder, as applicable,
under the Acts, or (b) an opinion of counsel reasonably satisfactory to the
Corporation that registration is not required under such Acts. In addition, this
Warrant may be transferred or assigned only if such transferee or assignee shall
be an "accredited investor", as described in Section 17 hereof, and such
transfer or assignment is made expressly subject to the terms and conditions of
this Warrant. If the Holder seeks an opinion as to transfer without registration
from Holder's counsel, the Corporation shall provide such factual information to
Holder's counsel as Holder's counsel reasonably request for the purpose of
rendering such opinion. Each certificate evidencing shares of Common Stock
purchased hereunder will bear a legend describing the restrictions on transfer
contained in this paragraph unless, in the opinion of counsel reasonably
acceptable to the Corporation, the shares need no longer to be subject to the
transfer restrictions.
13. Transfer. Except as otherwise provided in this Warrant, this Warrant is
transferable only on the books of the Corporation by the Holder in person or by
attorney, on surrender of this Warrant. properly endorsed.
14. Recognition of Holder. Prior to due presentment for registration of
transfer of this Warrant, the Corporation shall treat the Holder as the person
exclusively entitled to receive notices and otherwise to exercise rights under
this Warrant. All notices required or permitted to be given to the Holder shall
be in writing and shall be given by first class mail, postage prepaid, addressed
to the Holder at the address of the Holder appearing in the records of the
Corporation.
15. Payment of Taxes. The Corporation shall pay all taxes and other
governmental charges, other than applicable income taxes and transfer taxes, if
any, which shall be payable by Holder, that may be imposed with respect to the
issuance of shares of Common Stock pursuant to the exercise of this Warrant.
16. Headings. The headings in this Warrant are for purposes of convenience
in reference only, shall not be deemed to constitute a part of this Warrant and
shall not affect the meaning or construction of any of the provisions of this
Warrant.
17. Accredited Investor Status. The Holder represents and warrants to the
Corporation that Holder is an "accredited investor" as that term is defined in
Rule 501 of Regulation D, promulgated under the Securities Act of
1933, as amended.
18. Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the present state of
incorporation of the Company without regard to such state's principles of
conflict of laws.
- 5 -
19. Miscellaneous. This Warrant may not be changed, waived, discharged or
terminated except by an instrument in writing signed by the Corporation and the
Holder. This Warrant shall inure to the benefit of and shall be binding upon the
successors and assigns of the Corporation and the Holder.
PHC, INC., a Massachusetts corporation
By: /s/ Bruce A Shear
Authorized Officer
Printed Name: Bruce A. Shear
Title: President
200 Lake Street -- Suite 102
Peabody, Massachusetts 01960
- 6 -
PHC, Inc.
Form of Transfer
(To be executed by the Holder to transfer the Warrant)
For value received the undersigned registered holder of the attached Warrant
hereby sells, assigns, and transfers the Warrant to the Assignee(s) named below:
Name of
Assignee: ____________________________________________
Address: ____________________________________________
____________________________________________
Assignee's Taxpayer ID No.: _____________________________
Number of shares
subject to transferred Warrant: ____________________________
The undersigned registered holder further irrevocably appoints as its
attorney-in-fact (with full power of substitution) to transfer this Warrant as
aforesaid on the books of the Corporation.
Date: ______________________ ________________________________
Signature
- 7 -
PHC, Inc.
Exercise Form
(To be executed by the Holder to purchase
Common Stock pursuant to the Warrant)
The undersigned holder of the attached Warrant hereby: (1) irrevocably elects to
exercise purchase rights represented by such Warrant for, and to purchase,
______ shares of Common Stock of PHC, Inc., a Massachusetts corporation,
pursuant to the Warrant Certificate and encloses payment of $ _______________
therefor (in cash, by wire, or by certified or bank cashier's check); (2)
requests that a certificate for the shares be issued in the name of the
undersigned; and (3) if such number of shares is not all of the shares
purchasable under this Warrant, that a new Warrant of like tenor for the balance
of the remaining shares purchasable under this Warrant be issued under the terms
and conditions of the Warrant.
Date: _________________________ _________________________________
Signature
- 8 -
Exhibit 10.66
[PHC, INC. LETTERHEAD]
August 11, 1999
Heller Healthcare Finance, Inc.
Two Wisconsin Circle, 4th Floor
Chevy Chase, Maryland 20815
Attention: Michael Gardullo, Vice President
Re: Loan and Security Agreement by and among HELLER HEALTHCARE FINANCE,
INC. f/k/a HCFP FUNDING, INC. ("Leader") and PHC OF MICHIGAN, INC.,
PHC OF UTAH, INC., PHC OF VIRGINIA, INC., PHC OF RHODE ISLAND,
INC., and PIONEER COUNSELING OF VIRGINIA, INC. (collectively,
'Borrower") dated as of February 18, 1998
Dear Mr. Gardullo:
Reference is made to that certain Loan and Security Agreement dated
February 18, 1998 (as it has been or may be amended or restated, the "Loan
Agreement"), by and between Borrower and Lender. All capitalized terms used but
not defined in this Letter Agreement shall have the respective meanings given
them in the Loan Agreement.
Lender and Borrower hereby agree to the following terms regarding an
additional loan in the maximum amount of Three Hundred Twelve Thousand Seven
Hundred Seventy-Eight and No/100 Dollars ($312,778.00) to be made by Lender to
Borrower on the date of this Letter Agreement, in the form of an overline
facility established by this Letter Agreement (the "Overline Loan"):
1. Except as expressly modified by the terms of this Letter Agreement the
Overline Loan will be treated for all purposes as a Revolving Credit Loan under
the Loan Agreement, and all principal, interest, fees and other costs and
expenses relating to The Overline Loan (the "Overline Obligations") shall be
treated as additional Obligations under the Loan Agreement and the other Loan
Documents.
2. The Overline Loan shall continue to bear interest at the Base Rate as
specified in Loan Agreement.
3. Borrower shall make a payment of Fifty Thousand and No/100 Dollars
($50.000.00) on or before August 31, 1999. All remaining Overline Obligations
shall be repaid in full no later than September 27, 1999 (the "Overline Maturity
Date").
h:\WP\Legal\Clients\PHCINC\Overline.wpd
Heller Healthcare Finance, Inc.
August 11, 1999
Page 2
4. Borrower may request that the Overline Maturity Date be extended by
fifteen (15) calendar days. If the extension is granted, which decision
shall be made in the exercise of Lender's sole discretion. and which shall
be subject to the condition set forth in paragraph 7 below. Borrower shall
pay a fee of Five Hundred and No/100 Dollars ($500.00) and an additional Five
Hundred ($500.00) for each (15) day extension. In no event will the Overline
Maturity Date be extended beyond December 31, 1999
5. The failure to repay the Overline Obligations at the Overline
Maturity Date, as it may be extended, shall constitute an immediate Event of
Default under the Loan Agreement. Lender shall be entitled to apply amounts
transferred to the Concentration Account pursuant to Section 2.3 of the Loan
Agreement in satisfaction of the Overline Obligations of Borrower.
6. The Overline Obligations of Borrower under this Letter Agreement
shall be additionally secured by the execution and delivery of an
Unconditional Guaranty of Payment and Performance by Bruce A. Shear, which
Guaranty guarantees the payment of the Overline Obligations.
7. Borrower agrees that Lender shall perform an audit of Borrower's
books and records no later than October 15, 1999, and that no extension of
the Overline Maturity Date shall be made beyond that date unless such audit
has been performed and the results are satisfactory to Lender in the exercise
of its reasonable lending judgment. Borrower acknowledges and agrees that
Lender retains all existing rights to audit and examine Borrower's books and
records as set forth in the Loan Agreement.
8. Concurrently with the execution of this Letter Agreement, Borrower
shall pay to Lender an Overline Fee of Forty-Five Thousand and No/100 Dollars
($45,000.00), which shall be deducted from the funding of the Overline Loan.
9. The Maximum Loan Amount under the Loan Agreement shall be inclusive
of the Overline Loan.
10. Except as specifically modified by this Letter Agreement, the Loan
Agreement, and all other Loan Documents, shall remain in full force and
effect, and are hereby ratified and confirmed.
11. The execution, delivery and effectiveness of this Letter Agreement
shall not, except as expressly provided in this Letter Agreement, operate as
a waiver of any right, power or remedy of Lender, nor constitute a waiver of
any provision of the Loan Agreement, or any other documents, instruments and
agreements executed or delivered in connection with the Loan Agreement.
h:\WP\Legal\Clients\PHCINC\Overline.wpd
Heller Healthcare Finance, Inc.
August 11, 1999
Page 3
12. This Letter Agreement shall be governed by and construed in
accordance with the laws of the State of Maryland.
13. This Letter Agreement may be executed in counterparts, and both
counterparts taken together shall be deemed to constitute one and the same
instrument.
If these conditions are acceptable to Lender, please so signify by
signing below where indicated.
Very truly yours,
PHC, INC. INC.
a Massachusetts corporation
(on behalf of all entities comprising
"Borrower")
By: /s/ Bruce A. Shear
Name: Bruce A. Shear
Title: President
THE FOREGOING IS ACKNOWLEDGED AND AGREED TO AS OF THE DAY OF AUGUST ___,
1999.
HELLER HEALTHCARE FINANCE, INC.
f/k/a HCFP FUNDING, INC.
a Delaware corporation
By: __________________________________
Name:
Title:
h:\WP\Legal\Clients\PHCINC\Overline.wpd
THIS GUARANTY CONTAINS PROVISIONS FOR WAIVER
OF JURY TRIAL
UNCONDITIONAL GUARANTY OF PAYMENT AND PERFORMANCE
THIS UNCONDITIONAL GUARANTY OF PAYMENT AND PERFORMANCE (the "Guaranty")
is dated as of August 11, 1999 and is made by Bruce A. Shear, an individual
"Guarantor"), in favor of HELLER HEALTHCARE FINANCE, INC. f/k/a HCFP
FUNDING, INC., a Delaware corporation ("Lender").
RECITALS
WHEREAS, pursuant to a certain Loan and Security Agreement dated as of
February 18, 1998 (as the agreement may from time to time be amended,
modified or supplemented, the "Loan Agreement"), by and among PHC OF
MICHIGAN, INC., PHC OF UTAH, INC., PHC OF VIRGINIA INC., PHC OF RHODE ISLAND,
INC., and PIONEER COUNSELING OF VIRGINIA, INC. (collectively, "Borrower") and
Lender, the parties entered into certain revolving credit financing
arrangements; and
WHEREAS, Lender has agreed to make available to Borrower an Overline
Loan, in the maximum aggregate principal amount of Three Hundred Twelve
thousand Seven Hundred Seventy-Eight and No/100 Dollars ($312,778.00) (the
"Overline Loan") which shall be treated for all purposes as a Revolving
Credit Loan under the Loan Agreement, and all principal, interest, fees and
other costs and expenses relating to the Overline Loan ("Overline
Obligations") shall be treated as additional Obligations under the Loan
Agreement and the other Loan Documents; and
WHEREAS, Lender is willing to make the Overline Loan but only upon the
condition, among others, that Guarantor shall have executed and delivered to
Lender this Guaranty.
NOW, THEREFOR, in consideration of the premises and of the mutual
covenants contained in this Guaranty and for other good and valuable
consideration, the receipt of which is hereby acknowledged, the parties agree
as follows:
1. All capitalized terms used but not defined in this Guaranty shall
have the respective meanings given them in the Loan Agreement.
2. To induce Lender to execute and deliver the Overline Loan and to
make the Overline Loan upon the terms and conditions set forth therein, and
in consideration thereof, Guarantor hereby unconditionally and irrevocably
guarantees to Lender, and to its successors, endorsees, transferees and
assigns, Borrower's prompt and complete payment when due, whether at the
stated maturity, by acceleration or otherwise, of the Overline Obligations
and Borrower's prompt and complete performance of all of its other covenants,
obligations and agreements prompt and complete performance of all of its
other covenant related to the Overline Loan.
h:\WP\Legal\Clients\PHCINC\Overline.wpd
3. Guarantor hereby waives notice of the acceptance of this
Guaranty and of the extending of credit as above specified and the state of
indebtedness of Borrower at any time, and expressly agrees to any extensions,
renewals, accelerations or modifications of such credit or any of the terms
of such credit, and waives diligence, presentment, demand of payment, protest
or notice, whether of non-payment, dishonor, protest or otherwise, of any
document or documents and notice of any extension, renewal, modification or
default and assent to the release, substitution or variation of any
collateral that may at any time be held as security for any credit extended
to Borrower, all without relieving Guarantor of any liability under this
Guaranty. The obligations of Guarantor under this Guaranty shall be an
unconditional obligation to make prompt payment and performance to Lender
irrespective of the genuineness, validity, regularity or enforceability of
any indebtedness or evidence of indebtedness of Borrower to Lender or of
other circumstances that might otherwise under the laws of any jurisdiction
constitute a legal or equitable discharge of a surety or a guarantor or a bar
(in the nature of a moratorium or otherwise) to the enforcement of Lender's
rights either (i) against Borrower on all or any part of its Overline
Obligations or (ii) under this Guaranty.
4. Notwithstanding any payment or payments made by Guarantor under
this Guaranty or any setoff or application of funds of Guarantor by Lender,
Guarantor shall not be entitled to be subrogated to any of the rights of
Lender against Borrower or any collateral security or guarantee or right of
offset held by Lender for the payment or performance of the Overline
Obligations, nor shall Guarantor seek any reimbursement from Borrower in
respect of payments made by Guarantor under this Guaranty, until all amounts
then owing and any other performance then due to Lender by Borrower for or on
account of the Overline Obligations are paid and satisfied in full. Upon
such payment and satisfaction in full, Guarantor shall be subrogated to all
rights of Lender against Borrower or any collateral security or guarantee or
right of offset held by Lender for the payment and performance of the
Overline Obligations.
5. Any indebtedness of Borrower now or hereafter owed to or held by
Guarantor is hereby subordinated to the indebtedness of Borrower to Lender;
and such indebtedness of Borrower to Guarantor if Lender so requests shall be
collected, enforced and received by Guarantor as trustee for Lender and be
paid over to Lender on account of the indebtedness of Borrower to Lender but
without reducing or affecting in any manner the liability of Guarantor under
the other provisions of this Guaranty.
6. This is intended to be and shall be construed as a continuing
guarantee and shall remain in full force and effect and shall be binding in
accordance with and to the extent of its terms upon Guarantor and Guarantor's
heirs and assigns, and shall inure to the benefit of Lender, and its
successors, endorsers, transferees and assigns
2
h:\WP\Legal\Clients\PHCINC\Overline.wpd
7. If all or any part of the overline Obligations of Borrower to
Lender are not paid when due, and if collections of Accounts under the Loan
Agreement are not sufficient to pay the portion of the Overline Obligations
that are due, Guarantor hereby guarantees that it will pay the same to
Lender, upon demand, without set-off or counterclaim and without reduction by
reason of any taxes, levies, imposts, charges and withholdings, restrictions
or conditions of any nature that are now or may hereafter be imposed, levied
or assessed by any country, political subdivision or taxing authority, all of
which will be for the account of and paid by Guarantor, and Lender need not
first proceed to preserve, utilize or exhaust any other right or remedy
against Borrower or any other guarantor or any security that Lender may have
to obtain payment. The payment shall be made in immediately available funds
to Lender's office at 2 Wisconsin Circle, Fourth Floor, Chevy Chase, Maryland
20815, Attention: Steven M. Curwin, Deputy General Counsel, or at such other
place as Lender may designate in writing.
8. No failure to exercise and no delay in exercising, on the part of
Lender, any right, power or privilege under this Guaranty shall operate as a
waiver of the right, power or privilege, nor shall any single or partial
exercise of any right, power or privilege preclude any other or further
exercise of the right, power or privilege, or the exercise of any other power
or right. The rights and remedies provided in this Guaranty are cumulative
and not exclusive of any rights or remedies provided by law.
9. Notice or demand to the parties to this Guaranty shall be
sufficiently given if in writing and personally delivered, or mailed by
registered or certified first class mail, postage prepaid, return receipt
requested, or sent by commercial courier against receipt, to the party
intended and at the address or addresses specified in the preamble to this
Guaranty. Any party may designate a change of address by notice in writing
to the other parties, the notice to be effective ten (10) days after mailing
or delivery as provided in this Section 9.
10.Guarantor hereby represents, warrants, and covenants to Lender:
(a) Guarantor has the full right, power and authority to enter
into this Guaranty.
(b) The execution, delivery and performance of this Guaranty will
not violate any provision of law or any order of any court or governmental
agency or conflict with, or result in a breach of, or constitute (with or
without notice or lapse of time or both) a default under, or result in the
creation of any security interest, lien, charge or encumbrance upon any
property or assets of Guarantor, pursuant to any agreement, indenture or
other instrument to which it is a party or by which it may be bound.
(c) Except as disclosed to Lender in writing prior to the
execution of this Guaranty, no action, suit, investigation or proceeding is
pending or known to be threatened against or affecting Guarantor that, if
adversely determined, would have a material adverse effect upon its
financial condition.
3
h:\WP\Legal\Clients\PHCINC\Overline.wpd
(d) Guarantor is not in default under any provision of any
indenture relating to borrowed money, any agreement to which it is a party or
by which it is bound, any other indenture, or any order, regulation, ruling
or requirement of a court or public body or authority by which it is bound,
which default would have a material adverse effect on the financial position
of Guarantor.
(e) No license, consent or approval of, or filing with, any
governmental body or other regulatory authority is required for the making
and performance of, or any instrument or transaction contemplated by, this
Guaranty. Guarantor holds all certificates and authorizations of all
governmental agencies and authorities required by law to enable it to engage
in the business currently transacted by it, except those certificates and
authorizations as to which the failure to so hold would not, in the
aggregate, have a material adverse effect on Guarantor.
11. No provision of this Guaranty shall be waived, amended or
supplemented except by a written instrument executed by Lender-
12. The obligations of Guarantor under this Guaranty shall continue in
full force and effect and shall remain in operation until all of the Overline
Obligations shall have been paid in full or otherwise fully satisfied, and
continue to be effective or be reinstated, as the case may be, if at any time
payment or other satisfaction of any of the Overline Obligations is rescinded
or must otherwise be restored or returned upon the bankruptcy, insolvency, or
reorganization of Borrower, or otherwise, as though such payment had not been
made or other satisfaction occurred. No invalidity, irregularity or
unenforceability by reason of applicable bankruptcy laws or any other similar
law, or any law or order of any government or government agency purporting to
reduce, amend or otherwise affect, the Overline Obligations, shall impair,
affect, be a defense to or claim against the obligations of Guarantor under
this Guaranty.
13. In addition to its guarantee of Borrower's payment of the Overline
Obligations and Borrower's performance of all covenants, obligations and
agreements contained in the Loan Documents related to the Overline
Obligations, Guarantor shall pay all actual costs and expenses (including
reasonable attorney's fees) paid or incurred by Lender in connection with the
enforcement of this Guaranty.
14. Guarantor hereby agrees to execute any and all further documents,
agreements, and instruments, and take all further actions, that Lender shall
reasonably request to effectuate or further preserve, evidence, perfect or
protect the rights purported to be created in favor of Lender under this
Guaranty.
15. Guarantor hereby assumes responsibility for keeping itself informed
of the financial condition of Borrower, and any and all endorsers and/or
other guarantors of any instrument or document evidencing all or any part of
the Overline Obligations, and of all other circumstances bearing upon the
risk of nonpayment of the Overline Obligations, or any part of the Overline
Obligations, that diligent inquiry would reveal, and Guarantor hereby agrees
that to advise Guarantor of information known to Lender regarding such Lender
shall have no duty condition or any such circumstances. If Lender, in its
sole discretion, undertakes at any time or from time to time to provide any
such information to Guarantor, Lender shall be under no obligation (i) to
undertake any investigation not a part of its regular business routine, (ii)
to disclose any information that, pursuant to accepted or reasonable
commercial finance practices, Lender wishes to maintain confidential, or
(iii) to make any other or future disclosures of such information or any
other information to Guarantor.
4
h:\WP\Legal\Clients\PHCINC\Overline.wpd
16. This Guaranty may be executed in one or more counterpart copies,
each of which shall be an original and all of which together shall constitute
one and the same instrument, and it is not necessary that all parties'
signatures appear on each counterpart.
17. If any term, covenant or condition of this Guaranty, or the
application of such term, covenant or condition to any party or circumstance,
shall be found by a court of competent jurisdiction to be, to any extent,
invalid or unenforceable, the remainder of this Guaranty and the application
of such terms, covenant, or condition to parties or circumstances other than
those as to which it is held invalid or unenforceable, shall not be affected
thereby, and each term, covenant or condition shall be valid and enforced to
the fullest extent permitted by law. Upon determination that any such term
is invalid, illegal or unenforceable, the parties to this Guaranty shall
amend this Guaranty so as to effect the original intent of the parties as
closely as possible in an acceptable manner.
18. THIS GUARANTY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE
WITH, THE LAWS OF THE STATE OF MARYLAND, WITHOUT REGARD TO ANY OTHERWISE
APPLICABLE PRINCIPLES OF CONFLICTS OF LAWS. IF ANY ACTION ARISING OUT OF
THIS GUARANTY IS COMMENCED BY LENDER IN THE STATE COURTS OF THE STATE OF
MARYLAND OR IN THE U.S. DISTRICT COURT FOR THE DISTRICT OF MARYLAND,
GUARANTOR HEREBY CONSENTS TO THE JURISDICTION OF ANY SUCH COURT IN ANY SUCH
ACTION AND TO THE LAYING OF VENUE IN TIRE STATE OF MARYLAND. ANY PROCESS IN
ANY SUCH ACTION SHALL BE DULY SERVED IF MAILED BY REGISTERED MAIL, POSTAGE
PREPAID, TO GUARANTOR AT ITS ADDRESS SET FORTH IN THE PREAMBLE TO THIS
GUARANTY.
19. GUARANTOR HEREBY (A) COVENANTS AND AGREES NOT TO ELECT A TRIAL BY
JURY OF ANY ISSUE TRIABLE OF RIGHT BY A JURY, AND (B) WAIVES ANY RIGHT TO
TRIAL BY JURY FULLY TO THE EXTENT THAT ANY SUCH RIGHT SHALL NOW OR HEREAFTER
EXIST. THIS WAIVER OF RIGHT TO TRIAL BY JURY IS SEPARATELY GIVEN, KNOWINGLY
AND VOLUNTARILY, BY GUARANTOR, AND THIS WAIVER IS INTENDED TO ENCOMPASS
INDIVIDUALLY EACH INSTANCE AND EACH ISSUE AS TO WHICH THE RIGHT TO A JURY
TRIAL WOULD OTHERWISE ACCRUE. LENDER IS HEREBY AUTHORIZED AND REQUESTED TO
SUBMIT THIS GUARANTY TO ANY COURT HAVING JURISDICTION OVER THE SUBJECT MATTER
AND THE PARTIES HERETO, SO AS TO SERVE AS CONCLUSIVE, EVIDENCE OF GUARANTOR'S
WAIVER OF THE RIGHT TO JURY TRIAL. FURTHER, GUARANTOR HEREBY CERTIFIES THAT
NO REPRESENTATIVE OR AGENT OF LENDER (INCLUDING LENDER'S COUNSEL) HAS
REPRESENTED, EXPRESSLY OR OTHERWISE, TO GUARANTOR THAT LENDER WILL NOT SEEK
TO ENFORCE THIS WAIVER OF RIGHT TO JURY TRIAL PROVISION.
5
h:\WP\Legal\Clients\PHCINC\Overline.wpd
20. GUARANTOR AUTHORIZES ANY ATTORNEY ADMITTED TO PRACTICE BEFORE ANY
COURT OF RECORD IN THE UNITED STATES OR THE CLERK OF SUCH COURT TO APPEAR ON
BEHALF OF GUARANTOR IN ANY COURT IN ONE OR MORE PROCEEDINGS, OR BEFORE ANY
CLERK THEREOF OF PROTHONOTARY OR OTHER COURT OFFICIAL, AND TO CONFESS
JUDGMENT AGAINST GUARANTOR IN FAVOR OF LENDER IN THE FULL AMOUNT DUE ON THIS
GUARANTY (INCLUDING PRINCIPAL, ACCRUED INTEREST AND ANY AND ALL CHARGES, FEES
AND COSTS) PLUS ATTORNEYS' FEES EQUAL TO FIFTEEN PERCENT (15%) OF THE AMOUNT
DUE, PLUS COURT COSTS, ALL WITHOUT PRIOR NOTICE OR OPPORTUNITY OF BORROWER
FOR PRIOR HEARING. GUARANTOR AGREES AND CONSENTS THAT VENUE AND JURISDICTION
SHALL BE PROPER IN THE CIRCUIT COURT OF ANY COUNTY OF THE STATE OF MARYLAND
OR OF BALTIMORE CITY, MARYLAND, OR IN THE UNITED STATES DISTRICT COURT FOR
THE DISTRICT OF MARYLAND. GUARANTOR WAIVES THE BENEFIT OF ANY AND EVERY
STATUTE, ORDINANCE, OR RULE OF COURT WHICH MAY BE LAWFULLY WAIVED CONFERRING
UPON GUARANTOR ANY RIGHT OR PLEDGE OF EXEMPTION, HOMESTEAD RIGHTS, STAY OF
EXECUTION, OR SUPPLEMENTARY PROCEEDINGS, OR OTHER RELIEF FROM THE ENFORCEMENT
OR IMMEDIATE ENFORCEMENT OF A JUDGMENT OR RELATED PROCEEDINGS ON A JUDGMENT.
THE AUTHORITY AND POWER TO APPEAR FOR AND ENTER JUDGMENT AGAINST GUARANTOR
SHALL NOT BE EXHAUSTED BY ONE OR MORE EXERCISES THEREOF, OR BY ANY IMPERFECT
EXERCISE THEREOF, AND SHALL NOT BE EXTINGUISHED BY ANY JUDGMENT ENTERED
PURSUANT THERETO; SUCH AUTHORITY AND POWER MAY BE EXERCISED ON ONE OR MORE
OCCASIONS FROM TIME TO TIME, IN THE SAME OR DIFFERENT JURISDICTIONS, AS OFTEN
AS LENDER SHALL DEEM NECESSARY, CONVENIENT, OR PROPER.
6
h:\WP\Legal\Clients\PHCINC\Overline.wpd
IN WITNESS WHEREOF, Guarantor has caused this Guaranty to be
executed as of the date first written above.
WITNESS: GUARANTOR:
______________________________ /s/ Bruce A. Shear
ACKNOWLEDGMENT AND STIPULATION
The undersigned hereby acknowledges and stipulates that (i) she is the
spouse of Guarantor, (ii) Lender is looking to the property owned by
Guarantor and the property owned jointly by Guarantor and the undersigned to
support the Guaranty, and (iii) all property jointly owned with Guarantor,
whether as tenants-in-common, tenants in the entirety or joint tenants or as
community property, and whether now owned or hereafter acquired (whether
subject to the sole management of Guarantor or the undersigned), is subject
to, and may be used for, the payment and performance of Guarantor's
obligations under the above Guaranty. Notwithstanding the foregoing, Lender
shall have no recourse against the separate property of the undersigned for
satisfaction of any such obligations.
This Acknowledgment and Stipulation is entered into as of August 11,
1999 for the benefit of Lender.
WITNESS:
___________________________________ _________________________________________
Name:
7
h:\WP\Legal\Clients\PHCINC\Overline.wpd
Exhibit 10.67
AMENDMENT NO. 3 TO SECURED BRIDGE NOTE
THIS AMENDMENT NO. 3 TO SECURED BRIDGE NOTE (the "Amendment") is
hereby entered into as of the 10th day of May, 1999 by and among PHC, INC., a
Massachusetts corporation ("Borrower"), and HCFP FUNDING II, INC., a Delaware
corporation ("Lender").
A. Borrower and Lender entered into that certain Secured Bridge Note
(the "Note") dated March 10, 1998 in the principal sum of Three Hundred
Fifty and 00/100 Dollars ($350,000.00), which had an original Maturity Date
of July 10, 1998.
B. Pursuant to Amendment No. 1 to Secured Bridge Note dated as of July
10, 1998, Lender agreed to extend the Maturity Date of the Note until
November 10, 1998.
C. Pursuant to Amendment No. 2 to Secured Bridge Note dated as of
November 10, 1998, Lender agreed to extend the Maturity Date of the Note
until May 10, 1999.
D. Borrower has requested that the Maturity Date of the Note be
extended for an additional two (2) months, which extension of the Maturity
Date is essential to Borrower in continuing to finance its operations.
E. Lender has agreed to extend the Maturity Date upon the terms and
conditions of this Amendment.
NOW, THEREFORE, the parties agree as follows:
1. Capitalized terms used and not otherwise defined in this Amendment
shall have the meanings given them in the Note.
2. Borrower and Lender hereby affirm and agree that the Maturity Date
of the Note is hereby extended to July 10, 1999.
3. This Amendment may be executed in several counterparts, and each
copy so executed shall be deemed an original.
4. Except as expressly stated in this Amendment, the terms,
conditions, and provisions of the Note, as amended by this Amendment, shall
remain in full force and effect and shall not be modified or otherwise
affected by the execution of this Amendment.
H:\WP\LEGAL\CLIENTS\PHCINC\secnote3amend.wpd
IN WITNESS WHEREOF, the parties have executed or caused this Amendment
to be executed by their respective officers thereunto duly authorized as of
the day and year first above written.
LENDER:
HCFP FUNDING II, INC.
a Delaware corporation
By: /s/ Jeffrey P. Hoffman
Title: Vice President
BORROWER:
PHC, INC
a Massachusetts corporation
By: /s/ Bruce A. Shear
Title: President
5. Upon execution of this Letter Agreement, a fee of Ten Thousand and
00/100 Dollars ($10,000) will be charged to the Revolving Loan Balance (the
"Extension Fee"). In addition, during the extension period, the lender will
determine the terms of a proposed Revolving Credit Line. If approved, the
$10,000 Extension Fee will be applied against the Due Diligence, legal costs,
and any fees charged for this new Loan.
H:\WP\LEGAL\CLIENTS\PHCINC\secnote3amend.wpd
2
Exhibit 99.1
CAUTIONARY STATEMENT FOR PURPOSES
OF THE SAFE HARBOR" PROVISIONS OF THE
RIVATE LITIGATION REFORM ACT OF 1995
PHC, Inc. (the "Company") desires to take advantage of the new "safe
harbor" provisions of the Private Securities Litigation Reform Act of 1995 and
is including this Exhibit 99.1 in its Form 10-KSB in order to do so.
The Company wishes to caution readers that the following important factors,
among others, in some cases have affected, and in the future could affect, the
Company's actual results and could cause the Company's actual consolidated
results for the Company's current quarter and beyond, to differ materially from
those expressed in any forward-looking statements made by, or on behalf of, the
Company.
During its last fiscal year and in certain other fiscal years of its
operation, the Company has generated losses and there can be no assurance that
future losses will not occur.
The Company has experienced a significant increase in accounts receivable
in recent years and there can be no assurance that this trend will not continue,
and that if it does, that it will not have a material adverse effect on the
Company's cash flow and financial performance.
The Company historically experiences and expects to continue to experience
a decline in revenue in its fiscal quarters ending December 31 due to a
seasonality decline in revenue from the Company's substance abuse facilities
during such period.
Payment for the company's substance abuse treatment is provided by private
insurance carriers and managed care organizations; payment for long-term and
subacute care is provided by private insurance carriers, managed care
organizations and the Medicare and Medicaid programs; payment for psychiatric
services is provided by private insurance carriers, managed care organizations
and the Medicare and Medicaid programs. In general, revenues derived from the
Medicare and Medicaid programs in connection with the long-term and subacute
care services provided by the Company have been less profitable to the Company
than revenues derived from private insurers and managed care organizations in
connection with the substance abuse treatment provided by the Company and
changes in the sources of the Company's revenues could significantly alter the
Company's profitability.
Additionally, the Company experiences greater delays in the collection of
amounts reimbursable by the Medicare and Medicaid programs than in the
collection of amounts reimbursable by private insurers and managed care
organizations. Accordingly, a change in the Company's service mix from substance
abuse to long-term care could have a materially adverse effect on the Company as
would an increase in the percentage of the Company's patients who are insured by
Medicare or Medicaid.
Cost containment pressures from private insurers in the Medicare and
Medicaid programs may begin to restrict the amount that the Company can charge
for its services.
There can be no assurance that the Company's existing facilities will
continue to meet, or that proposed facilities will meet, the requirements for
reimbursement by third party or government payors.
The Company has substantial receivables from Medicare and Medicaid which
constitute a concentration of credit risk should these agencies defer or be
unable to make reimbursement payments as due.
The Company often experiences significant delays in the collection of
amounts reimbursable by third-party payors. Although the Company believes it
maintains an adequate allowance for doubtful accounts, if the amount of
receivables which eventually becomes uncollectible exceeds such allowance, the
Company could be materially adversely affected.
If a growing number of managed care organizations and insurance companies
adopt policies which limit the length of stay for substance abuse treatment, the
Company's business would be materially adversely affected.
There can be no assurance that occupancy rates at the Company's facilities
will continue at present levels. Similarly, there can be no assurance that the
patient census will not decrease in the future.
There can be no assurance that the Company will be successful in
identifying appropriate acquisition opportunities, or if it does, that the
Company will be successful in acquiring such facilities or that such acquired
facilities will be profitable. The failure of the company to implement its
acquisition strategy could have a materially adverse effect an the Company's
financial performance. Moreover, the inherent risks of expansion could also have
a material adverse effect on the Company's business.
Additionally, the company's acquisition program will be directed by the
President and Chief Executive officer of the Company and the Company does not
intend to seek stockholder approval for any such acquisitions unless required by
applicable law or regulations. Accordingly, investors will be substantially
dependent upon the business judgment of management in making such acquisitions.
Furthermore, the company's acquisition strategy is highly dependent on access to
capital, of which there can be no assurance.
The Company and the healthcare industry in general are subject to extensive
federal, state and local regulation with respect to licensure and conduct of
operations. There can be no assurance that the Company will be able to obtain
new licenses to affect its acquisition strategy or maintain its existing
licenses and reimbursement program participation approvals.
It is not possible to accurately predict the content or impact of future
legislation and regulations affecting the healthcare industry. In addition, both
the Medicare and Medicaid programs are subject to statutory and regulatory
changes and there can be no assurances that payments under those programs to the
Company will, in the future, remain at a level comparable to the present level
or be sufficient to cover the cost allocable to such patients.
Bruce A. Shear the President and Chief Executive officer of the Company
together with his affiliates is able to control all matters requiring approval
of the stockholders, including the election of a majority of the directors, as a
result of his ownership of the Company's stock.
There can be no assurance that the Company will be successful in hiring or
retaining the personnel it requires for continued growth, or that the Company
will be able to continue to attract and retain highly qualified personnel,
particularly skilled healthcare personnel. The healthcare business is highly
competitive and subject to excess capacity.
The Company has entered into relationships with large employers, healthcare
institutions, labor unions and other key clients to provide treatment for
chemical dependency and substance abuse as well as other services and the loss
of any of these key clients would require the Company to expend considerable
effort to replace patient referrals and would result in revenue losses to the
Company and attendant loss in income.
Existing environmental contamination at certain of the Company's facilities
and potential future environmental contamination at facilities acquired by the
company could have a materially adverse effect on the Company's operations.
On October 31, 1994, the Company was served with a summons for a Civil
Action in the Superior Court Department of the Trial Court of the Commonwealth
of Massachusetts by NovaCare, Inc. ("NovaCare"), an entity which contracted with
the Company in 1992 to provide rehabilitation therapy and related administrative
services to the Company's long-term care facility (the "Action"). The complaint
alleged that the Company owed NovaCare contractual damages in the amount of
approximately $587,000, plus interest, attorney fees, costs of collection, and
double or triple damages pursuant to a Massachusetts statute prohibiting unfair
and deceptive trade practices. The Company filed a counterclaim alleging that
NovaCare breached the contract in question and that the Company may be owed
damages in excess of the amount sought by NovaCare.
On February 13, 1996, the company settled the Action by agreeing to pay
NovaCare an amount less than its claim. The Company is not paying NovaCare
accrued interest, attorney's fees, costs of collection, or multiple damages. A
portion of the settlement amount has already been paid. The balance of the
settlement amount is payable over twelve (12) months with interest on the unpaid
balance at 9.5%. In the event that the Company defaults on its obligation to pay
the settlement amount, it has agreed to entry of judgment against it in the
amount of $457, 637.46 (the "Judgment"). The Judgment represents the full unpaid
balance of NovaCare's claim against the Company, including interest, attorney's
fees, and costs of collection. Any amounts paid by the Company to NovaCare after
February 9, 1996 shall be deducted from the Judgment. Until the settlement
amount is paid, NovaCare will continue to hold a mortgage on a day care property
owned by the Company in Saugus, Massachusetts. As of Fiscal Year Ended June 30,
1997, this obligation has been paid in full.
Interruption by fire, earthquakes or other catastrophic events, power
failures, work stoppages, regulatory actions or other causes to any of the
Company's operations could have a materially adverse impact on the Company.
The company has and in the future may enter into transactions in which it
acquires businesses or obtains financing for a consideration that includes the
issuance of stock, warrants, options or convertible debt at a price less than
the value at which the Company's stock may then be trading in the public markets
or which are convertible into or exercisable for Common Stock at a conversion
rate or exercise price less than such value. Such transactions may result in
significant dilution to the existing holders of the Company's stock.
The Company has authorized 1,000,000 shares of Preferred Stock, the terms
of which may be fixed and which may be issued by the Company's Board of
Directors, without stockholder approval. The issuance of the Preferred Stock
could have the effect of making it more difficult for a third party to acquire
the Company and may result in the issuance of stock that dilutes the existing
stockholders and has liquidation, redemption, dividend and other preferences
superior to the Company's outstanding Class A Common Stock.
NOTE:
THIS DOES NOT DISCUSS PREFERRED STOCK, REDEMPTION OF WARRANTS, THE EFFECTS
OF DE-LISTING FROM NASDAQ, PENNY STOCK RULES OR THIN FLOAT. THOSE SUBJECTS ARE,
HOWEVER, INCLUDED IN THE RISK-FACTOR SECTION OF THE 06/97 S-3.